Andrew Berchuck | Scholars@Duke

Andrew Berchuck
James M. Ingram Professor of Gynecologic Oncology

Dr. Andrew Berchuck is Director of the Duke Division of Gynecologic Oncology and holds the James M. Ingram Distinguished Professorship. He is a practicing oncologist who is actively involved in the surgical and chemotherapy management of women with ovarian, endometrial and lower genital tract cancers. This includes minimally invasive laparoscopic surgical approaches. He also has developed a research program that focuses on the molecular-genetic alterations involved in malignant transformation of the ovarian and endometrial epithelium. He has published over 300 peer-reviewed papers in these areas. The objectives of his research include 1) identification of ovarian cancer susceptibility polymorphisms through a population-based case-control molecular epidemiologic study, and 2) use of genomic approaches to elucidate the molecular heterogenetity of ovarian cancer. Thirty fellows and residents have worked in his lab, several of whom are now funded investigators. His research efforts have been recognized nationally and he has received awards for best oral presentation at the annual meetings of both the Society of Gynecologic Oncology and the International Gynecologic Cancer Society. Dr. Berchuck was awarded the Barbara Thomason Ovarian Cancer Research Professorship by the American Cancer Society in 2006. He has served as editor of several books in the field including Principles and Practice of Gynecologic Oncology . Dr. Berchuck also has a major commitment to national activities, and was President of the Society of Gynecologic Oncology in 2008. He served as chair of the scientific advisory committee of the Ovarian Cancer Research Fund (http://www.ocrf.org ) in New York City. Finally, he is also head of the steering committee of the international Ovarian Cancer Association Consortium (OCAC), a group of 50 case-control studies that are working together to identify ovarian cancer susceptibility polymorphisms (www.srl.cam.ac.uk/consortia/ocac/index.html ).

Current Appointments & Affiliations

James M. Ingram Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology, Obstetrics and Gynecology 2013
Professor of Obstetrics and Gynecology, Obstetrics and Gynecology, Gynecologic Oncology, Obstetrics and Gynecology 1997
Chief of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology, Obstetrics and Gynecology 2006
Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 1987

Contact Information

25171 Morris Bldg, Durham, NC 27710
Box 3079 Med Ctr, Durham, NC 27710
berch001@mc.duke.edu (919) 684-3765

Background
Education, Training, & Certifications
- M.D., Case Western Reserve University 1980
Duke Appointment History
- Associate Professor of Obstetrics and Gynecology, Obstetrics and Gynecology, Gynecologic Oncology, Obstetrics and Gynecology 1994 - 1997
- Associate Professor of Obstetrics and Gynecology, Obstetrics and Gynecology, Gynecologic Oncology, Obstetrics and Gynecology 1992 - 1994
Recognition
In the News
- DEC 17, 2015
  
  News Tip: Ovarian Cancer Expert Available to Comment on New Screening Study
- NOV 18, 2014 Duke Research Blog
  
  His Lab Work Makes Organic Chem More than a 'Weed-Out'
Expertise
Subject Headings
Research
Selected Grants
- Mutation analysis of pap smear samples and associated tissues for ovarian cancer diagnostics awarded by Genendeavor LLC 2017 - 2022
- Building Interdisciplinary Research Careers in Women's Health awarded by National Institutes of Health 2002 - 2022
- Translational Research in Surgical Oncology awarded by National Institutes of Health 2002 - 2021
- Immune modulation of CaMKK2 in the ovarian tumor microenvironment awarded by American Association of Obstetricians and Gynecologists Foundation 2019 - 2020
- Kastan Gray Foundation Project awarded by Gray Foundation 2017 - 2019
- Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors awarded by MD Anderson Cancer Center 2016 - 2019
- Janet Burros Ovarian Cancer Repository awarded by Cancer Data Initiative 2018 - 2019
- Triggering human anti-tumor stringent response to target recurrent ovarian cancer awarded by Department of Defense 2017 - 2019
- Tissue and Data Acquisition Activity for the Study of Gynecologic Disease awarded by Henry M. Jackson Foundation 2016 - 2019
- Tissue and Data Acquisition Activity for the Study of Gynecologic Disease awarded by Henry M. Jackson Foundation 2016 - 2017
- Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors awarded by MD Anderson Cancer Center 2015 - 2016
- Clinical Oncology Research Career Development Program awarded by National Institutes of Health 2009 - 2015
- Endometrial Cancer TCGA Project awarded by National Institutes of Health 2010 - 2015
- Epidemiology of Ovarian Cancer in African-American Women awarded by National Institutes of Health 2010 - 2015
- TGCA Purchase Order awarded by Leidos Biomedical Research, Inc. 2014
- Gene Regulation in Recurrent Ovarian Cancers awarded by Gynecologic Cancer Foundation 2011 - 2014
- The Molecular Epidemiology Of Ovarian Cancer awarded by National Institutes of Health 1998 - 2012
- Tissue and Data Acquisition Activity for the Study of Gynecologic Disease awarded by United States Army Medical Research and Materiel Command 2010 - 2011
- Society of Gynecologic Investigation Annual Meeting awarded by National Institutes of Health 2004 - 2009
- Genomics Tests for Ovarian Cancer Detection and Management awarded by Agency for Healthcare Research and Quality 2005 - 2006
- (CGN Supplement): CGN Ovarian Cancer Screening in High Risk Women Pilot 2 awarded by National Institutes of Health 2001 - 2003
- Spore In Breast Cancer awarded by National Institutes of Health 1995 - 1998
- Spore In Breast Cancer awarded by National Institutes of Health 1995 - 1998
- Spore In Breast Cancer awarded by National Institutes of Health 1995 - 1998
- Molecular Epidemiolgy Of Epithelial Ovarian Cancer awarded by National Institutes of Health 1994 - 1997
- Growth Regulation & Transformation Of Ovarian Cancer Epith awarded by National Institutes of Health 1994 - 1997
- Growth Regulation And Transformation Of Ovarian Epithelium awarded by National Institutes of Health 1992 - 1997
- Molecular Epidemiology Of Epithelial Ovarian Cancer awarded by National Institutes of Health 1994 - 1996
- Hyperthermia And Perfusion Effects In Cancer Therapy awarded by National Institutes of Health 1993 - 1995
Publications & Artistic Works
Selected Publications
- Books
  - Barakat, RR, Berchuck, A, Markman, M, and Randall, ME. Principles and practice of gynecologic oncology: Sixth edition. May 8, 2013.
  - Luesley, DM, Lawton, FG, and Berchuck, A. Preface. January 1, 2005.
  - Luesley, DM, Lawton, FG, and Berchuck, A. Uterine cancer. January 1, 2005.
- Academic Articles
  - Kim, S, Wang, M, Tyrer, JP, Jensen, A, Wiensch, A, Liu, G, Lee, AW, Ness, RB, Salvatore, M, Tworoger, SS, Whittemore, AS, Anton-Culver, H, Sieh, W, Olson, SH, Berchuck, A, Goode, EL, Goodman, MT, Doherty, JA, Chenevix-Trench, G, Rossing, MA, Webb, PM, Giles, GG, Terry, KL, Ziogas, A, Fortner, RT, Menon, U, Gayther, SA, Wu, AH, Song, H, Brooks-Wilson, A, Bandera, EV, Cook, LS, Cramer, DW, Milne, RL, Winham, SJ, Kjaer, SK, Modugno, F, Thompson, PJ, Chang-Claude, J, Harris, HR, Schildkraut, JM, Le, ND, Wentzensen, N, Trabert, B, Høgdall, E, Huntsman, D, Pike, MC, Pharoah, PDP, Pearce, CL, and Mukherjee, B. "A comprehensive gene-environment interaction analysis in Ovarian Cancer using genome-wide significant common variants.(Accepted)" International Journal of Cancer 144, no. 9 (May 2019): 2192-2205. Full Text
  - Yang, Y, Wu, L, Shu, X, Lu, Y, Shu, X-O, Cai, Q, Beeghly-Fadiel, A, Li, B, Ye, F, Berchuck, A, Anton-Culver, H, Banerjee, S, Benitez, J, Bjørge, L, Brenton, JD, Butzow, R, Campbell, IG, Chang-Claude, J, Chen, K, Cook, LS, Cramer, DW, deFazio, A, Dennis, J, Doherty, JA, Dörk, T, Eccles, DM, Edwards, DV, Fasching, PA, Fortner, RT, Gayther, SA, Giles, GG, Glasspool, RM, Goode, EL, Goodman, MT, Gronwald, J, Harris, HR, Heitz, F, Hildebrandt, MA, Høgdall, E, Høgdall, CK, Huntsman, DG, Kar, SP, Karlan, BY, Kelemen, LE, Kiemeney, LA, Kjaer, SK, Koushik, A, Lambrechts, D, Le, ND, Levine, DA, Massuger, LF, Matsuo, K, May, T, McNeish, IA, Menon, U, Modugno, F, Monteiro, AN, Moorman, PG, Moysich, KB, Ness, RB, Nevanlinna, H, Olsson, H, Onland-Moret, NC, Park, SK, Paul, J, Pearce, CL, Pejovic, T, Phelan, CM, Pike, MC, Ramus, SJ, Riboli, E, Rodriguez-Antona, C, Romieu, I, Sandler, DP, Schildkraut, JM, Setiawan, VW, Shan, K, Siddiqui, N, Sieh, W, Stampfer, MJ, Sutphen, R, Swerdlow, AJ, Szafron, LM, Teo, SH, Tworoger, SS, Tyrer, JP, Webb, PM, Wentzensen, N, White, E, Willett, WC, Wolk, A, Woo, YL, Wu, AH, Yan, L, Yannoukakos, D, Chenevix-Trench, G, Sellers, TA, Pharoah, PDP, Zheng, W, and Long, J. "Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk." Cancer Research 79, no. 3 (February 2019): 505-517. Full Text
  - Jiang, X, Finucane, HK, Schumacher, FR, Schmit, SL, Tyrer, JP, Han, Y, Michailidou, K, Lesseur, C, Kuchenbaecker, KB, Dennis, J, Conti, DV, Casey, G, Gaudet, MM, Huyghe, JR, Albanes, D, Aldrich, MC, Andrew, AS, Andrulis, IL, Anton-Culver, H, Antoniou, AC, Antonenkova, NN, Arnold, SM, Aronson, KJ, Arun, BK, Bandera, EV, Barkardottir, RB, Barnes, DR, Batra, J, Beckmann, MW, Benitez, J, Benlloch, S, Berchuck, A, Berndt, SI, Bickeböller, H, Bien, SA, Blomqvist, C, Boccia, S, Bogdanova, NV, Bojesen, SE, Bolla, MK, Brauch, H, Brenner, H, Brenton, JD, Brook, MN, Brunet, J, Brunnström, H, Buchanan, DD, Burwinkel, B, Butzow, R, Cadoni, G, Caldés, T, Caligo, MA, Campbell, I, Campbell, PT, Cancel-Tassin, G, Cannon-Albright, L, Campa, D, Caporaso, N, Carvalho, AL, Chan, AT, Chang-Claude, J, Chanock, SJ, Chen, C, Christiani, DC, Claes, KBM, Claessens, F, Clements, J, Collée, JM, Correa, MC, Couch, FJ, Cox, A, Cunningham, JM, Cybulski, C, Czene, K, Daly, MB, deFazio, A, Devilee, P, Diez, O, Gago-Dominguez, M, Donovan, JL, Dörk, T, Duell, EJ, Dunning, AM, Dwek, M, Eccles, DM, Edlund, CK, Edwards, DRV, Ellberg, C, Evans, DG, Fasching, PA, Ferris, RL, Liloglou, T, Figueiredo, JC, Fletcher, O, Fortner, RT, Fostira, F, Franceschi, S, Friedman, E, Gallinger, SJ, Ganz, PA, Garber, J, García-Sáenz, JA, Gayther, SA, Giles, GG, Godwin, AK, Goldberg, MS, Goldgar, DE, Goode, EL, Goodman, MT, Goodman, G, Grankvist, K, Greene, MH, Gronberg, H, Gronwald, J, Guénel, P, Håkansson, N, Hall, P, Hamann, U, Hamdy, FC, Hamilton, RJ, Hampe, J, Haugen, A, Heitz, F, Herrero, R, Hillemanns, P, Hoffmeister, M, Høgdall, E, Hong, Y-C, Hopper, JL, Houlston, R, Hulick, PJ, Hunter, DJ, Huntsman, DG, Idos, G, Imyanitov, EN, Ingles, SA, Isaacs, C, Jakubowska, A, James, P, Jenkins, MA, Johansson, M, Johansson, M, John, EM, Joshi, AD, Kaneva, R, Karlan, BY, Kelemen, LE, Kühl, T, Khaw, K-T, Khusnutdinova, E, Kibel, AS, Kiemeney, LA, Kim, J, Kjaer, SK, Knight, JA, Kogevinas, M, Kote-Jarai, Z, Koutros, S, Kristensen, VN, Kupryjanczyk, J, Lacko, M, Lam, S, Lambrechts, D, Landi, MT, Lazarus, P, Le, ND, Lee, E, Lejbkowicz, F, Lenz, H-J, Leslie, G, Lessel, D, Lester, J, Levine, DA, Li, L, Li, CI, Lindblom, A, Lindor, NM, Liu, G, Loupakis, F, Lubiński, J, Maehle, L, Maier, C, Mannermaa, A, Marchand, LL, Margolin, S, May, T, McGuffog, L, Meindl, A, Middha, P, Miller, A, Milne, RL, MacInnis, RJ, Modugno, F, Montagna, M, Moreno, V, Moysich, KB, Mucci, L, Muir, K, Mulligan, AM, Nathanson, KL, Neal, DE, Ness, AR, Neuhausen, SL, Nevanlinna, H, Newcomb, PA, Newcomb, LF, Nielsen, FC, Nikitina-Zake, L, Nordestgaard, BG, Nussbaum, RL, Offit, K, Olah, E, Olama, AAA, Olopade, OI, Olshan, AF, Olsson, H, Osorio, A, Pandha, H, Park, JY, Pashayan, N, Parsons, MT, Pejovic, T, Penney, KL, Peters, WHM, Phelan, CM, Phipps, AI, Plaseska-Karanfilska, D, Pring, M, Prokofyeva, D, Radice, P, Stefansson, K, Ramus, SJ, Raskin, L, Rennert, G, Rennert, HS, van Rensburg, EJ, Riggan, MJ, Risch, HA, Risch, A, Roobol, MJ, Rosenstein, BS, Rossing, MA, De Ruyck, K, Saloustros, E, Sandler, DP, Sawyer, EJ, Schabath, MB, Schleutker, J, Schmidt, MK, Setiawan, VW, Shen, H, Siegel, EM, Sieh, W, Singer, CF, Slattery, ML, Sorensen, KD, Southey, MC, Spurdle, AB, Stanford, JL, Stevens, VL, Stintzing, S, Stone, J, Sundfeldt, K, Sutphen, R, Swerdlow, AJ, Tajara, EH, Tangen, CM, Tardon, A, Taylor, JA, Teare, MD, Teixeira, MR, Terry, MB, Terry, KL, Thibodeau, SN, Thomassen, M, Bjørge, L, Tischkowitz, M, Toland, AE, Torres, D, Townsend, PA, Travis, RC, Tung, N, Tworoger, SS, Ulrich, CM, Usmani, N, Vachon, CM, Van Nieuwenhuysen, E, Vega, A, Aguado-Barrera, ME, Wang, Q, Webb, PM, Weinberg, CR, Weinstein, S, Weissler, MC, Weitzel, JN, West, CML, White, E, Whittemore, AS, Wichmann, H-E, Wiklund, F, Winqvist, R, Wolk, A, Woll, P, Woods, M, Wu, AH, Wu, X, Yannoukakos, D, Zheng, W, Zienolddiny, S, Ziogas, A, Zorn, KK, Lane, JM, Saxena, R, Thomas, D, Hung, RJ, Diergaarde, B, McKay, J, Peters, U, Hsu, L, García-Closas, M, Eeles, RA, Chenevix-Trench, G, Brennan, PJ, Haiman, CA, Simard, J, Easton, DF, Gruber, SB, Pharoah, PDP, Price, AL, Pasaniuc, B, Amos, CI, Kraft, P, and Lindström, S. "Shared heritability and functional enrichment across six solid cancers." Nature Communications 10, no. 1 (January 25, 2019): 431-null. Full Text
  - Peres, LC, Cushing-Haugen, KL, Köbel, M, Harris, HR, Berchuck, A, Rossing, MA, Schildkraut, JM, and Doherty, JA. "Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage." Journal of the National Cancer Institute 111, no. 1 (January 2019): 60-68. Full Text
  - Korkut, A, Zaidi, S, Kanchi, RS, Rao, S, Gough, NR, Schultz, A, Li, X, Lorenzi, PL, Berger, AC, Robertson, G, Kwong, LN, Datto, M, Roszik, J, Ling, S, Ravikumar, V, Manyam, G, Rao, A, Shelley, S, Liu, Y, Ju, Z, Hansel, D, de Velasco, G, Pennathur, A, Andersen, JB, O'Rourke, CJ, Ohshiro, K, Jogunoori, W, Nguyen, B-N, Li, S, Osmanbeyoglu, HU, Ajani, JA, Mani, SA, Houseman, A, Wiznerowicz, M, Chen, J, Gu, S, Ma, W, Zhang, J, Tong, P, Cherniack, AD, Deng, C, Resar, L, Cancer Genome Atlas Research Network, , Weinstein, JN, Mishra, L, and Akbani, R. "A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily." Cell Systems 7, no. 4 (October 2018): 422-437.e7. Full Text
  - Peres, LC, Cushing-Haugen, KL, Anglesio, M, Wicklund, K, Bentley, R, Berchuck, A, Kelemen, LE, Nazeran, TM, Gilks, CB, Harris, HR, Huntsman, DG, Schildkraut, JM, Rossing, MA, Köbel, M, and Doherty, JA. "Histotype classification of ovarian carcinoma: A comparison of approaches." Gynecologic Oncology 151, no. 1 (October 2018): 53-60. Full Text
  - Rambau, PF, Vierkant, RA, Intermaggio, MP, Kelemen, LE, Goodman, MT, Herpel, E, Pharoah, PD, Kommoss, S, Jimenez-Linan, M, Karlan, BY, Gentry-Maharaj, A, Menon, U, Polo, SH, Candido Dos Reis, FJ, Doherty, JA, Gayther, SA, Sharma, R, Larson, MC, Harnett, PR, Hatfield, E, de Andrade, JM, Nelson, GS, Steed, H, Schildkraut, JM, Carney, ME, Høgdall, E, Whittemore, AS, Widschwendter, M, Kennedy, CJ, Wang, F, Wang, Q, Wang, C, Armasu, SM, Daley, F, Coulson, P, Jones, ME, Anglesio, MS, Chow, C, de Fazio, A, García-Closas, M, Brucker, SY, Cybulski, C, Harris, HR, Hartkopf, AD, Huzarski, T, Jensen, A, Lubiński, J, Oszurek, O, Benitez, J, Mina, F, Staebler, A, Taran, FA, Pasternak, J, Talhouk, A, Rossing, MA, Hendley, J, AOCS Group, , Edwards, RP, Fereday, S, Modugno, F, Ness, RB, Sieh, W, El-Bahrawy, MA, Winham, SJ, Lester, J, Kjaer, SK, Gronwald, J, Sinn, P, Fasching, PA, Chang-Claude, J, Moysich, KB, Bowtell, DD, Hernandez, BY, Luk, H, Behrens, S, Shah, M, Jung, A, Ghatage, P, Alsop, J, Alsop, K, García-Donas, J, Thompson, PJ, Swerdlow, AJ, Karpinskyj, C, Cazorla-Jiménez, A, García, MJ, Deen, S, Wilkens, LR, Palacios, J, Berchuck, A, Koziak, JM, Brenton, JD, Cook, LS, Goode, EL, Huntsman, DG, Ramus, SJ, and Köbel, M. "Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study." The Journal of Pathology. Clinical Research 4, no. 4 (October 2018): 250-261. Full Text
  - Wang, Y, Xu, X, Maglic, D, Dill, MT, Mojumdar, K, Ng, PK-S, Jeong, KJ, Tsang, YH, Moreno, D, Bhavana, VH, Peng, X, Ge, Z, Chen, H, Li, J, Chen, Z, Zhang, H, Han, L, Du, D, Creighton, CJ, Mills, GB, Cancer Genome Atlas Research Network, , Camargo, F, and Liang, H. "Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer." Cell Reports 25, no. 5 (October 2018): 1304-1317.e5. Full Text
  - Lu, Y, Beeghly-Fadiel, A, Wu, L, Guo, X, Li, B, Schildkraut, JM, Im, HK, Chen, YA, Permuth, JB, Reid, BM, Teer, JK, Moysich, KB, Andrulis, IL, Anton-Culver, H, Arun, BK, Bandera, EV, Barkardottir, RB, Barnes, DR, Benitez, J, Bjorge, L, Brenton, J, Butzow, R, Caldes, T, Caligo, MA, Campbell, I, Chang-Claude, J, Claes, KBM, Couch, FJ, Cramer, DW, Daly, MB, deFazio, A, Dennis, J, Diez, O, Domchek, SM, Dörk, T, Easton, DF, Eccles, DM, Fasching, PA, Fortner, RT, Fountzilas, G, Friedman, E, Ganz, PA, Garber, J, Giles, GG, Godwin, AK, Goldgar, DE, Goodman, MT, Greene, MH, Gronwald, J, Hamann, U, Heitz, F, Hildebrandt, MAT, Høgdall, CK, Hollestelle, A, Hulick, PJ, Huntsman, DG, Imyanitov, EN, Isaacs, C, Jakubowska, A, James, P, Karlan, BY, Kelemen, LE, Kiemeney, LA, Kjaer, SK, Kwong, A, Le, ND, Leslie, G, Lesueur, F, Levine, DA, Mattiello, A, May, T, McGuffog, L, McNeish, IA, Merritt, MA, Modugno, F, Montagna, M, Neuhausen, SL, Nevanlinna, H, Nielsen, FC, Nikitina-Zake, L, Nussbaum, RL, Offit, K, Olah, E, Olopade, OI, Olson, SH, Olsson, H, Osorio, A, Park, SK, Parsons, MT, Peeters, PHM, Pejovic, T, Peterlongo, P, Phelan, CM, Pujana, MA, Ramus, SJ, Rennert, G, Risch, H, Rodriguez, GC, Rodríguez-Antona, C, Romieu, I, Rookus, MA, Rossing, MA, Rzepecka, IK, Sandler, DP, Schmutzler, RK, Setiawan, VW, Sharma, P, Sieh, W, Simard, J, Singer, CF, Song, H, Southey, MC, Spurdle, AB, Sutphen, R, Swerdlow, AJ, Teixeira, MR, Teo, SH, Thomassen, M, Tischkowitz, M, Toland, AE, Trichopoulou, A, Tung, N, Tworoger, SS, van Rensburg, EJ, Vanderstichele, A, Vega, A, Edwards, DV, Webb, PM, Weitzel, JN, Wentzensen, N, White, E, Wolk, A, Wu, AH, Yannoukakos, D, Zorn, KK, Gayther, SA, Antoniou, AC, Berchuck, A, Goode, EL, Chenevix-Trench, G, Sellers, TA, Pharoah, PDP, Zheng, W, and Long, J. "A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk." Cancer Research 78, no. 18 (September 2018): 5419-5430. Full Text
  - Kelemen, LE, Earp, M, Fridley, BL, Chenevix-Trench, G, Australian Ovarian Cancer Study Group, , Fasching, PA, Beckmann, MW, Ekici, AB, Hein, A, Lambrechts, D, Lambrechts, S, Van Nieuwenhuysen, E, Vergote, I, Rossing, MA, Doherty, JA, Chang-Claude, J, Behrens, S, Moysich, KB, Cannioto, R, Lele, S, Odunsi, K, Goodman, MT, Shvetsov, YB, Thompson, PJ, Wilkens, LR, Dörk, T, Antonenkova, N, Bogdanova, N, Hillemanns, P, Runnebaum, IB, du Bois, A, Harter, P, Heitz, F, Schwaab, I, Butzow, R, Pelttari, LM, Nevanlinna, H, Modugno, F, Edwards, RP, Kelley, JL, Ness, RB, Karlan, BY, Lester, J, Orsulic, S, Walsh, C, Kjaer, SK, Jensen, A, Cunningham, JM, Vierkant, RA, Giles, GG, Bruinsma, F, Southey, MC, Hildebrandt, MAT, Liang, D, Lu, K, Wu, X, Sellers, TA, Levine, DA, Schildkraut, JM, Iversen, ES, Terry, KL, Cramer, DW, Tworoger, SS, Poole, EM, Bandera, EV, Olson, SH, Orlow, I, Vestrheim Thomsen, LC, Bjorge, L, Krakstad, C, Tangen, IL, Kiemeney, LA, Aben, KKH, Massuger, LFAG, van Altena, AM, Pejovic, T, Bean, Y, Kellar, M, Cook, LS, Le, ND, Brooks-Wilson, A, Gronwald, J, Cybulski, C, Jakubowska, A, Lubiński, J, Wentzensen, N, Brinton, LA, Lissowska, J, Hogdall, E, Engelholm, SA, Hogdall, C, Lundvall, L, Nedergaard, L, Pharoah, PDP, Dicks, E, Song, H, Tyrer, JP, McNeish, I, Siddiqui, N, Carty, K, Glasspool, R, Paul, J, Campbell, IG, Eccles, D, Whittemore, AS, McGuire, V, Rothstein, JH, Sieh, W, Narod, SA, Phelan, CM, McLaughlin, JR, Risch, HA, Anton-Culver, H, Ziogas, A, Menon, U, Gayther, SA, Gentry-Maharaj, A, Ramus, SJ, Wu, AH, Pearce, CL, Lee, AW, Pike, MC, Kupryjanczyk, J, Podgorska, A, Plisiecka-Halasa, J, Sawicki, W, Goode, EL, Berchuck, A, and Ovarian Cancer Association Consortium, . "rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology." International Journal of Molecular Sciences 19, no. 9 (August 21, 2018). Full Text
  - Kahles, A, Lehmann, KV, Toussaint, NC, Hüser, M, Stark, SG, Sachsenberg, T, Stegle, O, Kohlbacher, O, Sander, C, Caesar-Johnson, SJ, Demchok, JA, Felau, I, Kasapi, M, Ferguson, ML, Hutter, CM, Sofia, HJ, Tarnuzzer, R, Wang, Z, Yang, L, Zenklusen, JC, Zhang, J, Chudamani, S, Liu, J, Lolla, L, Naresh, R, Pihl, T, Sun, Q, Wan, Y, Wu, Y, Cho, J, DeFreitas, T, Frazer, S, Gehlenborg, N, Getz, G, Heiman, DI, Kim, J, Lawrence, MS, Lin, P, Meier, S, Noble, MS, Saksena, G, Voet, D, Zhang, H, Bernard, B, Chambwe, N, Dhankani, V, Knijnenburg, T, Kramer, R, Leinonen, K, Liu, Y, Miller, M, Reynolds, S, Shmulevich, I, Thorsson, V, Zhang, W, Akbani, R, Broom, BM, Hegde, AM, Ju, Z, Kanchi, RS, Korkut, A, Li, J, Liang, H, Ling, S, Liu, W, Lu, Y, Mills, GB, Ng, KS, Rao, A, Ryan, M, Wang, J, Weinstein, JN, Abeshouse, A, Armenia, J, Chakravarty, D, Chatila, WK, de Bruijn, I, Gao, J, Gross, BE, Heins, ZJ, Kundra, R, and La, K. "Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients." Cancer Cell 34, no. 2 (August 13, 2018): 211-224.e6. Full Text
  - Bailey, MH, Tokheim, C, Porta-Pardo, E, Sengupta, S, Bertrand, D, Weerasinghe, A, Colaprico, A, Wendl, MC, Kim, J, Reardon, B, Kwok-Shing Ng, P, Jeong, KJ, Cao, S, Wang, Z, Gao, J, Gao, Q, Wang, F, Liu, EM, Mularoni, L, Rubio-Perez, C, Nagarajan, N, Cortés-Ciriano, I, Zhou, DC, Liang, W-W, Hess, JM, Yellapantula, VD, Tamborero, D, Gonzalez-Perez, A, Suphavilai, C, Ko, JY, Khurana, E, Park, PJ, Van Allen, EM, Liang, H, MC3 Working Group, , Cancer Genome Atlas Research Network, , Lawrence, MS, Godzik, A, Lopez-Bigas, N, Stuart, J, Wheeler, D, Getz, G, Chen, K, Lazar, AJ, Mills, GB, Karchin, R, and Ding, L. "Comprehensive Characterization of Cancer Driver Genes and Mutations." Cell 174, no. 4 (August 2018): 1034-1035. Full Text
  - Chenevix-Trench, G, Beesley, J, Pharoah, PDP, and Berchuck, A. "The importance of using public data to validate reported associations." Plos Genetics 14, no. 6 (June 29, 2018): e1007416-null. Full Text
  - Ricketts, CJ, De Cubas, AA, Fan, H, Smith, CC, Lang, M, Reznik, E, Bowlby, R, Gibb, EA, Akbani, R, Beroukhim, R, Bottaro, DP, Choueiri, TK, Gibbs, RA, Godwin, AK, Haake, S, Hakimi, AA, Henske, EP, Hsieh, JJ, Ho, TH, Kanchi, RS, Krishnan, B, Kwiatkowski, DJ, Lui, W, Merino, MJ, Mills, GB, Myers, J, Nickerson, ML, Reuter, VE, Schmidt, LS, Shelley, CS, Shen, H, Shuch, B, Signoretti, S, Srinivasan, R, Tamboli, P, Thomas, G, Vincent, BG, Vocke, CD, Wheeler, DA, Yang, L, Kim, WY, Robertson, AG, Caesar-Johnson, SJ, Demchok, JA, Felau, I, Kasapi, M, Ferguson, ML, Hutter, CM, Sofia, HJ, Tarnuzzer, R, Wang, Z, Zenklusen, JC, Zhang, J, Chudamani, S, Liu, J, Lolla, L, Naresh, R, Pihl, T, Sun, Q, Wan, Y, Wu, Y, Cho, J, DeFreitas, T, Frazer, S, Gehlenborg, N, Getz, G, Heiman, DI, Kim, J, Lawrence, MS, Lin, P, Meier, S, Noble, MS, Saksena, G, Voet, D, Zhang, H, Bernard, B, Chambwe, N, Dhankani, V, and Knijnenburg, T. "Erratum: The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (Cell Reports (2018) 23(1) (313–326.e5) (S2211124718304364) (10.1016/j.celrep.2018.03.075))." Cell Reports 23, no. 12 (June 19, 2018): 3698-null. Full Text
  - Davidson, BA, Ehrisman, J, Abbott, S, Harmon, Z, Secord, AA, Berchuck, A, Lee, PS, Valea, FA, Li, X, Havrilesky, LJ, and Hall, AHS. "Prospective Evaluation of Lymph Node Processing at Staging Surgery for High-grade Endometrial Cancer." International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists 37, no. 3 (May 2018): 252-255. Full Text
  - Wang, Z, Yang, B, Zhang, M, Guo, W, Wu, Z, Wang, Y, Jia, L, Li, S, Cancer Genome Atlas Research Network, , Xie, W, and Yang, D. "lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer." Cancer Cell 33, no. 4 (April 2, 2018): 706-720.e9. Full Text
  - Campbell, JD, Yau, C, Bowlby, R, Liu, Y, Brennan, K, Fan, H, Taylor, AM, Wang, C, Walter, V, Akbani, R, Byers, LA, Creighton, CJ, Coarfa, C, Shih, J, Cherniack, AD, Gevaert, O, Prunello, M, Shen, H, Anur, P, Chen, J, Cheng, H, Hayes, DN, Bullman, S, Pedamallu, CS, Ojesina, AI, Sadeghi, S, Mungall, KL, Robertson, AG, Benz, C, Schultz, A, Kanchi, RS, Gay, CM, Hegde, A, Diao, L, Wang, J, Ma, W, Sumazin, P, Chiu, H-S, Chen, T-W, Gunaratne, P, Donehower, L, Rader, JS, Zuna, R, Al-Ahmadie, H, Lazar, AJ, Flores, ER, Tsai, KY, Zhou, JH, Rustgi, AK, Drill, E, Shen, R, Wong, CK, Cancer Genome Atlas Research Network, , Stuart, JM, Laird, PW, Hoadley, KA, Weinstein, JN, Peto, M, Pickering, CR, Chen, Z, and Van Waes, C. "Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas." Cell Reports 23, no. 1 (April 2018): 194-212.e6. Full Text
  - Chen, H, Li, C, Peng, X, Zhou, Z, Weinstein, JN, Cancer Genome Atlas Research Network, , and Liang, H. "A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples." Cell 173, no. 2 (April 2018): 386-399.e12. Full Text
  - Chiu, H-S, Somvanshi, S, Patel, E, Chen, T-W, Singh, VP, Zorman, B, Patil, SL, Pan, Y, Chatterjee, SS, Cancer Genome Atlas Research Network, , Sood, AK, Gunaratne, PH, and Sumazin, P. "Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context." Cell Reports 23, no. 1 (April 2018): 297-312.e12. Full Text
  - Ding, L, Bailey, MH, Porta-Pardo, E, Thorsson, V, Colaprico, A, Bertrand, D, Gibbs, DL, Weerasinghe, A, Huang, K-L, Tokheim, C, Cortés-Ciriano, I, Jayasinghe, R, Chen, F, Yu, L, Sun, S, Olsen, C, Kim, J, Taylor, AM, Cherniack, AD, Akbani, R, Suphavilai, C, Nagarajan, N, Stuart, JM, Mills, GB, Wyczalkowski, MA, Vincent, BG, Hutter, CM, Zenklusen, JC, Hoadley, KA, Wendl, MC, Shmulevich, L, Lazar, AJ, Wheeler, DA, Getz, G, and Cancer Genome Atlas Research Network, . "Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics." Cell 173, no. 2 (April 2018): 305-320.e10. Full Text
  - Dixon-Suen, SC, Nagle, CM, Thrift, AP, Pharoah, PDP, Ewing, A, Pearce, CL, Zheng, W, Australian Ovarian Cancer Study Group, , Chenevix-Trench, G, Fasching, PA, Beckmann, MW, Lambrechts, D, Vergote, I, Lambrechts, S, Van Nieuwenhuysen, E, Rossing, MA, Doherty, JA, Wicklund, KG, Chang-Claude, J, Jung, AY, Moysich, KB, Odunsi, K, Goodman, MT, Wilkens, LR, Thompson, PJ, Shvetsov, YB, Dörk, T, Park-Simon, T-W, Hillemanns, P, Bogdanova, N, Butzow, R, Nevanlinna, H, Pelttari, LM, Leminen, A, Modugno, F, Ness, RB, Edwards, RP, Kelley, JL, Heitz, F, du Bois, A, Harter, P, Schwaab, I, Karlan, BY, Lester, J, Orsulic, S, Rimel, BJ, Kjær, SK, Høgdall, E, Jensen, A, Goode, EL, Fridley, BL, Cunningham, JM, Winham, SJ, Giles, GG, Bruinsma, F, Milne, RL, Southey, MC, Hildebrandt, MAT, Wu, X, Lu, KH, Liang, D, Levine, DA, Bisogna, M, Schildkraut, JM, Berchuck, A, Cramer, DW, Terry, KL, Bandera, EV, Olson, SH, Salvesen, HB, Thomsen, LCV, Kopperud, RK, Bjorge, L, Kiemeney, LA, Massuger, LFAG, Pejovic, T, Bruegl, A, Cook, LS, Le, ND, Swenerton, KD, Brooks-Wilson, A, Kelemen, LE, Lubiński, J, Huzarski, T, Gronwald, J, Menkiszak, J, Wentzensen, N, Brinton, L, Yang, H, Lissowska, J, Høgdall, CK, Lundvall, L, Song, H, Tyrer, JP, Campbell, I, Eccles, D, Paul, J, Glasspool, R, Siddiqui, N, Whittemore, AS, Sieh, W, McGuire, V, Rothstein, JH, Narod, SA, Phelan, C, Risch, HA, McLaughlin, JR, Anton-Culver, H, Ziogas, A, Menon, U, Gayther, SA, Ramus, SJ, Gentry-Maharaj, A, Wu, AH, Pike, MC, Tseng, C-C, Kupryjanczyk, J, Dansonka-Mieszkowska, A, Budzilowska, A, Rzepecka, IK, Webb, PM, and Ovarian Cancer Association Consortium, . "Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study." British Journal of Cancer 118, no. 8 (April 2018): 1123-1129. Full Text
  - Gao, Q, Liang, W-W, Foltz, SM, Mutharasu, G, Jayasinghe, RG, Cao, S, Liao, W-W, Reynolds, SM, Wyczalkowski, MA, Yao, L, Yu, L, Sun, SQ, Fusion Analysis Working Group, , Cancer Genome Atlas Research Network, , Chen, K, Lazar, AJ, Fields, RC, Wendl, MC, Van Tine, BA, Vij, R, Chen, F, Nykter, M, Shmulevich, I, and Ding, L. "Driver Fusions and Their Implications in the Development and Treatment of Human Cancers." Cell Reports 23, no. 1 (April 2018): 227-238.e3. Full Text
  - Hoadley, KA, Yau, C, Hinoue, T, Wolf, DM, Lazar, AJ, Drill, E, Shen, R, Taylor, AM, Cherniack, AD, Thorsson, V, Akbani, R, Bowlby, R, Wong, CK, Wiznerowicz, M, Sanchez-Vega, F, Robertson, AG, Schneider, BG, Lawrence, MS, Noushmehr, H, Malta, TM, Cancer Genome Atlas Network, , Stuart, JM, Benz, CC, and Laird, PW. "Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer." Cell 173, no. 2 (April 2018): 291-304.e6. Full Text
  - Huang, K-L, Mashl, RJ, Wu, Y, Ritter, DI, Wang, J, Oh, C, Paczkowska, M, Reynolds, S, Wyczalkowski, MA, Oak, N, Scott, AD, Krassowski, M, Cherniack, AD, Houlahan, KE, Jayasinghe, R, Wang, L-B, Zhou, DC, Liu, D, Cao, S, Kim, YW, Koire, A, McMichael, JF, Hucthagowder, V, Kim, T-B, Hahn, A, Wang, C, McLellan, MD, Al-Mulla, F, Johnson, KJ, Cancer Genome Atlas Research Network, , Lichtarge, O, Boutros, PC, Raphael, B, Lazar, AJ, Zhang, W, Wendl, MC, Govindan, R, Jain, S, Wheeler, D, Kulkarni, S, Dipersio, JF, Reimand, J, Meric-Bernstam, F, Chen, K, Shmulevich, I, Plon, SE, Chen, F, and Ding, L. "Pathogenic Germline Variants in 10,389 Adult Cancers." Cell 173, no. 2 (April 2018): 355-370.e14. Full Text
  - Malta, TM, Sokolov, A, Gentles, AJ, Burzykowski, T, Poisson, L, Weinstein, JN, Kamińska, B, Huelsken, J, Omberg, L, Gevaert, O, Colaprico, A, Czerwińska, P, Mazurek, S, Mishra, L, Heyn, H, Krasnitz, A, Godwin, AK, Lazar, AJ, Cancer Genome Atlas Research Network, , Stuart, JM, Hoadley, KA, Laird, PW, Noushmehr, H, and Wiznerowicz, M. "Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation." Cell 173, no. 2 (April 2018): 338-354.e15. Full Text
  - Ong, J-S, Hwang, L-D, Cuellar-Partida, G, Martin, NG, Chenevix-Trench, G, Quinn, MCJ, Cornelis, MC, Gharahkhani, P, Webb, PM, MacGregor, S, and Ovarian Cancer Association Consortium, . "Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study." International Journal of Epidemiology 47, no. 2 (April 2018): 450-459. Full Text
  - Peng, X, Chen, Z, Farshidfar, F, Xu, X, Lorenzi, PL, Wang, Y, Cheng, F, Tan, L, Mojumdar, K, Du, D, Ge, Z, Li, J, Thomas, GV, Birsoy, K, Liu, L, Zhang, H, Zhao, Z, Marchand, C, Weinstein, JN, Cancer Genome Atlas Research Network, , Bathe, OF, and Liang, H. "Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers." Cell Reports 23, no. 1 (April 2018): 255-269.e4. Full Text
  - Peres, LC, Risch, H, Terry, KL, Webb, PM, Goodman, MT, Wu, AH, Alberg, AJ, Bandera, EV, Barnholtz-Sloan, J, Bondy, ML, Cote, ML, Funkhouser, E, Moorman, PG, Peters, ES, Schwartz, AG, Terry, PD, Manichaikul, A, Abbott, SE, Camacho, F, Jordan, SJ, Nagle, CM, Australian Ovarian Cancer Study Group, , Rossing, MA, Doherty, JA, Modugno, F, Moysich, K, Ness, R, Berchuck, A, Cook, L, Le, N, Brooks-Wilson, A, Sieh, W, Whittemore, A, McGuire, V, Rothstein, J, Anton-Culver, H, Ziogas, A, Pearce, CL, Tseng, C, Pike, M, Schildkraut, JM, and African American Cancer Epidemiology Study and the Ovarian Cancer Association Consortium, . "Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies." International Journal of Epidemiology 47, no. 2 (April 2018): 460-472. Full Text
  - Ricketts, CJ, De Cubas, AA, Fan, H, Smith, CC, Lang, M, Reznik, E, Bowlby, R, Gibb, EA, Akbani, R, Beroukhim, R, Bottaro, DP, Choueiri, TK, Gibbs, RA, Godwin, AK, Haake, S, Hakimi, AA, Henske, EP, Hsieh, JJ, Ho, TH, Kanchi, RS, Krishnan, B, Kwiatkowski, DJ, Lui, W, Merino, MJ, Mills, GB, Myers, J, Nickerson, ML, Reuter, VE, Schmidt, LS, Shelley, CS, Shen, H, Shuch, B, Signoretti, S, Srinivasan, R, Tamboli, P, Thomas, G, Vincent, BG, Vocke, CD, Wheeler, DA, Yang, L, Kim, WY, Robertson, AG, Cancer Genome Atlas Research Network, , Spellman, PT, Rathmell, WK, and Linehan, WM. "The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma." Cell Reports 23, no. 1 (April 2018): 313-326.e5. Full Text
  - Saltz, J, Gupta, R, Hou, L, Kurc, T, Singh, P, Nguyen, V, Samaras, D, Shroyer, KR, Zhao, T, Batiste, R, Van Arnam, J, Cancer Genome Atlas Research Network, , Shmulevich, I, Rao, AUK, Lazar, AJ, Sharma, A, and Thorsson, V. "Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images." Cell Reports 23, no. 1 (April 2018): 181-193.e7. Full Text
  - Seiler, M, Peng, S, Agrawal, AA, Palacino, J, Teng, T, Zhu, P, Smith, PG, Cancer Genome Atlas Research Network, , Buonamici, S, and Yu, L. "Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types." Cell Reports 23, no. 1 (April 2018): 282-296.e4. Full Text
  - Ellrott, K, Bailey, MH, Saksena, G, Covington, KR, Kandoth, C, Stewart, C, Hess, J, Ma, S, Chiotti, KE, McLellan, M, Sofia, HJ, Hutter, C, Getz, G, Wheeler, D, Ding, L, MC3 Working Group, , and Cancer Genome Atlas Research Network, . "Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines." Cell Systems 6, no. 3 (March 2018): 271-281.e7. Full Text
  - Schaub, FX, Dhankani, V, Berger, AC, Trivedi, M, Richardson, AB, Shaw, R, Zhao, W, Zhang, X, Ventura, A, Liu, Y, Ayer, DE, Hurlin, PJ, Cherniack, AD, Eisenman, RN, Bernard, B, Grandori, C, and Cancer Genome Atlas Network, . "Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas." Cell Systems 6, no. 3 (March 2018): 282-300.e2. Full Text
  - Babic, A, Harris, HR, Vitonis, AF, Titus, LJ, Jordan, SJ, Webb, PM, Australian Ovarian Cancer Study Group, , Risch, HA, Rossing, MA, Doherty, JA, Wicklund, K, Goodman, MT, Modugno, F, Moysich, KB, Ness, RB, Kjaer, SK, Schildkraut, J, Berchuck, A, Pearce, CL, Wu, AH, Cramer, DW, and Terry, KL. "Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association Consortium." International Journal of Cancer 142, no. 3 (February 2018): 460-469. Full Text
  - Harris, HR, Babic, A, Webb, PM, Nagle, CM, Jordan, SJ, Risch, HA, Rossing, MA, Doherty, JA, Goodman, MT, Modugno, F, Ness, RB, Moysich, KB, Kjær, SK, Høgdall, E, Jensen, A, Schildkraut, JM, Berchuck, A, Cramer, DW, Bandera, EV, Wentzensen, N, Kotsopoulos, J, Narod, SA, Phelan, CM, McLaughlin, JR, Anton-Culver, H, Ziogas, A, Pearce, CL, Wu, AH, Terry, KL, Ovarian Cancer Association Consortium, , and Australian Ovarian Cancer Study Group, . "Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 27, no. 2 (February 2018): 174-182. Full Text
  - Johnson, OK, Berchuck, A, Secord, AA, and Peterson, AC. "Urinary diversion in the genitourinary cancer survivor." Gynecologic Oncology 148, no. 2 (February 2018): 414-421. (Review) Full Text
  - Liu, G, Mukherjee, B, Lee, S, Lee, AW, Wu, AH, Bandera, EV, Jensen, A, Rossing, MA, Moysich, KB, Chang-Claude, J, Doherty, JA, Gentry-Maharaj, A, Kiemeney, L, Gayther, SA, Modugno, F, Massuger, L, Goode, EL, Fridley, BL, Terry, KL, Cramer, DW, Ramus, SJ, Anton-Culver, H, Ziogas, A, Tyrer, JP, Schildkraut, JM, Kjaer, SK, Webb, PM, Ness, RB, Menon, U, Berchuck, A, Pharoah, PD, Risch, H, Pearce, CL, and Ovarian Cancer Association Consortium, . "Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence." American Journal of Epidemiology 187, no. 2 (February 2018): 366-377. Full Text
  - Moss, HA, Berchuck, A, Neely, ML, Myers, ER, and Havrilesky, LJ. "Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in the United States: Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)." Jama Oncology 4, no. 2 (February 2018): 190-195. Full Text
  - Ugai, T, Kelemen, LE, Mizuno, M, Ong, J-S, Webb, PM, Chenevix-Trench, G, Australian Ovarian Cancer Study Group, , Wicklund, KG, Doherty, JA, Rossing, MA, Thompson, PJ, Wilkens, LR, Carney, ME, Goodman, MT, Schildkraut, JM, Berchuck, A, Cramer, DW, Terry, KL, Cai, H, Shu, X-O, Gao, Y-T, Xiang, Y-B, Van Den Berg, D, Pike, MC, Wu, AH, Pearce, CL, Matsuo, K, and Ovarian Cancer Association Consortium, . "Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium." Cancer science 109, no. 2 (February 2018): 435-445. Full Text
  - Earp, M, Tyrer, JP, Winham, SJ, Lin, H-Y, Chornokur, G, Dennis, J, Aben, KKH, Anton-Culver, H, Antonenkova, N, Bandera, EV, Bean, YT, Beckmann, MW, Bjorge, L, Bogdanova, N, Brinton, LA, Brooks-Wilson, A, Bruinsma, F, Bunker, CH, Butzow, R, Campbell, IG, Carty, K, Chang-Claude, J, Cook, LS, Cramer, DW, Cunningham, JM, Cybulski, C, Dansonka-Mieszkowska, A, Despierre, E, Doherty, JA, Dörk, T, du Bois, A, Dürst, M, Easton, DF, Eccles, DM, Edwards, RP, Ekici, AB, Fasching, PA, Fridley, BL, Gentry-Maharaj, A, Giles, GG, Glasspool, R, Goodman, MT, Gronwald, J, Harter, P, Hein, A, Heitz, F, Hildebrandt, MAT, Hillemanns, P, Hogdall, CK, Høgdall, E, Hosono, S, Iversen, ES, Jakubowska, A, Jensen, A, Ji, B-T, Jung, AY, Karlan, BY, Kellar, M, Kiemeney, LA, Kiong Lim, B, Kjaer, SK, Krakstad, C, Kupryjanczyk, J, Lambrechts, D, Lambrechts, S, Le, ND, Lele, S, Lester, J, Levine, DA, Li, Z, Liang, D, Lissowska, J, Lu, K, Lubinski, J, Lundvall, L, Massuger, LFAG, Matsuo, K, McGuire, V, McLaughlin, JR, McNeish, I, Menon, U, Milne, RL, Modugno, F, Moysich, KB, Ness, RB, Nevanlinna, H, Odunsi, K, Olson, SH, Orlow, I, Orsulic, S, Paul, J, Pejovic, T, Pelttari, LM, Permuth, JB, Pike, MC, Poole, EM, Rosen, B, Rossing, MA, Rothstein, JH, Runnebaum, IB, Rzepecka, IK, Schernhammer, E, Schwaab, I, Shu, X-O, Shvetsov, YB, Siddiqui, N, Sieh, W, Song, H, Southey, MC, Spiewankiewicz, B, Sucheston-Campbell, L, Tangen, IL, Teo, S-H, Terry, KL, Thompson, PJ, Thomsen, L, Tworoger, SS, van Altena, AM, Vergote, I, Vestrheim Thomsen, LC, Vierkant, RA, Walsh, CS, Wang-Gohrke, S, Wentzensen, N, Whittemore, AS, Wicklund, KG, Wilkens, LR, Woo, Y-L, Wu, AH, Wu, X, Xiang, Y-B, Yang, H, Zheng, W, Ziogas, A, Lee, AW, Pearce, CL, Berchuck, A, Schildkraut, JM, Ramus, SJ, Monteiro, ANA, Narod, SA, Sellers, TA, Gayther, SA, Kelemen, LE, Chenevix-Trench, G, Risch, HA, Pharoah, PDP, Goode, EL, and Phelan, CM. "Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility." Plos One 13, no. 7 (January 2018): e0197561-null. Full Text
  - Berchuck, A, Secord, AA, Moss, HA, and Havrilesky, LJ. "Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All?." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 35, no. 36 (December 2017): 3999-4002. Full Text
  - Moore, KN, Tritchler, D, Kaufman, KM, Lankes, H, Quinn, MCJ, Ovarian Cancer Association Consortium, , Van Le, L, Berchuck, A, Backes, FJ, Tewari, KS, Lee, RB, Kesterson, JP, Wenham, RM, Armstrong, DK, Krivak, TC, Bookman, MA, and Birrer, MJ. "Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study." Gynecologic Oncology 147, no. 2 (November 2017): 396-401. Full Text
  - Bateman, NW, Dubil, EA, Wang, G, Hood, BL, Oliver, JM, Litzi, TA, Gist, GD, Mitchell, DA, Blanton, B, Phippen, NT, Tian, C, Zahn, CM, Cohn, DE, Havrilesky, LJ, Berchuck, A, Shriver, CD, Darcy, KM, Hamilton, CA, Conrads, TP, and Maxwell, GL. "Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients." Cancer 123, no. 20 (October 2017): 4004-4012. Full Text
  - Glubb, DM, Johnatty, SE, Quinn, MCJ, O'Mara, TA, Tyrer, JP, Gao, B, Fasching, PA, Beckmann, MW, Lambrechts, D, Vergote, I, Velez Edwards, DR, Beeghly-Fadiel, A, Benitez, J, Garcia, MJ, Goodman, MT, Thompson, PJ, Dörk, T, Dürst, M, Modungo, F, Moysich, K, Heitz, F, du Bois, A, Pfisterer, J, Hillemanns, P, AGO Study Group, , Karlan, BY, Lester, J, Goode, EL, Cunningham, JM, Winham, SJ, Larson, MC, McCauley, BM, Kjær, SK, Jensen, A, Schildkraut, JM, Berchuck, A, Cramer, DW, Terry, KL, and Salvesen, HB et al. "Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci." Oncotarget 8, no. 39 (September 2017): 64670-64684. Full Text
  - Janouskova, H, El Tekle, G, Bellini, E, Udeshi, ND, Rinaldi, A, Ulbricht, A, Bernasocchi, T, Civenni, G, Losa, M, Svinkina, T, Bielski, CM, Kryukov, GV, Cascione, L, Napoli, S, Enchev, RI, Mutch, DG, Carney, ME, Berchuck, A, Winterhoff, BJN, Broaddus, RR, Schraml, P, Moch, H, Bertoni, F, Catapano, CV, Peter, M, Carr, SA, Garraway, LA, Wild, PJ, and Theurillat, J-PP. "Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors." Nature Medicine 23, no. 9 (September 2017): 1046-1054. Full Text
  - "RE: “RISK PREDICTION FOR EPITHELIAL OVARIAN CANCER IN 11 UNITED STATES–BASED CASE-CONTROL STUDIES: INCORPORATION OF EPIDEMIOLOGIC RISK FACTORS AND 17 CONFIRMED GENETIC LOCI”." American Journal of Epidemiology 186, no. 1 (July 1, 2017): 130-130. Full Text
  - Skates, SJ, Greene, MH, Buys, SS, Mai, PL, Brown, P, Piedmonte, M, Rodriguez, G, Schorge, JO, Sherman, M, Daly, MB, Rutherford, T, Brewster, WR, O'Malley, DM, Partridge, E, Boggess, J, Drescher, CW, Isaacs, C, Berchuck, A, Domchek, S, Davidson, SA, Edwards, R, Elg, SA, Wakeley, K, Phillips, K-A, Armstrong, D, Horowitz, I, Fabian, CJ, Walker, J, Sluss, PM, Welch, W, Minasian, L, Horick, NK, Kasten, CH, Nayfield, S, Alberts, D, Finkelstein, DM, and Lu, KH. "Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 23, no. 14 (July 2017): 3628-3637. Full Text
  - Witkowski, L, Donini, N, Byler-Dann, R, Knost, JA, Albrecht, S, Berchuck, A, McCluggage, WG, Hasselblatt, M, and Foulkes, WD. "The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases." Familial Cancer 16, no. 3 (July 2017): 395-399. Full Text
  - Glubb, DM, Johnatty, SE, Quinn, MCJ, O'Mara, TA, Tyrer, JP, Gao, B, Fasching, PA, Beckmann, MW, Lambrechts, D, Vergote, I, Velez Edwards, DR, Beeghly-Fadiel, A, Benitez, J, Garcia, MJ, Goodman, MT, Thompson, PJ, Dörk, T, Dürst, M, Modungo, F, Moysich, K, Heitz, F, du Bois, A, Pfisterer, J, Hillemanns, P, Karlan, BY, Lester, J, Goode, EL, Cunningham, JM, Winham, SJ, Larson, MC, McCauley, BM, Kjær, SK, Jensen, A, Schildkraut, JM, Berchuck, A, Cramer, DW, Terry, KL, Salvesen, HB, Bjorge, L, Webb, PM, Grant, P, Pejovic, T, Moffitt, M, Hogdall, CK, Hogdall, E, Paul, J, Glasspool, R, Bernardini, M, Tone, A, Huntsman, D, Woo, M, Group, A, deFazio, A, Kennedy, CJ, Pharoah, PDP, MacGregor, S, and Chenevix-Trench, G. "Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci." Oncotarget (June 15, 2017). Full Text
  - Kar, SP, Berchuck, A, Gayther, SA, Goode, EL, Moysich, KB, Pearce, CL, Ramus, SJ, Schildkraut, JM, Sellers, TA, and Pharoah, PDP. "Common Genetic Variation and Susceptibility to Ovarian Cancer: Current Insights and Future Directions." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (June 14, 2017). Full Text
  - Praestegaard, C, Jensen, A, Jensen, SM, Nielsen, TSS, Webb, PM, Nagle, CM, DeFazio, A, Australian Ovarian Cancer Study Group, , Høgdall, E, Rossing, MA, Doherty, JA, Wicklund, KG, Goodman, MT, Modugno, F, Moysich, K, Ness, RB, Edwards, R, Matsuo, K, Hosono, S, Goode, EL, Winham, SJ, Fridley, BL, Cramer, DW, Terry, KL, Schildkraut, JM, Berchuck, A, Bandera, EV, Paddock, LE, Massuger, LF, Wentzensen, N, Pharoah, P, Song, H, Whittemore, A, McGuire, V, Sieh, W, Rothstein, J, Anton-Culver, H, Ziogas, A, Menon, U, Gayther, SA, Ramus, SJ, Gentry-Maharaj, A, Wu, AH, Pearce, CL, Pike, M, Lee, AW, Sutphen, R, Chang-Claude, J, Risch, HA, Kjaer, SK, and Ovarian Cancer Association Consortium, . "Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies." International Journal of Cancer 140, no. 11 (June 2017): 2422-2435. Full Text
  - Berchuck, A, Havrilesky, LJ, and Kauff, ND. "Is There a Role for Ovarian Cancer Screening in High-Risk Women?." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 35, no. 13 (May 2017): 1384-1386. Full Text
  - Minlikeeva, AN, Freudenheim, JL, Cannioto, RA, Szender, JB, Eng, KH, Modugno, F, Ness, RB, LaMonte, MJ, Friel, G, Segal, BH, Odunsi, K, Mayor, P, Zsiros, E, Schmalfeldt, B, Klapdor, R, Dӧrk, T, Hillemanns, P, Kelemen, LE, Kӧbel, M, Steed, H, de Fazio, A, Australian Ovarian Cancer Study Group, , Jordan, SJ, Nagle, CM, Risch, HA, Rossing, MA, Doherty, JA, Goodman, MT, Edwards, R, Matsuo, K, Mizuno, M, Karlan, BY, Kjær, SK, Høgdall, E, Jensen, A, Schildkraut, JM, Terry, KL, Cramer, DW, Bandera, EV, Paddock, LE, Kiemeney, LA, Massuger, LF, Kupryjanczyk, J, Berchuck, A, Chang-Claude, J, Diergaarde, B, Webb, PM, Moysich, KB, and Ovarian Cancer Association Consortium, . "History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium." Cancer Causes & Control : Ccc 28, no. 5 (May 2017): 469-486. Full Text
  - Phelan, CM, Kuchenbaecker, KB, Tyrer, JP, Kar, SP, Lawrenson, K, Winham, SJ, Dennis, J, Pirie, A, Riggan, MJ, Chornokur, G, Earp, MA, Lyra, PC, Lee, JM, Coetzee, S, Beesley, J, McGuffog, L, Soucy, P, Dicks, E, Lee, A, Barrowdale, D, Lecarpentier, J, Leslie, G, Aalfs, CM, Aben, KKH, Adams, M, Adlard, J, Andrulis, IL, Anton-Culver, H, Antonenkova, N, AOCS study group, , Aravantinos, G, Arnold, N, Arun, BK, Arver, B, Azzollini, J, Balmaña, J, Banerjee, SN, Barjhoux, L, Barkardottir, RB, Bean, Y, Beckmann, MW, Beeghly-Fadiel, A, Benitez, J, Bermisheva, M, Bernardini, MQ, Birrer, MJ, Bjorge, L, Black, A, Blankstein, K, Blok, MJ, Bodelon, C, Bogdanova, N, Bojesen, A, Bonanni, B, Borg, Å, Bradbury, AR, Brenton, JD, Brewer, C, Brinton, L, Broberg, P, Brooks-Wilson, A, Bruinsma, F, Brunet, J, Buecher, B, Butzow, R, Buys, SS, Caldes, T, Caligo, MA, Campbell, I, Cannioto, R, Carney, ME, Cescon, T, Chan, SB, Chang-Claude, J, Chanock, S, Chen, XQ, Chiew, Y-E, Chiquette, J, Chung, WK, Claes, KBM, Conner, T, Cook, LS, Cook, J, Cramer, DW, Cunningham, JM, D'Aloisio, AA, Daly, MB, Damiola, F, Damirovna, SD, Dansonka-Mieszkowska, A, Dao, F, Davidson, R, DeFazio, A, Delnatte, C, Doheny, KF, Diez, O, Ding, YC, Doherty, JA, Domchek, SM, Dorfling, CM, Dörk, T, Dossus, L, Duran, M, Dürst, M, Dworniczak, B, Eccles, D, Edwards, T, Eeles, R, Eilber, U, Ejlertsen, B, Ekici, AB, Ellis, S, Elvira, M, EMBRACE Study, , Eng, KH, Engel, C, Evans, DG, Fasching, PA, Ferguson, S, Ferrer, SF, Flanagan, JM, Fogarty, ZC, Fortner, RT, Fostira, F, Foulkes, WD, Fountzilas, G, Fridley, BL, Friebel, TM, Friedman, E, Frost, D, Ganz, PA, Garber, J, García, MJ, Garcia-Barberan, V, Gehrig, A, GEMO Study Collaborators, , Gentry-Maharaj, A, Gerdes, A-M, Giles, GG, Glasspool, R, Glendon, G, Godwin, AK, Goldgar, DE, Goranova, T, Gore, M, Greene, MH, Gronwald, J, Gruber, S, Hahnen, E, Haiman, CA, Håkansson, N, Hamann, U, Hansen, TVO, Harrington, PA, Harris, HR, Hauke, J, HEBON Study, , Hein, A, Henderson, A, Hildebrandt, MAT, Hillemanns, P, Hodgson, S, Høgdall, CK, Høgdall, E, Hogervorst, FBL, Holland, H, Hooning, MJ, Hosking, K, Huang, R-Y, Hulick, PJ, Hung, J, Hunter, DJ, Huntsman, DG, Huzarski, T, Imyanitov, EN, Isaacs, C, Iversen, ES, Izatt, L, Izquierdo, A, Jakubowska, A, James, P, Janavicius, R, Jernetz, M, Jensen, A, Jensen, UB, John, EM, Johnatty, S, Jones, ME, Kannisto, P, Karlan, BY, Karnezis, A, Kast, K, KConFab Investigators, , Kennedy, CJ, Khusnutdinova, E, Kiemeney, LA, Kiiski, JI, Kim, S-W, Kjaer, SK, Köbel, M, Kopperud, RK, Kruse, TA, Kupryjanczyk, J, Kwong, A, Laitman, Y, Lambrechts, D, Larrañaga, N, Larson, MC, Lazaro, C, Le, ND, Le Marchand, L, Lee, JW, Lele, SB, Leminen, A, Leroux, D, Lester, J, Lesueur, F, Levine, DA, Liang, D, Liebrich, C, Lilyquist, J, Lipworth, L, Lissowska, J, Lu, KH, Lubinński, J, Luccarini, C, Lundvall, L, Mai, PL, Mendoza-Fandiño, G, Manoukian, S, Massuger, LFAG, May, T, Mazoyer, S, McAlpine, JN, McGuire, V, McLaughlin, JR, McNeish, I, Meijers-Heijboer, H, Meindl, A, Menon, U, Mensenkamp, AR, Merritt, MA, Milne, RL, Mitchell, G, Modugno, F, Moes-Sosnowska, J, Moffitt, M, Montagna, M, Moysich, KB, Mulligan, AM, Musinsky, J, Nathanson, KL, Nedergaard, L, Ness, RB, Neuhausen, SL, Nevanlinna, H, Niederacher, D, Nussbaum, RL, Odunsi, K, Olah, E, Olopade, OI, Olsson, H, Olswold, C, O'Malley, DM, Ong, K-R, Onland-Moret, NC, OPAL study group, , Orr, N, Orsulic, S, Osorio, A, Palli, D, Papi, L, Park-Simon, T-W, Paul, J, Pearce, CL, Pedersen, IS, Peeters, PHM, Peissel, B, Peixoto, A, Pejovic, T, Pelttari, LM, Permuth, JB, Peterlongo, P, Pezzani, L, Pfeiler, G, Phillips, K-A, Piedmonte, M, Pike, MC, Piskorz, AM, Poblete, SR, Pocza, T, Poole, EM, Poppe, B, Porteous, ME, Prieur, F, Prokofyeva, D, Pugh, E, Pujana, MA, Pujol, P, Radice, P, Rantala, J, Rappaport-Fuerhauser, C, Rennert, G, Rhiem, K, Rice, P, Richardson, A, Robson, M, Rodriguez, GC, Rodríguez-Antona, C, Romm, J, Rookus, MA, Rossing, MA, Rothstein, JH, Rudolph, A, Runnebaum, IB, Salvesen, HB, Sandler, DP, Schoemaker, MJ, Senter, L, Setiawan, VW, Severi, G, Sharma, P, Shelford, T, Siddiqui, N, Side, LE, Sieh, W, Singer, CF, Sobol, H, Song, H, Southey, MC, Spurdle, AB, Stadler, Z, Steinemann, D, Stoppa-Lyonnet, D, Sucheston-Campbell, LE, Sukiennicki, G, Sutphen, R, Sutter, C, Swerdlow, AJ, Szabo, CI, Szafron, L, Tan, YY, Taylor, JA, Tea, M-K, Teixeira, MR, Teo, S-H, Terry, KL, Thompson, PJ, Thomsen, LCV, Thull, DL, Tihomirova, L, Tinker, AV, Tischkowitz, M, Tognazzo, S, Toland, AE, Tone, A, Trabert, B, Travis, RC, Trichopoulou, A, Tung, N, Tworoger, SS, van Altena, AM, Van Den Berg, D, van der Hout, AH, van der Luijt, RB, Van Heetvelde, M, Van Nieuwenhuysen, E, van Rensburg, EJ, Vanderstichele, A, Varon-Mateeva, R, Vega, A, Edwards, DV, Vergote, I, Vierkant, RA, Vijai, J, Vratimos, A, Walker, L, Walsh, C, Wand, D, Wang-Gohrke, S, Wappenschmidt, B, Webb, PM, Weinberg, CR, Weitzel, JN, Wentzensen, N, Whittemore, AS, Wijnen, JT, Wilkens, LR, Wolk, A, Woo, M, Wu, X, Wu, AH, Yang, H, Yannoukakos, D, Ziogas, A, Zorn, KK, Narod, SA, Easton, DF, Amos, CI, Schildkraut, JM, Ramus, SJ, Ottini, L, Goodman, MT, Park, SK, Kelemen, LE, Risch, HA, Thomassen, M, Offit, K, Simard, J, Schmutzler, RK, Hazelett, D, Monteiro, AN, Couch, FJ, Berchuck, A, Chenevix-Trench, G, Goode, EL, Sellers, TA, Gayther, SA, Antoniou, AC, and Pharoah, PDP. "Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer." Nature Genetics 49, no. 5 (May 2017): 680-691. Full Text
  - Dixon, SC, Nagle, CM, Wentzensen, N, Trabert, B, Beeghly-Fadiel, A, Schildkraut, JM, Moysich, KB, deFazio, A, Australian Ovarian Cancer Study Group, , Risch, HA, Rossing, MA, Doherty, JA, Wicklund, KG, Goodman, MT, Modugno, F, Ness, RB, Edwards, RP, Jensen, A, Kjær, SK, Høgdall, E, Berchuck, A, Cramer, DW, Terry, KL, Poole, EM, Bandera, EV, Paddock, LE, Anton-Culver, H, Ziogas, A, Menon, U, Gayther, SA, Ramus, SJ, Gentry-Maharaj, A, Pearce, CL, Wu, AH, Pike, MC, and Webb, PM. "Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium." British Journal of Cancer 116, no. 9 (April 2017): 1223-1228. (Letter) Full Text
  - Zuber, V, Bettella, F, Witoelar, A, PRACTICAL Consortium, , CRUK GWAS, , BCAC Consortium, , TRICL Consortium, , Andreassen, OA, Mills, IG, and Urbanucci, A. "Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer." Bmc Genomics 18, no. 1 (March 31, 2017): 270-null. Full Text
  - Sucheston-Campbell, LE, Cannioto, R, Clay, AI, Etter, JL, Eng, KH, Liu, S, Battaglia, S, Hu, Q, Szender, JB, Minlikeeva, A, Joseph, JM, Mayor, P, Abrams, SI, Segal, BH, Wallace, PK, Soh, KT, Zsiros, E, Anton-Culver, H, Bandera, EV, Beckmann, MW, Berchuck, A, Bjorge, L, Bruegl, A, Campbell, IG, Campbell, SP, Chenevix-Trench, G, Cramer, DW, Dansonka-Mieszkowska, A, Dao, F, Diergaarde, B, Doerk, T, Doherty, JA, du Bois, A, Eccles, D, Engelholm, SA, Fasching, PA, Gayther, SA, Gentry-Maharaj, A, Glasspool, RM, Goodman, MT, Gronwald, J, Harter, P, Hein, A, Heitz, F, Hillemmanns, P, Høgdall, C, Høgdall, EVS, Huzarski, T, Jensen, A, Johnatty, SE, Jung, A, Karlan, BY, Klapdor, R, Kluz, T, Konopka, B, Kjær, SK, Kupryjanczyk, J, Lambrechts, D, Lester, J, Lubiński, J, Levine, DA, Lundvall, L, McGuire, V, McNeish, IA, Menon, U, Modugno, F, Ness, RB, Orsulic, S, Paul, J, Pearce, CL, Pejovic, T, Pharoah, P, Ramus, SJ, Rothstein, J, Rossing, MA, Rübner, M, Schildkraut, JM, Schmalfeldt, B, Schwaab, I, Siddiqui, N, Sieh, W, Sobiczewski, P, Song, H, Terry, KL, Van Nieuwenhuysen, E, Vanderstichele, A, Vergote, I, Walsh, CS, Webb, PM, Wentzensen, N, Whittemore, AS, Wu, AH, Ziogas, A, Odunsi, K, Chang-Claude, J, Goode, EL, Moysich, KB, and Australian Ovarian Cancer Study, . "No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 26, no. 3 (March 2017): 420-424. Full Text
  - Kar, SP, Adler, E, Tyrer, J, Hazelett, D, Anton-Culver, H, Bandera, EV, Beckmann, MW, Berchuck, A, Bogdanova, N, Brinton, L, Butzow, R, Campbell, I, Carty, K, Chang-Claude, J, Cook, LS, Cramer, DW, Cunningham, JM, Dansonka-Mieszkowska, A, Doherty, JA, Dörk, T, Dürst, M, Eccles, D, Fasching, PA, Flanagan, J, Gentry-Maharaj, A, Glasspool, R, Goode, EL, Goodman, MT, Gronwald, J, Heitz, F, Hildebrandt, MAT, Høgdall, E, Høgdall, CK, Huntsman, DG, Jensen, A, Karlan, BY, Kelemen, LE, Kiemeney, LA, Kjaer, SK, Kupryjanczyk, J, Lambrechts, D, Levine, DA, Li, Q, Lissowska, J, Lu, KH, Lubiński, J, Massuger, LFAG, McGuire, V, McNeish, I, Menon, U, Modugno, F, Monteiro, AN, Moysich, KB, Ness, RB, Nevanlinna, H, Paul, J, Pearce, CL, Pejovic, T, Permuth, JB, Phelan, C, Pike, MC, Poole, EM, Ramus, SJ, Risch, HA, Rossing, MA, Salvesen, HB, Schildkraut, JM, Sellers, TA, Sherman, M, Siddiqui, N, Sieh, W, Song, H, Southey, M, Terry, KL, Tworoger, SS, Walsh, C, Wentzensen, N, Whittemore, AS, Wu, AH, Yang, H, Zheng, W, Ziogas, A, Freedman, ML, Gayther, SA, Pharoah, PDP, and Lawrenson, K. "Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci." British Journal of Cancer 116, no. 4 (February 2017): 524-535. Full Text
  - Amos, CI, Dennis, J, Wang, Z, Byun, J, Schumacher, FR, Gayther, SA, Casey, G, Hunter, DJ, Sellers, TA, Gruber, SB, Dunning, AM, Michailidou, K, Fachal, L, Doheny, K, Spurdle, AB, Li, Y, Xiao, X, Romm, J, Pugh, E, Coetzee, GA, Hazelett, DJ, Bojesen, SE, Caga-Anan, C, Haiman, CA, Kamal, A, Luccarini, C, Tessier, D, Vincent, D, Bacot, F, Van Den Berg, DJ, Nelson, S, Demetriades, S, Goldgar, DE, Couch, FJ, Forman, JL, Giles, GG, Conti, DV, Bickeböller, H, Risch, A, Waldenberger, M, Brüske-Hohlfeld, I, Hicks, BD, Ling, H, McGuffog, L, Lee, A, Kuchenbaecker, K, Soucy, P, Manz, J, Cunningham, JM, Butterbach, K, Kote-Jarai, Z, Kraft, P, FitzGerald, L, Lindström, S, Adams, M, McKay, JD, Phelan, CM, Benlloch, S, Kelemen, LE, Brennan, P, Riggan, M, O'Mara, TA, Shen, H, Shi, Y, Thompson, DJ, Goodman, MT, Nielsen, SF, Berchuck, A, Laboissiere, S, Schmit, SL, Shelford, T, Edlund, CK, Taylor, JA, Field, JK, Park, SK, Offit, K, Thomassen, M, Schmutzler, R, Ottini, L, Hung, RJ, Marchini, J, Amin Al Olama, A, Peters, U, Eeles, RA, Seldin, MF, Gillanders, E, Seminara, D, Antoniou, AC, Pharoah, PDP, Chenevix-Trench, G, Chanock, SJ, Simard, J, and Easton, DF. "The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 26, no. 1 (January 2017): 126-135. (Review) Full Text
  - Rasmussen, CB, Kjaer, SK, Albieri, V, Bandera, EV, Doherty, JA, Høgdall, E, Webb, PM, Jordan, SJ, Rossing, MA, Wicklund, KG, Goodman, MT, Modugno, F, Moysich, KB, Ness, RB, Edwards, RP, Schildkraut, JM, Berchuck, A, Olson, SH, Kiemeney, LA, Massuger, LFAG, Narod, SA, Phelan, CM, Anton-Culver, H, Ziogas, A, Wu, AH, Pearce, CL, Risch, HA, Jensen, A, , and on behalf of the Ovarian Cancer Association Consortium, . "Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies." American Journal of Epidemiology 185, no. 1 (January 2017): 8-20. (Review) Full Text
  - Reid, BM, Permuth, JB, Chen, YA, Teer, JK, Monteiro, ANA, Chen, Z, Tyrer, J, Berchuck, A, Chenevix-Trench, G, Doherty, JA, Goode, EL, Iverson, ES, Lawrenson, K, Pearce, CL, Pharoah, PD, Phelan, CM, Ramus, SJ, Rossing, MA, Schildkraut, JM, Cheng, JQ, Gayther, SA, Sellers, TA, Ovarian Cancer Association Consortium, , and Australian Ovarian Cancer Study Group and the Ovarian Cancer Association Consortium, . "Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 26, no. 1 (January 2017): 116-125. Full Text
  - Cass, I, Duska, LR, Blank, SV, Cheng, G, Dupont, NC, Frederick, PJ, Hill, EK, Matthews, CM, Pua, TL, Rath, KS, Ruskin, R, Thaker, PH, Berchuck, A, Gostout, BS, Kushner, DM, and Fowler, JM. "Stress and burnout among gynecologic oncologists: A society of gynecologic oncology evidence-based review and recommendations." Obstetrical and Gynecological Survey 71, no. 12 (December 1, 2016): 715-717. Full Text
  - Karami, S, Han, Y, Pande, M, Cheng, I, Rudd, J, Pierce, BL, Nutter, EL, Schumacher, FR, Kote-Jarai, Z, Lindstrom, S, Witte, JS, Fang, S, Han, J, Kraft, P, Hunter, DJ, Song, F, Hung, RJ, McKay, J, Gruber, SB, Chanock, SJ, Risch, A, Shen, H, Haiman, CA, Boardman, L, Ulrich, CM, Casey, G, Peters, U, Amin Al Olama, A, Berchuck, A, Berndt, SI, Bezieau, S, Brennan, P, Brenner, H, Brinton, L, Caporaso, N, Chan, AT, Chang-Claude, J, Christiani, DC, Cunningham, JM, Easton, D, Eeles, RA, Eisen, T, Gala, M, Gallinger, SJ, Gayther, SA, Goode, EL, Grönberg, H, Henderson, BE, Houlston, R, Joshi, AD, Küry, S, Landi, MT, Le Marchand, L, Muir, K, Newcomb, PA, Permuth-Wey, J, Pharoah, P, Phelan, C, Potter, JD, Ramus, SJ, Risch, H, Schildkraut, J, Slattery, ML, Song, H, Wentzensen, N, White, E, Wiklund, F, Zanke, BW, Sellers, TA, Zheng, W, Chatterjee, N, Amos, CI, Doherty, JA, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and and TRICL, . "Telomere structure and maintenance gene variants and risk of five cancer types." International Journal of Cancer 139, no. 12 (December 2016): 2655-2670. Full Text
  - Lee, AW, Bomkamp, A, Bandera, EV, Jensen, A, Ramus, SJ, Goodman, MT, Rossing, MA, Modugno, F, Moysich, KB, Chang-Claude, J, Rudolph, A, Gentry-Maharaj, A, Terry, KL, Gayther, SA, Cramer, DW, Doherty, JA, Schildkraut, JM, Kjaer, SK, Ness, RB, Menon, U, Berchuck, A, Mukherjee, B, Roman, L, Pharoah, PD, Chenevix-Trench, G, Olson, S, Hogdall, E, Wu, AH, Pike, MC, Stram, DO, Pearce, CL, and Ovarian Cancer Association Consortium, . "A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer." International Journal of Cancer 139, no. 12 (December 2016): 2646-2654. Full Text
  - Southey, MC, Goldgar, DE, Winqvist, R, Pylkäs, K, Couch, F, Tischkowitz, M, Foulkes, WD, Dennis, J, Michailidou, K, van Rensburg, EJ, Heikkinen, T, Nevanlinna, H, Hopper, JL, Dörk, T, Claes, KB, Reis-Filho, J, Teo, ZL, Radice, P, Catucci, I, Peterlongo, P, Tsimiklis, H, Odefrey, FA, Dowty, JG, Schmidt, MK, Broeks, A, Hogervorst, FB, Verhoef, S, Carpenter, J, Clarke, C, Scott, RJ, Fasching, PA, Haeberle, L, Ekici, AB, Beckmann, MW, Peto, J, Dos-Santos-Silva, I, Fletcher, O, Johnson, N, Bolla, MK, Sawyer, EJ, Tomlinson, I, Kerin, MJ, Miller, N, Marme, F, Burwinkel, B, Yang, R, Guénel, P, Truong, T, Menegaux, F, Sanchez, M, Bojesen, S, Nielsen, SF, Flyger, H, Benitez, J, Zamora, MP, Perez, JIA, Menéndez, P, Anton-Culver, H, Neuhausen, S, Ziogas, A, Clarke, CA, Brenner, H, Arndt, V, Stegmaier, C, Brauch, H, Brüning, T, Ko, Y-D, Muranen, TA, Aittomäki, K, Blomqvist, C, Bogdanova, NV, Antonenkova, NN, Lindblom, A, Margolin, S, Mannermaa, A, Kataja, V, Kosma, V-M, Hartikainen, JM, Spurdle, AB, Investigators, K, Australian Ovarian Cancer Study Group, , Wauters, E, Smeets, D, Beuselinck, B, Floris, G, Chang-Claude, J, Rudolph, A, Seibold, P, Flesch-Janys, D, Olson, JE, Vachon, C, Pankratz, VS, McLean, C, Haiman, CA, Henderson, BE, Schumacher, F, Le Marchand, L, Kristensen, V, Alnæs, GG, Zheng, W, Hunter, DJ, Lindstrom, S, Hankinson, SE, Kraft, P, Andrulis, I, Knight, JA, Glendon, G, Mulligan, AM, Jukkola-Vuorinen, A, Grip, M, Kauppila, S, Devilee, P, Tollenaar, RAEM, Seynaeve, C, Hollestelle, A, Garcia-Closas, M, Figueroa, J, Chanock, SJ, Lissowska, J, Czene, K, Darabi, H, Eriksson, M, Eccles, DM, Rafiq, S, Tapper, WJ, Gerty, SM, Hooning, MJ, Martens, JWM, Collée, JM, Tilanus-Linthorst, M, Hall, P, Li, J, Brand, JS, Humphreys, K, Cox, A, Reed, MWR, Luccarini, C, Baynes, C, Dunning, AM, Hamann, U, Torres, D, Ulmer, HU, Rüdiger, T, Jakubowska, A, Lubinski, J, Jaworska, K, Durda, K, Slager, S, Toland, AE, Ambrosone, CB, Yannoukakos, D, Swerdlow, A, Ashworth, A, Orr, N, Jones, M, González-Neira, A, Pita, G, Alonso, MR, Álvarez, N, Herrero, D, Tessier, DC, Vincent, D, Bacot, F, Simard, J, Dumont, M, Soucy, P, Eeles, R, Muir, K, Wiklund, F, Gronberg, H, Schleutker, J, Nordestgaard, BG, Weischer, M, Travis, RC, Neal, D, Donovan, JL, Hamdy, FC, Khaw, K-T, Stanford, JL, Blot, WJ, Thibodeau, S, Schaid, DJ, Kelley, JL, Maier, C, Kibel, AS, Cybulski, C, Cannon-Albright, L, Butterbach, K, Park, J, Kaneva, R, Batra, J, Teixeira, MR, Kote-Jarai, Z, Olama, AAA, Benlloch, S, Renner, SP, Hartmann, A, Hein, A, Ruebner, M, Lambrechts, D, Van Nieuwenhuysen, E, Vergote, I, Lambretchs, S, Doherty, JA, Rossing, MA, Nickels, S, Eilber, U, Wang-Gohrke, S, Odunsi, K, Sucheston-Campbell, LE, Friel, G, Lurie, G, Killeen, JL, Wilkens, LR, Goodman, MT, Runnebaum, I, Hillemanns, PA, Pelttari, LM, Butzow, R, Modugno, F, Edwards, RP, Ness, RB, Moysich, KB, du Bois, A, Heitz, F, Harter, P, Kommoss, S, Karlan, BY, Walsh, C, Lester, J, Jensen, A, Kjaer, SK, Høgdall, E, Peissel, B, Bonanni, B, Bernard, L, Goode, EL, Fridley, BL, Vierkant, RA, Cunningham, JM, Larson, MC, Fogarty, ZC, Kalli, KR, Liang, D, Lu, KH, Hildebrandt, MAT, Wu, X, Levine, DA, Dao, F, Bisogna, M, Berchuck, A, Iversen, ES, Marks, JR, Akushevich, L, Cramer, DW, Schildkraut, J, Terry, KL, Poole, EM, Stampfer, M, Tworoger, SS, Bandera, EV, Orlow, I, Olson, SH, Bjorge, L, Salvesen, HB, van Altena, AM, Aben, KKH, Kiemeney, LA, Massuger, LFAG, Pejovic, T, Bean, Y, Brooks-Wilson, A, Kelemen, LE, Cook, LS, Le, ND, Górski, B, Gronwald, J, Menkiszak, J, Høgdall, CK, Lundvall, L, Nedergaard, L, Engelholm, SA, Dicks, E, Tyrer, J, Campbell, I, McNeish, I, Paul, J, Siddiqui, N, Glasspool, R, Whittemore, AS, Rothstein, JH, McGuire, V, Sieh, W, Cai, H, Shu, X-O, Teten, RT, Sutphen, R, McLaughlin, JR, Narod, SA, Phelan, CM, Monteiro, AN, Fenstermacher, D, Lin, H-Y, Permuth, JB, Sellers, TA, Chen, YA, Tsai, Y-Y, Chen, Z, Gentry-Maharaj, A, Gayther, SA, Ramus, SJ, Menon, U, Wu, AH, Pearce, CL, Van Den Berg, D, Pike, MC, Dansonka-Mieszkowska, A, Plisiecka-Halasa, J, Moes-Sosnowska, J, Kupryjanczyk, J, Pharoah, PD, Song, H, Winship, I, Chenevix-Trench, G, Giles, GG, Tavtigian, SV, Easton, DF, and Milne, RL. "PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS." Journal of Medical Genetics 53, no. 12 (December 2016): 800-811. Full Text
  - Cass, I, Duska, LR, Blank, SV, Cheng, G, duPont, NC, Frederick, PJ, Hill, EK, Matthews, CM, Pua, TL, Rath, KS, Ruskin, R, Thaker, PH, Berchuck, A, Gostout, BS, Kushner, DM, and Fowler, JM. "Stress and burnout among gynecologic oncologists: A Society of Gynecologic Oncology Evidence-based Review and Recommendations." Gynecologic Oncology 143, no. 2 (November 2016): 421-427. (Review) Full Text
  - Permuth, JB, Reid, B, Earp, M, Chen, YA, Monteiro, ANA, Chen, Z, AOCS Study Group, , Chenevix-Trench, G, Fasching, PA, Beckmann, MW, Lambrechts, D, Vanderstichele, A, Van Niewenhuyse, E, Vergote, I, Rossing, MA, Doherty, JA, Chang-Claude, J, Moysich, K, Odunsi, K, Goodman, MT, Shvetsov, YB, Wilkens, LR, Thompson, PJ, Dörk, T, Bogdanova, N, Butzow, R, Nevanlinna, H, Pelttari, L, Leminen, A, Modugno, F, Edwards, RP, Ness, RB, Kelley, J, Heitz, F, Karlan, B, Lester, J, Kjaer, SK, Jensen, A, Giles, G, Hildebrandt, M, Liang, D, Lu, KH, Wu, X, Levine, DA, Bisogna, M, Berchuck, A, Cramer, DW, Terry, KL, Tworoger, SS, Poole, EM, Bandera, EV, Fridley, B, Cunningham, J, Winham, SJ, Olson, SH, Orlow, I, Bjorge, L, Kiemeney, LA, Massuger, L, Pejovic, T, Moffitt, M, Le, N, Cook, LS, Brooks-Wilson, A, Kelemen, LE, Gronwald, J, Lubinski, J, Wentzensen, N, Brinton, LA, Lissowska, J, Yang, H, Hogdall, E, Hogdall, C, Lundvall, L, Pharoah, PDP, Song, H, Campbell, I, Eccles, D, McNeish, I, Whittemore, A, McGuire, V, Sieh, W, Rothstein, J, Phelan, CM, Risch, H, Narod, S, McLaughlin, J, Anton-Culver, H, Ziogas, A, Menon, U, Gayther, S, Ramus, SJ, Gentry-Maharaj, A, Pearce, CL, Wu, AH, Kupryjanczyk, J, Dansonka-Mieszkowska, A, Schildkraut, JM, Cheng, JQ, Goode, EL, and Sellers, TA. "Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration." Oncotarget 7, no. 45 (November 2016): 72381-72394. Full Text
  - Clyde, MA, Palmieri Weber, R, Iversen, ES, Poole, EM, Doherty, JA, Goodman, MT, Ness, RB, Risch, HA, Rossing, MA, Terry, KL, Wentzensen, N, Whittemore, AS, Anton-Culver, H, Bandera, EV, Berchuck, A, Carney, ME, Cramer, DW, Cunningham, JM, Cushing-Haugen, KL, Edwards, RP, Fridley, BL, Goode, EL, Lurie, G, McGuire, V, Modugno, F, Moysich, KB, Olson, SH, Pearce, CL, Pike, MC, Rothstein, JH, Sellers, TA, Sieh, W, Stram, D, Thompson, PJ, Vierkant, RA, Wicklund, KG, Wu, AH, Ziogas, A, and Tworoger, SS et al. "Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci." American journal of epidemiology 184, no. 8 (October 15, 2016): 579-589.
  - Clyde, MA, Palmieri Weber, R, Iversen, ES, Poole, EM, Doherty, JA, Goodman, MT, Ness, RB, Risch, HA, Rossing, MA, Terry, KL, Wentzensen, N, Whittemore, AS, Anton-Culver, H, Bandera, EV, Berchuck, A, Carney, ME, Cramer, DW, Cunningham, JM, Cushing-Haugen, KL, Edwards, RP, Fridley, BL, Goode, EL, Lurie, G, McGuire, V, Modugno, F, Moysich, KB, Olson, SH, Pearce, CL, Pike, MC, Rothstein, JH, Sellers, TA, Sieh, W, Stram, D, Thompson, PJ, Vierkant, RA, Wicklund, KG, Wu, AH, Ziogas, A, Tworoger, SS, Schildkraut, JM, , and on behalf of the Ovarian Cancer Association Consortium, . "Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci." American Journal of Epidemiology 184, no. 8 (October 3, 2016): 579-589. Full Text Open Access Copy
  - Hampras, SS, Sucheston-Campbell, LE, Cannioto, R, Chang-Claude, J, Modugno, F, Dörk, T, Hillemanns, P, Preus, L, Knutson, KL, Wallace, PK, Hong, C-C, Friel, G, Davis, W, Nesline, M, Pearce, CL, Kelemen, LE, Goodman, MT, Bandera, EV, Terry, KL, Schoof, N, Eng, KH, Clay, A, Singh, PK, Joseph, JM, Aben, KKH, Anton-Culver, H, Antonenkova, N, Baker, H, Bean, Y, Beckmann, MW, Bisogna, M, Bjorge, L, Bogdanova, N, Brinton, LA, Brooks-Wilson, A, Bruinsma, F, Butzow, R, Campbell, IG, Carty, K, Cook, LS, Cramer, DW, Cybulski, C, Dansonka-Mieszkowska, A, Dennis, J, Despierre, E, Dicks, E, Doherty, JA, du Bois, A, Dürst, M, Easton, D, Eccles, D, Edwards, RP, Ekici, AB, Fasching, PA, Fridley, BL, Gao, Y-T, Gentry-Maharaj, A, Giles, GG, Glasspool, R, Gronwald, J, Harrington, P, Harter, P, Hasmad, HN, Hein, A, Heitz, F, Hildebrandt, MAT, Hogdall, C, Hogdall, E, Hosono, S, Iversen, ES, Jakubowska, A, Jensen, A, Ji, B-T, Karlan, BY, Kellar, M, Kelley, JL, Kiemeney, LA, Klapdor, R, Kolomeyevskaya, N, Krakstad, C, Kjaer, SK, Kruszka, B, Kupryjanczyk, J, Lambrechts, D, Lambrechts, S, Le, ND, Lee, AW, Lele, S, Leminen, A, Lester, J, Levine, DA, Liang, D, Lissowska, J, Liu, S, Lu, K, Lubinski, J, Lundvall, L, Massuger, LFAG, Matsuo, K, McGuire, V, McLaughlin, JR, McNeish, I, Menon, U, Moes-Sosnowska, J, Narod, SA, Nedergaard, L, Nevanlinna, H, Nickels, S, Olson, SH, Orlow, I, Weber, RP, Paul, J, Pejovic, T, Pelttari, LM, Perkins, B, Permuth-Wey, J, Pike, MC, Plisiecka-Halasa, J, Poole, EM, Risch, HA, Rossing, MA, Rothstein, JH, Rudolph, A, Runnebaum, IB, Rzepecka, IK, Salvesen, HB, Schernhammer, E, Schmitt, K, Schwaab, I, Shu, X-O, Shvetsov, YB, Siddiqui, N, Sieh, W, Song, H, Southey, MC, Tangen, IL, Teo, S-H, Thompson, PJ, Timorek, A, Tsai, Y-Y, Tworoger, SS, Tyrer, J, van Altena, AM, Vergote, I, Vierkant, RA, Walsh, C, Wang-Gohrke, S, Wentzensen, N, Whittemore, AS, Wicklund, KG, Wilkens, LR, Wu, AH, Wu, X, Woo, Y-L, Yang, H, Zheng, W, Ziogas, A, Gayther, SA, Ramus, SJ, Sellers, TA, Schildkraut, JM, Phelan, CM, Berchuck, A, Chenevix-Trench, G, Cunningham, JM, Pharoah, PP, Ness, RB, Odunsi, K, Goode, EL, and Moysich, KB. "Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer." Oncotarget 7, no. 43 (October 2016): 69097-69110. Full Text
  - Ong, J-S, Cuellar-Partida, G, Lu, Y, Australian Ovarian Cancer Study, , Fasching, PA, Hein, A, Burghaus, S, Beckmann, MW, Lambrechts, D, Van Nieuwenhuysen, E, Vergote, I, Vanderstichele, A, Anne Doherty, J, Anne Rossing, M, Chang-Claude, J, Eilber, U, Rudolph, A, Wang-Gohrke, S, Goodman, MT, Bogdanova, N, Dörk, T, Dürst, M, Hillemanns, P, Runnebaum, IB, Antonenkova, N, Butzow, R, Leminen, A, Nevanlinna, H, Pelttari, LM, Edwards, RP, Kelley, JL, Modugno, F, Moysich, KB, Ness, RB, Cannioto, R, Høgdall, E, Høgdall, CK, Jensen, A, Giles, GG, Bruinsma, F, Kjaer, SK, Hildebrandt, MA, Liang, D, Lu, KH, Wu, X, Bisogna, M, Dao, F, Levine, DA, Cramer, DW, Terry, KL, Tworoger, SS, Stampfer, M, Missmer, S, Bjorge, L, Salvesen, HB, Kopperud, RK, Bischof, K, Aben, KK, Kiemeney, LA, Massuger, LF, Brooks-Wilson, A, Olson, SH, McGuire, V, Rothstein, JH, Sieh, W, Whittemore, AS, Cook, LS, Le, ND, Gilks, CB, Gronwald, J, Jakubowska, A, Lubiński, J, Kluz, T, Song, H, Tyrer, JP, Wentzensen, N, Brinton, L, Trabert, B, Lissowska, J, McLaughlin, JR, Narod, SA, Phelan, C, Anton-Culver, H, Ziogas, A, Eccles, D, Campbell, I, Gayther, SA, Gentry-Maharaj, A, Menon, U, Ramus, SJ, Wu, AH, Dansonka-Mieszkowska, A, Kupryjanczyk, J, Timorek, A, Szafron, L, Cunningham, JM, Fridley, BL, Winham, SJ, Bandera, EV, Poole, EM, Morgan, TK, Risch, HA, Goode, EL, Schildkraut, JM, Pearce, CL, Berchuck, A, Pharoah, PD, Chenevix-Trench, G, Gharahkhani, P, Neale, RE, Webb, PM, and MacGregor, S. "Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study." International Journal of Epidemiology 45, no. 5 (October 2016): 1619-1630. Full Text
  - Lawrenson, K, Kar, S, McCue, K, Kuchenbaeker, K, Michailidou, K, Tyrer, J, Beesley, J, Ramus, SJ, Li, Q, Delgado, MK, Lee, JM, Aittomäki, K, Andrulis, IL, Anton-Culver, H, Arndt, V, Arun, BK, Arver, B, Bandera, EV, Barile, M, Barkardottir, RB, Barrowdale, D, Beckmann, MW, Benitez, J, Berchuck, A, Bisogna, M, Bjorge, L, Blomqvist, C, Blot, W, Bogdanova, N, Bojesen, A, Bojesen, SE, Bolla, MK, Bonanni, B, Børresen-Dale, A-L, Brauch, H, Brennan, P, Brenner, H, Bruinsma, F, Brunet, J, Buhari, SA, Burwinkel, B, Butzow, R, Buys, SS, Cai, Q, Caldes, T, Campbell, I, Canniotto, R, Chang-Claude, J, Chiquette, J, Choi, J-Y, Claes, KBM, GEMO Study Collaborators, , Cook, LS, Cox, A, Cramer, DW, Cross, SS, Cybulski, C, Czene, K, Daly, MB, Damiola, F, Dansonka-Mieszkowska, A, Darabi, H, Dennis, J, Devilee, P, Diez, O, Doherty, JA, Domchek, SM, Dorfling, CM, Dörk, T, Dumont, M, Ehrencrona, H, Ejlertsen, B, Ellis, S, EMBRACE, , Engel, C, Lee, E, Evans, DG, Fasching, PA, Feliubadalo, L, Figueroa, J, Flesch-Janys, D, Fletcher, O, Flyger, H, Foretova, L, Fostira, F, Foulkes, WD, Fridley, BL, Friedman, E, Frost, D, Gambino, G, Ganz, PA, Garber, J, García-Closas, M, Gentry-Maharaj, A, Ghoussaini, M, Giles, GG, Glasspool, R, Godwin, AK, Goldberg, MS, Goldgar, DE, González-Neira, A, Goode, EL, Goodman, MT, Greene, MH, Gronwald, J, Guénel, P, Haiman, CA, Hall, P, Hallberg, E, Hamann, U, Hansen, TVO, Harrington, PA, Hartman, M, Hassan, N, Healey, S, Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), , Heitz, F, Herzog, J, Høgdall, E, Høgdall, CK, Hogervorst, FBL, Hollestelle, A, Hopper, JL, Hulick, PJ, Huzarski, T, Imyanitov, EN, KConFab Investigators, , Australian Ovarian Cancer Study Group, , Isaacs, C, Ito, H, Jakubowska, A, Janavicius, R, Jensen, A, John, EM, Johnson, N, Kabisch, M, Kang, D, Kapuscinski, M, Karlan, BY, Khan, S, Kiemeney, LA, Kjaer, SK, Knight, JA, Konstantopoulou, I, Kosma, V-M, Kristensen, V, Kupryjanczyk, J, Kwong, A, de la Hoya, M, Laitman, Y, Lambrechts, D, Le, N, De Leeneer, K, Lester, J, Levine, DA, Li, J, Lindblom, A, Long, J, Lophatananon, A, Loud, JT, Lu, K, Lubinski, J, Mannermaa, A, Manoukian, S, Le Marchand, L, Margolin, S, Marme, F, Massuger, LFAG, Matsuo, K, Mazoyer, S, McGuffog, L, McLean, C, McNeish, I, Meindl, A, Menon, U, Mensenkamp, AR, Milne, RL, Montagna, M, Moysich, KB, Muir, K, Mulligan, AM, Nathanson, KL, Ness, RB, Neuhausen, SL, Nevanlinna, H, Nord, S, Nussbaum, RL, Odunsi, K, Offit, K, Olah, E, Olopade, OI, Olson, JE, Olswold, C, O'Malley, D, Orlow, I, Orr, N, Osorio, A, Park, SK, Pearce, CL, Pejovic, T, Peterlongo, P, Pfeiler, G, Phelan, CM, Poole, EM, Pylkäs, K, Radice, P, Rantala, J, Rashid, MU, Rennert, G, Rhenius, V, Rhiem, K, Risch, HA, Rodriguez, G, Rossing, MA, Rudolph, A, Salvesen, HB, Sangrajrang, S, Sawyer, EJ, Schildkraut, JM, Schmidt, MK, Schmutzler, RK, Sellers, TA, Seynaeve, C, Shah, M, Shen, C-Y, Shu, X-O, Sieh, W, Singer, CF, Sinilnikova, OM, Slager, S, Song, H, Soucy, P, Southey, MC, Stenmark-Askmalm, M, Stoppa-Lyonnet, D, Sutter, C, Swerdlow, A, Tchatchou, S, Teixeira, MR, Teo, SH, Terry, KL, Terry, MB, Thomassen, M, Tibiletti, MG, Tihomirova, L, Tognazzo, S, Toland, AE, Tomlinson, I, Torres, D, Truong, T, Tseng, C-C, Tung, N, Tworoger, SS, Vachon, C, van den Ouweland, AMW, van Doorn, HC, van Rensburg, EJ, Van't Veer, LJ, Vanderstichele, A, Vergote, I, Vijai, J, Wang, Q, Wang-Gohrke, S, Weitzel, JN, Wentzensen, N, Whittemore, AS, Wildiers, H, Winqvist, R, Wu, AH, Yannoukakos, D, Yoon, S-Y, Yu, J-C, Zheng, W, Zheng, Y, Khanna, KK, Simard, J, Monteiro, AN, French, JD, Couch, FJ, Freedman, ML, Easton, DF, Dunning, AM, Pharoah, PD, Edwards, SL, Chenevix-Trench, G, Antoniou, AC, and Gayther, SA. "Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus." Nature Communications 7 (September 7, 2016): 12675-null. Full Text
  - Cannioto, R, LaMonte, MJ, Risch, HA, Hong, CC, Sucheston-Campbell, LE, Eng, KH, Szender, JB, Chang-Claude, J, Schmalfeldt, B, Klapdor, R, Gower, E, Minlikeeva, AN, Zirpoli, G, Bandera, EV, Berchuck, A, Cramer, D, Doherty, JA, Edwards, RP, Fridley, BL, Goode, EL, Goodman, MT, Hogdall, E, Hosono, S, Jensen, A, Jordan, S, Kjaer, SK, Matsuo, K, Ness, RB, Olsen, CM, Olson, SH, Pearce, CL, Pike, MC, Rossing, MA, Szamreta, EA, Thompson, PJ, Tseng, CC, Vierkant, RA, Webb, PM, Wentzensen, N, Wicklund, KG, Winham, SJ, Wu, AH, Modugno, F, Schildkraut, JM, Terry, KL, Kelemen, LE, and Moysich, KB. "Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium." Obstetrical and Gynecological Survey 71, no. 9 (September 1, 2016): 528-530. Full Text
  - Gaillard, S, Yi, J, Dumbauld, C, Ehrisman, J, Berchuck, A, and Weinhold, K. "Evaluating the Repertoire of Immune Checkpoint Markers Expressed Within Ovarian Cancers." JOURNAL OF WOMENS HEALTH 25, no. 9 (September 2016): 962-962. Link to Item
  - Kar, SP, Beesley, J, Amin Al Olama, A, Michailidou, K, Tyrer, J, Kote-Jarai, Z, Lawrenson, K, Lindstrom, S, Ramus, SJ, Thompson, DJ, ABCTB Investigators, , Kibel, AS, Dansonka-Mieszkowska, A, Michael, A, Dieffenbach, AK, Gentry-Maharaj, A, Whittemore, AS, Wolk, A, Monteiro, A, Peixoto, A, Kierzek, A, Cox, A, Rudolph, A, Gonzalez-Neira, A, Wu, AH, Lindblom, A, Swerdlow, A, AOCS Study Group & Australian Cancer Study (Ovarian Cancer), , APCB BioResource, , Ziogas, A, Ekici, AB, Burwinkel, B, Karlan, BY, Nordestgaard, BG, Blomqvist, C, Phelan, C, McLean, C, Pearce, CL, Vachon, C, Cybulski, C, Slavov, C, Stegmaier, C, Maier, C, Ambrosone, CB, Høgdall, CK, Teerlink, CC, Kang, D, Tessier, DC, Schaid, DJ, Stram, DO, Cramer, DW, Neal, DE, Eccles, D, Flesch-Janys, D, Edwards, DRV, Wokozorczyk, D, Levine, DA, Yannoukakos, D, Sawyer, EJ, Bandera, EV, Poole, EM, Goode, EL, Khusnutdinova, E, Høgdall, E, Song, F, Bruinsma, F, Heitz, F, Modugno, F, Hamdy, FC, Wiklund, F, Giles, GG, Olsson, H, Wildiers, H, Ulmer, H-U, Pandha, H, Risch, HA, Darabi, H, Salvesen, HB, Nevanlinna, H, Gronberg, H, Brenner, H, Brauch, H, Anton-Culver, H, Song, H, Lim, H-Y, McNeish, I, Campbell, I, Vergote, I, Gronwald, J, Lubiński, J, Stanford, JL, Benítez, J, Doherty, JA, Permuth, JB, Chang-Claude, J, Donovan, JL, Dennis, J, Schildkraut, JM, Schleutker, J, Hopper, JL, Kupryjanczyk, J, Park, JY, Figueroa, J, Clements, JA, Knight, JA, Peto, J, Cunningham, JM, Pow-Sang, J, Batra, J, Czene, K, Lu, KH, Herkommer, K, Khaw, K-T, kConFab Investigators, , Matsuo, K, Muir, K, Offitt, K, Chen, K, Moysich, KB, Aittomäki, K, Odunsi, K, Kiemeney, LA, Massuger, LFAG, Fitzgerald, LM, Cook, LS, Cannon-Albright, L, Hooning, MJ, Pike, MC, Bolla, MK, Luedeke, M, Teixeira, MR, Goodman, MT, Schmidt, MK, Riggan, M, Aly, M, Rossing, MA, Beckmann, MW, Moisse, M, Sanderson, M, Southey, MC, Jones, M, Lush, M, Hildebrandt, MAT, Hou, M-F, Schoemaker, MJ, Garcia-Closas, M, Bogdanova, N, Rahman, N, NBCS Investigators, , Le, ND, Orr, N, Wentzensen, N, Pashayan, N, Peterlongo, P, Guénel, P, Brennan, P, Paulo, P, Webb, PM, Broberg, P, Fasching, PA, Devilee, P, Wang, Q, Cai, Q, Li, Q, Kaneva, R, Butzow, R, Kopperud, RK, Schmutzler, RK, Stephenson, RA, MacInnis, RJ, Hoover, RN, Winqvist, R, Ness, R, Milne, RL, Travis, RC, Benlloch, S, Olson, SH, McDonnell, SK, Tworoger, SS, Maia, S, Berndt, S, Lee, SC, Teo, S-H, Thibodeau, SN, Bojesen, SE, Gapstur, SM, Kjær, SK, Pejovic, T, Tammela, TLJ, GENICA Network, , PRACTICAL consortium, , Dörk, T, Brüning, T, Wahlfors, T, Key, TJ, Edwards, TL, Menon, U, Hamann, U, Mitev, V, Kosma, V-M, Setiawan, VW, Kristensen, V, Arndt, V, Vogel, W, Zheng, W, Sieh, W, Blot, WJ, Kluzniak, W, Shu, X-O, Gao, Y-T, Schumacher, F, Freedman, ML, Berchuck, A, Dunning, AM, Simard, J, Haiman, CA, Spurdle, A, Sellers, TA, Hunter, DJ, Henderson, BE, Kraft, P, Chanock, SJ, Couch, FJ, Hall, P, Gayther, SA, Easton, DF, Chenevix-Trench, G, Eeles, R, Pharoah, PDP, and Lambrechts, D. "Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types." Cancer Discovery 6, no. 9 (September 2016): 1052-1067. Full Text
  - Ehrisman, J, Secord, AA, Berchuck, A, Lee, PS, Di Santo, N, Lopez-Acevedo, M, Broadwater, G, Valea, FA, and Havrilesky, LJ. "Performance of sentinel lymph node biopsy in high-risk endometrial cancer." Gynecologic Oncology Reports 17 (August 2016): 69-71. Full Text
  - Lee, AW, Ness, RB, Roman, LD, Terry, KL, Schildkraut, JM, Chang-Claude, J, Doherty, JA, Menon, U, Cramer, DW, Gayther, SA, Risch, H, Gentry-Maharaj, A, Goodman, MT, Modugno, F, Eilber, U, Moysich, KB, Berchuck, A, Rossing, MA, Jensen, A, Wicklund, KG, Cushing-Haugen, KL, Hogdall, E, Rudolph, A, Thompson, PJ, Wilkens, LR, Kjaer, SK, Carney, ME, Stram, DO, Ramus, SJ, Wu, AH, Pike, MC, and Pearce, CL. "Association between menopausal estrogen-only therapy and ovarian carcinoma risk." Obstetrical and Gynecological Survey 71, no. 8 (August 1, 2016): 470-471. Full Text
  - Permuth, JB, Pirie, A, Ann Chen, Y, Lin, H-Y, Reid, BM, Chen, Z, Monteiro, A, Dennis, J, Mendoza-Fandino, G, AOCS Study Group, , Australian Cancer Study (Ovarian Cancer), , Anton-Culver, H, Bandera, EV, Bisogna, M, Brinton, L, Brooks-Wilson, A, Carney, ME, Chenevix-Trench, G, Cook, LS, Cramer, DW, Cunningham, JM, Cybulski, C, D'Aloisio, AA, Anne Doherty, J, Earp, M, Edwards, RP, Fridley, BL, Gayther, SA, Gentry-Maharaj, A, Goodman, MT, Gronwald, J, Hogdall, E, Iversen, ES, Jakubowska, A, Jensen, A, Karlan, BY, Kelemen, LE, Kjaer, SK, Kraft, P, Le, ND, Levine, DA, Lissowska, J, Lubinski, J, Matsuo, K, Menon, U, Modugno, R, Moysich, KB, Nakanishi, T, Ness, RB, Olson, S, Orlow, I, Pearce, CL, Pejovic, T, Poole, EM, Ramus, SJ, Anne Rossing, M, Sandler, DP, Shu, X-O, Song, H, Taylor, JA, Teo, S-H, Terry, KL, Thompson, PJ, Tworoger, SS, Webb, PM, Wentzensen, N, Wilkens, LR, Winham, S, Woo, Y-L, Wu, AH, Yang, H, Zheng, W, Ziogas, A, Phelan, CM, Schildkraut, JM, Berchuck, A, Goode, EL, Pharoah, PDP, Sellers, TA, and Ovarian Cancer Association Consortium, . "Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk." Human Molecular Genetics 25, no. 16 (August 2016): 3600-3612. Full Text
  - Cannioto, R, LaMonte, MJ, Risch, HA, Hong, C-C, Sucheston-Campbell, LE, Eng, KH, Brian Szender, J, Chang-Claude, J, Schmalfeldt, B, Klapdor, R, Gower, E, Minlikeeva, AN, Zirpoli, GR, Bandera, EV, Berchuck, A, Cramer, D, Doherty, JA, Edwards, RP, Fridley, BL, Goode, EL, Goodman, MT, Hogdall, E, Hosono, S, Jensen, A, Jordan, S, Australian Ovarian Cancer Study Group, , Kjaer, SK, Matsuo, K, Ness, RB, Olsen, CM, Olson, SH, Leigh Pearce, C, Pike, MC, Anne Rossing, M, Szamreta, EA, Thompson, PJ, Tseng, C-C, Vierkant, RA, Webb, PM, Wentzensen, N, Wicklund, KG, Winham, SJ, Wu, AH, Modugno, F, Schildkraut, JM, Terry, KL, Kelemen, LE, and Moysich, KB. "Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 25, no. 7 (July 2016): 1114-1124. (Review) Full Text
  - Cuellar-Partida, G, Lu, Y, Dixon, SC, Australian Ovarian Cancer Study, , Fasching, PA, Hein, A, Burghaus, S, Beckmann, MW, Lambrechts, D, Van Nieuwenhuysen, E, Vergote, I, Vanderstichele, A, Doherty, JA, Rossing, MA, Chang-Claude, J, Rudolph, A, Wang-Gohrke, S, Goodman, MT, Bogdanova, N, Dörk, T, Dürst, M, Hillemanns, P, Runnebaum, IB, Antonenkova, N, Butzow, R, Leminen, A, Nevanlinna, H, Pelttari, LM, Edwards, RP, Kelley, JL, Modugno, F, Moysich, KB, Ness, RB, Cannioto, R, Høgdall, E, Høgdall, C, Jensen, A, Giles, GG, Bruinsma, F, Kjaer, SK, Hildebrandt, MAT, Liang, D, Lu, KH, Wu, X, Bisogna, M, Dao, F, Levine, DA, Cramer, DW, Terry, KL, Tworoger, SS, Stampfer, M, Missmer, S, Bjorge, L, Salvesen, HB, Kopperud, RK, Bischof, K, Aben, KKH, Kiemeney, LA, Massuger, LFAG, Brooks-Wilson, A, Olson, SH, McGuire, V, Rothstein, JH, Sieh, W, Whittemore, AS, Cook, LS, Le, ND, Blake Gilks, C, Gronwald, J, Jakubowska, A, Lubiński, J, Kluz, T, Song, H, Tyrer, JP, Wentzensen, N, Brinton, L, Trabert, B, Lissowska, J, McLaughlin, JR, Narod, SA, Phelan, C, Anton-Culver, H, Ziogas, A, Eccles, D, Campbell, I, Gayther, SA, Gentry-Maharaj, A, Menon, U, Ramus, SJ, Wu, AH, Dansonka-Mieszkowska, A, Kupryjanczyk, J, Timorek, A, Szafron, L, Cunningham, JM, Fridley, BL, Winham, SJ, Bandera, EV, Poole, EM, Morgan, TK, Goode, EL, Schildkraut, JM, Pearce, CL, Berchuck, A, Pharoah, PDP, Webb, PM, Chenevix-Trench, G, Risch, HA, and MacGregor, S. "Assessing the genetic architecture of epithelial ovarian cancer histological subtypes." Human Genetics 135, no. 7 (July 2016): 741-756. Full Text
  - Cannioto, RA, LaMonte, MJ, Kelemen, LE, Risch, HA, Eng, KH, Minlikeeva, AN, Hong, C-C, Szender, JB, Sucheston-Campbell, L, Joseph, JM, Berchuck, A, Chang-Claude, J, Cramer, DW, DeFazio, A, Diergaarde, B, Dörk, T, Doherty, JA, Edwards, RP, Fridley, BL, Friel, G, Goode, EL, Goodman, MT, Hillemanns, P, Hogdall, E, Hosono, S, Kelley, JL, Kjaer, SK, Klapdor, R, Matsuo, K, Odunsi, K, Nagle, CM, Olsen, CM, Paddock, LE, Pearce, CL, Pike, MC, Rossing, MA, Schmalfeldt, B, Segal, BH, Szamreta, EA, Thompson, PJ, Tseng, C-C, Vierkant, R, Schildkraut, JM, Wentzensen, N, Wicklund, KG, Winham, SJ, Wu, AH, Modugno, F, Ness, RB, Jensen, A, Webb, PM, Terry, K, Bandera, EV, and Moysich, KB. "Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium." British Journal of Cancer 115, no. 1 (June 14, 2016): 95-101. (Letter) Full Text
  - "What Women and Their Physicians Need to Know About the UKCTOCS Study and Ovarian Cancer Screening." American Family Physician 93, no. 11 (June 2016): 903-904.
  - Dixon, SC, Nagle, CM, Thrift, AP, Pharoah, PD, Pearce, CL, Zheng, W, Painter, JN, AOCS Group & Australian Cancer Study (Ovarian Cancer), , Chenevix-Trench, G, Fasching, PA, Beckmann, MW, Lambrechts, D, Vergote, I, Lambrechts, S, Van Nieuwenhuysen, E, Rossing, MA, Doherty, JA, Wicklund, KG, Chang-Claude, J, Rudolph, A, Moysich, KB, Odunsi, K, Goodman, MT, Wilkens, LR, Thompson, PJ, Shvetsov, YB, Dörk, T, Park-Simon, T-W, Hillemanns, P, Bogdanova, N, Butzow, R, Nevanlinna, H, Pelttari, LM, Leminen, A, Modugno, F, Ness, RB, Edwards, RP, Kelley, JL, Heitz, F, Karlan, BY, Kjær, SK, Høgdall, E, Jensen, A, Goode, EL, Fridley, BL, Cunningham, JM, Winham, SJ, Giles, GG, Bruinsma, F, Milne, RL, Southey, MC, Hildebrandt, MAT, Wu, X, Lu, KH, Liang, D, Levine, DA, Bisogna, M, Schildkraut, JM, Berchuck, A, Cramer, DW, Terry, KL, Bandera, EV, Olson, SH, Salvesen, HB, Thomsen, LC, Kopperud, RK, Bjorge, L, Kiemeney, LA, Massuger, LFAG, Pejovic, T, Cook, LS, Le, ND, Swenerton, KD, Brooks-Wilson, A, Kelemen, LE, Lubiński, J, Huzarski, T, Gronwald, J, Menkiszak, J, Wentzensen, N, Brinton, L, Yang, H, Lissowska, J, Høgdall, CK, Lundvall, L, Song, H, Tyrer, JP, Campbell, I, Eccles, D, Paul, J, Glasspool, R, Siddiqui, N, Whittemore, AS, Sieh, W, McGuire, V, Rothstein, JH, Narod, SA, Phelan, C, Risch, HA, McLaughlin, JR, Anton-Culver, H, Ziogas, A, Menon, U, Gayther, SA, Ramus, SJ, Gentry-Maharaj, A, Wu, AH, Pike, MC, Tseng, C-C, Kupryjanczyk, J, Dansonka-Mieszkowska, A, Budzilowska, A, Spiewankiewicz, B, Webb, PM, and Ovarian Cancer Association Consortium, . "Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study." International Journal of Epidemiology 45, no. 3 (June 2016): 884-895. Full Text
  - Erondu, CO, Alberg, AJ, Bandera, EV, Barnholtz-Sloan, J, Bondy, M, Cote, ML, Funkhouser, E, Peters, E, Schwartz, AG, Terry, PD, Wallace, K, Akushevich, L, Wang, F, Crankshaw, S, Berchuck, A, Schildkraut, JM, and Moorman, PG. "The Association Between Body Mass Index and Presenting Symptoms in African American Women with Ovarian Cancer." Journal of Women'S Health (2002) 25, no. 6 (June 2016): 571-578. Full Text
  - Witkowski, L, Goudie, C, Ramos, P, Boshari, T, Brunet, J-S, Karnezis, AN, Longy, M, Knost, JA, Saloustros, E, McCluggage, WG, Stewart, CJR, Hendricks, WPD, Cunliffe, H, Huntsman, DG, Pautier, P, Levine, DA, Trent, JM, Berchuck, A, Hasselblatt, M, and Foulkes, WD. "The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type." Gynecologic oncology 141, no. 3 (June 2016): 454-460. Full Text
  - Lee, AW, Ness, RB, Roman, LD, Terry, KL, Schildkraut, JM, Chang-Claude, J, Doherty, JA, Menon, U, Cramer, DW, Gayther, SA, Risch, H, Gentry-Maharaj, A, Goodman, MT, Modugno, F, Eilber, U, Moysich, KB, Berchuck, A, Rossing, MA, Jensen, A, Wicklund, KG, Cushing-Haugen, KL, Hogdall, E, Rudolph, A, Thompson, PJ, Wilkens, LR, Kjaer, SK, Carney, ME, Stram, DO, Ramus, SJ, Wu, AH, Pike, MC, Pearce, CL, and Ovarian Cancer Association Consortium, . "Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk." Obstetrics and Gynecology 127, no. 5 (May 2016): 828-836. Full Text
  - Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, and Consortium of Modifiers of BRCA1 and BRCA2, , Hollestelle, A, van der Baan, FH, Berchuck, A, Johnatty, SE, Aben, KK, Agnarsson, BA, Aittomäki, K, Alducci, E, Andrulis, IL, Anton-Culver, H, Antonenkova, NN, Antoniou, AC, Apicella, C, Arndt, V, Arnold, N, Arun, BK, Arver, B, Ashworth, A, Australian Ovarian Cancer Study Group, , Baglietto, L, Balleine, R, Bandera, EV, Barrowdale, D, Bean, YT, Beckmann, L, Beckmann, MW, Benitez, J, Berger, A, Berger, R, Beuselinck, B, Bisogna, M, Bjorge, L, Blomqvist, C, Bogdanova, NV, Bojesen, A, Bojesen, SE, Bolla, MK, Bonanni, B, Brand, JS, Brauch, H, Breast Cancer Family Register, , Brenner, H, Brinton, L, Brooks-Wilson, A, Bruinsma, F, Brunet, J, Brüning, T, Budzilowska, A, Bunker, CH, Burwinkel, B, Butzow, R, Buys, SS, Caligo, MA, Campbell, I, Carter, J, Chang-Claude, J, Chanock, SJ, Claes, KBM, Collée, JM, Cook, LS, Couch, FJ, Cox, A, Cramer, D, Cross, SS, Cunningham, JM, Cybulski, C, Czene, K, Damiola, F, Dansonka-Mieszkowska, A, Darabi, H, de la Hoya, M, deFazio, A, Dennis, J, Devilee, P, Dicks, EM, Diez, O, Doherty, JA, Domchek, SM, Dorfling, CM, Dörk, T, Silva, IDS, du Bois, A, Dumont, M, Dunning, AM, Duran, M, Easton, DF, Eccles, D, Edwards, RP, Ehrencrona, H, Ejlertsen, B, Ekici, AB, Ellis, SD, EMBRACE, , Engel, C, Eriksson, M, Fasching, PA, Feliubadalo, L, Figueroa, J, Flesch-Janys, D, Fletcher, O, Fontaine, A, Fortuzzi, S, Fostira, F, Fridley, BL, Friebel, T, Friedman, E, Friel, G, Frost, D, Garber, J, García-Closas, M, Gayther, SA, GEMO Study Collaborators, , GENICA Network, , Gentry-Maharaj, A, Gerdes, A-M, Giles, GG, Glasspool, R, Glendon, G, Godwin, AK, Goodman, MT, Gore, M, Greene, MH, Grip, M, Gronwald, J, Gschwantler Kaulich, D, Guénel, P, Guzman, SR, Haeberle, L, Haiman, CA, Hall, P, Halverson, SL, Hamann, U, Hansen, TVO, Harter, P, Hartikainen, JM, Healey, S, HEBON, , Hein, A, Heitz, F, Henderson, BE, Herzog, J, T Hildebrandt, MA, Høgdall, CK, Høgdall, E, Hogervorst, FBL, Hopper, JL, Humphreys, K, Huzarski, T, Imyanitov, EN, Isaacs, C, Jakubowska, A, Janavicius, R, Jaworska, K, Jensen, A, Jensen, UB, Johnson, N, Jukkola-Vuorinen, A, Kabisch, M, Karlan, BY, Kataja, V, Kauff, N, KConFab Investigators, , Kelemen, LE, Kerin, MJ, Kiemeney, LA, Kjaer, SK, Knight, JA, Knol-Bout, JP, Konstantopoulou, I, Kosma, V-M, Krakstad, C, Kristensen, V, Kuchenbaecker, KB, Kupryjanczyk, J, Laitman, Y, Lambrechts, D, Lambrechts, S, Larson, MC, Lasa, A, Laurent-Puig, P, Lazaro, C, Le, ND, Le Marchand, L, Leminen, A, Lester, J, Levine, DA, Li, J, Liang, D, Lindblom, A, Lindor, N, Lissowska, J, Long, J, Lu, KH, Lubinski, J, Lundvall, L, Lurie, G, Mai, PL, Mannermaa, A, Margolin, S, Mariette, F, Marme, F, Martens, JWM, Massuger, LFAG, Maugard, C, Mazoyer, S, McGuffog, L, McGuire, V, McLean, C, McNeish, I, Meindl, A, Menegaux, F, Menéndez, P, Menkiszak, J, Menon, U, Mensenkamp, AR, Miller, N, Milne, RL, Modugno, F, Montagna, M, Moysich, KB, Müller, H, Mulligan, AM, Muranen, TA, Narod, SA, Nathanson, KL, Ness, RB, Neuhausen, SL, Nevanlinna, H, Neven, P, Nielsen, FC, Nielsen, SF, Nordestgaard, BG, Nussbaum, RL, Odunsi, K, Offit, K, Olah, E, Olopade, OI, Olson, JE, Olson, SH, Oosterwijk, JC, Orlow, I, Orr, N, Orsulic, S, Osorio, A, Ottini, L, Paul, J, Pearce, CL, Pedersen, IS, Peissel, B, Pejovic, T, Pelttari, LM, Perkins, J, Permuth-Wey, J, Peterlongo, P, Peto, J, Phelan, CM, Phillips, K-A, Piedmonte, M, Pike, MC, Platte, R, Plisiecka-Halasa, J, Poole, EM, Poppe, B, Pylkäs, K, Radice, P, Ramus, SJ, Rebbeck, TR, Reed, MWR, Rennert, G, Risch, HA, Robson, M, Rodriguez, GC, Romero, A, Rossing, MA, Rothstein, JH, Rudolph, A, Runnebaum, I, Salani, R, Salvesen, HB, Sawyer, EJ, Schildkraut, JM, Schmidt, MK, Schmutzler, RK, Schneeweiss, A, Schoemaker, MJ, Schrauder, MG, Schumacher, F, Schwaab, I, Scuvera, G, Sellers, TA, Severi, G, Seynaeve, CM, Shah, M, Shrubsole, M, Siddiqui, N, Sieh, W, Simard, J, Singer, CF, Sinilnikova, OM, Smeets, D, Sohn, C, Soller, M, Song, H, Soucy, P, Southey, MC, Stegmaier, C, Stoppa-Lyonnet, D, Sucheston, L, SWE-BRCA, , Swerdlow, A, Tangen, IL, Tea, M-K, Teixeira, MR, Terry, KL, Terry, MB, Thomassen, M, Thompson, PJ, Tihomirova, L, Tischkowitz, M, Toland, AE, Tollenaar, RAEM, Tomlinson, I, Torres, D, Truong, T, Tsimiklis, H, Tung, N, Tworoger, SS, Tyrer, JP, Vachon, CM, Van 't Veer, LJ, van Altena, AM, Van Asperen, CJ, van den Berg, D, van den Ouweland, AMW, van Doorn, HC, Van Nieuwenhuysen, E, van Rensburg, EJ, Vergote, I, Verhoef, S, Vierkant, RA, Vijai, J, Vitonis, AF, von Wachenfeldt, A, Walsh, C, Wang, Q, Wang-Gohrke, S, Wappenschmidt, B, Weischer, M, Weitzel, JN, Weltens, C, Wentzensen, N, Whittemore, AS, Wilkens, LR, Winqvist, R, Wu, AH, Wu, X, Yang, HP, Zaffaroni, D, Pilar Zamora, M, Zheng, W, Ziogas, A, Chenevix-Trench, G, Pharoah, PDP, Rookus, MA, Hooning, MJ, and Goode, EL. "No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer." Gynecologic Oncology 141, no. 2 (May 2016): 386-401. (Review) Full Text
  - Usset, JL, Raghavan, R, Tyrer, JP, McGuire, V, Sieh, W, Webb, P, Chang-Claude, J, Rudolph, A, Anton-Culver, H, Berchuck, A, Brinton, L, Cunningham, JM, DeFazio, A, Doherty, JA, Edwards, RP, Gayther, SA, Gentry-Maharaj, A, Goodman, MT, Høgdall, E, Jensen, A, Johnatty, SE, Kiemeney, LA, Kjaer, SK, Larson, MC, Lurie, G, Massuger, L, Menon, U, Modugno, F, Moysich, KB, Ness, RB, Pike, MC, Ramus, SJ, Rossing, MA, Rothstein, J, Song, H, Thompson, PJ, van den Berg, DJ, Vierkant, RA, Wang-Gohrke, S, Wentzensen, N, Whittemore, AS, Wilkens, LR, Wu, AH, Yang, H, Pearce, CL, Schildkraut, JM, Pharoah, P, Goode, EL, Fridley, BL, and Ovarian Cancer Association Consortium and the Australian Cancer Study, . "Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 25, no. 5 (May 2016): 780-790. Full Text
  - Præstegaard, C, Kjaer, SK, Nielsen, TSS, Jensen, SM, Webb, PM, Nagle, CM, Høgdall, E, Risch, HA, Rossing, MA, Doherty, JA, Wicklund, KG, Goodman, MT, Modugno, F, Moysich, K, Ness, RB, Edwards, RP, Goode, EL, Winham, SJ, Fridley, BL, Cramer, DW, Terry, KL, Schildkraut, JM, Berchuck, A, Bandera, EV, Paddock, L, Kiemeney, LA, Massuger, LF, Wentzensen, N, Pharoah, P, Song, H, Whittemore, AS, McGuire, V, Sieh, W, Rothstein, J, Anton-Culver, H, Ziogas, A, Menon, U, Gayther, SA, Ramus, SJ, Gentry-Maharaj, A, Wu, AH, Pearce, CL, Pike, MC, Lee, AW, Chang-Claude, J, Jensen, A, and Ovarian Cancer Association Consortium, . "The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies." Cancer Epidemiology 41 (April 2016): 71-79. Full Text
  - Brancu, M, Mann-Wrobel, M, Beckham, JC, Wagner, HR, Elliott, A, Robbins, AT, Wong, M, Berchuck, AE, and Runnals, JJ. "Subthreshold posttraumatic stress disorder: A meta-analytic review of DSM-IV prevalence and a proposed DSM-5 approach to measurement." Psychological Trauma : Theory, Research, Practice and Policy 8, no. 2 (March 2016): 222-232. Full Text
  - Winham, SJ, Pirie, A, Chen, YA, Larson, MC, Fogarty, ZC, Earp, MA, Anton-Culver, H, Bandera, EV, Cramer, D, Doherty, JA, Goodman, MT, Gronwald, J, Karlan, BY, Kjaer, SK, Levine, DA, Menon, U, Ness, RB, Pearce, CL, Pejovic, T, Rossing, MA, Wentzensen, N, Bean, YT, Bisogna, M, Brinton, LA, Carney, ME, Cunningham, JM, Cybulski, C, deFazio, A, Dicks, EM, Edwards, RP, Gayther, SA, Gentry-Maharaj, A, Gore, M, Iversen, ES, Jensen, A, Johnatty, SE, Lester, J, Lin, H-Y, Lissowska, J, Lubinski, J, Menkiszak, J, Modugno, F, Moysich, KB, Orlow, I, Pike, MC, Ramus, SJ, Song, H, Terry, KL, Thompson, PJ, Tyrer, JP, van den Berg, DJ, Vierkant, RA, Vitonis, AF, Walsh, C, Wilkens, LR, Wu, AH, Yang, H, Ziogas, A, Berchuck, A, Chenevix-Trench, G, Schildkraut, JM, Permuth-Wey, J, Phelan, CM, Pharoah, PDP, Fridley, BL, Sellers, TA, Goode, EL, and Australian Ovarian Cancer Study Group, . "Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 25, no. 3 (March 2016): 446-454. Full Text
  - Earp, M, Winham, SJ, Larson, N, Permuth, JB, Sicotte, H, Chien, J, Anton-Culver, H, Bandera, EV, Berchuck, A, Cook, LS, Cramer, D, Doherty, JA, Goodman, MT, Levine, DA, Monteiro, ANA, Ness, RB, Pearce, CL, Rossing, MA, Tworoger, SS, Wentzensen, N, Bisogna, M, Brinton, L, Brooks-Wilson, A, Carney, ME, Cunningham, JM, Edwards, RP, Fogarty, ZC, Iversen, ES, Kraft, P, Larson, MC, Le, ND, Lin, H-Y, Lissowska, J, Modugno, F, Moysich, KB, Olson, SH, Pike, MC, Poole, EM, Rider, DN, Terry, KL, Thompson, PJ, van den Berg, D, Vierkant, RA, Vitonis, AF, Wilkens, LR, Wu, AH, Yang, HP, Ziogas, A, Phelan, CM, Schildkraut, JM, Chen, YA, Sellers, TA, Fridley, BL, and Goode, EL. "A targeted genetic association study of epithelial ovarian cancer susceptibility." Oncotarget 7, no. 7 (February 2016): 7381-7389. Full Text
  - French, JD, Johnatty, SE, Lu, Y, Beesley, J, Gao, B, Kalimutho, M, Henderson, MJ, Russell, AJ, Kar, S, Chen, X, Hillman, KM, Kaufmann, S, Sivakumaran, H, O'Reilly, M, Wang, C, Korbie, DJ, Australian Ovarian Cancer Study Group, , Australian Ovarian Cancer Study, , Lambrechts, D, Despierre, E, Van Nieuwenhuysen, E, Lambrechts, S, Vergote, I, Karlan, B, Lester, J, Orsulic, S, Walsh, C, Fasching, PA, Beckmann, MW, Ekici, AB, Hein, A, Matsuo, K, Hosono, S, Pisterer, J, Hillemanns, P, Nakanishi, T, Yatabe, Y, Goodman, MT, Lurie, G, Matsuno, RK, Thompson, PJ, Pejovic, T, Bean, Y, Heitz, F, Harter, P, du Bois, A, Schwaab, I, Hogdall, E, Kjaer, SK, Jensen, A, Hogdall, C, Lundvall, L, Engelholm, SA, Brown, B, Flanagan, JM, Metcalf, MD, Siddiqui, N, Sellers, T, Fridley, B, Cunningham, J, Schildkraut, JM, Iversen, E, Weber, RP, Brennan, D, Berchuck, A, Pharoah, P, Harnett, P, Norris, MD, Haber, M, Goode, EL, Lee, JS, Khanna, KK, Meyer, KB, Chenevix-Trench, G, deFazio, A, Edwards, SL, MacGregor, S, and Ovarian Cancer Association Consortium, . "Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer." Oncotarget 7, no. 6 (February 2016): 6353-6368. Full Text
  - Lin, H-Y, Xiong, Y, Tyrer, J, Marchion, DC, Monteiro, AN, Berchuck, A, Schildkraut, JM, Goode, EL, Ramus, SJ, Gayther, SA, Pharoah, PD, Narod, SA, Sellers, TA, and Phelan, CM. "Abstract B27: Investigation of small GTPase genes in epithelial ovarian cancer." Clinical Cancer Research 22, no. 2 Supplement (January 15, 2016): B27-B27. Full Text
  - Lee, AW, Templeman, C, Stram, DA, Beesley, J, Tyrer, J, Berchuck, A, Pharoah, PP, Chenevix-Trench, G, Pearce, CL, and Ovarian Cancer Association Consortium, . "Evidence of a genetic link between endometriosis and ovarian cancer." Fertility and Sterility 105, no. 1 (January 2016): 35-43.e1-10-null. Full Text
  - Bolton, KL, Tyrer, J, Song, H, Ramus, SJ, Notaridou, M, Jones, C, Sher, T, Gentry-Maharaj, A, Wozniak, E, Tsai, YY, Weidhaas, J, Paik, D, Van Den Berg, DJ, Stram, DO, Pearce, CL, Wu, AH, Brewster, W, Anton-Culver, H, Ziogas, A, Narod, SA, Levine, DA, Kaye, SB, Brown, R, Paul, J, Flanagan, J, Sieh, W, Mcguire, V, Whittemore, AS, Campbell, I, Gore, ME, Lissowska, J, Yang, HP, Medrek, K, Gronwald, J, Lubinski, J, Jakubowska, A, Le, ND, Cook, LS, Kelemen, LE, Brooks-Wilson, A, Massuger, LFAG, Kiemeney, LA, Aben, KKH, Van Altena, AM, Houlston, R, Tomlinson, I, Palmieri, RT, Moorman, PG, Schildkraut, J, Iversen, ES, Phelan, C, Vierkant, RA, Cunningham, JM, Goode, EL, Fridley, BL, Kruger-Kjaer, S, Blaeker, J, Hogdall, E, Hogdall, C, Gross, J, Karlan, BY, Ness, RB, Edwards, RP, Odunsi, K, Moyisch, KB, Baker, JA, Modugno, F, Heikkinenen, T, Butzow, R, Nevanlinna, H, Leminen, A, Bogdanova, N, Antonenkova, N, Doerk, T, Hillemanns, P, Dürst, M, Runnebaum, I, Thompson, PJ, Carney, ME, Goodman, MT, Lurie, G, Wang-Gohrke, S, Hein, R, Chang-Claude, J, Rossing, MA, Cushing-Haugen, KL, Doherty, J, Chen, C, Rafnar, T, Besenbacher, S, Sulem, P, Stefansson, K, Birrer, MJ, Terry, KL, Hernandez, D, Cramer, DW, Vergote, I, Amant, F, Lambrechts, D, and Despierre, E. "Erratum: Common variants at 19p13 are associated with susceptibility to ovarian cancer (Nature Genetics (2010) 42 (880-884))." Nature Genetics 48, no. 1 (December 29, 2016): 101-null. Full Text
  - Amankwah, EK, Lin, H-Y, Tyrer, JP, Lawrenson, K, Dennis, J, Chornokur, G, Aben, KKH, Anton-Culver, H, Antonenkova, N, Bruinsma, F, Bandera, EV, Bean, YT, Beckmann, MW, Bisogna, M, Bjorge, L, Bogdanova, N, Brinton, LA, Brooks-Wilson, A, Bunker, CH, Butzow, R, Campbell, IG, Carty, K, Chen, Z, Chen, YA, Chang-Claude, J, Cook, LS, Cramer, DW, Cunningham, JM, Cybulski, C, Dansonka-Mieszkowska, A, du Bois, A, Despierre, E, Dicks, E, Doherty, JA, Dörk, T, Dürst, M, Easton, DF, Eccles, DM, Edwards, RP, Ekici, AB, Fasching, PA, Fridley, BL, Gao, Y-T, Gentry-Maharaj, A, Giles, GG, Glasspool, R, Goodman, MT, Gronwald, J, Harrington, P, Harter, P, Hasmad, HN, Hein, A, Heitz, F, Hildebrandt, MAT, Hillemanns, P, Hogdall, CK, Hogdall, E, Hosono, S, Iversen, ES, Jakubowska, A, Jensen, A, Ji, B-T, Karlan, BY, Jim, H, Kellar, M, Kiemeney, LA, Krakstad, C, Kjaer, SK, Kupryjanczyk, J, Lambrechts, D, Lambrechts, S, Le, ND, Lee, AW, Lele, S, Leminen, A, Lester, J, Levine, DA, Liang, D, Lim, BK, Lissowska, J, Lu, K, Lubinski, J, Lundvall, L, Massuger, LFAG, Matsuo, K, McGuire, V, McLaughlin, JR, McNeish, I, Menon, U, Milne, RL, Modugno, F, Moysich, KB, Ness, RB, Nevanlinna, H, Eilber, U, Odunsi, K, Olson, SH, Orlow, I, Orsulic, S, Weber, RP, Paul, J, Pearce, CL, Pejovic, T, Pelttari, LM, Permuth-Wey, J, Pike, MC, Poole, EM, Risch, HA, Rosen, B, Rossing, MA, Rothstein, JH, Rudolph, A, Runnebaum, IB, Rzepecka, IK, Salvesen, HB, Schernhammer, E, Schwaab, I, Shu, X-O, Shvetsov, YB, Siddiqui, N, Sieh, W, Song, H, Southey, MC, Spiewankiewicz, B, Sucheston-Campbell, L, Teo, S-H, Terry, KL, Thompson, PJ, Thomsen, L, Tangen, IL, Tworoger, SS, van Altena, AM, Vierkant, RA, Vergote, I, Walsh, CS, Wang-Gohrke, S, Wentzensen, N, Whittemore, AS, Wicklund, KG, Wilkens, LR, Wu, AH, Wu, X, Woo, Y-L, Yang, H, Zheng, W, Ziogas, A, Kelemen, LE, Berchuck, A, Georgia Chenevix-Trench on behalf of the AOCS management group, , Schildkraut, JM, Ramus, SJ, Goode, EL, Monteiro, ANA, Gayther, SA, Narod, SA, Pharoah, PDP, Sellers, TA, and Phelan, CM. "Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk." Genetic Epidemiology 39, no. 8 (December 2015): 689-697. Full Text
  - Johnatty, SE, Tyrer, JP, Kar, S, Beesley, J, Lu, Y, Gao, B, Fasching, PA, Hein, A, Ekici, AB, Beckmann, MW, Lambrechts, D, Van Nieuwenhuysen, E, Vergote, I, Lambrechts, S, Rossing, MA, Doherty, JA, Chang-Claude, J, Modugno, F, Ness, RB, Moysich, KB, Levine, DA, Kiemeney, LA, Massuger, LFAG, Gronwald, J, Lubiński, J, Jakubowska, A, Cybulski, C, Brinton, L, Lissowska, J, Wentzensen, N, Song, H, Rhenius, V, Campbell, I, Eccles, D, Sieh, W, Whittemore, AS, McGuire, V, Rothstein, JH, Sutphen, R, Anton-Culver, H, Ziogas, A, Gayther, SA, Gentry-Maharaj, A, Menon, U, Ramus, SJ, Pearce, CL, Pike, MC, Stram, DO, Wu, AH, Kupryjanczyk, J, Dansonka-Mieszkowska, A, Rzepecka, IK, Spiewankiewicz, B, Goodman, MT, Wilkens, LR, Carney, ME, Thompson, PJ, Heitz, F, du Bois, A, Schwaab, I, Harter, P, Pisterer, J, Hillemanns, P, AGO Study Group, , Karlan, BY, Walsh, C, Lester, J, Orsulic, S, Winham, SJ, Earp, M, Larson, MC, Fogarty, ZC, Høgdall, E, Jensen, A, Kjaer, SK, Fridley, BL, Cunningham, JM, Vierkant, RA, Schildkraut, JM, Iversen, ES, Terry, KL, Cramer, DW, Bandera, EV, Orlow, I, Pejovic, T, Bean, Y, Høgdall, C, Lundvall, L, McNeish, I, Paul, J, Carty, K, Siddiqui, N, Glasspool, R, Sellers, T, Kennedy, C, Chiew, Y-E, Berchuck, A, MacGregor, S, Pharoah, PDP, Goode, EL, deFazio, A, Webb, PM, Chenevix-Trench, G, and Australian Ovarian Cancer Study Group, . "Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 21, no. 23 (December 2015): 5264-5276. Full Text
  - Lawrenson, K, Iversen, ES, Tyrer, J, Weber, RP, Concannon, P, Hazelett, DJ, Li, Q, Marks, JR, Berchuck, A, Lee, JM, Aben, KKH, Anton-Culver, H, Antonenkova, N, Australian Cancer Study (Ovarian Cancer), , Australian Ovarian Cancer Study Group, , Bandera, EV, Bean, Y, Beckmann, MW, Bisogna, M, Bjorge, L, Bogdanova, N, Brinton, LA, Brooks-Wilson, A, Bruinsma, F, Butzow, R, Campbell, IG, Carty, K, Chang-Claude, J, Chenevix-Trench, G, Chen, A, Chen, Z, Cook, LS, Cramer, DW, Cunningham, JM, Cybulski, C, Plisiecka-Halasa, J, Dennis, J, Dicks, E, Doherty, JA, Dörk, T, du Bois, A, Eccles, D, Easton, DT, Edwards, RP, Eilber, U, Ekici, AB, Fasching, PA, Fridley, BL, Gao, Y-T, Gentry-Maharaj, A, Giles, GG, Glasspool, R, Goode, EL, Goodman, MT, Gronwald, J, Harter, P, Hasmad, HN, Hein, A, Heitz, F, Hildebrandt, MAT, Hillemanns, P, Hogdall, E, Hogdall, C, Hosono, S, Jakubowska, A, Paul, J, Jensen, A, Karlan, BY, Kjaer, SK, Kelemen, LE, Kellar, M, Kelley, JL, Kiemeney, LA, Krakstad, C, Lambrechts, D, Lambrechts, S, Le, ND, Lee, AW, Cannioto, R, Leminen, A, Lester, J, Levine, DA, Liang, D, Lissowska, J, Lu, K, Lubinski, J, Lundvall, L, Massuger, LFAG, Matsuo, K, McGuire, V, McLaughlin, JR, Nevanlinna, H, McNeish, I, Menon, U, Modugno, F, Moysich, KB, Narod, SA, Nedergaard, L, Ness, RB, Noor Azmi, MA, Odunsi, K, Olson, SH, Orlow, I, Orsulic, S, Pearce, CL, Pejovic, T, Pelttari, LM, Permuth-Wey, J, Phelan, CM, Pike, MC, Poole, EM, Ramus, SJ, Risch, HA, Rosen, B, Rossing, MA, Rothstein, JH, Rudolph, A, Runnebaum, IB, Rzepecka, IK, Salvesen, HB, Budzilowska, A, Sellers, TA, Shu, X-O, Shvetsov, YB, Siddiqui, N, Sieh, W, Song, H, Southey, MC, Sucheston, L, Tangen, IL, Teo, S-H, Terry, KL, Thompson, PJ, Timorek, A, Tworoger, SS, Van Nieuwenhuysen, E, Vergote, I, Vierkant, RA, Wang-Gohrke, S, Walsh, C, Wentzensen, N, Whittemore, AS, Wicklund, KG, Wilkens, LR, Woo, Y-L, Wu, X, Wu, AH, Yang, H, Zheng, W, Ziogas, A, Coetzee, GA, Freedman, ML, Monteiro, ANA, Moes-Sosnowska, J, Kupryjanczyk, J, Pharoah, PD, Gayther, SA, and Schildkraut, JM. "Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer." Carcinogenesis 36, no. 11 (November 2015): 1341-1353. Full Text
  - Kar, SP, Tyrer, JP, Li, Q, Lawrenson, K, Aben, KKH, Anton-Culver, H, Antonenkova, N, Chenevix-Trench, G, Australian Cancer Study, , Australian Ovarian Cancer Study Group, , Baker, H, Bandera, EV, Bean, YT, Beckmann, MW, Berchuck, A, Bisogna, M, Bjørge, L, Bogdanova, N, Brinton, L, Brooks-Wilson, A, Butzow, R, Campbell, I, Carty, K, Chang-Claude, J, Chen, YA, Chen, Z, Cook, LS, Cramer, D, Cunningham, JM, Cybulski, C, Dansonka-Mieszkowska, A, Dennis, J, Dicks, E, Doherty, JA, Dörk, T, du Bois, A, Dürst, M, Eccles, D, Easton, DF, Edwards, RP, Ekici, AB, Fasching, PA, Fridley, BL, Gao, Y-T, Gentry-Maharaj, A, Giles, GG, Glasspool, R, Goode, EL, Goodman, MT, Grownwald, J, Harrington, P, Harter, P, Hein, A, Heitz, F, Hildebrandt, MAT, Hillemanns, P, Hogdall, E, Hogdall, CK, Hosono, S, Iversen, ES, Jakubowska, A, Paul, J, Jensen, A, Ji, B-T, Karlan, BY, Kjaer, SK, Kelemen, LE, Kellar, M, Kelley, J, Kiemeney, LA, Krakstad, C, Kupryjanczyk, J, Lambrechts, D, Lambrechts, S, Le, ND, Lee, AW, Lele, S, Leminen, A, Lester, J, Levine, DA, Liang, D, Lissowska, J, Lu, K, Lubinski, J, Lundvall, L, Massuger, L, Matsuo, K, McGuire, V, McLaughlin, JR, McNeish, IA, Menon, U, Modugno, F, Moysich, KB, Narod, SA, Nedergaard, L, Ness, RB, Nevanlinna, H, Odunsi, K, Olson, SH, Orlow, I, Orsulic, S, Weber, RP, Pearce, CL, Pejovic, T, Pelttari, LM, Permuth-Wey, J, Phelan, CM, Pike, MC, Poole, EM, Ramus, SJ, Risch, HA, Rosen, B, Rossing, MA, Rothstein, JH, Rudolph, A, Runnebaum, IB, Rzepecka, IK, Salvesen, HB, Schildkraut, JM, Schwaab, I, Shu, X-O, Shvetsov, YB, Siddiqui, N, Sieh, W, Song, H, Southey, MC, Sucheston-Campbell, LE, Tangen, IL, Teo, S-H, Terry, KL, Thompson, PJ, Timorek, A, Tsai, Y-Y, Tworoger, SS, van Altena, AM, Van Nieuwenhuysen, E, Vergote, I, Vierkant, RA, Wang-Gohrke, S, Walsh, C, Wentzensen, N, Whittemore, AS, Wicklund, KG, Wilkens, LR, Woo, Y-L, Wu, X, Wu, A, Yang, H, Zheng, W, Ziogas, A, Sellers, TA, Monteiro, ANA, Freedman, ML, Gayther, SA, and Pharoah, PDP. "Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 24, no. 10 (October 2015): 1574-1584. (Review) Full Text
  - Lu, Y, Cuellar-Partida, G, Painter, JN, Nyholt, DR, Australian Ovarian Cancer Study, , International Endogene Consortium (IEC), , Morris, AP, Fasching, PA, Hein, A, Burghaus, S, Beckmann, MW, Lambrechts, D, Van Nieuwenhuysen, E, Vergote, I, Vanderstichele, A, Doherty, JA, Rossing, MA, Wicklund, KG, Chang-Claude, J, Eilber, U, Rudolph, A, Wang-Gohrke, S, Goodman, MT, Bogdanova, N, Dörk, T, Dürst, M, Hillemanns, P, Runnebaum, IB, Antonenkova, N, Butzow, R, Leminen, A, Nevanlinna, H, Pelttari, LM, Edwards, RP, Kelley, JL, Modugno, F, Moysich, KB, Ness, RB, Cannioto, R, Høgdall, E, Jensen, A, Giles, GG, Bruinsma, F, Kjaer, SK, Hildebrandt, MAT, Liang, D, Lu, KH, Wu, X, Bisogna, M, Dao, F, Levine, DA, Cramer, DW, Terry, KL, Tworoger, SS, Missmer, S, Bjorge, L, Salvesen, HB, Kopperud, RK, Bischof, K, Aben, KKH, Kiemeney, LA, Massuger, LFAG, Brooks-Wilson, A, Olson, SH, McGuire, V, Rothstein, JH, Sieh, W, Whittemore, AS, Cook, LS, Le, ND, Gilks, CB, Gronwald, J, Jakubowska, A, Lubiński, J, Gawełko, J, Song, H, Tyrer, JP, Wentzensen, N, Brinton, L, Trabert, B, Lissowska, J, Mclaughlin, JR, Narod, SA, Phelan, C, Anton-Culver, H, Ziogas, A, Eccles, D, Gayther, SA, Gentry-Maharaj, A, Menon, U, Ramus, SJ, Wu, AH, Dansonka-Mieszkowska, A, Kupryjanczyk, J, Timorek, A, Szafron, L, Cunningham, JM, Fridley, BL, Winham, SJ, Bandera, EV, Poole, EM, Morgan, TK, Risch, HA, Goode, EL, Schildkraut, JM, Webb, PM, Pearce, CL, Berchuck, A, Pharoah, PDP, Montgomery, GW, Zondervan, KT, Chenevix-Trench, G, and MacGregor, S. "Shared genetics underlying epidemiological association between endometriosis and ovarian cancer." Human Molecular Genetics 24, no. 20 (October 2015): 5955-5964. Full Text
  - Richards, EJ, Permuth-Wey, J, Li, Y, Chen, YA, Coppola, D, Reid, BM, Lin, H-Y, Teer, JK, Berchuck, A, Birrer, MJ, Lawrenson, K, Monteiro, ANA, Schildkraut, JM, Goode, EL, Gayther, SA, Sellers, TA, and Cheng, JQ. "A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer." Oncotarget 6, no. 33 (October 2015): 34745-34757. Full Text
  - Siamakpour-Reihani, S, Owzar, K, Jiang, C, Turner, T, Deng, Y, Bean, SM, Horton, JK, Berchuck, A, Marks, JR, Dewhirst, MW, and Alvarez Secord, A. "Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinoma." Gynecologic oncology 139, no. 1 (October 2015): 23-29. Full Text
  - Lawrenson, K, Li, Q, Kar, S, Seo, J-H, Tyrer, J, Spindler, TJ, Lee, J, Chen, Y, Karst, A, Drapkin, R, Aben, KKH, Anton-Culver, H, Antonenkova, N, Australian Ovarian Cancer Study Group, , Baker, H, Bandera, EV, Bean, Y, Beckmann, MW, Berchuck, A, Bisogna, M, Bjorge, L, Bogdanova, N, Brinton, LA, Brooks-Wilson, A, Bruinsma, F, Butzow, R, Campbell, IG, Carty, K, Chang-Claude, J, Chenevix-Trench, G, Chen, A, Chen, Z, Cook, LS, Cramer, DW, Cunningham, JM, Cybulski, C, Dansonka-Mieszkowska, A, Dennis, J, Dicks, E, Doherty, JA, Dörk, T, du Bois, A, Dürst, M, Eccles, D, Easton, DT, Edwards, RP, Eilber, U, Ekici, AB, Fasching, PA, Fridley, BL, Gao, Y-T, Gentry-Maharaj, A, Giles, GG, Glasspool, R, Goode, EL, Goodman, MT, Grownwald, J, Harrington, P, Harter, P, Hasmad, HN, Hein, A, Heitz, F, Hildebrandt, MAT, Hillemanns, P, Hogdall, E, Hogdall, C, Hosono, S, Iversen, ES, Jakubowska, A, James, P, Jensen, A, Ji, B-T, Karlan, BY, Kruger Kjaer, S, Kelemen, LE, Kellar, M, Kelley, JL, Kiemeney, LA, Krakstad, C, Kupryjanczyk, J, Lambrechts, D, Lambrechts, S, Le, ND, Lee, AW, Lele, S, Leminen, A, Lester, J, Levine, DA, Liang, D, Lissowska, J, Lu, K, Lubinski, J, Lundvall, L, Massuger, LFAG, Matsuo, K, McGuire, V, McLaughlin, JR, Nevanlinna, H, McNeish, I, Menon, U, Modugno, F, Moysich, KB, Narod, SA, Nedergaard, L, Ness, RB, Azmi, MAN, Odunsi, K, Olson, SH, Orlow, I, Orsulic, S, Weber, RP, Pearce, CL, Pejovic, T, Pelttari, LM, Permuth-Wey, J, Phelan, CM, Pike, MC, Poole, EM, Ramus, SJ, Risch, HA, Rosen, B, Rossing, MA, Rothstein, JH, Rudolph, A, Runnebaum, IB, Rzepecka, IK, Salvesen, HB, Schildkraut, JM, Schwaab, I, Sellers, TA, Shu, X-O, Shvetsov, YB, Siddiqui, N, Sieh, W, Song, H, Southey, MC, Sucheston, L, Tangen, IL, Teo, S-H, Terry, KL, Thompson, PJ, Timorek, A, Tsai, Y-Y, Tworoger, SS, van Altena, AM, Van Nieuwenhuysen, E, Vergote, I, Vierkant, RA, Wang-Gohrke, S, Walsh, C, Wentzensen, N, Whittemore, AS, Wicklund, KG, Wilkens, LR, Woo, Y-L, Wu, X, Wu, AH, Yang, H, Zheng, W, Ziogas, A, Monteiro, A, Pharoah, PD, Gayther, SA, and Freedman, ML. "Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer." Nature Communications 6 (September 22, 2015): 8234-null. Full Text
  - Kelemen, LE, Lawrenson, K, Tyrer, J, Li, Q, Lee, JM, Seo, J-H, Phelan, CM, Beesley, J, Chen, X, Spindler, TJ, Aben, KKH, Anton-Culver, H, Antonenkova, N, Australian Cancer Study, , Australian Ovarian Cancer Study Group, , and Ovarian Cancer Association Consortium, . "Genome-wide significant risk associations for mucinous ovarian carcinoma." Nature Genetics 47, no. 8 (August 2015): 888-897. Full Text
  - Coetzee, SG, Shen, HC, Hazelett, DJ, Lawrenson, K, Kuchenbaecker, K, Tyrer, J, Rhie, SK, Levanon, K, Karst, A, Drapkin, R, Ramus, SJ, Ovarian Cancer Association Consortium, The Consortium of Investigators of Modifiers of BRCA1/2, , Couch, FJ, Offit, K, Chenevix-Trench, G, Monteiro, ANA, Antoniou, A, Freedman, M, Coetzee, GA, Pharoah, PDP, Noushmehr, H, Gayther, SA, and Ovarian Cancer Association Consortium The Consortium of Investigators of Modifiers of BRCA1/2, . "Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci." Human molecular genetics 24, no. 13 (July 2015): 3595-3607. Full Text
  - Ness, R, Pearce, C, Stram, D, Berchuck, A, Pike, M, and Pharoah, P. "LIFETIME RISK OF OVARIAN CANCER BASED ON ENDOMETRIOSIS AND OTHER RISK FACTORS: IGCS-0014 06. Ovarian Cancer." International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 25 Suppl 1 (May 2015): 50-. Full Text
  - Ness, R, Pearce, C, Stram, D, Berchuck, A, Pike, M, and Pharoah, P. "LIFETIME RISK OF OVARIAN CANCER BASED ON ENDOMETRIOSIS AND OTHER RISK FACTORS." INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 25 (May 2015): 50-51. Full Text Link to Item
  - Berchuck, A, Witkowski, L, Hasselblatt, M, and Foulkes, WD. "Prophylactic oophorectomy for hereditary small cell carcinoma of the ovary, hypercalcemic type." Gynecologic oncology reports 12 (April 2015): 20-22. Full Text
  - Pearce, CL, Stram, DO, Ness, RB, Stram, DA, Roman, LD, Templeman, C, Lee, AW, Menon, U, Fasching, PA, McAlpine, JN, Doherty, JA, Modugno, F, Schildkraut, JM, Rossing, MA, Huntsman, DG, Wu, AH, Berchuck, A, Pike, MC, and Pharoah, PDP. "Population distribution of lifetime risk of ovarian cancer in the United States." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 24, no. 4 (April 2015): 671-676. Full Text
  - Lee, AW, Tyrer, JP, Doherty, JA, Stram, DA, Kupryjanczyk, J, Dansonka-Mieszkowska, A, Plisiecka-Halasa, J, Spiewankiewicz, B, Myers, EJ, Australian Cancer Study (Ovarian Cancer), , Australian Ovarian Cancer Study Group, , Chenevix-Trench, G, Fasching, PA, Beckmann, MW, Ekici, AB, Hein, A, Vergote, I, Van Nieuwenhuysen, E, Lambrechts, D, Wicklund, KG, Eilber, U, Wang-Gohrke, S, Chang-Claude, J, Rudolph, A, Sucheston-Campbell, L, Odunsi, K, Moysich, KB, Shvetsov, YB, Thompson, PJ, Goodman, MT, Wilkens, LR, Dörk, T, Hillemanns, P, Dürst, M, Runnebaum, IB, Bogdanova, N, Pelttari, LM, Nevanlinna, H, Leminen, A, Edwards, RP, Kelley, JL, Harter, P, Schwaab, I, Heitz, F, du Bois, A, Orsulic, S, Lester, J, Walsh, C, Karlan, BY, Hogdall, E, Kjaer, SK, Jensen, A, Vierkant, RA, Cunningham, JM, Goode, EL, Fridley, BL, Southey, MC, Giles, GG, Bruinsma, F, Wu, X, Hildebrandt, MAT, Lu, K, Liang, D, Bisogna, M, Levine, DA, Weber, RP, Schildkraut, JM, Iversen, ES, Berchuck, A, Terry, KL, Cramer, DW, Tworoger, SS, Poole, EM, Olson, SH, Orlow, I, Bandera, EV, Bjorge, L, Tangen, IL, Salvesen, HB, Krakstad, C, Massuger, LFAG, Kiemeney, LA, Aben, KKH, van Altena, AM, Bean, Y, Pejovic, T, Kellar, M, Le, ND, Cook, LS, Kelemen, LE, Brooks-Wilson, A, Lubinski, J, Gronwald, J, Cybulski, C, Jakubowska, A, Wentzensen, N, Brinton, LA, Lissowska, J, Yang, H, Nedergaard, L, Lundvall, L, Hogdall, C, Song, H, Campbell, IG, Eccles, D, Glasspool, R, Siddiqui, N, Carty, K, Paul, J, McNeish, IA, Sieh, W, McGuire, V, Rothstein, JH, Whittemore, AS, McLaughlin, JR, Risch, HA, Phelan, CM, Anton-Culver, H, Ziogas, A, Menon, U, Ramus, SJ, Gentry-Maharaj, A, Harrington, P, Pike, MC, Modugno, F, Rossing, MA, Ness, RB, Pharoah, PDP, Stram, DO, Wu, AH, and Pearce, CL. "Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study." Gynecologic Oncology 136, no. 3 (March 2015): 542-548. Full Text
  - Mo, L, Bachelder, RE, Kennedy, M, Chen, P-H, Chi, J-T, Berchuck, A, Cianciolo, G, and Pizzo, SV. "Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78." Molecular Cancer Therapeutics 14, no. 3 (March 2015): 747-756. Full Text
  - Kuchenbaecker, KB, Ramus, SJ, Tyrer, J, Lee, A, Shen, HC, Beesley, J, Lawrenson, K, McGuffog, L, Healey, S, Lee, JM, Spindler, TJ, Lin, YG, Pejovic, T, Bean, Y, Li, Q, Coetzee, S, Hazelett, D, Miron, A, Southey, M, Terry, MB, Goldgar, DE, Buys, SS, Janavicius, R, Dorfling, CM, van Rensburg, EJ, Neuhausen, SL, Ding, YC, Hansen, TVO, Jønson, L, Gerdes, A-M, Ejlertsen, B, Barrowdale, D, Dennis, J, Benitez, J, Osorio, A, Garcia, MJ, Komenaka, I, Weitzel, JN, Ganschow, P, Peterlongo, P, Bernard, L, Viel, A, Bonanni, B, Peissel, B, Manoukian, S, Radice, P, Papi, L, Ottini, L, Fostira, F, Konstantopoulou, I, Garber, J, Frost, D, Perkins, J, Platte, R, Ellis, S, EMBRACE, , Godwin, AK, Schmutzler, RK, Meindl, A, Engel, C, Sutter, C, Sinilnikova, OM, GEMO Study Collaborators, , Damiola, F, Mazoyer, S, Stoppa-Lyonnet, D, Claes, K, De Leeneer, K, Kirk, J, Rodriguez, GC, Piedmonte, M, O'Malley, DM, de la Hoya, M, Caldes, T, Aittomäki, K, Nevanlinna, H, Collée, JM, Rookus, MA, Oosterwijk, JC, Breast Cancer Family Registry, , Tihomirova, L, Tung, N, Hamann, U, Isaccs, C, Tischkowitz, M, Imyanitov, EN, Caligo, MA, Campbell, IG, Hogervorst, FBL, HEBON, , Olah, E, Diez, O, Blanco, I, Brunet, J, Lazaro, C, Pujana, MA, Jakubowska, A, Gronwald, J, Lubinski, J, Sukiennicki, G, Barkardottir, RB, Plante, M, Simard, J, Soucy, P, Montagna, M, Tognazzo, S, Teixeira, MR, KConFab Investigators, , Pankratz, VS, Wang, X, Lindor, N, Szabo, CI, Kauff, N, Vijai, J, Aghajanian, CA, Pfeiler, G, Berger, A, Singer, CF, Tea, M-K, Phelan, CM, Greene, MH, Mai, PL, Rennert, G, Mulligan, AM, Tchatchou, S, Andrulis, IL, Glendon, G, Toland, AE, Jensen, UB, Kruse, TA, Thomassen, M, Bojesen, A, Zidan, J, Friedman, E, Laitman, Y, Soller, M, Liljegren, A, Arver, B, Einbeigi, Z, Stenmark-Askmalm, M, Olopade, OI, Nussbaum, RL, Rebbeck, TR, Nathanson, KL, Domchek, SM, Lu, KH, Karlan, BY, Walsh, C, Lester, J, Australian Cancer Study (Ovarian Cancer Investigators), , Australian Ovarian Cancer Study Group, , Hein, A, Ekici, AB, Beckmann, MW, Fasching, PA, Lambrechts, D, Van Nieuwenhuysen, E, Vergote, I, Lambrechts, S, Dicks, E, Doherty, JA, Wicklund, KG, Rossing, MA, Rudolph, A, Chang-Claude, J, Wang-Gohrke, S, Eilber, U, Moysich, KB, Odunsi, K, Sucheston, L, Lele, S, Wilkens, LR, Goodman, MT, Thompson, PJ, Shvetsov, YB, Runnebaum, IB, Dürst, M, Hillemanns, P, Dörk, T, Antonenkova, N, Bogdanova, N, Leminen, A, Pelttari, LM, Butzow, R, Modugno, F, Kelley, JL, Edwards, RP, Ness, RB, du Bois, A, Heitz, F, Schwaab, I, Harter, P, Matsuo, K, Hosono, S, Orsulic, S, Jensen, A, Kjaer, SK, Hogdall, E, Hasmad, HN, Azmi, MAN, Teo, S-H, Woo, Y-L, Fridley, BL, Goode, EL, Cunningham, JM, Vierkant, RA, Bruinsma, F, Giles, GG, Liang, D, Hildebrandt, MAT, Wu, X, Levine, DA, Bisogna, M, Berchuck, A, Iversen, ES, Schildkraut, JM, Concannon, P, Weber, RP, Cramer, DW, Terry, KL, Poole, EM, Tworoger, SS, Bandera, EV, Orlow, I, Olson, SH, Krakstad, C, Salvesen, HB, Tangen, IL, Bjorge, L, van Altena, AM, Aben, KKH, Kiemeney, LA, Massuger, LFAG, Kellar, M, Brooks-Wilson, A, Kelemen, LE, Cook, LS, Le, ND, Cybulski, C, Yang, H, Lissowska, J, Brinton, LA, Wentzensen, N, Hogdall, C, Lundvall, L, Nedergaard, L, Baker, H, Song, H, Eccles, D, McNeish, I, Paul, J, Carty, K, Siddiqui, N, Glasspool, R, Whittemore, AS, Rothstein, JH, McGuire, V, Sieh, W, Ji, B-T, Zheng, W, Shu, X-O, Gao, Y-T, Rosen, B, Risch, HA, McLaughlin, JR, Narod, SA, Monteiro, AN, Chen, A, Lin, H-Y, Permuth-Wey, J, Sellers, TA, Tsai, Y-Y, Chen, Z, Ziogas, A, Anton-Culver, H, Gentry-Maharaj, A, Menon, U, Harrington, P, Lee, AW, Wu, AH, Pearce, CL, Coetzee, G, Pike, MC, Dansonka-Mieszkowska, A, Timorek, A, Rzepecka, IK, Kupryjanczyk, J, Freedman, M, Noushmehr, H, Easton, DF, Offit, K, Couch, FJ, Gayther, S, Pharoah, PP, Antoniou, AC, Chenevix-Trench, G, and Consortium of Investigators of Modifiers of BRCA1 and BRCA2, . "Identification of six new susceptibility loci for invasive epithelial ovarian cancer." Nature Genetics 47, no. 2 (February 2015): 164-171. Full Text
  - Maxwell, GL, Shoji, Y, Darcy, K, Litzi, T, Berchuck, A, Hamilton, CA, Conrads, TP, and Risinger, JI. "MicroRNAs in endometrial cancers from black and white patients." American Journal of Obstetrics and Gynecology 212, no. 2 (February 2015): 191.e1-191.10. Full Text
  - Maxwell, GL, Shoji, Y, Darcy, K, Litzi, T, Berchuck, A, Hamilton, CA, Conrads, TP, and Risinger, JI. "MicroRNAs in endometrial cancers from black and white patients." American journal of obstetrics and gynecology 212, no. 2 (February 1, 2015). Full Text
  - Teoh, D, Lowery, WJ, Jiang, X, Ehrisman, J, Halvorson, P, Broadwater, G, Bentley, R, Secord, AA, Sobolewski, C, Berchuck, A, Havrilesky, LJ, Valea, FA, and Lee, PS. "Vaginal Cuff Thermal Injury by Mode of Colpotomy at Total Laparoscopic Hysterectomy: A Randomized Clinical Trial." JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY 22, no. 2 (February 2015): 227-233. Full Text Link to Item
  - Chornokur, G, Lin, H-Y, Tyrer, JP, Lawrenson, K, Dennis, J, Amankwah, EK, Qu, X, Tsai, Y-Y, Jim, HSL, Chen, Z, Chen, AY, Permuth-Wey, J, Aben, KKH, Anton-Culver, H, Antonenkova, N, Bruinsma, F, Bandera, EV, Bean, YT, Beckmann, MW, Bisogna, M, Bjorge, L, Bogdanova, N, Brinton, LA, Brooks-Wilson, A, Bunker, CH, Butzow, R, Campbell, IG, Carty, K, Chang-Claude, J, Cook, LS, Cramer, DW, Cunningham, JM, Cybulski, C, Dansonka-Mieszkowska, A, du Bois, A, Despierre, E, Dicks, E, Doherty, JA, Dörk, T, Dürst, M, Easton, DF, Eccles, DM, Edwards, RP, Ekici, AB, Fasching, PA, Fridley, BL, Gao, Y-T, Gentry-Maharaj, A, Giles, GG, Glasspool, R, Goodman, MT, Gronwald, J, Harrington, P, Harter, P, Hein, A, Heitz, F, Hildebrandt, MAT, Hillemanns, P, Hogdall, CK, Hogdall, E, Hosono, S, Jakubowska, A, Jensen, A, Ji, B-T, Karlan, BY, Kelemen, LE, Kellar, M, Kiemeney, LA, Krakstad, C, Kjaer, SK, Kupryjanczyk, J, Lambrechts, D, Lambrechts, S, Le, ND, Lee, AW, Lele, S, Leminen, A, Lester, J, Levine, DA, Liang, D, Lim, BK, Lissowska, J, Lu, K, Lubinski, J, Lundvall, L, Massuger, LFAG, Matsuo, K, McGuire, V, McLaughlin, JR, McNeish, I, Menon, U, Milne, RL, Modugno, F, Moysich, KB, Ness, RB, Nevanlinna, H, Eilber, U, Odunsi, K, Olson, SH, Orlow, I, Orsulic, S, Weber, RP, Paul, J, Pearce, CL, Pejovic, T, Pelttari, LM, Pike, MC, Poole, EM, Risch, HA, Rosen, B, Rossing, MA, Rothstein, JH, Rudolph, A, Runnebaum, IB, Rzepecka, IK, Salvesen, HB, Schernhammer, E, Schwaab, I, Shu, X-O, Shvetsov, YB, Siddiqui, N, Sieh, W, Song, H, Southey, MC, Spiewankiewicz, B, Sucheston, L, Teo, S-H, Terry, KL, Thompson, PJ, Thomsen, L, Tangen, IL, Tworoger, SS, van Altena, AM, Vierkant, RA, Vergote, I, Walsh, CS, Wang-Gohrke, S, Wentzensen, N, Whittemore, AS, Wicklund, KG, Wilkens, LR, Wu, AH, Wu, X, Woo, Y-L, Yang, H, Zheng, W, Ziogas, A, Hasmad, HN, Berchuck, A, Georgia Chenevix-Trench, , AOCS management group, , Iversen, ES, Schildkraut, JM, Ramus, SJ, Goode, EL, Monteiro, ANA, Gayther, SA, Narod, SA, Pharoah, PDP, Sellers, TA, and Phelan, CM. "Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk." Plos One 10, no. 6 (January 2015): e0128106-null. Full Text
  - Jim, HSL, Lin, H-Y, Tyrer, JP, Lawrenson, K, Dennis, J, Chornokur, G, Chen, Z, Chen, AY, Permuth-Wey, J, Aben, KK, Anton-Culver, H, Antonenkova, N, Bruinsma, F, Bandera, EV, Bean, YT, Beckmann, MW, Bisogna, M, Bjorge, L, Bogdanova, N, Brinton, LA, Brooks-Wilson, A, Bunker, CH, Butzow, R, Campbell, IG, Carty, K, Chang-Claude, J, Cook, LS, Cramer, DW, Cunningham, JM, Cybulski, C, Dansonka-Mieszkowska, A, du Bois, A, Despierre, E, Sieh, W, Doherty, JA, Dörk, T, Dürst, M, Easton, DF, and Eccles, DM et al. "Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)." Journal of genetics and genome research 2, no. 2 (January 2015).
  - Siamakpour-Reihani, S, Owzar, K, Jiang, C, Turner, T, Deng, Y, Bean, SM, Horton, JK, Berchuck, A, Marks, JR, Dewhirst, MW, and Secord, AA. "Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinoma." Gynecologic Oncology 139, no. 1 (2015): 23-29. Full Text
  - Havrilesky, LJ, Alvarez Secord, A, Ehrisman, JA, Berchuck, A, Valea, FA, Lee, PS, Gaillard, SL, Samsa, GP, Cella, D, Weinfurt, KP, Abernethy, AP, and Reed, SD. "Patient preferences in advanced or recurrent ovarian cancer." Cancer 120, no. 23 (December 2014): 3651-3659. Full Text
  - Berchuck, A, Kuchenbaecker, K, Ramus, SJ, Tyrer, JP, Gayther, SA, Pharoah, PDP, Antoniou, AC, and Chenevix-Trench, G. "IDENTIFICATION OF SIX NOVEL, COMMON VARIANT GENETIC SUSCEPTIBILITY LOCI FOR INVASIVE EPITHELIAL OVARIAN CANCER." INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 24, no. 9 (November 2014): 13-13. Link to Item
  - Berchuck, A, Witkowski, L, Hasselblatt, M, Wallace, A, Clarke, BA, and Foulkes, WD. "PROPHYLACTIC OOPHORECTOMY FOR HEREDITARY SMALL-CELL CARCINOMA OF THE OVARY, HYPERCALCEMIC TYPE." INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 24, no. 9 (November 2014): 961-962. Link to Item
  - Ness, R, Pearce, CPC, Stram, DSD, Berchuck, ABA, Pike, MPM, Pharoah, PPP, and OCAC, . "LIFETIME RISK OF OVARIAN CANCER BASED ON ENDOMETRIOSIS AND OTHER RISK FACTORS." INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 24, no. 9 (November 2014): 441-442. Link to Item
  - Ness, R, Pearce, CPC, Templeman, CTC, Wu, AWA, Berchuck, ABA, and OCAC, . "ENDOMETRIOSIS AND OVARIAN CANCER: AN INTERNATIONAL POOLED ANALYSIS." INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 24, no. 9 (November 2014): 439-440. Link to Item
  - Kelemen, LE, Terry, KL, Goodman, MT, Webb, PM, Bandera, EV, McGuire, V, Rossing, MA, Wang, Q, Dicks, E, Tyrer, JP, Song, H, Kupryjanczyk, J, Dansonka-Mieszkowska, A, Plisiecka-Halasa, J, Timorek, A, Menon, U, Gentry-Maharaj, A, Gayther, SA, Ramus, SJ, Narod, SA, Risch, HA, McLaughlin, JR, Siddiqui, N, Glasspool, R, Paul, J, Carty, K, Gronwald, J, Lubiński, J, Jakubowska, A, Cybulski, C, Kiemeney, LA, Massuger, LFAG, van Altena, AM, Aben, KKH, Olson, SH, Orlow, I, Cramer, DW, Levine, DA, Bisogna, M, Giles, GG, Southey, MC, Bruinsma, F, Kjaer, SK, Høgdall, E, Jensen, A, Høgdall, CK, Lundvall, L, Engelholm, S-A, Heitz, F, du Bois, A, Harter, P, Schwaab, I, Butzow, R, Nevanlinna, H, Pelttari, LM, Leminen, A, Thompson, PJ, Lurie, G, Wilkens, LR, Lambrechts, D, Van Nieuwenhuysen, E, Lambrechts, S, Vergote, I, Beesley, J, AOCS Study Group/ACS Investigators, , Fasching, PA, Beckmann, MW, Hein, A, Ekici, AB, Doherty, JA, Wu, AH, Pearce, CL, Pike, MC, Stram, D, Chang-Claude, J, Rudolph, A, Dörk, T, Dürst, M, Hillemanns, P, Runnebaum, IB, Bogdanova, N, Antonenkova, N, Odunsi, K, Edwards, RP, Kelley, JL, Modugno, F, Ness, RB, Karlan, BY, Walsh, C, Lester, J, Orsulic, S, Fridley, BL, Vierkant, RA, Cunningham, JM, Wu, X, Lu, K, Liang, D, Hildebrandt, MAT, Weber, RP, Iversen, ES, Tworoger, SS, Poole, EM, Salvesen, HB, Krakstad, C, Bjorge, L, Tangen, IL, Pejovic, T, Bean, Y, Kellar, M, Wentzensen, N, Brinton, LA, Lissowska, J, Garcia-Closas, M, Campbell, IG, Eccles, D, Whittemore, AS, Sieh, W, Rothstein, JH, Anton-Culver, H, Ziogas, A, Phelan, CM, Moysich, KB, Goode, EL, Schildkraut, JM, Berchuck, A, Pharoah, PDP, Sellers, TA, Brooks-Wilson, A, Cook, LS, and Le, ND. "Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk." Molecular Nutrition & Food Research 58, no. 10 (October 2014): 2023-2035. Full Text
  - Kokosis, G, Schmitz, R, Secord, A, Havrilesky, L, Berchuck, A, Mantyh, C, and Erdmann, D. "Modifizierter doppelt gestielter VRAM-Lappen zur simultanen Rekonstruktion eines Perineum- und posterioren vaginalen Defekts." Der Gynäkologe 47, no. 10 (October 2014): 784-787. Full Text
  - Yamaguchi, K, Huang, Z, Matsumura, N, Mandai, M, Okamoto, T, Baba, T, Konishi, I, Berchuck, A, and Murphy, SK. "Epigenetic determinants of ovarian clear cell carcinoma biology." Int J Cancer 135, no. 3 (August 1, 2014): 585-597. Full Text Link to Item
  - Yamaguchi, K, Huang, Z, Matsumura, N, Mandai, M, Okamoto, T, Baba, T, Konishi, I, Berchuck, A, and Murphy, SK. "Epigenetic determinants of ovarian clear cell carcinoma biology." International Journal of Cancer 135, no. 3 (August 1, 2014): 585-597. Full Text
  - Block, MS, Charbonneau, B, Vierkant, RA, Fogarty, Z, Bamlet, WR, Pharoah, PDP, Georgia Chenevix-Trench, , for AOCS, , /ACS Group, , Rossing, MA, Cramer, D, Pearce, CL, Schildkraut, J, Menon, U, Kjaer, SK, Levine, DA, Gronwald, J, Culver, HA, Whittemore, AS, Karlan, BY, Lambrechts, D, Wentzensen, N, Kupryjanczyk, J, Chang-Claude, J, Bandera, EV, Hogdall, E, Heitz, F, Kaye, SB, Fasching, PA, Campbell, I, Goodman, MT, Pejovic, T, Bean, YT, Hays, LE, Lurie, G, Eccles, D, Hein, A, Beckmann, MW, Ekici, AB, Paul, J, Brown, R, Flanagan, JM, Harter, P, du Bois, A, Schwaab, I, Hogdall, CK, Lundvall, L, Olson, SH, Orlow, I, Paddock, LE, Rudolph, A, Eilber, U, Dansonka-Mieszkowska, A, Rzepecka, IK, Ziolkowska-Seta, I, Brinton, LA, Yang, H, Garcia-Closas, M, Despierre, E, Lambrechts, S, Vergote, I, Walsh, CS, Lester, J, Sieh, W, McGuire, V, Rothstein, JH, Ziogas, A, Lubiński, J, Cybulski, C, Menkiszak, J, Jensen, A, Gayther, SA, Ramus, SJ, Gentry-Maharaj, A, Berchuck, A, Wu, AH, Pike, MC, Van Den Berg, D, Terry, KL, Vitonis, AF, Ramirez, SM, Rider, DN, Knutson, KL, Sellers, TA, Phelan, CM, Doherty, JA, Johnatty, SE, deFazio, A, Song, H, Tyrer, J, Kalli, KR, Fridley, BL, Cunningham, JM, and Goode, EL. "Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 23, no. 7 (July 2014): 1421-1427. Full Text
  - Hedditch, EL, Gao, B, Russell, AJ, Lu, Y, Emmanuel, C, Beesley, J, Johnatty, SE, Chen, X, Harnett, P, George, J, Australian Ovarian Cancer Study Group, , Williams, RT, Flemming, C, Lambrechts, D, Despierre, E, Lambrechts, S, Vergote, I, Karlan, B, Lester, J, Orsulic, S, Walsh, C, Fasching, P, Beckmann, MW, Ekici, AB, Hein, A, Matsuo, K, Hosono, S, Nakanishi, T, Yatabe, Y, Pejovic, T, Bean, Y, Heitz, F, Harter, P, du Bois, A, Schwaab, I, Hogdall, E, Kjaer, SK, Jensen, A, Hogdall, C, Lundvall, L, Engelholm, SA, Brown, B, Flanagan, J, Metcalf, MD, Siddiqui, N, Sellers, T, Fridley, B, Cunningham, J, Schildkraut, J, Iversen, E, Weber, RP, Berchuck, A, Goode, E, Bowtell, DD, Chenevix-Trench, G, deFazio, A, Norris, MD, MacGregor, S, Haber, M, and Henderson, MJ. "ABCA transporter gene expression and poor outcome in epithelial ovarian cancer." Journal of the National Cancer Institute 106, no. 7 (July 2014). Full Text
  - Earp, MA, Kelemen, LE, Magliocco, AM, Swenerton, KD, Chenevix-Trench, G, Australian Cancer Study, , Australian Ovarian Cancer Study Group, , Lu, Y, Hein, A, Ekici, AB, Beckmann, MW, Fasching, PA, Lambrechts, D, Despierre, E, Vergote, I, Lambrechts, S, Doherty, JA, Rossing, MA, Chang-Claude, J, Rudolph, A, Friel, G, Moysich, KB, Odunsi, K, Sucheston-Campbell, L, Lurie, G, Goodman, MT, Carney, ME, Thompson, PJ, Runnebaum, IB, Dürst, M, Hillemanns, P, Dörk, T, Antonenkova, N, Bogdanova, N, Leminen, A, Nevanlinna, H, Pelttari, LM, Butzow, R, Bunker, CH, Modugno, F, Edwards, RP, Ness, RB, du Bois, A, Heitz, F, Schwaab, I, Harter, P, Karlan, BY, Walsh, C, Lester, J, Jensen, A, Kjær, SK, Høgdall, CK, Høgdall, E, Lundvall, L, Sellers, TA, Fridley, BL, Goode, EL, Cunningham, JM, Vierkant, RA, Giles, GG, Baglietto, L, Severi, G, Southey, MC, Liang, D, Wu, X, Lu, K, Hildebrandt, MAT, Levine, DA, Bisogna, M, Schildkraut, JM, Iversen, ES, Weber, RP, Berchuck, A, Cramer, DW, Terry, KL, Poole, EM, Tworoger, SS, Bandera, EV, Chandran, U, Orlow, I, Olson, SH, Wik, E, Salvesen, HB, Bjorge, L, Halle, MK, van Altena, AM, Aben, KKH, Kiemeney, LA, Massuger, LFAG, Pejovic, T, Bean, YT, Cybulski, C, Gronwald, J, Lubinski, J, Wentzensen, N, Brinton, LA, Lissowska, J, Garcia-Closas, M, Dicks, E, Dennis, J, Easton, DF, Song, H, Tyrer, JP, Pharoah, PDP, Eccles, D, Campbell, IG, Whittemore, AS, McGuire, V, Sieh, W, Rothstein, JH, Flanagan, JM, Paul, J, Brown, R, Phelan, CM, Risch, HA, McLaughlin, JR, Narod, SA, Ziogas, A, Anton-Culver, H, Gentry-Maharaj, A, Menon, U, Gayther, SA, Ramus, SJ, Wu, AH, Pearce, CL, Pike, MC, Dansonka-Mieszkowska, A, Rzepecka, IK, Szafron, LM, Kupryjanczyk, J, Cook, LS, Le, ND, Brooks-Wilson, A, and Ovarian Cancer Association Consortium, . "Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA." Human Genetics 133, no. 5 (May 2014): 481-497. Full Text
  - Witkowski, L, Carrot-Zhang, J, Albrecht, S, Fahiminiya, S, Hamel, N, Tomiak, E, Grynspan, D, Saloustros, E, Nadaf, J, Rivera, B, Gilpin, C, Castellsagué, E, Silva-Smith, R, Plourde, F, Wu, M, Saskin, A, Arseneault, M, Karabakhtsian, RG, Reilly, EA, Ueland, FR, Margiolaki, A, Pavlakis, K, Castellino, SM, Lamovec, J, Mackay, HJ, Roth, LM, Ulbright, TM, Bender, TA, Georgoulias, V, Longy, M, Berchuck, A, Tischkowitz, M, Nagel, I, Siebert, R, Stewart, CJR, Arseneau, J, McCluggage, WG, Clarke, BA, Riazalhosseini, Y, Hasselblatt, M, Majewski, J, and Foulkes, WD. "Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type." Nature Genetics 46, no. 5 (May 2014): 438-443. Full Text
  - Zhang, C, Havrilesky, LJ, Broadwater, G, Di Santo, N, Ehrisman, JA, Lee, PS, Berchuck, A, Alvarez Secord, A, Bean, S, Bentley, RC, and Valea, FA. "Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: a single institution study of 458 patients." Gynecologic oncology 133, no. 2 (May 2014): 211-215. Full Text
  - Charbonneau, B, Moysich, KB, Kalli, KR, Oberg, AL, Vierkant, RA, Fogarty, ZC, Block, MS, Maurer, MJ, Goergen, KM, Fridley, BL, Cunningham, JM, Rider, DN, Preston, C, Hartmann, LC, Lawrenson, K, Wang, C, Tyrer, J, Song, H, deFazio, A, Johnatty, SE, Doherty, JA, Phelan, CM, Sellers, TA, Ramirez, SM, Vitonis, AF, Terry, KL, Van Den Berg, D, Pike, MC, Wu, AH, Berchuck, A, Gentry-Maharaj, A, Ramus, SJ, Diergaarde, B, Shen, H, Jensen, A, Menkiszak, J, Cybulski, C, Lubiłski, J, Ziogas, A, Rothstein, JH, McGuire, V, Sieh, W, Lester, J, Walsh, C, Vergote, I, Lambrechts, S, Despierre, E, Garcia-Closas, M, Yang, H, Brinton, LA, Spiewankiewicz, B, Rzepecka, IK, Dansonka-Mieszkowska, A, Seibold, P, Rudolph, A, Paddock, LE, Orlow, I, Lundvall, L, Olson, SH, Hogdall, CK, Schwaab, I, du Bois, A, Harter, P, Flanagan, JM, Brown, R, Paul, J, Ekici, AB, Beckmann, MW, Hein, A, Eccles, D, Lurie, G, Hays, LE, Bean, YT, Pejovic, T, Goodman, MT, Campbell, I, Fasching, PA, Konecny, G, Kaye, SB, Heitz, F, Hogdall, E, Bandera, EV, Chang-Claude, J, Kupryjanczyk, J, Wentzensen, N, Lambrechts, D, Karlan, BY, Whittemore, AS, Culver, HA, Gronwald, J, Levine, DA, Kjaer, SK, Menon, U, Schildkraut, JM, Pearce, CL, Cramer, DW, Rossing, MA, Chenevix-Trench, G, AOCS group, , ACS, , Pharoah, PDP, Gayther, SA, Ness, RB, Odunsi, K, Sucheston, LE, Knutson, KL, and Goode, EL. "Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome." Cancer Immunology Research 2, no. 4 (April 2014): 332-340. Full Text
  - Charbonneau, B, Block, MS, Bamlet, WR, Vierkant, RA, Kalli, KR, Fogarty, Z, Rider, DN, Sellers, TA, Tworoger, SS, Poole, E, Risch, HA, Salvesen, HB, Kiemeney, LA, Baglietto, L, Giles, GG, Severi, G, Trabert, B, Wentzensen, N, Chenevix-Trench, G, for AOCS/ACS group, , Whittemore, AS, Sieh, W, Chang-Claude, J, Bandera, EV, Orlow, I, Terry, K, Goodman, MT, Thompson, PJ, Cook, LS, Rossing, MA, Ness, RB, Narod, SA, Kupryjanczyk, J, Lu, K, Butzow, R, Dörk, T, Pejovic, T, Campbell, I, Le, ND, Bunker, CH, Bogdanova, N, Runnebaum, IB, Eccles, D, Paul, J, Wu, AH, Gayther, SA, Hogdall, E, Heitz, F, Kaye, SB, Karlan, BY, Anton-Culver, H, Gronwald, J, Hogdall, CK, Lambrechts, D, Fasching, PA, Menon, U, Schildkraut, J, Pearce, CL, Levine, DA, Kjaer, SK, Cramer, D, Flanagan, JM, Phelan, CM, Brown, R, Massuger, LFAG, Song, H, Doherty, JA, Krakstad, C, Liang, D, Odunsi, K, Berchuck, A, Jensen, A, Lubinski, J, Nevanlinna, H, Bean, YT, Lurie, G, Ziogas, A, Walsh, C, Despierre, E, Brinton, L, Hein, A, Rudolph, A, Dansonka-Mieszkowska, A, Olson, SH, Harter, P, Tyrer, J, Vitonis, AF, Brooks-Wilson, A, Aben, KK, Pike, MC, Ramus, SJ, Wik, E, Cybulski, C, Lin, J, Sucheston, L, Edwards, R, McGuire, V, Lester, J, du Bois, A, Lundvall, L, Wang-Gohrke, S, Szafron, LM, Lambrechts, S, Yang, H, Beckmann, MW, Pelttari, LM, Van Altena, AM, van den Berg, D, Halle, MK, Gentry-Maharaj, A, Schwaab, I, Chandran, U, Menkiszak, J, Ekici, AB, Wilkens, LR, Leminen, A, Modugno, F, Friel, G, Rothstein, JH, Vergote, I, Garcia-Closas, M, Hildebrandt, MAT, Sobiczewski, P, Kelemen, LE, Pharoah, PDP, Moysich, K, Knutson, KL, Cunningham, JM, Fridley, BL, and Goode, EL. "Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10." Cancer Research 74, no. 3 (February 2014): 852-861. Full Text
  - Trabert, B, Ness, RB, Lo-Ciganic, W-H, Murphy, MA, Goode, EL, Poole, EM, Brinton, LA, Webb, PM, Nagle, CM, Jordan, SJ, Australian Ovarian Cancer Study Group, Australian Cancer Study (Ovarian Cancer), , Risch, HA, Rossing, MA, Doherty, JA, Goodman, MT, Lurie, G, Kjær, SK, Hogdall, E, Jensen, A, Cramer, DW, Terry, KL, Vitonis, A, Bandera, EV, Olson, S, King, MG, Chandran, U, Anton-Culver, H, Ziogas, A, Menon, U, Gayther, SA, Ramus, SJ, Gentry-Maharaj, A, Wu, AH, Pearce, CL, Pike, MC, Berchuck, A, Schildkraut, JM, Wentzensen, N, and Ovarian Cancer Association Consortium, . "Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium." Journal of the National Cancer Institute 106, no. 2 (February 2014): djt431-null. Full Text
  - Davidson, BA, Rubatt, JM, Corcoran, DL, Teoh, DK, Bernardini, MQ, Grace, LA, Soper, WJ, Berchuck, A, Siamakpour-Reihani, S, Chen, W, Owzar, K, Murphy, SK, and Secord, AA. "Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines." Frontiers in Oncology 4 (January 2014): 163-. Full Text
  - Earp, MA, Kelemen, LE, Magliocco, AM, Swenerton, KD, Chenevix-Trench, G, Lu, Y, Hein, A, Ekici, AB, Beckmann, MW, Fasching, PA, Lambrechts, D, Despierre, E, Vergote, I, Lambrechts, S, Doherty, JA, Rossing, MA, Chang-Claude, J, Rudolph, A, Friel, G, Moysich, KB, Odunsi, K, Sucheston-Campbell, L, Lurie, G, Goodman, MT, Carney, ME, Thompson, PJ, Runnebaum, IB, Dürst, M, Hillemanns, P, Dörk, T, Antonenkova, N, Bogdanova, N, Leminen, A, Nevanlinna, H, Pelttari, LM, Butzow, R, Bunker, CH, Modugno, F, Edwards, RP, Ness, RB, Du Bois, A, Heitz, F, Schwaab, I, Harter, P, Karlan, BY, Walsh, C, Lester, J, Jensen, A, Kjær, SK, Høgdall, CK, Høgdall, E, Lundvall, L, Sellers, TA, Fridley, BL, Goode, EL, Cunningham, JM, Vierkant, RA, Giles, GG, Baglietto, L, Severi, G, Southey, MC, Liang, D, Wu, X, Lu, K, Hildebrandt, MAT, Levine, DA, Bisogna, M, Schildkraut, JM, Iversen, ES, Weber, RP, Berchuck, A, Cramer, DW, Terry, KL, Poole, EM, Tworoger, SS, Bandera, EV, and Chandran, U. "Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA." Human Genetics 133, no. 5 (January 1, 2014): 481-497. Full Text
  - Havrilesky, LJ, Secord, AA, Ehrisman, JA, Berchuck, A, Valea, FA, Lee, PS, Gaillard, SL, Samsa, GP, Cella, D, Weinfurt, KP, Abernethy, AP, and Reed, SD. "Patient preferences in advanced or recurrent ovarian cancer." Cancer 120, no. 23 (January 1, 2014): 3651-3659. Full Text
  - Kokosis, G, Schmitz, R, Secord, AA, Havrilesky, LJ, Berchuck, A, Mantyh, CR, and Erdmann, D. "A modified bipedicle VRAM flap for simultaneous reconstruction of a perineal and posterior vaginal defect." Gynakologe 47, no. 10 (January 1, 2014): 784-787. Full Text
  - Trabert, B, Ness, RB, Lo-Ciganic, WH, Murphy, MA, Goode, EL, Poole, EM, Brinton, LA, Webb, PM, Nagle, CM, Jordan, SJ, Australian Ovarian Cancer Study Group, ACSOC, Risch, HA, Rossing, MA, Doherty, JA, Goodman, MT, Lurie, G, Kjær, SK, Hogdall, E, Jensen, A, Cramer, DW, Terry, KL, Vitonis, A, Bandera, EV, Olson, S, King, MG, Chandran, U, Anton-Culver, H, Ziogas, A, Menon, U, Gayther, SA, Ramus, SJ, Gentry-Maharaj, A, Wu, AH, Pearce, CL, Pike, MC, Berchuck, A, Schildkraut, JM, and Wentzensen, N et al. "Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium." Journal of the National Cancer Institute 106, no. 2 (January 1, 2014). Full Text
  - Witkowski, L, Carrot-Zhang, J, Albrecht, S, Fahiminiya, S, Hamel, N, Tomiak, E, Grynspan, D, Saloustros, E, Nadaf, J, Rivera, B, Gilpin, C, Castellsagué, E, Silva-Smith, R, Plourde, F, Wu, M, Saskin, A, Arseneault, M, Karabakhtsian, RG, Reilly, EA, Ueland, FR, Margiolaki, A, Pavlakis, K, Castellino, SM, Lamovec, J, Mackay, HJ, Roth, LM, Ulbright, TM, Bender, TA, Georgoulias, V, Longy, M, Berchuck, A, Tischkowitz, M, Nagel, I, Siebert, R, Stewart, CJR, Arseneau, J, McCluggage, WG, Clarke, BA, Riazalhosseini, Y, Hasselblatt, M, Majewski, J, and Foulkes, WD. "Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type." Nature Genetics 46, no. 5 (January 1, 2014): 438-443. Full Text
  - Zhang, C, Havrilesky, LJ, Broadwater, G, Di Santo, N, Ehrisman, JA, Lee, PS, Berchuck, A, Alvarez Secord, A, Bean, S, Bentley, RC, and Valea, FA. "Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: A single institution study of 458 patients." Gynecologic Oncology 133, no. 2 (January 1, 2014): 211-215. Full Text
  - Pooley, KA, Bojesen, SE, Weischer, M, Nielsen, SF, Thompson, D, Amin Al Olama, A, Michailidou, K, Tyrer, JP, Benlloch, S, Brown, J, Audley, T, Luben, R, Khaw, K-T, Neal, DE, Hamdy, FC, Donovan, JL, Kote-Jarai, Z, Baynes, C, Shah, M, Bolla, MK, Wang, Q, Dennis, J, Dicks, E, Yang, R, Rudolph, A, Schildkraut, J, Chang-Claude, J, Burwinkel, B, Chenevix-Trench, G, Pharoah, PDP, Berchuck, A, Eeles, RA, Easton, DF, Dunning, AM, and Nordestgaard, BG. "A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk." Human Molecular Genetics 22, no. 24 (December 2013): 5056-5064. Full Text
  - Rodriguez, GC, Barnes, HJ, Anderson, KE, Whitaker, RS, Berchuck, A, Petitte, JN, Lancaster, JM, Wenham, RM, Turbov, JM, Day, R, Maxwell, GL, and Carver, DK. "Evidence of a chemopreventive effect of progestin unrelated to ovulation on reproductive tract cancers in the egg-laying hen." Cancer Prev Res (Phila) 6, no. 12 (December 2013): 1283-1292. Full Text Link to Item
  - Johnatty, SE, Beesley, J, Gao, B, Chen, X, Lu, Y, Law, MH, Henderson, MJ, Russell, AJ, Hedditch, EL, Emmanuel, C, Fereday, S, Webb, PM, Australian Ovarian Cancer Study Group, , Goode, EL, Vierkant, RA, Fridley, BL, Cunningham, JM, Fasching, PA, Beckmann, MW, Ekici, AB, Hogdall, E, Kjaer, SK, Jensen, A, Hogdall, C, Brown, R, Paul, J, Lambrechts, S, Despierre, E, Vergote, I, Lester, J, Karlan, BY, Heitz, F, du Bois, A, Harter, P, Schwaab, I, Bean, Y, Pejovic, T, Levine, DA, Goodman, MT, Camey, ME, Thompson, PJ, Lurie, G, Shildkraut, J, Berchuck, A, Terry, KL, Cramer, DW, Norris, MD, Haber, M, MacGregor, S, deFazio, A, and Chenevix-Trench, G. "ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas." Gynecologic Oncology 131, no. 1 (October 2013): 8-14. Full Text
  - Schildkraut, JM, Iversen, ES, Akushevich, L, Whitaker, R, Bentley, RC, Berchuck, A, and Marks, JR. "Molecular signatures of epithelial ovarian cancer: analysis of associations with tumor characteristics and epidemiologic risk factors." Cancer Epidemiol Biomarkers Prev 22, no. 10 (October 2013): 1709-1721. Full Text Link to Item
  - Terry, KL, Karageorgi, S, Shvetsov, YB, Merritt, MA, Lurie, G, Thompson, PJ, Carney, ME, Weber, RP, Akushevich, L, Lo-Ciganic, W-H, Cushing-Haugen, K, Sieh, W, Moysich, K, Doherty, JA, Nagle, CM, Berchuck, A, Pearce, CL, Pike, M, Ness, RB, Webb, PM, Australian Cancer Study (Ovarian Cancer), , Australian Ovarian Cancer Study Group, , Rossing, MA, Schildkraut, J, Risch, H, Goodman, MT, and Ovarian Cancer Association Consortium, . "Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls." Cancer Prevention Research (Philadelphia, Pa.) 6, no. 8 (August 2013): 811-821. Full Text
  - Lopez-Acevedo, M, Havrilesky, LJ, Broadwater, G, Kamal, AH, Abernethy, AP, Berchuck, A, Alvarez Secord, A, Tulsky, JA, Valea, F, and Lee, PS. "Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer." Gynecologic Oncology 130, no. 1 (July 2013): 156-161. Full Text
  - Maxwell, GL, Allard, J, Gadisetti, CVR, Litzi, T, Casablanca, Y, Chandran, U, Darcy, KM, Levine, DA, Berchuck, A, Hamilton, CA, Conrads, TP, and Risinger, JI. "Transcript expression in endometrial cancers from Black and White patients." Gynecol Oncol 130, no. 1 (July 2013): 169-173. Full Text Link to Item
  - Barakat, RR, Berchuck, A, Markman, M, and Randall, ME. "Preface." Principles and Practice of Gynecologic Oncology: Sixth Edition (May 8, 2013): xi-xii.
  - Cancer Genome Atlas Research Network, , Kandoth, C, Schultz, N, Cherniack, AD, Akbani, R, Liu, Y, Shen, H, Robertson, AG, Pashtan, I, Shen, R, Benz, CC, Yau, C, Laird, PW, Ding, L, Zhang, W, Mills, GB, Kucherlapati, R, Mardis, ER, and Levine, DA. "Integrated genomic characterization of endometrial carcinoma." Nature 497, no. 7447 (May 2013): 67-73. Full Text
  - Pearce, CL, Rossing, MA, Lee, AW, Ness, RB, Webb, PM, for Australian Cancer Study (Ovarian Cancer), , Australian Ovarian Cancer Study Group, , Chenevix-Trench, G, Jordan, SM, Stram, DA, Chang-Claude, J, Hein, R, Nickels, S, Lurie, G, Thompson, PJ, Carney, ME, Goodman, MT, Moysich, K, Hogdall, E, Jensen, A, Goode, EL, Fridley, BL, Cunningham, JM, Vierkant, RA, Weber, RP, Ziogas, A, Anton-Culver, H, Gayther, SA, Gentry-Maharaj, A, Menon, U, Ramus, SJ, Brinton, L, Wentzensen, N, Lissowska, J, Garcia-Closas, M, Massuger, LFAG, Kiemeney, LALM, Van Altena, AM, Aben, KKH, Berchuck, A, Doherty, JA, Iversen, E, McGuire, V, Moorman, PG, Pharoah, P, Pike, MC, Risch, H, Sieh, W, Stram, DO, Terry, KL, Whittemore, A, Wu, AH, Schildkraut, JM, Kjaer, SK, and Ovarian Cancer Association Consortium, . "Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 22, no. 5 (May 2013): 880-890. Full Text
  - White, KL, Vierkant, RA, Fogarty, ZC, Charbonneau, B, Block, MS, Pharoah, PDP, Chenevix-Trench, G, for AOCS/ACS group,, , Rossing, MA, Cramer, DW, Pearce, CL, Schildkraut, JM, Menon, U, Kjaer, SK, Levine, DA, Gronwald, J, Culver, HA, Whittemore, AS, Karlan, BY, Lambrechts, D, Wentzensen, N, Kupryjanczyk, J, Chang-Claude, J, Bandera, EV, Hogdall, E, Heitz, F, Kaye, SB, Fasching, PA, Campbell, I, Goodman, MT, Pejovic, T, Bean, Y, Lurie, G, Eccles, D, Hein, A, Beckmann, MW, Ekici, AB, Paul, J, Brown, R, Flanagan, JM, Harter, P, du Bois, A, Schwaab, I, Hogdall, CK, Lundvall, L, Olson, SH, Orlow, I, Paddock, LE, Rudolph, A, Eilber, U, Dansonka-Mieszkowska, A, Rzepecka, IK, Ziolkowska-Seta, I, Brinton, L, Yang, H, Garcia-Closas, M, Despierre, E, Lambrechts, S, Vergote, I, Walsh, C, Lester, J, Sieh, W, McGuire, V, Rothstein, JH, Ziogas, A, Lubinski, J, Cybulski, C, Menkiszak, J, Jensen, A, Gayther, SA, Ramus, SJ, Gentry-Maharaj, A, Berchuck, A, Wu, AH, Pike, MC, Van Denberg, D, Terry, KL, Vitonis, AF, Doherty, JA, Johnatty, SE, Defazio, A, Song, H, Tyrer, J, Sellers, TA, Phelan, CM, Kalli, KR, Cunningham, JM, Fridley, BL, and Goode, EL. "Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 22, no. 5 (May 2013): 987-992. Full Text
  - Bojesen, SE, Pooley, KA, Johnatty, SE, Beesley, J, Michailidou, K, Tyrer, JP, Edwards, SL, Pickett, HA, Shen, HC, Smart, CE, Hillman, KM, Mai, PL, Lawrenson, K, Stutz, MD, Lu, Y, Karevan, R, Woods, N, Johnston, RL, French, JD, Chen, X, Weischer, M, Nielsen, SF, Maranian, MJ, Ghoussaini, M, Ahmed, S, Baynes, C, Bolla, MK, Wang, Q, Dennis, J, McGuffog, L, Barrowdale, D, Lee, A, Healey, S, Lush, M, Tessier, DC, Vincent, D, Bacot, F, Australian Cancer Study, , Australian Ovarian Cancer Study, , Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), , Gene Environment Interaction and Breast Cancer (GENICA), , Swedish Breast Cancer Study (SWE-BRCA), , Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), , Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE), , Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO), , Vergote, I, Lambrechts, S, Despierre, E, Risch, HA, González-Neira, A, Rossing, MA, Pita, G, Doherty, JA, Alvarez, N, Larson, MC, Fridley, BL, Schoof, N, Chang-Claude, J, Cicek, MS, Peto, J, Kalli, KR, Broeks, A, Armasu, SM, Schmidt, MK, Braaf, LM, Winterhoff, B, Nevanlinna, H, Konecny, GE, Lambrechts, D, Rogmann, L, Guénel, P, Teoman, A, Milne, RL, Garcia, JJ, Cox, A, Shridhar, V, Burwinkel, B, Marme, F, Hein, R, Sawyer, EJ, Haiman, CA, Wang-Gohrke, S, Andrulis, IL, Moysich, KB, Hopper, JL, Odunsi, K, Lindblom, A, Giles, GG, Brenner, H, Simard, J, Lurie, G, Fasching, PA, Carney, ME, Radice, P, Wilkens, LR, Swerdlow, A, Goodman, MT, Brauch, H, Garcia-Closas, M, Hillemanns, P, Winqvist, R, Dürst, M, Devilee, P, Runnebaum, I, Jakubowska, A, Lubinski, J, Mannermaa, A, Butzow, R, Bogdanova, NV, Dörk, T, Pelttari, LM, Zheng, W, Leminen, A, Anton-Culver, H, Bunker, CH, Kristensen, V, Ness, RB, Muir, K, Edwards, R, Meindl, A, Heitz, F, Matsuo, K, du Bois, A, Wu, AH, Harter, P, Teo, S-H, Schwaab, I, Shu, X-O, Blot, W, Hosono, S, Kang, D, Nakanishi, T, Hartman, M, Yatabe, Y, Hamann, U, Karlan, BY, Sangrajrang, S, Kjaer, SK, Gaborieau, V, Jensen, A, Eccles, D, Høgdall, E, Shen, C-Y, Brown, J, Woo, YL, Shah, M, Azmi, MAN, Luben, R, Omar, SZ, Czene, K, Vierkant, RA, Nordestgaard, BG, Flyger, H, Vachon, C, Olson, JE, Wang, X, Levine, DA, Rudolph, A, Weber, RP, Flesch-Janys, D, Iversen, E, Nickels, S, Schildkraut, JM, Silva, IDS, Cramer, DW, Gibson, L, Terry, KL, Fletcher, O, Vitonis, AF, van der Schoot, CE, Poole, EM, Hogervorst, FBL, Tworoger, SS, Liu, J, Bandera, EV, Li, J, Olson, SH, Humphreys, K, Orlow, I, Blomqvist, C, Rodriguez-Rodriguez, L, Aittomäki, K, Salvesen, HB, Muranen, TA, Wik, E, Brouwers, B, Krakstad, C, Wauters, E, Halle, MK, Wildiers, H, Kiemeney, LA, Mulot, C, Aben, KK, Laurent-Puig, P, Altena, AM, Truong, T, Massuger, LFAG, Benitez, J, Pejovic, T, Perez, JIA, Hoatlin, M, Zamora, MP, Cook, LS, Balasubramanian, SP, Kelemen, LE, Schneeweiss, A, Le, ND, Sohn, C, Brooks-Wilson, A, Tomlinson, I, Kerin, MJ, Miller, N, Cybulski, C, Henderson, BE, Menkiszak, J, Schumacher, F, Wentzensen, N, Le Marchand, L, Yang, HP, Mulligan, AM, Glendon, G, Engelholm, SA, Knight, JA, Høgdall, CK, Apicella, C, Gore, M, Tsimiklis, H, Song, H, Southey, MC, Jager, A, den Ouweland, AMW, Brown, R, Martens, JWM, Flanagan, JM, Kriege, M, Paul, J, Margolin, S, Siddiqui, N, Severi, G, Whittemore, AS, Baglietto, L, McGuire, V, Stegmaier, C, Sieh, W, Müller, H, Arndt, V, Labrèche, F, Gao, Y-T, Goldberg, MS, Yang, G, Dumont, M, McLaughlin, JR, Hartmann, A, Ekici, AB, Beckmann, MW, Phelan, CM, Lux, MP, Permuth-Wey, J, Peissel, B, Sellers, TA, Ficarazzi, F, Barile, M, Ziogas, A, Ashworth, A, Gentry-Maharaj, A, Jones, M, Ramus, SJ, Orr, N, Menon, U, Pearce, CL, Brüning, T, Pike, MC, Ko, Y-D, Lissowska, J, Figueroa, J, Kupryjanczyk, J, Chanock, SJ, Dansonka-Mieszkowska, A, Jukkola-Vuorinen, A, Rzepecka, IK, Pylkäs, K, Bidzinski, M, Kauppila, S, Hollestelle, A, Seynaeve, C, Tollenaar, RAEM, Durda, K, Jaworska, K, Hartikainen, JM, Kosma, V-M, Kataja, V, Antonenkova, NN, Long, J, Shrubsole, M, Deming-Halverson, S, Lophatananon, A, Siriwanarangsan, P, Stewart-Brown, S, Ditsch, N, Lichtner, P, Schmutzler, RK, Ito, H, Iwata, H, Tajima, K, Tseng, C-C, Stram, DO, van den Berg, D, Yip, CH, Ikram, MK, Teh, Y-C, Cai, H, Lu, W, Signorello, LB, Cai, Q, Noh, D-Y, Yoo, K-Y, Miao, H, Iau, PT-C, Teo, YY, McKay, J, Shapiro, C, Ademuyiwa, F, Fountzilas, G, Hsiung, C-N, Yu, J-C, Hou, M-F, Healey, CS, Luccarini, C, Peock, S, Stoppa-Lyonnet, D, Peterlongo, P, Rebbeck, TR, Piedmonte, M, Singer, CF, Friedman, E, Thomassen, M, Offit, K, Hansen, TVO, Neuhausen, SL, Szabo, CI, Blanco, I, Garber, J, Narod, SA, Weitzel, JN, Montagna, M, Olah, E, Godwin, AK, Yannoukakos, D, Goldgar, DE, Caldes, T, Imyanitov, EN, Tihomirova, L, Arun, BK, Campbell, I, Mensenkamp, AR, van Asperen, CJ, van Roozendaal, KEP, Meijers-Heijboer, H, Collée, JM, Oosterwijk, JC, Hooning, MJ, Rookus, MA, van der Luijt, RB, Os, TAM, Evans, DG, Frost, D, Fineberg, E, Barwell, J, Walker, L, Kennedy, MJ, Platte, R, Davidson, R, Ellis, SD, Cole, T, Bressac-de Paillerets, B, Buecher, B, Damiola, F, Faivre, L, Frenay, M, Sinilnikova, OM, Caron, O, Giraud, S, Mazoyer, S, Bonadona, V, Caux-Moncoutier, V, Toloczko-Grabarek, A, Gronwald, J, Byrski, T, Spurdle, AB, Bonanni, B, Zaffaroni, D, Giannini, G, Bernard, L, Dolcetti, R, Manoukian, S, Arnold, N, Engel, C, Deissler, H, Rhiem, K, Niederacher, D, Plendl, H, Sutter, C, Wappenschmidt, B, Borg, A, Melin, B, Rantala, J, Soller, M, Nathanson, KL, Domchek, SM, Rodriguez, GC, Salani, R, Kaulich, DG, Tea, M-K, Paluch, SS, Laitman, Y, Skytte, A-B, Kruse, TA, Jensen, UB, Robson, M, Gerdes, A-M, Ejlertsen, B, Foretova, L, Savage, SA, Lester, J, Soucy, P, Kuchenbaecker, KB, Olswold, C, Cunningham, JM, Slager, S, Pankratz, VS, Dicks, E, Lakhani, SR, Couch, FJ, Hall, P, Monteiro, ANA, Gayther, SA, Pharoah, PDP, Reddel, RR, Goode, EL, Greene, MH, Easton, DF, Berchuck, A, Antoniou, AC, Chenevix-Trench, G, and Dunning, AM. "Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer." Nature Genetics 45, no. 4 (April 2013): 371-384e2. Full Text
  - Grant, DJ, Hoyo, C, Akushevich, L, Iversen, ES, Whitaker, R, Marks, J, Berchuck, A, and Schildkraut, JM. "Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women." Gynecologic Oncology 129, no. 1 (April 2013): 173-178. Full Text
  - Pharoah, PDP, Tsai, Y-Y, Ramus, SJ, Phelan, CM, Goode, EL, Lawrenson, K, Buckley, M, Fridley, BL, Tyrer, JP, Shen, H, Weber, R, Karevan, R, Larson, MC, Song, H, Tessier, DC, Bacot, F, Vincent, D, Cunningham, JM, Dennis, J, Dicks, E, Australian Cancer Study, , Australian Ovarian Cancer Study Group, , Aben, KK, Anton-Culver, H, Antonenkova, N, Armasu, SM, Baglietto, L, Bandera, EV, Beckmann, MW, Birrer, MJ, Bloom, G, Bogdanova, N, Brenton, JD, Brinton, LA, Brooks-Wilson, A, Brown, R, Butzow, R, Campbell, I, Carney, ME, Carvalho, RS, Chang-Claude, J, Chen, YA, Chen, Z, Chow, W-H, Cicek, MS, Coetzee, G, Cook, LS, Cramer, DW, Cybulski, C, Dansonka-Mieszkowska, A, Despierre, E, Doherty, JA, Dörk, T, du Bois, A, Dürst, M, Eccles, D, Edwards, R, Ekici, AB, Fasching, PA, Fenstermacher, D, Flanagan, J, Gao, Y-T, Garcia-Closas, M, Gentry-Maharaj, A, Giles, G, Gjyshi, A, Gore, M, Gronwald, J, Guo, Q, Halle, MK, Harter, P, Hein, A, Heitz, F, Hillemanns, P, Hoatlin, M, Høgdall, E, Høgdall, CK, Hosono, S, Jakubowska, A, Jensen, A, Kalli, KR, Karlan, BY, Kelemen, LE, Kiemeney, LA, Kjaer, SK, Konecny, GE, Krakstad, C, Kupryjanczyk, J, Lambrechts, D, Lambrechts, S, Le, ND, Lee, N, Lee, J, Leminen, A, Lim, BK, Lissowska, J, Lubiński, J, Lundvall, L, Lurie, G, Massuger, LFAG, Matsuo, K, McGuire, V, McLaughlin, JR, Menon, U, Modugno, F, Moysich, KB, Nakanishi, T, Narod, SA, Ness, RB, Nevanlinna, H, Nickels, S, Noushmehr, H, Odunsi, K, Olson, S, Orlow, I, Paul, J, Pejovic, T, Pelttari, LM, Permuth-Wey, J, Pike, MC, Poole, EM, Qu, X, Risch, HA, Rodriguez-Rodriguez, L, Rossing, MA, Rudolph, A, Runnebaum, I, Rzepecka, IK, Salvesen, HB, Schwaab, I, Severi, G, Shen, H, Shridhar, V, Shu, X-O, Sieh, W, Southey, MC, Spellman, P, Tajima, K, Teo, S-H, Terry, KL, Thompson, PJ, Timorek, A, Tworoger, SS, van Altena, AM, van den Berg, D, Vergote, I, Vierkant, RA, Vitonis, AF, Wang-Gohrke, S, Wentzensen, N, Whittemore, AS, Wik, E, Winterhoff, B, Woo, YL, Wu, AH, Yang, HP, Zheng, W, Ziogas, A, Zulkifli, F, Goodman, MT, Hall, P, Easton, DF, Pearce, CL, Berchuck, A, Chenevix-Trench, G, Iversen, E, Monteiro, ANA, Gayther, SA, Schildkraut, JM, and Sellers, TA. "GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer." Nature Genetics 45, no. 4 (April 2013): 362-370e2. Full Text
  - Sfakianos, GP, Iversen, ES, Whitaker, R, Akushevich, L, Schildkraut, JM, Murphy, SK, Marks, JR, and Berchuck, A. "Validation of ovarian cancer gene expression signatures for survival and subtype in formalin fixed paraffin embedded tissues." Gynecol Oncol 129, no. 1 (April 2013): 159-164. Full Text Link to Item
  - Sieh, W, Salvador, S, McGuire, V, Weber, RP, Terry, KL, Rossing, MA, Risch, H, Wu, AH, Webb, PM, Moysich, K, Doherty, JA, Felberg, A, Miller, D, Jordan, SJ, Australian Cancer Study (Ovarian Cancer), , Australian Ovarian Cancer Study Group, , Goodman, MT, Lurie, G, Chang-Claude, J, Rudolph, A, Kjær, SK, Jensen, A, Høgdall, E, Bandera, EV, Olson, SH, King, MG, Rodriguez-Rodriguez, L, Kiemeney, LA, Marees, T, Massuger, LF, van Altena, AM, Ness, RB, Cramer, DW, Pike, MC, Pearce, CL, Berchuck, A, Schildkraut, JM, Whittemore, AS, and Ovarian Cancer Association Consortium, . "Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies." International Journal of Epidemiology 42, no. 2 (April 2013): 579-589. Full Text
  - Goode, EL, DeRycke, M, Kalli, KR, Oberg, AL, Cunningham, JM, Maurer, MJ, Fridley, BL, Armasu, SM, Serie, DJ, Ramar, P, Goergen, K, Vierkant, RA, Rider, DN, Sicotte, H, Wang, C, Winterhoff, B, Phelan, CM, Schildkraut, JM, Weber, RP, Iversen, E, Berchuck, A, Sutphen, R, Birrer, MJ, Hampras, S, Preus, L, Gayther, SA, Ramus, SJ, Wentzensen, N, Yang, HP, Garcia-Closas, M, Song, H, Tyrer, J, Pharoah, PPD, Konecny, G, Sellers, TA, Ness, RB, Sucheston, LE, Odunsi, K, Hartmann, LC, Moysich, KB, and Knutson, KL. "Inherited variants in regulatory T cell genes and outcome of ovarian cancer." Plos One 8, no. 1 (January 30, 2013): e53903-null. Full Text
  - Garg, K, Levine, DA, Olvera, N, Dao, F, Bisogna, M, Secord, AA, Berchuck, A, Cerami, E, Schultz, N, and Soslow, RA. "BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomas." The American Journal of Surgical Pathology 37, no. 1 (January 2013): 138-146. Full Text
  - Johnatty, SE, Beesley, J, Gao, B, Chen, X, Lu, Y, Law, MH, Henderson, MJ, Russell, AJ, Hedditch, EL, Emmanuel, C, and al, E. "ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and the Cancer Genome Atlas." Gynecologic Oncology 131, no. 1 (2013): 8-14. Full Text
  - Lopez-Acevedo, M, Havrilesky, LJ, Broadwater, G, Kamal, AH, Abernethy, AP, Berchuck, A, Secord, AA, Tulsky, JA, Valea, F, and Lee, PS. "Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer." Gynecologic Oncology 130, no. 1 (2013): 156-161. Full Text
  - Maxwell, GL, Allard, J, Gadisetti, CVR, Litzi, T, Casablanca, Y, Chandran, U, Darcy, KM, Levine, DA, Berchuck, A, Hamilton, CA, Conrads, TP, and Risinger, JI. "Transcript expression in endometrial cancers from Black and White patients." Gynecologic Oncology 130, no. 1 (2013): 169-173. Full Text
  - Permuth-Wey, J, Lawrenson, K, Shen, HC, Velkova, A, Tyrer, JP, Chen, Z, Lin, H-Y, Chen, YA, Tsai, Y-Y, Qu, X, Ramus, SJ, Karevan, R, Lee, J, Lee, N, Larson, MC, Aben, KK, Anton-Culver, H, Antonenkova, N, Antoniou, AC, Armasu, SM, Australian Cancer Study, , Australian Ovarian Cancer Study, , Bacot, F, Baglietto, L, Bandera, EV, Barnholtz-Sloan, J, Beckmann, MW, Birrer, MJ, Bloom, G, Bogdanova, N, Brinton, LA, Brooks-Wilson, A, Brown, R, Butzow, R, Cai, Q, Campbell, I, Chang-Claude, J, Chanock, S, Chenevix-Trench, G, Cheng, JQ, Cicek, MS, Coetzee, GA, Consortium of Investigators of Modifiers of BRCA1/2, , Cook, LS, Couch, FJ, Cramer, DW, Cunningham, JM, Dansonka-Mieszkowska, A, Despierre, E, Doherty, JA, Dörk, T, du Bois, A, Dürst, M, Easton, DF, Eccles, D, Edwards, R, Ekici, AB, Fasching, PA, Fenstermacher, DA, Flanagan, JM, Garcia-Closas, M, Gentry-Maharaj, A, Giles, GG, Glasspool, RM, Gonzalez-Bosquet, J, Goodman, MT, Gore, M, Górski, B, Gronwald, J, Hall, P, Halle, MK, Harter, P, Heitz, F, Hillemanns, P, Hoatlin, M, Høgdall, CK, Høgdall, E, Hosono, S, Jakubowska, A, Jensen, A, Jim, H, Kalli, KR, Karlan, BY, Kaye, SB, Kelemen, LE, Kiemeney, LA, Kikkawa, F, Konecny, GE, Krakstad, C, Kjaer, SK, Kupryjanczyk, J, Lambrechts, D, Lambrechts, S, Lancaster, JM, Le, ND, Leminen, A, Levine, DA, Liang, D, Lim, BK, Lin, J, Lissowska, J, Lu, KH, Lubiński, J, Lurie, G, Massuger, LFAG, Matsuo, K, McGuire, V, McLaughlin, JR, Menon, U, Modugno, F, Moysich, KB, Nakanishi, T, Narod, SA, Nedergaard, L, Ness, RB, Nevanlinna, H, Nickels, S, Noushmehr, H, Odunsi, K, Olson, SH, Orlow, I, Paul, J, Pearce, CL, Pejovic, T, Pelttari, LM, Pike, MC, Poole, EM, Raska, P, Renner, SP, Risch, HA, Rodriguez-Rodriguez, L, Rossing, MA, Rudolph, A, Runnebaum, IB, Rzepecka, IK, Salvesen, HB, Schwaab, I, Severi, G, Shridhar, V, Shu, X-O, Shvetsov, YB, Sieh, W, Song, H, Southey, MC, Spiewankiewicz, B, Stram, D, Sutphen, R, Teo, S-H, Terry, KL, Tessier, DC, Thompson, PJ, Tworoger, SS, van Altena, AM, Vergote, I, Vierkant, RA, Vincent, D, Vitonis, AF, Wang-Gohrke, S, Palmieri Weber, R, Wentzensen, N, Whittemore, AS, Wik, E, Wilkens, LR, Winterhoff, B, Woo, YL, Wu, AH, Xiang, Y-B, Yang, HP, Zheng, W, Ziogas, A, Zulkifli, F, Phelan, CM, Iversen, E, Schildkraut, JM, Berchuck, A, Fridley, BL, Goode, EL, Pharoah, PDP, Monteiro, ANA, Sellers, TA, and Gayther, SA. "Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31." Nature Communications 4 (January 2013): 1627-null. Full Text
  - Risinger, JI, Allard, J, Chandran, U, Day, R, Chandramouli, GVR, Miller, C, Zahn, C, Oliver, J, Litzi, T, Marcus, C, Dubil, E, Byrd, K, Cassablanca, Y, Becich, M, Berchuck, A, Darcy, KM, Hamilton, CA, Conrads, TP, and Maxwell, GL. "Gene expression analysis of early stage endometrial cancers reveals unique transcripts associated with grade and histology but not depth of invasion. (Published online)" Front Oncol 3 (2013): 139-. Full Text Link to Item
  - Sfakianos, GP, Iversen, ES, Whitaker, R, Akushevich, L, Schildkraut, JM, Murphy, SK, Marks, JR, and Berchuck, A. "Validation of ovarian cancer gene expression signatures for survival and subtype in formalin fixed paraffin embedded tissues." Gynecologic Oncology 129, no. 1 (2013): 159-164. Full Text
  - Shen, H, Fridley, BL, Song, H, Lawrenson, K, Cunningham, JM, Ramus, SJ, Cicek, MS, Tyrer, J, Stram, D, Larson, MC, Köbel, M, PRACTICAL Consortium, , Ziogas, A, Zheng, W, Yang, HP, Wu, AH, Wozniak, EL, Woo, YL, Winterhoff, B, Wik, E, Whittemore, AS, Wentzensen, N, Weber, RP, Vitonis, AF, Vincent, D, Vierkant, RA, Vergote, I, Van Den Berg, D, Van Altena, AM, Tworoger, SS, Thompson, PJ, Tessier, DC, Terry, KL, Teo, S-H, Templeman, C, Stram, DO, Southey, MC, Sieh, W, Siddiqui, N, Shvetsov, YB, Shu, X-O, Shridhar, V, Wang-Gohrke, S, Severi, G, Schwaab, I, Salvesen, HB, Rzepecka, IK, Runnebaum, IB, Rossing, MA, Rodriguez-Rodriguez, L, Risch, HA, Renner, SP, Poole, EM, Pike, MC, Phelan, CM, Pelttari, LM, Pejovic, T, Paul, J, Orlow, I, Omar, SZ, Olson, SH, Odunsi, K, Nickels, S, Nevanlinna, H, Ness, RB, Narod, SA, Nakanishi, T, Moysich, KB, Monteiro, ANA, Moes-Sosnowska, J, Modugno, F, Menon, U, McLaughlin, JR, McGuire, V, Matsuo, K, Adenan, NAM, Massuger, LFAG, Lurie, G, Lundvall, L, Lubiński, J, Lissowska, J, Levine, DA, Leminen, A, Lee, AW, Le, ND, Lambrechts, S, Lambrechts, D, Kupryjanczyk, J, Krakstad, C, Konecny, GE, Kjaer, SK, Kiemeney, LA, Kelemen, LE, Keeney, GL, Karlan, BY, Karevan, R, Kalli, KR, Kajiyama, H, Ji, B-T, Jensen, A, Jakubowska, A, Iversen, E, Hosono, S, Høgdall, CK, Høgdall, E, Hoatlin, M, Hillemanns, P, Heitz, F, Hein, R, Harter, P, Halle, MK, Hall, P, Gronwald, J, Gore, M, Goodman, MT, Giles, GG, Gentry-Maharaj, A, Garcia-Closas, M, Flanagan, JM, Fasching, PA, Ekici, AB, Edwards, R, Eccles, D, Easton, DF, Dürst, M, du Bois, A, Dörk, T, Doherty, JA, Despierre, E, Dansonka-Mieszkowska, A, Cybulski, C, Cramer, DW, Cook, LS, Chen, X, Charbonneau, B, Chang-Claude, J, Campbell, I, Butzow, R, Bunker, CH, Brueggmann, D, Brown, R, Brooks-Wilson, A, Brinton, LA, Bogdanova, N, Block, MS, Benjamin, E, Beesley, J, Beckmann, MW, Bandera, EV, Baglietto, L, Bacot, F, Armasu, SM, Antonenkova, N, Anton-Culver, H, Aben, KK, Liang, D, Wu, X, Lu, K, Hildebrandt, MAT, Australian Ovarian Cancer Study Group, , Australian Cancer Study, , Schildkraut, JM, Sellers, TA, Huntsman, D, Berchuck, A, Chenevix-Trench, G, Gayther, SA, Pharoah, PDP, Laird, PW, Goode, EL, and Pearce, CL. "Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer." Nature Communications 4 (January 2013): 1628-null. Full Text
  - Lopez-Acevedo, M, Zhang, C, Secord, AA, Lee, PS, Havrilesky, LJ, and Berchuck, A. "Predictors of failure to perform pelvic peritoneal cytology in endometrial cancer staging surgery." JOURNAL OF CLINICAL ONCOLOGY 30, no. 34 (December 1, 2012). Full Text Link to Item
  - Zhang, C, Secord, AA, Lee, PS, Havrilesky, LJ, and Berchuck, A. "Predictors of failure to perform pelvic peritoneal cytology in endometrial cancer staging surgery." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 30, no. 34_suppl (December 2012): 201-.
  - Secord, AA, Teoh, DK, Barry, WT, Yu, M, Broadwater, G, Havrilesky, LJ, Lee, PS, Berchuck, A, Lancaster, J, and Wenham, RM. "A phase I trial of dasatinib, an SRC-family kinase inhibitor, in combination with paclitaxel and carboplatin in patients with advanced or recurrent ovarian cancer." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 18, no. 19 (October 2012): 5489-5498. Full Text
  - Berchuck, A. "Genetic testing in ovarian cancer: getting better, and maybe not just for disease susceptibility anymore." Obstetrics and Gynecology 120, no. 2 Pt 1 (August 2012): 221-222. Full Text
  - Alvarez Secord, A, Berchuck, A, Higgins, RV, Nycum, LR, Kohler, MF, Puls, LE, Holloway, RW, Lewandowski, GS, Valea, FA, and Havrilesky, LJ. "A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer." Cancer 118, no. 13 (July 2012): 3283-3293. Full Text
  - Pearce, CL, and Berchuck, A. "Endometriosis and ovarian cancer - Authors' reply." The Lancet Oncology 13, no. 5 (May 1, 2012). (Letter) Full Text
  - Charbonneau, B, White, KL, Schildkraut, JM, Palmieri, RT, Iversen, E, Berchuck, A, Vierkant, RA, Rider, DN, Cicek, MS, Sutphen, R, Birrer, MJ, Pharoah, PPD, Song, H, Tyrer, J, Gayther, SA, Ramus, SJ, Wentzensen, N, Yang, HP, Garcia-Closas, M, Phelan, CM, Cunningham, JM, Fridley, BL, Sellers, TA, and Goode, EL. "Abstract 2603: Subtype-specific ovarian cancer risk associated with SNPs inIL1A:." Cancer Research 72, no. 8 Supplement (April 15, 2012): 2603-2603. Full Text
  - Huang, Z, Lowery, WJ, Berchuck, A, and Murphy, SK. "Abstract 5363: Aggregation rather than monoclonal expansion explains ovarian cancer spheroid formation." Cancer Research 72, no. 8 Supplement (April 15, 2012): 5363-5363. Full Text
  - Okamoto, T, Yamaguchi, K, Huang, Z, Whitaker, R, Konishi, I, Berchuck, A, and Murphy, SK. "Abstract LB-87: Methylated-mediated repression of ZNF154 in ovarian cancer is associated with poor overall survival." Cancer Research 72, no. 8 Supplement (April 15, 2012). Full Text
  - Bolton, KL, Ganda, C, Berchuck, A, Pharaoh, PDP, and Gayther, SA. "Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the Ovarian Cancer Association Consortium (OCAC)." Journal of Internal Medicine 271, no. 4 (April 2012): 366-378. (Review) Full Text
  - Chino, JP, Jones, E, Berchuck, A, Secord, AA, and Havrilesky, LJ. "The influence of radiation modality and lymph node dissection on survival in early-stage endometrial cancer." Int J Radiat Oncol Biol Phys 82, no. 5 (April 1, 2012): 1872-1879. Full Text Link to Item
  - Pearce, CL, Templeman, C, Rossing, MA, Lee, A, Near, AM, Webb, PM, Nagle, CM, Doherty, JA, Cushing-Haugen, KL, Wicklund, KG, Chang-Claude, J, Hein, R, Lurie, G, Wilkens, LR, Carney, ME, Goodman, MT, Moysich, K, Kjaer, SK, Hogdall, E, Jensen, A, Goode, EL, Fridley, BL, Larson, MC, Schildkraut, JM, Palmieri, RT, Cramer, DW, Terry, KL, Vitonis, AF, Titus, LJ, Ziogas, A, Brewster, W, Anton-Culver, H, Gentry-Maharaj, A, Ramus, SJ, Anderson, AR, Brueggmann, D, Fasching, PA, Gayther, SA, Huntsman, DG, Menon, U, Ness, RB, Pike, MC, Risch, H, Wu, AH, Berchuck, A, and Ovarian Cancer Association Consortium, . "Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies." The Lancet. Oncology 13, no. 4 (April 2012): 385-394. Full Text
  - Berchuck, A, Secord, AA, and Havrilesky, LJ. "Minimally invasive surgery for endometrial cancer: the horse is already out of the barn." J Clin Oncol 30, no. 7 (March 1, 2012): 681-682. Full Text Link to Item
  - Berchuck, A, Sfakianos, G, Whitaker, R, Levine, D, Murphy, S, Marks, J, and Iversen, E. "Frequency of the cancer genome atlas expression subtypes differs between early and advanced stage high grade serous ovarian cancers." GYNECOLOGIC ONCOLOGY 125 (March 2012): S133-S133. Full Text Link to Item
  - Murphy, S, Yang, H, Yamaguchi, K, Huang, Z, Konishi, I, and Berchuck, A. "DNA methylation profiles distinguish serous, mucinous and clear cell but not endometrioid epithelial ovarian cancers." GYNECOLOGIC ONCOLOGY 125 (March 2012): S99-S99. Full Text Link to Item
  - Rodriguez, GC, Turbov, JM, Berchuck, A, Stack, MS, Hurteau, JA, Thaete, LG, and Barry, CP. "Nonsteroidal antiinflammatory drugs and progestins synergistically enhance cell death in ovarian epithelial cells." Am J Obstet Gynecol 206, no. 3 (March 2012): 253.e1-253.e9. Full Text Link to Item
  - Sfakianos, G, Iversen, E, Lowery, W, Whitaker, R, Akushevich, L, Schildkraut, J, Marks, J, and Berchuck, A. "Clinical translation of the cancer genome atlas signature for ovarian cancer survival." GYNECOLOGIC ONCOLOGY 125 (March 2012): S42-S42. Full Text Link to Item
  - Stevens, KN, Kelemen, LE, Wang, X, Fridley, BL, Vierkant, RA, Fredericksen, Z, Armasu, SM, Tsai, Y-Y, Berchuck, A, Narod, SA, Phelan, CM, Sutphen, R, Birrer, MJ, Schildkraut, JM, Sellers, TA, Goode, EL, Ovarian Cancer Association Consortium, , and Couch, FJ. "Common variation in Nemo-like kinase is associated with risk of ovarian cancer." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 21, no. 3 (March 2012): 523-528. Full Text
  - Wallace, A, Darcy, K, Alvarez-Secord, A, Hutson, A, Tritchler, D, Kirchgraber, L, Grace, L, Whitaker, R, Berchuck, A, and Havrilesky, L. "Loss of p16 in advanced stage epithelial ovarian cancer is associated with chemoresistant disease, suboptimal debulking and poor progression-free survival: A Gynecologic Oncology Group study." GYNECOLOGIC ONCOLOGY 125 (March 2012): S37-S37. Full Text Link to Item
  - White, KL, Schildkraut, JM, Palmieri, RT, Iversen, ES, Berchuck, A, Vierkant, RA, Rider, DN, Charbonneau, B, Cicek, MS, Sutphen, R, Birrer, MJ, Pharoah, PPD, Song, H, Tyrer, J, Gayther, SA, Ramus, SJ, Wentzensen, N, Yang, HP, Garcia-Closas, M, Phelan, CM, Cunningham, JM, Fridley, BL, Sellers, TA, Goode, EL, and Ovarian Cancer Association Consortium, . "Ovarian cancer risk associated with inherited inflammation-related variants." Cancer Research 72, no. 5 (March 2012): 1064-1069. Full Text
  - Allard, JE, Chandramouli, GVR, Stagliano, K, Hood, BL, Litzi, T, Shoji, Y, Boyd, J, Berchuck, A, Conrads, TP, Maxwell, GL, and Risinger, JI. "Analysis of PSPHL as a Candidate Gene Influencing the Racial Disparity in Endometrial Cancer. (Published online)" Front Oncol 2 (2012): 65-. Full Text Link to Item
  - Havrilesky, LJ, Pokrzywinski, R, Revicki, D, Higgins, RV, Nycum, LR, Kohler, MF, Berchuck, A, Myers, ER, and Secord, AA. "Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancer." Cancer 118, no. 2 (January 2012): 386-391. Full Text
  - Kelemen, LE, Wang, Q, Dinu, I, Vierkant, RA, Tsai, Y-Y, Cunningham, JM, Phelan, CM, Fridley, BL, Amankwah, EK, Iversen, ES, Berchuck, A, Schildkraut, JM, Goode, EL, and Sellers, TA. "Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma." Frontiers in Genetics 3 (January 2012): 33-null. Full Text
  - Lowery, WJ, Schildkraut, JM, Akushevich, L, Bentley, R, Marks, JR, Huntsman, D, and Berchuck, A. "Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers." Int J Gynecol Cancer 22, no. 1 (January 2012): 9-14. Full Text Link to Item
  - Bondurant, AE, Huang, Z, Whitaker, RS, Simel, LR, Berchuck, A, and Murphy, SK. "Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancer." Gynecologic Oncology 123, no. 3 (December 2011): 581-587. Full Text
  - Marchion, DC, Cottrill, HM, Xiong, Y, Chen, N, Bicaku, E, Fulp, WJ, Bansal, N, Chon, HS, Stickles, XB, Kamath, SG, Hakam, A, Li, L, Su, D, Moreno, C, Judson, PL, Berchuck, A, Wenham, RM, Apte, SM, Gonzalez-Bosquet, J, Bloom, GC, Eschrich, SA, Sebti, S, Chen, D-T, and Lancaster, JM. "BAD phosphorylation determines ovarian cancer chemosensitivity and patient survival." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 17, no. 19 (October 2011): 6356-6366. Full Text
  - Risch, HA, Berchuck, A, and Pharoah, PDP. "Response to Weidhaas and Slack re: Comments on "The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implication for clinical testing"." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 17, no. 20 (October 2011). Full Text
  - Vaughan, S, Coward, JI, Bast, RC, Berchuck, A, Berek, JS, Brenton, JD, Coukos, G, Crum, CC, Drapkin, R, Etemadmoghadam, D, Friedlander, M, Gabra, H, Kaye, SB, Lord, CJ, Lengyel, E, Levine, DA, McNeish, IA, Menon, U, Mills, GB, Nephew, KP, Oza, AM, Sood, AK, Stronach, EA, Walczak, H, Bowtell, DD, and Balkwill, FR. "Rethinking ovarian cancer: recommendations for improving outcomes." Nature Reviews. Cancer 11, no. 10 (September 23, 2011): 719-725. Full Text
  - Skates, SJ, Mai, P, Horick, NK, Piedmonte, M, Drescher, CW, Isaacs, C, Armstrong, DK, Buys, SS, Rodriguez, GC, Horowitz, IR, Berchuck, A, Daly, MB, Domchek, S, Cohn, DE, Van Le, L, Schorge, JO, Newland, W, Davidson, SA, Barnes, M, Brewster, W, Azodi, M, Nerenstone, S, Kauff, ND, Fabian, CJ, Sluss, PM, Nayfield, SG, Kasten, CH, Finkelstein, DM, Greene, MH, and Lu, K. "Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status." Cancer Prevention Research (Philadelphia, Pa.) 4, no. 9 (September 2011): 1401-1408. Full Text
  - Teoh, D, Berchuck, A, Alvarez Secord, A, Lee, PS, Lowery, WJ, Sfakianos, GP, Valea, FA, Myers, ER, and Havrilesky, LJ. "Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer." Gynecol Oncol 122, no. 3 (September 2011): 467-472. Full Text Link to Item
  - Barnett, JC, Havrilesky, LJ, Bondurant, AE, Fleming, ND, Lee, PS, Secord, AA, Berchuck, A, and Valea, FA. "Adverse events associated with laparoscopy vs laparotomy in the treatment of endometrial cancer." Am J Obstet Gynecol 205, no. 2 (August 2011): 143.e1-143.e6. Full Text Link to Item
  - Permuth-Wey, J, Chen, Z, Tsai, Y-Y, Lin, H-Y, Chen, YA, Barnholtz-Sloan, J, Birrer, MJ, Chanock, SJ, Cramer, DW, Cunningham, JM, Fenstermacher, D, Fridley, BL, Garcia-Closas, M, Gayther, SA, Gentry-Maharaj, A, Gonzalez-Bosquet, J, Iversen, E, Jim, H, McLaughlin, J, Menon, U, Narod, SA, Phelan, CM, Ramus, SJ, Risch, H, Song, H, Sutphen, R, Terry, KL, Tyrer, J, Vierkant, RA, Wentzensen, N, Lancaster, JM, Cheng, JQ, Berchuck, A, Pharoah, PDP, Schildkraut, JM, Goode, EL, Sellers, TA, and Ovarian Cancer Association Consortium (OCAC), . "MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 20, no. 8 (August 2011): 1793-1797. Full Text
  - Pharoah, P, Antoniou, A, Berchuck, A, Chenevix-Trench, G, Gayther, S, Goode, E, Milne, R, Sellers, T, and Tyrer, J. "Association between KRAS rs61764370 and triple-negative breast cancer--a false positive?." Lancet Oncol 12, no. 8 (August 2011): 723-724. (Letter) Full Text Link to Item
  - Swaminathan, V, Mythreye, K, O'Brien, ET, Berchuck, A, Blobe, GC, and Superfine, R. "Mechanical stiffness grades metastatic potential in patient tumor cells and in cancer cell lines." Cancer Research 71, no. 15 (August 2011): 5075-5080. Full Text
  - Cancer Genome Atlas Research Network, . "Integrated genomic analyses of ovarian carcinoma." Nature 474, no. 7353 (June 29, 2011): 609-615. Full Text
  - Maxwell, GL, Hood, BL, Day, R, Chandran, U, Kirchner, D, Kolli, VSK, Bateman, NW, Allard, J, Miller, C, Sun, M, Flint, MS, Zahn, C, Oliver, J, Banerjee, S, Litzi, T, Parwani, A, Sandburg, G, Rose, S, Becich, MJ, Berchuck, A, Kohn, E, Risinger, JI, and Conrads, TP. "Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammation." Gynecologic Oncology 121, no. 3 (June 2011): 586-594. Full Text
  - Pearce, CL, Doherty, JA, Van Den Berg, DJ, Moysich, K, Hsu, C, Cushing-Haugen, KL, Conti, DV, Ramus, SJ, Gentry-Maharaj, A, Menon, U, Gayther, SA, Pharoah, PDP, Song, H, Kjaer, SK, Hogdall, E, Hogdall, C, Whittemore, AS, McGuire, V, Sieh, W, Gronwald, J, Medrek, K, Jakubowska, A, Lubinski, J, Chenevix-Trench, G, AOCS/ACS Study Group, , Beesley, J, Webb, PM, Berchuck, A, Schildkraut, JM, Iversen, ES, Moorman, PG, Edlund, CK, Stram, DO, Pike, MC, Ness, RB, Rossing, MA, and Wu, AH. "Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk." Human Molecular Genetics 20, no. 11 (June 2011): 2263-2272. Full Text
  - Pharoah, PDP, Palmieri, RT, Ramus, SJ, Gayther, SA, Andrulis, IL, Anton-Culver, H, Antonenkova, N, Antoniou, AC, Goldgar, D, BCFR Investigators, , Beattie, MS, Beckmann, MW, Birrer, MJ, Bogdanova, N, Bolton, KL, Brewster, W, Brooks-Wilson, A, Brown, R, Butzow, R, Caldes, T, Caligo, MA, Campbell, I, Chang-Claude, J, Chen, YA, Cook, LS, Couch, FJ, Cramer, DW, Cunningham, JM, Despierre, E, Doherty, JA, Dörk, T, Dürst, M, Eccles, DM, Ekici, AB, Easton, D, EMBRACE Investigators, , Fasching, PA, de Fazio, A, Fenstermacher, DA, Flanagan, JM, Fridley, BL, Friedman, E, Gao, B, Sinilnikova, O, GEMO Study Collaborators, , Gentry-Maharaj, A, Godwin, AK, Goode, EL, Goodman, MT, Gross, J, Hansen, TVO, Harnett, P, Rookus, M, HEBON Investigators, , Heikkinen, T, Hein, R, Høgdall, C, Høgdall, E, Iversen, ES, Jakubowska, A, Johnatty, SE, Karlan, BY, Kauff, ND, Kaye, SB, Chenevix-Trench, G, kConFab Investigators and the Consortium of Investigators of Modifiers of BRCA1/2, , Kelemen, LE, Kiemeney, LA, Kjaer, SK, Lambrechts, D, Lapolla, JP, Lázaro, C, Le, ND, Leminen, A, Leunen, K, Levine, DA, Lu, Y, Lundvall, L, Macgregor, S, Marees, T, Massuger, LF, McLaughlin, JR, Menon, U, Montagna, M, Moysich, KB, Narod, SA, Nathanson, KL, Nedergaard, L, Ness, RB, Nevanlinna, H, Nickels, S, Osorio, A, Paul, J, Pearce, CL, Phelan, CM, Pike, MC, Radice, P, Rossing, MA, Schildkraut, JM, Sellers, TA, Singer, CF, Song, H, Stram, DO, Sutphen, R, Lindblom, A, SWE-BRCA Investigators, , Terry, KL, Tsai, Y-Y, van Altena, AM, Vergote, I, Vierkant, RA, Vitonis, AF, Walsh, C, Wang-Gohrke, S, Wappenschmidt, B, Wu, AH, Ziogas, A, Berchuck, A, Risch, HA, and Ovarian Cancer Association Consortium, . "The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 17, no. 11 (June 2011): 3742-3750. Full Text
  - Amankwah, EK, Kelemen, LE, Wang, Q, Song, H, Chenevix-Trench, G, Australian Ovarian Cancer Study Group, , Beesley, J, Webb, PM, Australian Cancer Study (Ovarian Cancer), , Pearce, CL, Wu, AH, Pike, MC, Stram, DO, Chang-Claude, J, Wang-Gohrke, S, Ness, RB, Goode, EL, Cunningham, JM, Fridley, BL, Vierkant, RA, Tworoger, SS, Whittemore, AS, McGuire, V, Sieh, W, Gayther, SA, Gentry-Maharaj, A, Menon, U, Ramus, SJ, Rossing, MA, Doherty, JA, Goodman, MT, Carney, ME, Lurie, G, Wilkens, LR, Kjær, SK, Høgdall, E, Cramer, DW, Terry, KL, Garcia-Closas, M, Yang, H, Lissowska, J, Anton-Culver, H, Ziogas, A, Schildkraut, JM, Berchuck, A, Pharoah, PDP, and Ovarian Cancer Association Consortium, . "Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 20, no. 5 (May 2011): 1028-1031. Full Text
  - Berchuck, A, Pharoah, P, Ramus, S, Gayther, S, Palmieri, R, Pearce, C, Couch, F, Antonio, A, Goode, E, Schildkraut, J, Chenevix-Trench, G, Sellers, T, and Risch, H. "Association of KRAS SNP rs61764370 with risk of invasive epithelial ovarian cancer: Implications for clinical testing." Gynecologic Oncology 121, no. 2 (May 2011): S2-S3. Full Text
  - Goode, EL, White, KL, Vierkant, RA, Phelan, CM, Cunningham, JM, Schildkraut, JM, Berchuck, A, Larson, MC, Fridley, BL, Olson, JE, Webb, PM, Chen, X, Beesley, J, Chenevix-Trench, G, Sellers, TA, Ovarian Cancer Association Consortium, , and Australian Ovarian Cancer Study Group, . "Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk." Mol Carcinog 50, no. 5 (May 2011): 397-402. Full Text Link to Item
  - Notaridou, M, Quaye, L, Dafou, D, Jones, C, Song, H, Høgdall, E, Kjaer, SK, Christensen, L, Høgdall, C, Blaakaer, J, McGuire, V, Wu, AH, Van Den Berg, DJ, Pike, MC, Gentry-Maharaj, A, Wozniak, E, Sher, T, Jacobs, IJ, Tyrer, J, Schildkraut, JM, Moorman, PG, Iversen, ES, Jakubowska, A, Mędrek, K, Lubiński, J, Ness, RB, Moysich, KB, Lurie, G, Wilkens, LR, Carney, ME, Wang-Gohrke, S, Doherty, JA, Rossing, MA, Beckmann, MW, Thiel, FC, Ekici, AB, Chen, X, Beesley, J, Australian Ovarian Cancer Study Group/Australian Cancer Study (Ovarian Cancer), , Gronwald, J, Fasching, PA, Chang-Claude, J, Goodman, MT, Chenevix-Trench, G, Berchuck, A, Pearce, CL, Whittemore, AS, Menon, U, Pharoah, PDP, Gayther, SA, Ramus, SJ, and Ovarian Cancer Association Consortium, . "Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer." International Journal of Cancer 128, no. 9 (May 2011): 2063-2074. Full Text
  - Huang, Z, Yamaguchi, K, Berchuck, A, and Murphy, SK. "Abstract 3014: Quantitative accuracy of Illumina HumanMethylation27 Infinium BeadChip data assessed by pyrosequencing." Cancer Research 71, no. 8 Supplement (April 15, 2011): 3014-3014. Full Text
  - Berchuck, A, and Einstein, MH. "Prevention and early detection of cancer." Gynecol Oncol 121, no. 1 (April 2011): 1-. Full Text Link to Item
  - Berchuck, A, and Einstein, MH. "Gynecologic Oncology: Editorial." Gynecologic Oncology 121, no. 1 (April 1, 2011): 1-null. Full Text
  - Carver, DK, Barnes, HJ, Anderson, KE, Petitte, JN, Whitaker, R, Berchuck, A, and Rodriguez, GC. "Reduction of ovarian and oviductal cancers in calorie-restricted laying chickens." Cancer Prev Res (Phila) 4, no. 4 (April 2011): 562-567. Full Text Link to Item
  - Teoh, D, Ayeni, TA, Rubatt, JM, Adams, DJ, Grace, L, Starr, MD, Barry, WT, Berchuck, A, Murphy, SK, and Secord, AA. "Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cells." Gynecologic Oncology 121, no. 1 (April 2011): 187-192. Full Text
  - Berchuck, A, Pike, M, Schildkraut, J, and Pearce, C. "Common single-nucleotide polymorphisms in the BNC2, HOXD1 and MERIT40 regions contribute significantly to racial differences in ovarian cancer incidence." GYNECOLOGIC ONCOLOGY 121, no. 1 (March 2011): S7-S7. Full Text Link to Item
  - Chandavarkar, U, Campan, M, Houshdaran, S, Pearce, C, Shen, H, Widschwendter, M, Berchuck, A, Roman, L, and Laird, P. "DNA methylation markers associated with serous ovarian cancer subtypes." GYNECOLOGIC ONCOLOGY 121, no. 1 (March 2011): S48-S48. Full Text Link to Item
  - Lancaster, J, Chen, D, Marchion, D, Xiong, Y, Berchuck, A, Judson, P, Bosquet, JG, Wenham, R, Apte, S, and Fulp, W. "BAD apoptosis pathway expression and survival from cancer." GYNECOLOGIC ONCOLOGY 121, no. 1 (March 2011): S24-S24. Full Text Link to Item
  - Lowery, W, Schildkraut, J, Akushevich, L, Bentley, R, Huntsman, D, Marks, J, and Berchuck, A. "Loss of ARID1A is a frequent event in clear cell and endometrioid ovarian cancers." GYNECOLOGIC ONCOLOGY 121, no. 1 (March 2011): S21-S21. Full Text Link to Item
  - Sfakianos, G, Yan, J, Whitaker, R, Murphy, S, and Berchuck, A. "Concordant gene expression profiles in matched primary and recurrent serous ovarian cancers predict platinum response." GYNECOLOGIC ONCOLOGY 121, no. 1 (March 2011): S46-S46. Full Text Link to Item
  - Teoh, D, Myers, E, Berchuck, A, Alvarez-Secord, A, Lee, P, Lowery, W, Sfakiancs, G, and Havrilesky, L. "Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer." GYNECOLOGIC ONCOLOGY 121, no. 1 (March 2011): S11-S11. Full Text Link to Item
  - Yamaguchi, K, Baba, T, Konishi, I, Matsumura, N, Murphy, S, Huang, Z, and Berchuck, A. "Genes functionally regulated by methylation in ovarian cancer are involved in cell proliferation, development and morphogenesis." GYNECOLOGIC ONCOLOGY 121, no. 1 (March 2011): S69-S69. Full Text Link to Item
  - Yamaguchi, K, Baba, T, Matsumura, N, Mandai, M, Konishi, I, Berchuck, A, and Murphy, S. "Genomewide methylation analyses reveal a prominent role of HINF1 network genes, via hypomethylation, in ovarian clear cell carcinoma." GYNECOLOGIC ONCOLOGY 121, no. 1 (March 2011): S8-S8. Full Text Link to Item
  - Havrilesky, LJ, Sanders, GD, Kulasingam, S, Chino, JP, Berchuck, A, Marks, JR, and Myers, ER. "Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction." Cancer 117, no. 3 (February 1, 2011): 545-553. Full Text Link to Item
  - Amankwah, EK, Wang, Q, Schildkraut, JM, Tsai, Y-Y, Ramus, SJ, Fridley, BL, Beesley, J, Johnatty, SE, Webb, PM, Chenevix-Trench, G, Australian Ovarian Cancer Study Group, , Dale, LC, Lambrechts, D, Amant, F, Despierre, E, Vergote, I, Gayther, SA, Gentry-Maharaj, A, Menon, U, Chang-Claude, J, Wang-Gohrke, S, Anton-Culver, H, Ziogas, A, Dörk, T, Dürst, M, Antonenkova, N, Bogdanova, N, Brown, R, Flanagan, JM, Kaye, SB, Paul, J, Bützow, R, Nevanlinna, H, Campbell, I, Eccles, DM, Karlan, BY, Gross, J, Walsh, C, Pharoah, PDP, Song, H, Krüger Kjær, S, Høgdall, E, Høgdall, C, Lundvall, L, Nedergaard, L, Kiemeney, LALM, Massuger, LFAG, van Altena, AM, Vermeulen, SHHM, Le, ND, Brooks-Wilson, A, Cook, LS, Phelan, CM, Cunningham, JM, Vachon, CM, Vierkant, RA, Iversen, ES, Berchuck, A, Goode, EL, Sellers, TA, and Kelemen, LE. "Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium." Plos One 6, no. 5 (January 2011): e19642-null. Full Text
  - Campan, M, Moffitt, M, Houshdaran, S, Shen, H, Widschwendter, M, Daxenbichler, G, Long, T, Marth, C, Laird-Offringa, IA, Press, MF, Dubeau, L, Siegmund, KD, Wu, AH, Groshen, S, Chandavarkar, U, Roman, LD, Berchuck, A, Pearce, CL, and Laird, PW. "Genome-scale screen for DNA methylation-based detection markers for ovarian cancer." Plos One 6, no. 12 (January 2011): e28141-null. Full Text
  - Chino, JP, Berchuck, A, and Havrilesky, L. "What Are The Causes Of Death For Women With Early-stage Endometrial Cancer?." INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 81, no. 2 (2011): S470-S470. Full Text Link to Item
  - Lurie, G, Wilkens, LR, Thompson, PJ, Shvetsov, YB, Matsuno, RK, Carney, ME, Palmieri, RT, Wu, AH, Pike, MC, Pearce, CL, Menon, U, Gentry-Maharaj, A, Gayther, SA, Ramus, SJ, Whittemore, AS, McGuire, V, Sieh, W, Pharoah, PDP, Song, H, Gronwald, J, Jakubowska, A, Cybulski, C, Lubinski, J, Schildkraut, JM, Berchuck, A, Krüger Kjær, S, Høgdall, E, Fasching, PA, Beckmann, MW, Ekici, AB, Hein, A, Chenevix-Trench, G, Webb, PM, Beesley, J, and Australian Ovarian Cancer Study Group, et al. "Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium." PLoS One 6, no. 6 (2011): e20703-. Full Text Link to Item
  - Matsumura, N, Huang, Z, Mori, S, Baba, T, Fujii, S, Konishi, I, Iversen, ES, Berchuck, A, and Murphy, SK. "Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer." Genome Research 21, no. 1 (January 2011): 74-82. Full Text
  - Murphy, SK, and Berchuck, A. "Ovarian Cancer Progenitor/Stem Cells: Therapeutic Potential." (2011): 223-244. Full Text
  - Near, AM, Wu, AH, Templeman, C, Van Den Berg, DJ, Doherty, JA, Rossing, MA, Goode, EL, Cunningham, JM, Vierkant, RA, Fridley, BL, Chenevix-Trench, G, Webb, PM, Kjær, SK, Hogdall, E, Gayther, SA, Ramus, SJ, Menon, U, Gentry-Maharaj, A, Schildkraut, JM, Moorman, PG, Palmieri, RT, Ness, RB, Moysich, K, Cramer, DW, Terry, KL, Vitonis, AF, Pike, MC, Berchuck, A, Pearce, CL, Ovarian Cancer Association Consortium, , Australian Cancer Study (Ovarian Cancer) (ACS), , and Australian Ovarian Cancer Study Group (AOCS), . "Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort." Fertility and Sterility 95, no. 1 (January 2011): 40-45. Full Text
  - Wallace, AH, Havrilesky, LJ, Valea, FA, Barnett, JC, Berchuck, A, and Myers, ER. "Projecting the need for gynecologic oncologists for the next 40 years." Obstetrics and Gynecology 116, no. 6 (December 2010): 1366-1372. Full Text
  - Bolton, KL, Tyrer, J, Song, H, Ramus, SJ, Notaridou, M, Jones, C, Sher, T, Gentry-Maharaj, A, Wozniak, E, Tsai, Y-Y, Weidhaas, J, Paik, D, Van Den Berg, DJ, Stram, DO, Pearce, CL, Wu, AH, Brewster, W, Anton-Culver, H, Ziogas, A, Narod, SA, Levine, DA, Kaye, SB, Brown, R, Paul, J, Flanagan, J, Sieh, W, McGuire, V, Whittemore, AS, Campbell, I, Gore, ME, Lissowska, J, Yang, HP, Medrek, K, Gronwald, J, Lubinski, J, Jakubowska, A, Le, ND, Cook, LS, Kelemen, LE, Brooks-Wilson, A, Massuger, LFAG, Kiemeney, LA, Aben, KKH, van Altena, AM, Houlston, R, Tomlinson, I, Palmieri, RT, Moorman, PG, Schildkraut, J, Iversen, ES, Phelan, C, Vierkant, RA, Cunningham, JM, Goode, EL, Fridley, BL, Kruger-Kjaer, S, Blaeker, J, Hogdall, E, Hogdall, C, Gross, J, Karlan, BY, Ness, RB, Edwards, RP, Odunsi, K, Moyisch, KB, Baker, JA, Modugno, F, Heikkinenen, T, Butzow, R, Nevanlinna, H, Leminen, A, Bogdanova, N, Antonenkova, N, Doerk, T, Hillemanns, P, Dürst, M, Runnebaum, I, Thompson, PJ, Carney, ME, Goodman, MT, Lurie, G, Wang-Gohrke, S, Hein, R, Chang-Claude, J, Rossing, MA, Cushing-Haugen, KL, Doherty, J, Chen, C, Rafnar, T, Besenbacher, S, Sulem, P, Stefansson, K, Birrer, MJ, Terry, KL, Hernandez, D, Cramer, DW, Vergote, I, Amant, F, Lambrechts, D, Despierre, E, Fasching, PA, Beckmann, MW, Thiel, FC, Ekici, AB, Chen, X, Australian Ovarian Cancer Study Group, , Australian Cancer Study (Ovarian Cancer), , Ovarian Cancer Association Consortium, , Johnatty, SE, Webb, PM, Beesley, J, Chanock, S, Garcia-Closas, M, Sellers, T, Easton, DF, Berchuck, A, Chenevix-Trench, G, Pharoah, PDP, and Gayther, SA. "Common variants at 19p13 are associated with susceptibility to ovarian cancer." Nature Genetics 42, no. 10 (October 2010): 880-884. Full Text
  - Goode, EL, Chenevix-Trench, G, Song, H, Ramus, SJ, Notaridou, M, Lawrenson, K, Widschwendter, M, Vierkant, RA, Larson, MC, Kjaer, SK, Birrer, MJ, Berchuck, A, Schildkraut, J, Tomlinson, I, Kiemeney, LA, Cook, LS, Gronwald, J, Garcia-Closas, M, Gore, ME, Campbell, I, Whittemore, AS, Sutphen, R, Phelan, C, Anton-Culver, H, Pearce, CL, Lambrechts, D, Rossing, MA, Chang-Claude, J, Moysich, KB, Goodman, MT, Dörk, T, Nevanlinna, H, Ness, RB, Rafnar, T, Hogdall, C, Hogdall, E, Fridley, BL, Cunningham, JM, Sieh, W, McGuire, V, Godwin, AK, Cramer, DW, Hernandez, D, Levine, D, Lu, K, Iversen, ES, Palmieri, RT, Houlston, R, van Altena, AM, Aben, KKH, Massuger, LFAG, Brooks-Wilson, A, Kelemen, LE, Le, ND, Jakubowska, A, Lubinski, J, Medrek, K, Stafford, A, Easton, DF, Tyrer, J, Bolton, KL, Harrington, P, Eccles, D, Chen, A, Molina, AN, Davila, BN, Arango, H, Tsai, Y-Y, Chen, Z, Risch, HA, McLaughlin, J, Narod, SA, Ziogas, A, Brewster, W, Gentry-Maharaj, A, Menon, U, Wu, AH, Stram, DO, Pike, MC, Wellcome Trust Case-Control Consortium, , Beesley, J, Webb, PM, Australian Cancer Study (Ovarian Cancer), , Australian Ovarian Cancer Study Group, , Ovarian Cancer Association Consortium (OCAC), , Chen, X, Ekici, AB, Thiel, FC, Beckmann, MW, Yang, H, Wentzensen, N, Lissowska, J, Fasching, PA, Despierre, E, Amant, F, Vergote, I, Doherty, J, Hein, R, Wang-Gohrke, S, Lurie, G, Carney, ME, Thompson, PJ, Runnebaum, I, Hillemanns, P, Dürst, M, Antonenkova, N, Bogdanova, N, Leminen, A, Butzow, R, Heikkinen, T, Stefansson, K, Sulem, P, Besenbacher, S, Sellers, TA, Gayther, SA, Pharoah, PDP, and Ovarian Cancer Association Consortium (OCAC), . "A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24." Nature Genetics 42, no. 10 (October 2010): 874-879. Full Text
  - Berek, JS, Chalas, E, Edelson, M, Moore, DH, Burke, WM, Cliby, WA, Berchuck, A, and Society of Gynecologic Oncologists Clinical Practice Committee, . "Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer." Obstetrics and Gynecology 116, no. 3 (September 2010): 733-743. (Review) Full Text
  - Johnatty, SE, Beesley, J, Chen, X, Macgregor, S, Duffy, DL, Spurdle, AB, deFazio, A, Gava, N, Webb, PM, Rossing, MA, Doherty, JA, Goodman, MT, Lurie, G, Thompson, PJ, Wilkens, LR, Ness, RB, Moysich, KB, Chang-Claude, J, Wang-Gohrke, S, Cramer, DW, Terry, KL, Hankinson, SE, Tworoger, SS, Garcia-Closas, M, Yang, H, Lissowska, J, Chanock, SJ, Pharoah, PD, Song, H, Whitemore, AS, Pearce, CL, Stram, DO, Wu, AH, Pike, MC, Gayther, SA, Ramus, SJ, Menon, U, Gentry-Maharaj, A, Anton-Culver, H, Ziogas, A, Hogdall, E, Kjaer, SK, Hogdall, C, Berchuck, A, Schildkraut, JM, Iversen, ES, Moorman, PG, Phelan, CM, Sellers, TA, Cunningham, JM, Vierkant, RA, Rider, DN, Goode, EL, Haviv, I, Chenevix-Trench, G, Ovarian Cancer Association Consortium, , Australian Ovarian Cancer Study Group, , and Australian Cancer Study (Ovarian Cancer), . "Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot"." Plos Genetics 6, no. 7 (July 8, 2010): e1001016-null. Full Text
  - Dafou, D, Grun, B, Sinclair, J, Lawrenson, K, Benjamin, EC, Hogdall, E, Kruger-Kjaer, S, Christensen, L, Sowter, HM, Al-Attar, A, Edmondson, R, Darby, S, Berchuck, A, Laird, PW, Pearce, CL, Ramus, SJ, Jacobs, IJ, and Gayther, SA. "Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers." Neoplasia 12, no. 7 (July 2010): 579-589. Link to Item
  - Kelemen, LE, Goodman, MT, McGuire, V, Rossing, MA, Webb, PM, Australian Cancer Study (Ovarian Cancer) Study Group, , Köbel, M, Anton-Culver, H, Beesley, J, Berchuck, A, Brar, S, Carney, ME, Chang-Claude, J, Chenevix-Trench, G, Australian Ovarian Cancer Study Group, , Cramer, DW, Cunningham, JM, Dicioccio, RA, Doherty, JA, Easton, DF, Fredericksen, ZS, Fridley, BL, Gates, MA, Gayther, SA, Gentry-Maharaj, A, Høgdall, E, Kjaer, SK, Lurie, G, Menon, U, Moorman, PG, Moysich, K, Ness, RB, Palmieri, RT, Pearce, CL, Pharoah, PDP, Ramus, SJ, Song, H, Stram, DO, Tworoger, SS, Van Den Berg, D, Vierkant, RA, Wang-Gohrke, S, Whittemore, AS, Wilkens, LR, Wu, AH, Schildkraut, JM, Sellers, TA, Goode, EL, and Ovarian Cancer Association Consortium, . "Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 19, no. 7 (July 2010): 1822-1830. Full Text
  - Bernardini, MQ, Baba, T, Lee, PS, Barnett, JC, Sfakianos, GP, Secord, AA, Murphy, SK, Iversen, E, Marks, JR, and Berchuck, A. "Expression signatures of TP53 mutations in serous ovarian cancers." Bmc Cancer 10 (May 26, 2010): 237-null. Full Text Open Access Copy
  - Chino, JP, Jones, E, Berchuck, A, and Havrilesky, L. "Influence of radiation modality and nodal dissection on survival in high-risk early-stage endometrial cancer." Journal of Clinical Oncology 28, no. 15_suppl (May 20, 2010): 5027-5027. Full Text
  - Kondoh, E, Mori, S, Yamaguchi, K, Baba, T, Matsumura, N, Cory Barnett, J, Whitaker, RS, Konishi, I, Fujii, S, Berchuck, A, and Murphy, SK. "Targeting slow-proliferating ovarian cancer cells." Int J Cancer 126, no. 10 (May 15, 2010): 2448-2456. Full Text Link to Item
  - Schildkraut, JM, Iversen, ES, Wilson, MA, Clyde, MA, Moorman, PG, Palmieri, RT, Whitaker, R, Bentley, RC, Marks, JR, and Berchuck, A. "Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer.(Published online)" Plos One 5, no. 4 (April 8, 2010): e10061-null. Full Text Open Access Copy Link to Item
  - Lee, PS, Teaberry, VS, Bland, AE, Huang, Z, Whitaker, RS, Baba, T, Fujii, S, Secord, AA, Berchuck, A, and Murphy, SK. "Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer." Int J Cancer 126, no. 6 (March 15, 2010): 1378-1389. Full Text Link to Item
  - Alvarez-Secord, A, Berchuck, A, Higgins, R, Nycum, L, Kohler, M, Puls, L, Holloway, R, Lewandowski, G, Valea, F, and Havrilesky, L. "A multicenter, randomized, phase II study evaluating the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer." GYNECOLOGIC ONCOLOGY 116, no. 3 (March 2010): S3-S3. Link to Item
  - Barnett, J, Havrilesky, L, Flemming, N, Bland, A, Lee, P, Alvarez-Secord, A, Berchuck, A, and Valea, F. "Adverse events associated with laparoscopy versus laparotomy in the treatment of stage I endometrial cancer." GYNECOLOGIC ONCOLOGY 116, no. 3 (March 2010): S147-S147. Link to Item
  - Barnett, JC, Bean, SM, Whitaker, RS, Kondoh, E, Baba, T, Fujii, S, Marks, JR, Dressman, HK, Murphy, SK, and Berchuck, A. "Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype." Gynecologic Oncology 116, no. 3 (March 2010): 556-562. Full Text
  - Havrilesky, L, Sanders, G, Kulasingam, S, Berchuck, A, Dressman, H, Lancaster, J, Marks, J, and Myers, E. "Indolent and aggressive phenotypes of epithelial ovarian cancer: Implications for screening." GYNECOLOGIC ONCOLOGY 116, no. 3 (March 2010): S107-S107. Link to Item
  - Humphrey, M, Chen, N, Xiong, Y, Marchion, D, Bicaku, E, Chon, H, Berchuck, A, Bansal, N, Apte, S, Wenham, R, and Lancaster, J. "Genomic analysis defines biological pathway differences between early- and advanced-stage ovarian cancers." GYNECOLOGIC ONCOLOGY 116, no. 3 (March 2010): S22-S22. Link to Item
  - Sfakianos, G, Yamaguchi, K, Murphy, S, and Berchuck, A. "Gene expression profiling of invasive serous ovarian cancers from formalin-fixed, paraffin-embedded tissues using DASL." GYNECOLOGIC ONCOLOGY 116, no. 3 (March 2010): S136-S137. Link to Item
  - Teoh, D, Ayeni, T, Rubatt, J, Adams, D, Grace, L, Starr, M, Dressman, H, Berchuck, A, and Alvarez-Secord, A. "Genomic SRC signature and SRC protein expression in ovarian cancers may predict response to the SRC inhibitor dasatinib." GYNECOLOGIC ONCOLOGY 116, no. 3 (March 2010): S151-S152. Link to Item
  - Wallace, A, Havrilesky, L, Valea, F, Barnett, J, Berchuck, A, and Myers, E. "Projecting the need for gynecologic oncologists for the next 40 years: Not enough, too many or just right?." GYNECOLOGIC ONCOLOGY 116, no. 3 (March 2010): S52-S53. Link to Item
  - Phelan, CM, Tsai, Y-Y, Goode, EL, Vierkant, RA, Fridley, BL, Beesley, J, Chen, XQ, Webb, PM, Chanock, S, Cramer, DW, Moysich, K, Edwards, RP, Chang-Claude, J, Garcia-Closas, M, Yang, H, Wang-Gohrke, S, Hein, R, Green, AC, Lissowska, J, Carney, ME, Lurie, G, Wilkens, LR, Ness, RB, Pearce, CL, Wu, AH, Van Den Berg, DJ, Stram, DO, Terry, KL, Whiteman, DC, Whittemore, AS, DiCioccio, RA, McGuire, V, Doherty, JA, Rossing, MA, Anton-Culver, H, Ziogas, A, Hogdall, C, Hogdall, E, Krüger Kjaer, S, Blaakaer, J, Quaye, L, Ramus, SJ, Jacobs, I, Song, H, Pharoah, PDP, Iversen, ES, Marks, JR, Pike, MC, Gayther, SA, Cunningham, JM, Goodman, MT, Schildkraut, JM, Chenevix-Trench, G, Berchuck, A, Sellers, TA, Ovarian Cancer Association Consortium, Australian Cancer Study (Ovarian Cancer), , and Australian Ovarian Cancer Study Group, . "Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 19, no. 2 (February 2010): 600-604. Full Text
  - White, KL, Sellers, TA, Fridley, BL, Vierkant, RA, Phelan, CM, Tsai, Y-Y, Kalli, KR, Berchuck, A, Iversen, ES, Hartmann, LC, Liebow, M, Armasu, S, Fredericksen, Z, Larson, MC, Duggan, D, Couch, FJ, Schildkraut, JM, Cunningham, JM, and Goode, EL. "Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer." Twin Res Hum Genet 13, no. 1 (February 2010): 43-56. Full Text Link to Item
  - Peedicayil, A, Vierkant, RA, Hartmann, LC, Fridley, BL, Fredericksen, ZS, White, KL, Elliott, EA, Phelan, CM, Tsai, Y-Y, Berchuck, A, Iversen, ES, Couch, FJ, Peethamabaran, P, Larson, MC, Kalli, KR, Kosel, ML, Shridhar, V, Rider, DN, Liebow, M, Cunningham, JM, Schildkraut, JM, Sellers, TA, and Goode, EL. "Risk of ovarian cancer and inherited variants in relapse-associated genes." Plos One 5, no. 1 (January 27, 2010): e8884-null. Full Text Open Access Copy
  - Barnett, JC, Bean, SM, Nakayama, JM, Kondoh, E, Murphy, SK, and Berchuck, A. "High poly(adenosine diphosphate-ribose) polymerase expression and poor survival in advanced-stage serous ovarian cancer." Obstet Gynecol 115, no. 1 (January 2010): 49-54. Full Text Link to Item
  - Doherty, JA, Rossing, MA, Cushing-Haugen, KL, Chen, C, Van Den Berg, DJ, Wu, AH, Pike, MC, Ness, RB, Moysich, K, Chenevix-Trench, G, Beesley, J, Webb, PM, Chang-Claude, J, Wang-Gohrke, S, Goodman, MT, Lurie, G, Thompson, PJ, Carney, ME, Hogdall, E, Kjaer, SK, Hogdall, C, Goode, EL, Cunningham, JM, Fridley, BL, Vierkant, RA, Berchuck, A, Moorman, PG, Schildkraut, JM, Palmieri, RT, Cramer, DW, Terry, KL, Yang, HP, Garcia-Closas, M, Chanock, S, Lissowska, J, Song, H, Pharoah, PDP, Shah, M, Perkins, B, McGuire, V, Whittemore, AS, Di Cioccio, RA, Gentry-Maharaj, A, Menon, U, Gayther, SA, Ramus, SJ, Ziogas, A, Brewster, W, Anton-Culver, H, Australian Ovarian Cancer Study Management Group, , Australian Cancer Study (Ovarian Cancer), , Pearce, CL, and Ovarian Cancer Association Consortium (OCAC), . "ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 19, no. 1 (January 2010): 245-250. Full Text
  - Johnatty, SE, Beesley, J, Chen, X, Macgregor, S, Duffy, DL, Spurdle, AB, Fazio, AD, Gava, N, Webb, PM, Rossing, MA, Doherty, JA, Goodman, MT, Lurie, G, Thompson, PJ, Wilkens, LR, Ness, RB, Moysich, KB, Chang-Claude, J, Wang-Gohrke, S, Cramer, DW, Terry, KL, Hankinson, SE, Tworoger, SS, Garcia-Closas, M, Yang, H, Lissowska, J, Chanock, SJ, Pharoah, PD, Song, H, Whitemore, AS, Pearce, CL, Stram, DO, Wu, AH, Pike, MC, Gayther, SA, Ramus, SJ, Menon, U, Gentry-Maharaj, A, Anton-Culver, H, and Ziogas, A et al. "Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "Hot-Spot"." PLoS Genetics 6, no. 7 (2010): 1-10. Full Text
  - Jewell, EL, Darcy, KM, Hutson, A, Lee, PS, Havrilesky, LJ, Grace, LA, Berchuck, A, and Secord, AA. "Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group study." Gynecologic Oncology 115, no. 3 (December 2009): 424-429. Full Text
  - Pearce, CL, Near, AM, Van Den Berg, DJ, Ramus, SJ, Gentry-Maharaj, A, Menon, U, Gayther, SA, Anderson, AR, Edlund, CK, Wu, AH, Chen, X, Beesley, J, Webb, PM, Holt, SK, Chen, C, Doherty, JA, Rossing, MA, Whittemore, AS, McGuire, V, Dicioccio, RA, Goodman, MT, Lurie, G, Carney, ME, Wilkens, LR, Ness, RB, Moysich, KB, Edwards, R, Jennison, E, Kjaer, SK, Hogdall, E, Hogdall, CK, Goode, EL, Sellers, TA, Vierkant, RA, Cunningham, JM, Schildkraut, JM, Berchuck, A, Moorman, PG, Iversen, ES, Cramer, DW, Terry, KL, Vitonis, AF, Titus-Ernstoff, L, Song, H, Pharoah, PDP, Spurdle, AB, Anton-Culver, H, Ziogas, A, Brewster, W, Galitovskiy, V, and Chenevix-Trench, G. "Erratum: Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium (British Journal of Cancer (2009) 100 (412-420) DOI: 10.1038/sj.bjc.6604820 www.bjcancer.com)." British Journal of Cancer 101, no. 10 (November 1, 2009): 1805-null. Full Text
  - Cunningham, JM, Vierkant, RA, Sellers, TA, Phelan, C, Rider, DN, Liebow, M, Schildkraut, J, Berchuck, A, Couch, FJ, Wang, X, Fridley, BL, Ovarian Cancer Association Consortium, , Gentry-Maharaj, A, Menon, U, Hogdall, E, Kjaer, S, Whittemore, A, DiCioccio, R, Song, H, Gayther, SA, Ramus, SJ, Pharaoh, PDP, and Goode, EL. "Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis." British Journal of Cancer 101, no. 8 (October 2009): 1461-1468. Full Text
  - Lee, PS, Bland, A, Valea, FA, Havrilesky, LJ, Berchuck, A, and Secord, AA. "Robotic-assisted laparoscopic gynecologic procedures in a fellowship training program." Jsls : Journal of the Society of Laparoendoscopic Surgeons 13, no. 4 (October 2009): 467-472. Full Text
  - Moorman, PG, Palmieri, RT, Akushevich, L, Berchuck, A, and Schildkraut, JM. "Ovarian cancer risk factors in African-American and white women." American Journal of Epidemiology 170, no. 5 (September 2009): 598-606. Full Text
  - Song, H, Ramus, SJ, Tyrer, J, Bolton, KL, Gentry-Maharaj, A, Wozniak, E, Anton-Culver, H, Chang-Claude, J, Cramer, DW, DiCioccio, R, Dörk, T, Goode, EL, Goodman, MT, Schildkraut, JM, Sellers, T, Baglietto, L, Beckmann, MW, Beesley, J, Blaakaer, J, Carney, ME, Chanock, S, Chen, Z, Cunningham, JM, Dicks, E, Doherty, JA, Dürst, M, Ekici, AB, Fenstermacher, D, Fridley, BL, Giles, G, Gore, ME, De Vivo, I, Hillemanns, P, Hogdall, C, Hogdall, E, Iversen, ES, Jacobs, IJ, Jakubowska, A, Li, D, Lissowska, J, Lubiński, J, Lurie, G, McGuire, V, McLaughlin, J, Medrek, K, Moorman, PG, Moysich, K, Narod, S, Phelan, C, Pye, C, Risch, H, Runnebaum, IB, Severi, G, Southey, M, Stram, DO, Thiel, FC, Terry, KL, Tsai, Y-Y, Tworoger, SS, Van Den Berg, DJ, Vierkant, RA, Wang-Gohrke, S, Webb, PM, Wilkens, LR, Wu, AH, Yang, H, Brewster, W, Ziogas, A, Australian Cancer (Ovarian) Study, , Australian Ovarian Cancer Study Group, , Ovarian Cancer Association Consortium, , Houlston, R, Tomlinson, I, Whittemore, AS, Rossing, MA, Ponder, BAJ, Pearce, CL, Ness, RB, Menon, U, Kjaer, SK, Gronwald, J, Garcia-Closas, M, Fasching, PA, Easton, DF, Chenevix-Trench, G, Berchuck, A, Pharoah, PDP, and Gayther, SA. "A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2." Nature Genetics 41, no. 9 (September 2009): 996-1000. Full Text
  - Berchuck, A. "Microarray analysis of gene expression in gynecologic cancers--still only the beginning." Gynecol Oncol 114, no. 1 (July 2009): 1-2. Full Text Link to Item
  - Bernardini, MQ, May, T, Khalifa, MA, Bland, AE, Nofech-Mozes, S, Berchuck, A, Covens, A, and Havrilesky, L. "Evaluation of two management strategies for preoperative grade 1 endometrial cancer." Obstet Gynecol 114, no. 1 (July 2009): 7-15. Full Text Link to Item
  - Ding, X, Mohd, AB, Huang, Z, Baba, T, Bernardini, MQ, Lyerly, HK, Berchuck, A, Murphy, SK, Buermeyer, AB, and Devi, GR. "MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibition." British Journal of Cancer 101, no. 2 (July 2009): 269-277. Full Text
  - Song, H, Ramus, SJ, Kjaer, SK, DiCioccio, RA, Chenevix-Trench, G, Pearce, CL, Hogdall, E, Whittemore, AS, McGuire, V, Hogdall, C, Blaakaer, J, Wu, AH, Van Den Berg, DJ, Stram, DO, Menon, U, Gentry-Maharaj, A, Jacobs, IJ, Webb, PM, Beesley, J, Chen, X, Australian Cancer (Ovarian) Study, , Australian Ovarian Cancer Study Group, , Rossing, MA, Doherty, JA, Chang-Claude, J, Wang-Gohrke, S, Goodman, MT, Lurie, G, Thompson, PJ, Carney, ME, Ness, RB, Moysich, K, Goode, EL, Vierkant, RA, Cunningham, JM, Anderson, S, Schildkraut, JM, Berchuck, A, Iversen, ES, Moorman, PG, Garcia-Closas, M, Chanock, S, Lissowska, J, Brinton, L, Anton-Culver, H, Ziogas, A, Brewster, WR, Ponder, BAJ, Easton, DF, Gayther, SA, Pharoah, PDP, and Ovarian Cancer Association Consortium (OCAC), . "Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study." Human Molecular Genetics 18, no. 12 (June 2009): 2297-2304. Full Text
  - Huang, Z, Wen, Y, Simel, L, Price, T, Berchuck, A, and Murphy, SK. "CTCF binding at a novel intragenic binding site is associated with elevated IGF2 expression in serous epithelial ovarian cancer." CANCER RESEARCH 69 (May 1, 2009). Link to Item
  - Kondoh, E, Baba, T, Matsumura, N, Konishi, I, Fujii, S, Berchuck, A, and Murphy, S. "UCN-01 is effective in targeting ovarian cancer spheroids." CANCER RESEARCH 69 (May 1, 2009). Link to Item
  - Schildkraut, J, Iversen, E, Marks, J, Wilson, M, Clyde, M, Palmieri, R, Moorman, P, and Berchuck, A. "Association between serous invasive ovarian cancer and variants in candidate DNA damage response genes." Cancer Research 69 (May 1, 2009). Link to Item
  - Teoh, D, Ayeni, T, Rubatt, J, Whitaker, R, Dressman, H, Berchuck, A, and Secord, A. "In vitro characterization of the antitumor effects of dasatinib (BMS-354825) in combination with paclitaxel and carboplatin in human ovarian cancer cell lines." CANCER RESEARCH 69 (May 1, 2009). Link to Item
  - Berchuck, A, Iversen, ES, Luo, J, Clarke, JP, Horne, H, Levine, DA, Boyd, J, Alonso, MA, Secord, AA, Bernardini, MQ, Barnett, JC, Boren, T, Murphy, SK, Dressman, HK, Marks, JR, and Lancaster, JM. "Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 15, no. 7 (April 2009): 2448-2455. Full Text
  - Fasching, PA, Gayther, S, Pearce, L, Schildkraut, JM, Goode, E, Thiel, F, Chenevix-Trench, G, Chang-Claude, J, Wang-Gohrke, S, Ramus, S, Pharoah, P, Berchuck, A, and OCAC (Ovarian Cancer Association Consortium), . "Role of genetic polymorphisms and ovarian cancer susceptibility." Molecular Oncology 3, no. 2 (April 2009): 171-181. (Review) Full Text
  - Schildkraut, JM, Goode, EL, Clyde, MA, Iversen, ES, Moorman, PG, Berchuck, A, Marks, JR, Lissowska, J, Brinton, L, Peplonska, B, Cunningham, JM, Vierkant, RA, Rider, DN, Chenevix-Trench, G, Webb, PM, Beesley, J, Chen, X, Phelan, C, Sutphen, R, Sellers, TA, Pearce, L, Wu, AH, Van Berg, DD, Conti, D, Elund, CK, Anderson, R, Goodman, MT, Lurie, G, Carney, ME, Thompson, PJ, Gayther, SA, Ramus, SJ, Jacobs, I, Kjaer, SK, Hogdall, E, Blaakaer, J, Hogdall, C, Easton, DF, Song, H, Pharoah, PDP, Whittemore, AS, McGuire, V, Quaye, L, Anton-Culver, H, Ziogas, A, Terry, KL, Cramer, DW, Hankinson, SE, Tworoger, SS, Calingaert, B, Chanock, S, Sherman, M, and Garcia-Closas, M. "Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer." Cancer Research 69, no. 6 (March 15, 2009): 2349-2357. Full Text
  - Rubatt, JM, Darcy, KM, Hutson, A, Bean, SM, Havrilesky, LJ, Grace, LA, Berchuck, A, and Secord, AA. "Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study." Gynecol Oncol 112, no. 3 (March 2009): 469-474. Full Text Link to Item
  - Matsumura, N, Huang, Z, Baba, T, Lee, PS, Barnett, JC, Mori, S, Chang, JT, Kuo, W-L, Gusberg, AH, Whitaker, RS, Gray, JW, Fujii, S, Berchuck, A, and Murphy, SK. "Yin yang 1 modulates taxane response in epithelial ovarian cancer." Molecular Cancer Research : Mcr 7, no. 2 (February 10, 2009): 210-220. Full Text
  - Baba, T, Kang, HS, Matsumura, N, Hamanishi, J, Mandai, M, Berchuck, A, Murphy, SK, and Konishi, I. "Loss of GPR54 correlates with stem cell activity in high-grade endometrial cancer." GYNECOLOGIC ONCOLOGY 112, no. 2 (February 2009): S78-S78. Link to Item
  - Barnett, JC, Iverson, E, Dressman, H, Whitaker, R, Murphy, SK, Lancaster, J, and Berchuck, A. "Validation of the MAL gene as a predictor of survival in advanced-stage high-grade serous ovarian cancer." GYNECOLOGIC ONCOLOGY 112, no. 2 (February 2009): S123-S124. Link to Item
  - Barnett, JC, Kondoh, E, Whitaker, R, Murphy, SK, and Berchuck, A. "High poly (ADP-ribose) polymerase (PARP) expression is associated with poor survival in advanced-stage serous ovarian cancer." GYNECOLOGIC ONCOLOGY 112, no. 2 (February 2009): S107-S107. Link to Item
  - Barnett, JC, Whitaker, R, Kondoh, E, Baba, T, Murphy, SK, and Berchuck, A. "Ovarian cancer tumor-infiltrating regulatory T cells are associated with a metastatic phenotype." GYNECOLOGIC ONCOLOGY 112, no. 2 (February 2009): S11-S11. Link to Item
  - Cragun, J, Xiong, Y, Boren, TP, Indermaur, MD, Sayer, R, Humphrey, MM, Cottrill, HM, Kamath, S, Hakam, A, Apte, SM, Wenham, RM, Berchuck, A, and Lancaster, JM. "Genomic predictors of ovarian cancer response to salvage therapy." GYNECOLOGIC ONCOLOGY 112, no. 2 (February 2009): S133-S133. Link to Item
  - Hakim, AA, Barry, CP, Barnes, HJ, Anderson, KE, Petitte, J, Whitaker, R, Lancaster, JM, Wenham, RM, Carver, DK, Turbov, J, Berchuck, A, Kopelovich, L, and Rodriguez, GC. "Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu." Cancer Prev Res (Phila) 2, no. 2 (February 2009): 114-121. Full Text Link to Item
  - Kondoh, E, Baba, T, Malsumura, N, Konishi, I, Fujii, S, Berchuck, A, and Murphy, SK. "7-hydroxystaurosporine (UCN-01) is effective in targeting ovarian cancer spheroids." GYNECOLOGIC ONCOLOGY 112, no. 2 (February 2009): S161-S162. Link to Item
  - Murphy, SK, Huang, Z, Wen, Y, Simel, LR, Price, TM, and Berchuck, A. "Intragenic methylation at a novel CTCF binding site is associated with elevated IGF2 expression in serous epithelial ovarian cancer." GYNECOLOGIC ONCOLOGY 112, no. 2 (February 2009): S138-S138. Link to Item
  - Yamaguchi, K, Mandai, M, Matsumura, N, Baba, T, Oura, T, Matsui, S, Murphy, SK, Berchuck, A, Fujii, S, and Konishi, I. "Gene signature specific for ovarian clear cell carcinoma is induced by the contents of endometriotic cysts." GYNECOLOGIC ONCOLOGY 112, no. 2 (February 2009): S132-S132. Link to Item
  - Baba, T, Convery, PA, Matsumura, N, Whitaker, RS, Kondoh, E, Perry, T, Huang, Z, Bentley, RC, Mori, S, Fujii, S, Marks, JR, Berchuck, A, and Murphy, SK. "Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells." Oncogene 28, no. 2 (January 15, 2009): 209-218. Full Text Link to Item
  - Pearce, CL, Near, AM, Van Den Berg, DJ, Ramus, SJ, Gentry-Maharaj, A, Menon, U, Gayther, SA, Anderson, AR, Edlund, CK, Wu, AH, Chen, X, Beesley, J, Webb, PM, Holt, SK, Chen, C, Doherty, JA, Rossing, MA, Whittemore, AS, McGuire, V, DiCioccio, RA, Goodman, MT, Lurie, G, Carney, ME, Wilkens, LR, Ness, RB, Moysich, KB, Edwards, R, Jennison, E, Kjaer, SK, Hogdall, E, Hogdall, CK, Goode, EL, Sellers, TA, Vierkant, RA, Cunningham, JM, Schildkraut, JM, Berchuck, A, Moorman, PG, Iversen, ES, Cramer, DW, Terry, KL, Vitonis, AF, Titus-Ernstoff, L, Song, H, Pharoah, PDP, Spurdle, AB, Anton-Culver, H, Ziogas, A, Brewster, W, Galitovskiy, V, Chenevix-Trench, G, Australian Cancer Study, , and Australian Ovarian Cancer Study Group, . "Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium." British Journal of Cancer 100, no. 2 (January 6, 2009): 412-420. Full Text
  - Bland, AE, Calingaert, B, Secord, AA, Lee, PS, Valea, FA, Berchuck, A, Soper, JT, and Havrilesky, L. "Relationship between tamoxifen use and high risk endometrial cancer histologic types." Gynecol Oncol 112, no. 1 (January 2009): 150-154. Full Text Link to Item
  - Pearce, CL, Near, AM, Van Den Berg, DJ, Ramus, SJ, Gentry-Maharaj, A, Menon, U, Gayther, SA, Anderson, AR, Edlund, CK, Wu, AH, Chen, X, Beesley, J, Webb, PM, Holt, SK, Chen, C, Doherty, JA, Rossing, MA, Whittemore, AS, McGuire, V, DiCioccio, RA, Goodman, MT, Lurie, G, Carney, ME, Wilkens, LR, Ness, RB, Moysich, KB, Edwards, R, Jennison, E, Kjaer, SK, Hogdall, E, Hogdall, CK, Goode, EL, Sellers, TA, Vierkant, RA, Cunningham, JC, Schildkraut, JM, Berchuck, A, Moorman, PG, Iversen, ES, Cramer, DW, Terry, KL, Vitonis, AF, Titus-Ernstoff, L, Song, H, Pharoah, PDP, Spurdle, AB, Anton-Culver, H, Ziogas, A, Brewster, W, Galitovskiy, V, and Chenevix-Trench, G. "Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium." British Journal of Cancer 100, no. 2 (January 2009): 412-420. Full Text
  - Palmieri, RT, Wilson, MA, Iversen, ES, Clyde, MA, Calingaert, B, Moorman, PG, Poole, C, Anderson, AR, Anderson, S, Anton-Culver, H, Beesley, J, Hogdall, E, Brewster, W, Carney, ME, Chen, X, Chenevix-Trench, G, Chang-Claude, J, Cunningham, JM, Dicioccio, RA, Doherty, JA, Easton, DF, Edlund, CK, Gayther, SA, Gentry-Maharaj, A, Goode, EL, Goodman, MT, Kjaer, SK, Hogdall, CK, Hopkins, MP, Jenison, EL, Blaakaer, J, Lurie, G, McGuire, V, Menon, U, Moysich, KB, Ness, RB, Pearce, CL, Pharoah, PDP, Pike, MC, Ramus, SJ, Rossing, MA, Song, H, Terada, KY, Vandenberg, D, Vierkant, RA, Wang-Gohrke, S, Webb, PM, Whittemore, AS, Wu, AH, Ziogas, A, Berchuck, A, Schildkraut, JM, Ovarian Cancer Association Consortium, , Australian Cancer Study (Ovarian Cancer Group), , and Australian Ovarian Cancer Study Group, . "Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 17, no. 12 (December 2008): 3567-3572. Full Text
  - Havrilesky, LJ, Whitehead, CM, Rubatt, JM, Cheek, RL, Groelke, J, He, Q, Malinowski, DP, Fischer, TJ, and Berchuck, A. "Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence." Gynecol Oncol 110, no. 3 (September 2008): 374-382. Full Text Link to Item
  - Ramus, SJ, Vierkant, RA, Johnatty, SE, Pike, MC, Van Den Berg, DJ, Wu, AH, Pearce, CL, Menon, U, Gentry-Maharaj, A, Gayther, SA, DiCioccio, RA, McGuire, V, Whittemore, AS, Song, H, Easton, DF, Pharoah, PDP, Garcia-Closas, M, Chanock, S, Lissowska, J, Brinton, L, Terry, KL, Cramer, DW, Tworoger, SS, Hankinson, SE, Berchuck, A, Moorman, PG, Schildkraut, JM, Cunningham, JM, Liebow, M, Kjaer, SK, Hogdall, E, Hogdall, C, Blaakaer, J, Ness, RB, Moysich, KB, Edwards, RP, Carney, ME, Lurie, G, Goodman, MT, Wang-Gohrke, S, Kropp, S, Chang-Claude, J, Webb, PM, Chen, X, Beesley, J, Chenevix-Trench, G, and Goode, EL. "Consortium analysis of 7 candidate SNPs for ovarian cancer." International Journal of Cancer 123, no. 2 (July 2008): 380-388. Full Text
  - Risch, HA. "Cyclin E overexpression relates to ovarian cancer histology but not to risk factors." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 17, no. 7 (July 2008): 1841-null. (Letter) Full Text
  - Berchuck, A. "Scientific innovation--pathway to progress in women's cancer." Gynecol Oncol 109, no. 3 (June 2008): 316-322. Full Text Link to Item
  - Cragun, JM, Boren, T, Xiong, Y, Indermaur, M, Kamath, S, Cottrill, H, Balducci, L, Sayer, R, Dressman, HK, Berchuck, A, and Lancaster, J. "Gene expression determinants of ovarian cancer platinum-response in older women." J Clin Oncol 26, no. 15_suppl (May 20, 2008): 22059-. Link to Item
  - Cragun, JM, Boren, T, Xiong, Y, Indermaur, M, Kamath, S, Cottrill, H, Balducci, L, Sayer, R, Dressman, HK, Berchuck, A, and Lancaster, J. "Gene expression determinants of ovarian cancer platinum-response in older women." JOURNAL OF CLINICAL ONCOLOGY 26, no. 15 (May 20, 2008). Full Text Link to Item
  - Moorman, PG, Calingaert, B, Palmieri, RT, Iversen, ES, Bentley, RC, Halabi, S, Berchuck, A, and Schildkraut, JM. "Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women." Am J Epidemiol 167, no. 9 (May 1, 2008): 1059-1069. Full Text Link to Item
  - Wright, JD, Secord, AA, Numnum, TM, Rocconi, RP, Powell, MA, Berchuck, A, Alvarez, RD, Gibb, RK, Trinkaus, K, Rader, JS, and Mutch, DG. "A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer." International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 18, no. 3 (May 2008): 400-406. Full Text
  - Allard, J, Risinger, JI, Day, R, Chandran, U, Litzi, T, Rose, G, Berchuck, A, and Maxwell, G. "Microarray analysis of microdissected stage I endometrial cancers reveals gene expression patterns associated with inflammation." GYNECOLOGIC ONCOLOGY 108, no. 3 (March 2008): S80-S81. Link to Item
  - Baba, T, Mori, S, Matsumura, N, Bernardini, M, Fujii, S, Berchuck, A, and Murphy, SK. "Microarray analysis identifies NSC668814 as a potentially active chemotherapeutic agent for platinum-resistant ovarian cancers with TP53 mutations." GYNECOLOGIC ONCOLOGY 108, no. 3 (March 2008): S72-S72. Link to Item
  - Barnett, JC, Bland, A, Whitaker, R, Calingaert, B, Bentley, RC, Lee, PS, Moorman, PC, Schildkraut, JM, and Berchuck, A. "The prognostic significance of p53 and cyclin E overexpression in ovarian cancer: A population-based study." GYNECOLOGIC ONCOLOGY 108, no. 3 (March 2008): S125-S125. Link to Item
  - Bernardini, MQ, Lee, P, Baba, T, Whitaker, RS, Murphy, SK, and Berchuck, A. "Microarray analysis defines patterns of gene expression associated with mutation of TP53 in ovarian cancer." GYNECOLOGIC ONCOLOGY 108, no. 3 (March 2008): S84-S84. Link to Item
  - Kondoh, E, Baba, T, Matsurnura, N, Fujii, S, Berchuck, A, and Murphy, SK. "Targeting dormant ovarian cancer cells." GYNECOLOGIC ONCOLOGY 108, no. 3 (March 2008): S13-S14. Link to Item
  - Matsumura, N, Huang, Z, Perry, T, Kroyer, D, Baba, T, Mori, S, Fujii, S, Berchuck, A, and Murphy, SK. "Methylation in ovarian cancer is related to poor prognosis and suppression of the transforming growth factor signaling pathway." GYNECOLOGIC ONCOLOGY 108, no. 3 (March 2008): S104-S104. Link to Item
  - Ramus, SJ, Vierkant, RA, Jonhatty, S, Schildkraut, JM, Pharoah, PD, Chenevix-Trench, G, Pearce, CL, Berchuck, A, and Goode, EL. "Ovarian Cancer Association Consortium analysis of seven candidate ovarian cancer susceptibility polymorphisms." GYNECOLOGIC ONCOLOGY 108, no. 3 (March 2008): S29-S30. Link to Item
  - Risinger, JI, Allard, J, Day, R, Chandran, U, Litzi, T, Rose, G, Berchuck, A, and Maxwell, G. "Gene expression analysis of stage I serous and endornetrioid endometrial cancers." GYNECOLOGIC ONCOLOGY 108, no. 3 (March 2008): S76-S76. Link to Item
  - Rubatt, JM, Secord, AA, Iversen, E, Grace, L, Soper, W, and Berchuck, A. "Regulation of angiogenic gene expression in p53 wild type and mutant ovarian cancer cells by hypoxia and radiation." GYNECOLOGIC ONCOLOGY 108, no. 3 (March 2008): S84-S84. Link to Item
  - Schildkraut, JM, Moorman, PG, Bland, AE, Halabi, S, Calingaert, B, Whitaker, R, Lee, PS, Elkins-Williams, T, Bentley, RC, Marks, JR, and Berchuck, A. "Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup." Cancer Epidemiol Biomarkers Prev 17, no. 3 (March 2008): 585-593. Full Text Link to Item
  - Pearce, CL, Wu, AH, Gayther, SA, Bale, AE, Australian Cancer Study (Ovarian Cancer) and Australian Cancer Study Group, , Beck, PA, Beesley, J, Chanock, S, Cramer, DW, DiCioccio, R, Edwards, R, Fredericksen, ZS, Garcia-Closas, M, Goode, EL, Green, AC, Hartmann, LC, Hogdall, E, Kjaer, SK, Lissowska, J, McGuire, V, Modugno, F, Moysich, K, Ness, RB, Ramus, SJ, Risch, HA, Sellers, TA, Song, H, Stram, DO, Terry, KL, Webb, PM, Whiteman, DC, Whittemore, AS, Zheng, W, Pharoah, PDP, Chenevix-Trench, G, Pike, MC, Schildkraut, J, Berchuck, A, and Ovarian Cancer Association Consortium, . "Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis." British Journal of Cancer 98, no. 2 (January 22, 2008): 282-288. Full Text
  - Berchuck, A, Schildkraut, JM, Pearce, CL, Chenevix-Trench, G, and Pharoah, PD. "Role of genetic polymorphisms in ovarian cancer susceptibility: Development of an international ovarian cancer association consortium." Advances in Experimental Medicine and Biology 622 (2008): 53-67. Full Text
  - Berchuck, A, Schildkraut, JM, Pearce, CL, Chenevix-Trench, G, and Pharoah, PD. "Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international ovarian cancer association consortium." Adv Exp Med Biol 622 (2008): 53-67. (Review) Full Text Link to Item
  - Berchuck, A. "Foreword." Gynecologic Oncology 108, no. 3 SUPPL. (2008): S1-. Full Text
  - Zhang, Z, Yu, Y, Xu, F, Berchuck, A, van Haaften-Day, C, Havrilesky, LJ, de Bruijn, HWA, van der Zee, AGJ, Woolas, RP, Jacobs, IJ, Skates, S, Chan, DW, and Bast, RC. "Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer." Gynecologic Oncology 107, no. 3 (December 2007): 526-531. Full Text
  - Alvarez Secord, A, Havrilesky, LJ, Bae-Jump, V, Chin, J, Calingaert, B, Bland, A, Rutledge, TL, Berchuck, A, Clarke-Pearson, DL, and Gehrig, PA. "The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer." Gynecol Oncol 107, no. 2 (November 2007): 285-291. Full Text Link to Item
  - Lancaster, JM, Powell, CB, Kauff, ND, Cass, I, Chen, L-M, Lu, KH, Mutch, DG, Berchuck, A, Karlan, BY, Herzog, TJ, and Society of Gynecologic Oncologists Education Committee, . "Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions." Gynecologic Oncology 107, no. 2 (November 2007): 159-162. Full Text
  - Allard, JE, Risinger, JI, Morrison, C, Young, G, Rose, GS, Fowler, J, Berchuck, A, and Maxwell, GL. "Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas." Gynecol Oncol 107, no. 1 (October 2007): 52-57. Full Text Link to Item
  - Berchuck, A. "Chemotherapy administration for ovarian cancer by gynecologic oncologists and medical oncologists." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 25, no. 23 (August 2007): 3552-null. (Letter) Full Text
  - Karlan, BY, Berchuck, A, and Mutch, D. "The role of genetic testing for cancer susceptibility in gynecologic practice." Obstet Gynecol 110, no. 1 (July 2007): 155-167. (Review) Full Text Link to Item
  - Secord, AA, Darcy, KM, Hutson, A, Lee, PS, Havrilesky, LJ, Grace, LA, Berchuck, A, and Gynecologic Oncology Group study, . "Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study." Gynecol Oncol 106, no. 1 (July 2007): 221-232. Full Text Link to Item
  - Dainty, LA, Risinger, JI, Morrison, C, Chandramouli, GVR, Bidus, MA, Zahn, C, Rose, GS, Fowler, J, Berchuck, A, and Maxwell, GL. "Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma." Gynecol Oncol 105, no. 3 (June 2007): 563-570. Full Text Link to Item
  - Havrilesky, LJ, Secord, AA, Bae-Jump, V, Ayeni, T, Calingaert, B, Clarke-Pearson, DL, Berchuck, A, and Gehrig, PA. "Outcomes in surgical stage I uterine papillary serous carcinoma." Gynecol Oncol 105, no. 3 (June 2007): 677-682. Full Text Link to Item
  - Spillman, MA, Lacy, J, Murphy, SK, Whitaker, RS, Grace, L, Teaberry, V, Marks, JR, and Berchuck, A. "Regulation of the metastasis suppressor gene MKK4 in ovarian cancer." Gynecol Oncol 105, no. 2 (May 2007): 312-320. Full Text Link to Item
  - Gayther, SA, Song, H, Ramus, SJ, Kjaer, SK, Whittemore, AS, Quaye, L, Tyrer, J, Shadforth, D, Hogdall, E, Hogdall, C, Blaeker, J, DiCioccio, R, McGuire, V, Webb, PM, Beesley, J, Green, AC, Whiteman, DC, Australian Ovarian Cancer Study Group, , Goodman, MT, Lurie, G, Carney, ME, Modugno, F, Ness, RB, Edwards, RP, Moysich, KB, Goode, EL, Couch, FJ, Cunningham, JM, Sellers, TA, Wu, AH, Pike, MC, Iversen, ES, Marks, JR, Garcia-Closas, M, Brinton, L, Lissowska, J, Peplonska, B, Easton, DF, Jacobs, I, Ponder, BAJ, Schildkraut, J, Pearce, CL, Chenevix-Trench, G, Berchuck, A, Pharoah, PDP, and Ovarian Cancer Association Consortium, . "Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer." Cancer Research 67, no. 7 (April 2007): 3027-3035. Full Text
  - Risinger, JI, Chandramouli, GVR, Maxwell, GL, Custer, M, Pack, S, Loukinov, D, Aprelikova, O, Litzi, T, Schrump, DS, Murphy, SK, Berchuck, A, Lobanenkov, V, and Barrett, JC. "Global expression analysis of cancer/testis genes in uterine cancers reveals a high incidence of BORIS expression." Clin Cancer Res 13, no. 6 (March 15, 2007): 1713-1719. Full Text Link to Item
  - Alvarez Secord, A, Gehrig, PA, Havrilesky, LJ, Bae-Jump, V, Chin, J, Calingaert, B, Bland, A, Rutledge, T, Berchuck, A, and Clarke-Pearson, DL. "The role of multimodality adjuvant chemotherapy and radiation in women with advanced-stage endometrial cancer." GYNECOLOGIC ONCOLOGY 104, no. 3 (March 2007): S6-S6. Link to Item
  - Berchuck, A. "Society of gynecologic oncologists." Journal of Oncology Practice 3, no. 2 (March 1, 2007): 108-109. Full Text
  - Havrilesky, LJ, Whitehead, C, Rubatt, J, Cheek, RL, Groelke, J, He, Q, Malinowski, DP, Fischer, TJ, and Berchuck, A. "Preclinical evaluation of biomarkers for ovarian cancer detection and monitoring for disease recurrence." GYNECOLOGIC ONCOLOGY 104, no. 3 (March 2007): S12-S12. Link to Item
  - Schildkraut, JM, Murphy, SK, Palmieri, RT, Iversen, E, Moorman, PG, Huang, Z, Halabi, S, Calingaert, B, Gusberg, A, Marks, JR, and Berchuck, A. "Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer." Cancer Epidemiol Biomarkers Prev 16, no. 3 (March 2007): 473-480. Full Text Link to Item
  - Kingsley, CB, Kuo, W-L, Polikoff, D, Berchuck, A, Gray, JW, and Jain, AN. "Magellan: a web based system for the integrated analysis of heterogeneous biological data and annotations; application to DNA copy number and expression data in ovarian cancer. (Published online)" Cancer Inform 2 (February 5, 2007): 10-21. Link to Item
  - Havrilesky, LJ, Cragun, JM, Calingaert, B, Alvarez Secord, A, Valea, FA, Clarke-Pearson, DL, Berchuck, A, and Soper, JT. "The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer." Gynecol Oncol 104, no. 2 (February 2007): 401-405. Full Text Link to Item
  - Secord, AA, Havrilesky, LJ, Carney, ME, Soper, JT, Clarke-Pearson, DL, Rodriguez, GC, and Berchuck, A. "Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer." Int J Clin Oncol 12, no. 1 (February 2007): 31-36. Full Text Link to Item
  - Soper, JT, Secord, AA, Havrilesky, LJ, Berchuck, A, and Clarke-Pearson, DL. "Comparison of gracilis and rectus abdominis myocutaneous flap neovaginal reconstruction performed during radical pelvic surgery: flap-specific morbidity." Int J Gynecol Cancer 17, no. 1 (January 2007): 298-303. Full Text Link to Item
  - Maxwell, GL, Schildkraut, JM, Calingaert, B, Risinger, JI, Dainty, L, Marchbanks, PA, Berchuck, A, Barrett, JC, and Rodriguez, GC. "Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk." Gynecologic Oncology 103, no. 2 (November 2006): 535-540. Full Text
  - McDaniel, ML, and Berchuck, A. "... what about this mole?." Contemporary Ob/Gyn 51, no. 11 (November 1, 2006): 44-46.
  - Guillem, JG, Wood, WC, Moley, JF, Berchuck, A, Karlan, BY, Mutch, DG, Gagel, RF, Weitzel, J, Morrow, M, Weber, BL, Giardiello, F, Rodriguez-Bigas, MA, Church, J, Gruber, S, Offit, K, ASCO, , and SSO, . "ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 24, no. 28 (October 2006): 4642-4660. (Review) Full Text
  - Guillem, JG, Wood, WC, Moley, JF, Berchuck, A, Karlan, BY, Mutch, DG, Gagel, RF, Weitzel, J, Morrow, M, Weber, BL, Giardiello, F, Rodriguez-Bigas, MA, Church, J, Gruber, S, and Offit, K. "ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes." Ann Surg Oncol 13, no. 10 (October 2006): 1296-1321. (Review) Full Text Link to Item
  - Myers, ER, Havrilesky, LJ, Kulasingam, SL, Sanders, GD, Cline, KE, Gray, RN, Berchuck, A, and McCrory, DC. "Genomic tests for ovarian cancer detection and management." Evid Rep Technol Assess (Full Rep) , no. 145 (October 2006): 1-100. (Review) Link to Item
  - Secord, AA, and Berchuck, A. "Targeted bio weapons in the war against gynecologic cancers." Contemporary Ob/Gyn 51, no. 10 (October 1, 2006): 48-54. (Review)
  - Lancaster, JM, Dressman, HK, Clarke, JP, Sayer, RA, Martino, MA, Cragun, JM, Henriott, AH, Gray, J, Sutphen, R, Elahi, A, Whitaker, RS, West, M, Marks, JR, Nevins, JR, and Berchuck, A. "Identification of genes associated with ovarian cancer metastasis using microarray expression analysis." Int J Gynecol Cancer 16, no. 5 (September 2006): 1733-1745. Full Text Link to Item
  - Lancaster, JM, Sayer, RA, Blanchette, C, Calingaert, B, Konidari, I, Gray, J, Schildkraut, J, Schomberg, DW, Marks, JR, and Berchuck, A. "High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels." International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 16, no. 4 (July 2006): 1529-1535. Full Text
  - Lutman, CV, Havrilesky, LJ, Cragun, JM, Secord, AA, Calingaert, B, Berchuck, A, Clarke-Pearson, DL, and Soper, JT. "Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology." Gynecol Oncol 102, no. 1 (July 2006): 92-97. Full Text Link to Item
  - Alvarez Secord, A, Havrilesky, LJ, Higgins, RV, Nycum, LR, Kohler, MF, Puls, LE, Holloway, R, Soper, JT, Valea, FA, and Berchuck, A. "A comparison of combination docetaxel/carboplatin versus sequential docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer." J Clin Oncol 24, no. 18_suppl (June 20, 2006): 5092-. Link to Item
  - Wright, JD, Alvarezsecord, A, Numnum, TM, Rocconi, RP, Powell, MA, Berchuck, A, Alvarez, RD, Trinkaus, K, Rader, JS, and Mutch, DG. "A multi-institutional evaluation of the safety and efficacy of bevacizumab for recurrent, platinum-resistant ovarian cancer." J Clin Oncol 24, no. 18_suppl (June 20, 2006): 5019-. Link to Item
  - Gynecologic Oncology Group, , Secord, AA, Lee, PS, Darcy, KM, Havrilesky, LJ, Grace, LA, Marks, JR, and Berchuck, A. "Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study." Gynecologic Oncology 101, no. 3 (June 2006): 390-397. Full Text
  - Jewell, E, Secord, AA, Brotherton, T, and Berchuck, A. "Use of trastuzumab in the treatment of metastatic endometrial cancer." International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 16, no. 3 (May 2006): 1370-1373. Full Text
  - Jones, MB, Houwink, AP, Freeman, BK, Greenwood, TM, Lafky, JM, Lingle, WL, Berchuck, A, Maxwell, GL, Podratz, KC, and Maihle, NJ. "The granulin-epithelin precursor is a steroid-regulated growth factor in endometrial cancer." Journal of the Society for Gynecologic Investigation 13, no. 4 (May 2006): 304-311. Full Text
  - Murphy, SK, Huang, Z, Wen, Y, Spillman, MA, Whitaker, RS, Simel, LR, Nichols, TD, Marks, JR, and Berchuck, A. "Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer." Mol Cancer Res 4, no. 4 (April 2006): 283-292. Full Text Link to Item
  - Jones, E, Alvarez Secord, A, Prosnitz, LR, Samulski, TV, Oleson, JR, Berchuck, A, Clarke-Pearson, D, Soper, J, Dewhirst, MW, and Vujaskovic, Z. "Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma." Int J Hyperthermia 22, no. 2 (March 2006): 161-172. Full Text Link to Item
  - Bidus, MA, Risinger, JI, Chandramouli, GVR, Dainty, LA, Litzi, TJ, Berchuck, A, Barrett, JC, and Maxwell, GL. "Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray." Clin Cancer Res 12, no. 1 (January 1, 2006): 83-88. Full Text Link to Item
  - Bild, AH, Yao, G, Chang, JT, Wang, Q, Potti, A, Chasse, D, Joshi, M-B, Harpole, D, Lancaster, JM, Berchuck, A, Olson, JA, Marks, JR, Dressman, HK, West, M, and Nevins, JR. "Oncogenic pathway signatures in human cancers as a guide to targeted therapies." Nature 439, no. 7074 (January 2006): 353-357. Full Text
  - Huang, Z, Wen, Y, Shandilya, R, Marks, JR, Berchuck, A, and Murphy, SK. "High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer. (Published online)" Nucleic Acids Res 34, no. 2 (2006): 555-563. Full Text Link to Item
  - Risinger, JI, Chandramouli, GVR, Maxwell, GL, Litzi, T, Berchuck, A, and Umar, A. "Gene expression analysis of tumor infiltrating lymphocyte markers in endometrial cancers indicates no significant increases in those cases with microsatellite instability." Cancer Biomark 2, no. 1-2 (2006): 61-68. Link to Item
  - Schildkraut, JM, Moorman, PG, Halabi, S, Calingaert, B, Marks, JR, and Berchuck, A. "Analgesic drug use and risk of ovarian cancer." Epidemiology 17, no. 1 (January 2006): 104-107. Link to Item
  - Havrilesky, LJ, Cragun, JM, Calingaert, B, Synan, I, Secord, AA, Soper, JT, Clarke-Pearson, DL, and Berchuck, A. "Resection of lymph node metastases influences survival in stage IIIC endometrial cancer." Gynecologic Oncology 99, no. 3 (December 2005): 689-695. Full Text
  - Hoyo, C, Berchuck, A, Halabi, S, Bentley, RC, Moorman, P, Calingaert, B, and Schildkraut, JM. "Anthropometric measurements and epithelial ovarian cancer risk in African-American and White women." Cancer Causes Control 16, no. 8 (October 2005): 955-963. Full Text Link to Item
  - Marquez, RT, Baggerly, KA, Patterson, AP, Liu, J, Broaddus, R, Frumovitz, M, Atkinson, EN, Smith, DI, Hartmann, L, Fishman, D, Berchuck, A, Whitaker, R, Gershenson, DM, Mills, GB, Bast, RC, and Lu, KH. "Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 11, no. 17 (September 2005): 6116-6126. Full Text
  - Moorman, PG, Schildkraut, JM, Calingaert, B, Halabi, S, and Berchuck, A. "Menopausal hormones and risk of ovarian cancer." Am J Obstet Gynecol 193, no. 1 (July 2005): 76-82. Full Text Link to Item
  - Risinger, JI, Maxwell, GL, Chandramouli, GVR, Aprelikova, O, Litzi, T, Umar, A, Berchuck, A, and Barrett, JC. "Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signaling." Cancer Res 65, no. 12 (June 15, 2005): 5031-5037. Full Text Link to Item
  - Alvarez Secord, A, Jones, EL, Hahn, CA, Petros, WP, Yu, D, Havrilesky, LJ, Soper, JT, Berchuck, A, Spasojevic, I, Clarke-Pearson, DL, Prosnitz, LR, and Dewhirst, MW. "Phase I/II trial of intravenous Doxil and whole abdomen hyperthermia in patients with refractory ovarian cancer." International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 21, no. 4 (June 2005): 333-347. Full Text
  - Cragun, JM, Havrilesky, LJ, Calingaert, B, Synan, I, Secord, AA, Soper, JT, Clarke-Pearson, DL, and Berchuck, A. "Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 23, no. 16 (June 2005): 3668-3675. Full Text
  - Kelemen, L, James, M, Spurdle, A, Campbell, I, Chang-Claude, J, Peel, D, Anton-Culver, H, Berchuck, A, Schildkraut, J, Whittemore, A, McGurie, V, DiCioccio, RA, Duffy, D, and Chenevix-Trench, G. "BRAF polymorphisms and the risk of ovarian cancer of low malignant potential." Gynecologic Oncology 97, no. 3 (June 2005): 807-812. Full Text
  - Martino, MA, Elahi, A, Sutphen, R, Klippel, C, Boren, T, Dressman, HK, Berchuck, A, and Lancaster, JM. "Expression analysis of genes involved in ovarian cancer metastasis." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 23, no. 16_suppl (June 2005): 5038-.
  - Maxwell, GL, Chandramouli, GVR, Dainty, L, Litzi, TJ, Berchuck, A, Barrett, JC, and Risinger, JI. "Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer." Clin Cancer Res 11, no. 11 (June 1, 2005): 4056-4066. Full Text Link to Item
  - Moorman, PG, Berchuck, A, Calingaert, B, Halabi, S, and Schildkraut, AM. "Antidepressant medication use for and risk of ovarian cancer (vol 105, pg 725, 2005)." OBSTETRICS AND GYNECOLOGY 105, no. 6 (June 2005): 1495-1495. Link to Item
  - Berchuck, A, Iversen, ES, Lancaster, JM, Pittman, J, Luo, J, Lee, P, Murphy, S, Dressman, HK, Febbo, PG, West, M, Nevins, JR, and Marks, JR. "Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers." Clin Cancer Res 11, no. 10 (May 15, 2005): 3686-3696. Full Text Link to Item
  - Soper, JT, Havrilesky, LJ, Secord, AA, Berchuck, A, and Clarke-Pearson, DL. "Rectus abdominis myocutaneous flaps for neovaginal reconstruction after radical pelvic surgery." Int J Gynecol Cancer 15, no. 3 (May 2005): 542-548. Full Text Link to Item
  - Soper, JT, Secord, AA, Havrilesky, LJ, Berchuck, A, and Clarke-Pearson, DL. "Rectus abdominis myocutaneous and myoperitoneal flaps for neovaginal reconstruction after radical pelvic surgery: comparison of flap-related morbidity." Gynecol Oncol 97, no. 2 (May 2005): 596-601. Full Text Link to Item
  - Spillman, MA, Schildkraut, JM, Halabi, S, Moorman, P, Calingaert, B, Bentley, RC, Marks, JR, Murphy, S, and Berchuck, A. "Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk." Gynecol Oncol 97, no. 2 (May 2005): 543-549. Full Text Link to Item
  - Moorman, PG, Berchuck, A, Calingaert, B, Halabi, S, and Schildkraut, JM. "Antidepressant medication use [corrected] and risk of ovarian cancer." Obstet Gynecol 105, no. 4 (April 2005): 725-730. Full Text Link to Item
  - "Notice of a Second Report of the Same Case." Obstetrics & Gynecology 105, no. 3 (March 2005): 673-673. Full Text
  - Sayer, RA, Lancaster, JM, Pittman, J, Gray, J, Whitaker, R, Marks, JR, and Berchuck, A. "High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer." Gynecol Oncol 96, no. 2 (February 2005): 355-361. Full Text Link to Item
  - Berchuck, A, Schildkraut, JM, Wenham, RM, Calingaert, B, Ali, S, Henriott, A, Halabi, S, Rodriguez, GC, Gertig, D, Purdie, DM, Kelemen, L, Spurdle, AB, Marks, J, and Chenevix-Trench, G. "Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers." Cancer Epidemiol Biomarkers Prev 13, no. 12 (December 2004): 2141-2147. Link to Item
  - Spillman, MA, and Berchuck, A. "Stretching the surface epithelium." J Soc Gynecol Investig 11, no. 8 (December 2004): 501-502. Full Text Link to Item
  - Skates, SJ, Horick, N, Yu, Y, Xu, F-J, Berchuck, A, Havrilesky, LJ, de Bruijn, HWA, van der Zee, AGJ, Woolas, RP, Jacobs, IJ, Zhang, Z, and Bast, RC. "Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 22, no. 20 (October 2004): 4059-4066. Full Text
  - Bast, R, Yu, Y, Li, J, Sokoll, L, Rai, A, Rosenzweig, J, Cameron, B, Wang, Y, Berchuck, A, Van Haaften-Day, C, Hacker, N, De Bruij, H, Van Der Zee, A, Jacobs, I, and Fung, E. "Serum proteomics yield new biomarkers for ovarian cancer." Cancer Biology and Therapy 3, no. 9 (September 1, 2004): 794-795.
  - Zhang, Z, Bast, RC, Yu, Y, Li, J, Sokoll, LJ, Rai, AJ, Rosenzweig, JM, Cameron, B, Wang, YY, Meng, X-Y, Berchuck, A, Van Haaften-Day, C, Hacker, NF, de Bruijn, HWA, van der Zee, AGJ, Jacobs, IJ, Fung, ET, and Chan, DW. "Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer." Cancer Res 64, no. 16 (August 15, 2004): 5882-5890. Full Text Link to Item
  - Alvarez Secord, A, Sayer, R, Snyder, SA, Broadwater, G, Rodriguez, GC, Berchuck, A, and Blackwell, K. "The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer." Gynecologic Oncology 94, no. 1 (July 2004): 74-79. Full Text
  - Berchuck, A, Secord, AA, Havrilesky, LJ, Wenham, R, Soper, JT, and Clarke-Pearson, DL. "Phase I/II trial of combination topotecan and vinorelbine in patients with refractory gynecologic cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 22, no. 14_suppl (July 2004): 5152-.
  - Jones, EL, Prosnitz, LR, Samulski, TV, Soper, J, Berchuck, A, Clarke-Pearson, D, Dewhirst, MW, and Vujaskovic, Z. "Intraperitoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 22, no. 14_suppl (July 2004): 5038-.
  - Secord, AA, Jones, E, Hahn, CA, Havrilesky, LJ, Soper, JT, Berchuck, A, Clarke-Pearson, DL, Prosnitz, LR, and Dewhirst, MW. "Phase I/II trial of intravenous liposomal doxorubicin and whole abdomen hyperthermia in patients with refractory ovarian cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 22, no. 14_suppl (July 2004): 5089-.
  - Lu, KH, Patterson, AP, Wang, L, Marquez, RT, Atkinson, EN, Baggerly, KA, Ramoth, LR, Rosen, DG, Liu, J, Hellstrom, I, Smith, D, Hartmann, L, Fishman, D, Berchuck, A, Schmandt, R, Whitaker, R, Gershenson, DM, Mills, GB, and Bast, RC. "Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 10, no. 10 (May 2004): 3291-3300. Full Text
  - Rendi, MH, Suh, N, Lamph, WW, Krajewski, S, Reed, JC, Heyman, RA, Berchuck, A, Liby, K, Risingsong, R, Royce, DB, Williams, CR, and Sporn, MB. "The selective estrogen receptor modulator arzoxifene and the rexinoid LG100268 cooperate to promote transforming growth factor beta-dependent apoptosis in breast cancer." Cancer Research 64, no. 10 (May 2004): 3566-3571. Full Text
  - Berchuck, A, Iversen, ES, Lancaster, JM, Dressman, HK, West, M, Nevins, JR, and Marks, JR. "Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays." Am J Obstet Gynecol 190, no. 4 (April 2004): 910-925. Full Text Link to Item
  - Lancaster, JM, Dressman, HK, Whitaker, RS, Havrilesky, L, Gray, J, Marks, JR, Nevins, JR, and Berchuck, A. "Gene expression patterns that characterize advanced stage serous ovarian cancers." J Soc Gynecol Investig 11, no. 1 (January 2004): 51-59. Link to Item
  - Berchuck, A, Alvarez, AA, and Stout, JE. "Abdominal pain and bloating in two 20-something patients." Contemporary Ob/Gyn 48, no. 1 (December 1, 2003): 51-58.
  - Khabbaz, A, Lutman, CV, and Berchuck, A. "What caused this woman's 'myoma'?." Contemporary Ob/Gyn 48, no. 11 (December 1, 2003): 108-112.
  - Havrilesky, L, Darcy, KM, Hamdan, H, Priore, RL, Leon, J, Bell, J, Berchuck, A, and Gynecologic Oncology Group Study, . "Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study." J Clin Oncol 21, no. 20 (October 15, 2003): 3814-3825. Full Text Link to Item
  - Tanyi, JL, Hasegawa, Y, Lapushin, R, Morris, AJ, Wolf, JK, Berchuck, A, Lu, K, Smith, DI, Kalli, K, Hartmann, LC, McCune, K, Fishman, D, Broaddus, R, Cheng, KW, Atkinson, EN, Yamal, JM, Bast, RC, Felix, EA, Newman, RA, and Mills, GB. "Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer." Clinical Cancer Research 9, no. 10 I (October 1, 2003): 3534-3545.
  - Wenham, RM, Schildkraut, JM, McLean, K, Calingaert, B, Bentley, RC, Marks, J, and Berchuck, A. "Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer." Clin Cancer Res 9, no. 12 (October 1, 2003): 4396-4403. Link to Item
  - Tanyi, JL, Hasegawa, Y, Lapushin, R, Morris, AJ, Wolf, JK, Berchuck, A, Lu, K, Smith, DI, Kalli, K, Hartmann, LC, McCune, K, Fishman, D, Broaddus, R, Cheng, KW, Atkinson, EN, Yamal, JM, Bast, RC, Felix, EA, Newman, RA, and Mills, GB. "Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer." Clin Cancer Res 9, no. 10 Pt 1 (September 1, 2003): 3534-3545. Link to Item
  - Tanyi, JL, Hasegawa, Y, Lapushin, R, Morris, AJ, Wolf, JK, Berchuck, A, Lu, K, Smith, DI, Kalli, K, Hartmann, LC, McCune, K, Fishman, D, Broaddus, R, Cheng, KW, Atkinson, EN, Yamal, JM, Bast, RC, Felix, EA, Newman, RA, and Mills, GB. "Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer." Clinical Cancer Research 9, no. 10 (September 1, 2003): 3534-3545. (Academic Article) Link to Item
  - Wenham, RM, Calingaert, B, Ali, S, McClean, K, Whitaker, R, Bentley, R, Lancaster, JM, Schildkraut, J, Marks, J, and Berchuck, A. "Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer." Journal of the Society for Gynecologic Investigation 10, no. 6 (September 2003): 381-387. Full Text
  - Havrilesky, LJ, Peterson, BL, Dryden, DK, Soper, JT, Clarke-Pearson, DL, and Berchuck, A. "Predictors of clinical outcomes in the laparoscopic management of adnexal masses." Obstet Gynecol 102, no. 2 (August 2003): 243-251. Link to Item
  - Jones, EL, Samulski, TV, Dewhirst, MW, Alvarez-Secord, A, Berchuck, A, Clarke-Pearson, D, Havrilesky, LJ, Soper, J, and Prosnitz, LR. "A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma." Cancer 98, no. 2 (July 15, 2003): 277-282. Full Text Link to Item
  - Havrilesky, LJ, Wong, TZ, Secord, AA, Berchuck, A, Clarke-Pearson, DL, and Jones, EL. "The role of PET scanning in the detection of recurrent cervical cancer." Gynecologic Oncology 90, no. 1 (July 2003): 186-190. Full Text
  - Vine, MF, Calingaert, B, Berchuck, A, and Schildkraut, JM. "Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls." Gynecologic Oncology 90, no. 1 (July 2003): 75-82. Full Text
  - Lancaster, JM, Wenham, RM, Halabi, S, Calingaert, B, Marks, JR, Moorman, PG, Bentley, RC, Berchuck, A, and Schildkraut, JM. "No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina." Cancer Epidemiol Biomarkers Prev 12, no. 3 (March 2003): 226-227. Link to Item
  - Risinger, JI, Maxwell, GL, Berchuck, A, and Barrett, JC. "Promoter hypermethylation as an epigenetic component in Type I and Type II endometrial cancers." Ann N Y Acad Sci 983 (March 2003): 208-212. (Review) Link to Item
  - van den Brûle, F, Califice, S, Garnier, F, Fernandez, PL, Berchuck, A, and Castronovo, V. "Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin." Lab Invest 83, no. 3 (March 2003): 377-386. Link to Item
  - Lancaster, JM, Sayer, R, Blanchette, C, Calingaert, B, Whitaker, R, Schildkraut, J, Marks, J, and Berchuck, A. "High expression of tumor necrosis factor-related apoptosis-inducing ligand is associated with favorable ovarian cancer survival." Clin Cancer Res 9, no. 2 (February 2003): 762-766. Link to Item
  - Gray, JW, Suzuki, S, Kuo, W-L, Polikoff, D, Deavers, M, Smith-McCune, K, Berchuck, A, Pinkel, D, Albertson, D, and Mills, GB. "Specific keynote: genome copy number abnormalities in ovarian cancer." Gynecol Oncol 88, no. 1 Pt 2 (January 2003): S16-S21. (Review) Link to Item
  - Havrilesky, LJ, Alvarez, AA, Sayer, RA, Lancaster, JM, Soper, JT, Berchuck, A, Clarke-Pearson, DL, Rodriguez, GC, and Carney, ME. "Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancer." Gynecologic Oncology 88, no. 1 (January 2003): 51-57. Full Text
  - Lancaster, JM, Havrilesky, LJ, and Berchuck, A. "The Genetic Etiology of Sporadic Ovarian Cancer." (January 1, 2003): 139-155. (Chapter) Full Text
  - Risinger, JI, Maxwell, GL, Chandramouli, GVR, Jazaeri, A, Aprelikova, O, Patterson, T, Berchuck, A, and Barrett, JC. "Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer." Cancer Research 63, no. 1 (January 2003): 6-11.
  - Moorman, PG, Schildkraut, JM, Calingaert, B, Halabi, S, Vine, MF, and Berchuck, A. "Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States)." Cancer Causes & Control : Ccc 13, no. 9 (November 2002): 807-811. Full Text
  - Wenham, RM, Lancaster, JM, and Berchuck, A. "Molecular aspects of ovarian cancer." Best Pract Res Clin Obstet Gynaecol 16, no. 4 (August 2002): 483-497. (Review) Link to Item
  - Dixon, D, Flake, GP, Moore, AB, He, H, Haseman, JK, Risinger, JI, Lancaster, JM, Berchuck, A, Barrett, JC, and Robboy, SJ. "Cell proliferation and apoptosis in human uterine leiomyomas and myometria." Virchows Arch 441, no. 1 (July 2002): 53-62. Full Text Link to Item
  - Rodriguez, GC, Nagarsheth, NP, Lee, KL, Bentley, RC, Walmer, DK, Cline, M, Whitaker, RS, Isner, P, Berchuck, A, Dodge, RK, and Hughes, CL. "Progestin-induced apoptosis in the Macaque ovarian epithelium: differential regulation of transforming growth factor-beta." Journal of the National Cancer Institute 94, no. 1 (January 2002): 50-60. Full Text
  - Wenham, RM, and Berchuck, A. "The molecular biology of Sertoli-Leydig cell tumors of the ovary." CME Journal of Gynecologic Oncology 7, no. 2 (2002): 121-125.
  - Havrilesky, LJ, Alvarez, AA, Whitaker, RS, Marks, JR, and Berchuck, A. "Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations." Gynecologic oncology 83, no. 3 (December 2001): 491-500. Full Text
  - Vine, MF, Ness, RB, Calingaert, B, Schildkraut, JM, and Berchuck, A. "Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor." Gynecologic Oncology 83, no. 3 (December 2001): 466-471. Full Text
  - van Haaften-Day, C, Shen, Y, Xu, F, Yu, Y, Berchuck, A, Havrilesky, LJ, de Bruijn, HW, van der Zee, AG, Bast, RC, and Hacker, NF. "OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal." Cancer 92, no. 11 (December 2001): 2837-2844. Full Text
  - van Haaften-Day, C, Shen, Y, Xu, F, Yu, Y, Berchuck, A, Havrilesky, LJ, de Bruijn, HWA, van der Zee, AGJ, Bast, RC, and Hacker, NF. "OVXL, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma a critical appraisal." Cancer 92, no. 11 (December 1, 2001): 2837-2844. Full Text
  - Stout, JE, Woods, CW, Alvarez, AA, Berchuck, A, and Dukes Hamilton, C. "Mycobacterium bovis peritonitis mimicking ovarian cancer in a young woman." Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 33, no. 4 (August 2001): E14-E16. Full Text
  - Alvarez, AA, Lambers, AR, Lancaster, JM, Maxwell, GL, Ali, S, Gumbs, C, Berchuck, A, and Futreal, PA. "Allele loss on chromosome 1p36 in epithelial ovarian cancers." Gynecologic oncology 82, no. 1 (July 2001): 94-98. Full Text
  - Moorman, PG, Calingaert, B, Vine, M, Halabi, S, Berchuck, A, and Schildkraut, JM. "Comparison of two methods for calculating lifetime ovulatory cycles." AMERICAN JOURNAL OF EPIDEMIOLOGY 153, no. 11 (June 1, 2001): S138-S138. Link to Item
  - Vine, MF, Ness, RB, Calingaert, B, Schildkraut, JM, and Berchuck, A. "Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor." AMERICAN JOURNAL OF EPIDEMIOLOGY 153, no. 11 (June 1, 2001): S112-S112. Link to Item
  - Lancaster, JM, Risinger, JI, Carney, ME, Barrett, JC, and Berchuck, A. "Mutational analysis of the PTEN gene in human uterine sarcomas." Am J Obstet Gynecol 184, no. 6 (May 2001): 1051-1053. Full Text Link to Item
  - Havrilesky, LJ, McMahon, CP, Lobenhofer, EK, Whitaker, R, Marks, JR, and Berchuck, A. "Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones." Journal of the Society for Gynecologic Investigation 8, no. 2 (March 2001): 104-113. Full Text
  - Maxwell, GL, Risinger, JI, Alvarez, AA, Barrett, JC, and Berchuck, A. "Favorable survival associated with microsatellite instability in endometrioid endometrial cancers." Obstet Gynecol 97, no. 3 (March 2001): 417-422. Link to Item
  - Alvarez, AA, Moore, WF, Robboy, SJ, Bentley, RC, Gumbs, C, Futreal, PA, and Berchuck, A. "K-ras mutations in Müllerian inclusion cysts associated with serous borderline tumors of the ovary." Gynecol Oncol 80, no. 2 (February 2001): 201-206. Full Text Link to Item
  - Suzuki, S, Moore, DH, Ginzinger, DG, Godfrey, TE, Barclay, J, Powell, B, Pinkel, D, Zaloudek, C, Lu, K, Mills, G, Berchuck, A, and Gray, JW. "An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer." Cancer Res 60, no. 19 (October 1, 2000): 5382-5385. Link to Item
  - Maxwell, GL, Risinger, JI, Hayes, KA, Alvarez, AA, Dodge, RK, Barrett, JC, and Berchuck, A. "Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers." Clinical cancer research : an official journal of the American Association for Cancer Research 6, no. 8 (August 2000): 2999-3005.
  - Peng, H, Xu, F, Pershad, R, Hunt, KK, Frazier, ML, Berchuck, A, Gray, JW, Hogg, D, Bast, RC, and Yu, Y. "ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers." Int J Cancer 86, no. 5 (June 1, 2000): 690-694. Link to Item
  - Moore, WF, Bentley, RC, Berchuck, A, and Robboy, SJ. "Some mullerian inclusion cysts in lymph nodes may sometimes be metastases from serous borderline tumors of the ovary." Am J Surg Pathol 24, no. 5 (May 2000): 710-718. Link to Item
  - Ahmed, MN, Kim, K, Haddad, B, Berchuck, A, and Qumsiyeh, MB. "Comparative genomic hybridization studies in hydatidiform moles and choriocarcinoma: amplification of 7q21-q31 and loss of 8p12-p21 in choriocarcinoma." Cancer Genetics and Cytogenetics 116, no. 1 (January 2000): 10-15. Full Text
  - Berchuck, A, and Myers, E. "Letter to the editor." Gynecol Oncol 76, no. 1 (January 2000): 142-143. Full Text Link to Item
  - Bösze, P, Bast, RC, Berchuck, A, Burke, HB, Buller, RE, Creasman, WT, Dubeau, L, Fox, H, Geisler, HE, Geisler, JP, Henson, DE, Rustin, GJ, Vermorken, JB, Wells, M, and Wilbanks, GD. "Conseusus statements on prognostic factors in epithelial ovarian carcinoma. Report of the Consensus Meeting organized by the European Society of Gynaecological Oncology, ESGO." Eur J Gynaecol Oncol 21, no. 5 (2000): 513-526. (Review) Link to Item
  - Schildkraut, JM, Halabi, S, Bastos, E, Marchbanks, PA, McDonald, JA, and Berchuck, A. "Prognostic factors in early-onset epithelial ovarian cancer: a population-based study." Obstet Gynecol 95, no. 1 (January 2000): 119-127. Link to Item
  - Sevinc, A, Buyukberber, S, Sari, R, Nguyen, HN, Priore, GD, Berchuck, A, Myers, E, and Nagourney, RA. "Elevated serum CA-125 levels: Hepatitis or ascites? [1] (multiple letters)." Gynecologic Oncology 76, no. 1 (2000): 141-143.
  - Berchuck, A, Alvarez, A, and Futreal, PA. "Prognosis of BRCA1 and 2-associated ovarian cancers." Cme Journal of Gynecologic Oncology 4, no. 1 (December 1, 1999): 108-111. (Review)
  - Berchuck, A, Lambers, A, and Schildkraut, JM. "Relationship between alterations in the p53 tumor suppressor gene and prognosis of ovarian cancer." Cme Journal of Gynecologic Oncology 4, no. 2 (December 1, 1999): 215-218. (Review)
  - Berchuck, A, Schildkraut, JM, Marks, JR, and Futreal, PA. "Managing hereditary ovarian cancer risk." Cancer 86, no. 11 Suppl (December 1, 1999): 2517-2524. (Review) Link to Item
  - Zweemer, RP, Berchuck, A, and Jacobs, IJ. "Somatic genetic events in BRCA1 and BRCA2-related ovarian cancer." Cme Journal of Gynecologic Oncology 4, no. 1 (December 1, 1999): 112-115. (Review)
  - Berchuck, A, Schildkraut, JM, Marks, JR, and Futreal, PA. "Managing hereditary ovarian cancer risk." Cancer 86, no. 8 SUPPL. (October 15, 1999): 1697-1704.
  - Ashih, H, Gustilo-Ashby, T, Myers, ER, Andrews, J, Clarke-Pearson, DL, Berry, D, and Berchuck, A. "Cost-effectiveness of treatment of early stage endometrial cancer." Gynecol Oncol 74, no. 2 (August 1999): 208-216. Full Text Link to Item
  - Brown, MR, Chuaqui, R, Vocke, CD, Berchuck, A, Middleton, LP, Emmert-Buck, MR, and Kohn, EC. "Allelic loss on chromosome arm 8p: analysis of sporadic epithelial ovarian tumors." Gynecol Oncol 74, no. 1 (July 1999): 98-102. (Review) Full Text Link to Item
  - Lambers, AR, Gumbs, C, Ali, S, Marks, JR, Iglehart, JD, Berchuck, A, and Futreal, PA. "Bcl10 is not a target for frequent mutation in human carcinomas." British Journal of Cancer 80, no. 10 (July 1999): 1575-1576. Full Text
  - Zweemer, RP, Shaw, PA, Verheijen, RM, Ryan, A, Berchuck, A, Ponder, BA, Risch, H, McLaughlin, JR, Narod, SA, Menko, FH, Kenemans, P, and Jacobs, IJ. "Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations." J Clin Pathol 52, no. 5 (May 1999): 372-375. Link to Item
  - Zhang, Z, Barnhill, SD, Zhang, H, Xu, F, Yu, Y, Jacobs, I, Woolas, RP, Berchuck, A, Madyastha, KR, and Bast, RC. "Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses." Gynecologic Oncology 73, no. 1 (April 1999): 56-61. Full Text
  - Berchuck, A, Carney, ME, and Futreal, PA. "Genetic susceptibility testing and prophylactic oophorectomy." Eur J Obstet Gynecol Reprod Biol 82, no. 2 (February 1999): 159-164. (Review) Link to Item
  - Berchuck, A, Schildkraut, JM, Marks, JR, and Futreal, PA. "Managing hereditary ovarian cancer risk." Cancer 86, no. 11 SUPPL. (1999): 2517-2524.
  - Moore, WF, Berchuck, A, and Robboy, SJ. "Mullerian inclusion cysts - Possible metastases of serous borderline tumors of the ovary." LABORATORY INVESTIGATION 79, no. 1 (January 1999): 120A-120A. Link to Item
  - Risinger, JI, Hayes, K, Maxwell, GL, Carney, ME, Dodge, RK, Barrett, JC, and Berchuck, A. "PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics." Clin Cancer Res 4, no. 12 (December 1998): 3005-3010. Link to Item
  - van der Heijden, O, Chiu, HC, Park, TC, Takahashi, H, LiVolsi, VA, Risinger, JI, Barrett, JC, Berchuck, A, Evans, AC, Behbakht, K, Menzin, AW, Liu, PC, Benjamin, I, Morgan, MA, King, SA, Rubin, SC, and Boyd, J. "Allelotype analysis of uterine leiomyoma: localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7q." Mol Carcinog 23, no. 4 (December 1998): 243-247. Link to Item
  - Maxwell, , Risinger, , Shaw, , Alvarez, , Barrett, , Futreal, , and Berchuck, . "Mutations in the PTEN tumor suppressor gene in cervical carcinomas." International Journal of Gynecological Cancer 8, no. 6 (November 1998): 489-493. Full Text
  - Berchuck, A, Heron, KA, Carney, ME, Lancaster, JM, Fraser, EG, Vinson, VL, Deffenbaugh, AM, Miron, A, Marks, JR, Futreal, PA, and Frank, TS. "Frequency of germline and somatic BRCA1 mutations in ovarian cancer." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 4, no. 10 (October 1998): 2433-2437.
  - Carney, ME, Maxwell, GL, Lancaster, JM, Gumbs, C, Marks, J, Berchuck, A, and Futreal, PA. "Aberrant splicing of the TSG101 tumor suppressor gene in human breast and ovarian cancers." J Soc Gynecol Investig 5, no. 5 (September 1998): 281-285. Link to Item
  - Bast, RC, Pusztai, L, Kerns, BJ, MacDonald, JA, Jordan, P, Daly, L, Boyer, CM, Mendelsohn, J, and Berchuck, A. "Coexpression of the HER-2 gene product, p185HER-2, and epidermal growth factor receptor, p170EGF-R, on epithelial ovarian cancers and normal tissues." Hybridoma 17, no. 4 (August 1998): 313-321. Full Text
  - Boente, MP, Berchuck, A, Whitaker, RS, Kalén, A, Xu, FJ, Clarke-Pearson, DL, Bell, RM, and Bast, RC. "Suppression of diacylglycerol levels by antibodies reactive with the c-erbB-2 (HER-2/neu) gene product p185c-erbB-2 in breast and ovarian cancer cell lines." Gynecol Oncol 70, no. 1 (July 1998): 49-55. Full Text Link to Item
  - Lancaster, JM, Berchuck, A, Carney, ME, Wiseman, R, and Taylor, JA. "Progesterone receptor gene polymorphism and risk for breast and ovarian cancer." Br J Cancer 78, no. 2 (July 1998): 277-. (Letter) Link to Item
  - Maxwell, GL, Risinger, JI, Tong, B, Shaw, H, Barrett, JC, Berchuck, A, and Futreal, PA. "Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers." Gynecol Oncol 70, no. 1 (July 1998): 13-16. Full Text Link to Item
  - Maxwell, GL, Risinger, JI, Gumbs, C, Shaw, H, Bentley, RC, Barrett, JC, Berchuck, A, and Futreal, PA. "Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias." Cancer Res 58, no. 12 (June 15, 1998): 2500-2503. Link to Item
  - Arrigo, L, Pierre, Y, Berchuck, A, Morris, DL, Yeung, KK, and Very, DL. "The Bayer Immuno 1 (TM) CA 125 II (TM) assay: An automated assay for the clinical management of ovarian cancer patients." CLINICAL CHEMISTRY 44 (June 1998): A44-A44. Link to Item
  - Berchuck, A, Carney, M, Lancaster, JM, Marks, J, and Futreal, AP. "Familial breast-ovarian cancer syndromes: BRCA1 and BRCA2." Clin Obstet Gynecol 41, no. 1 (March 1998): 157-166. (Review) Link to Item
  - Berchuck, A. "Molecular genetics of hereditary ovarian cancer - The Boyd article reviewed." ONCOLOGY-NEW YORK 12, no. 3 (March 1998): 410-+. Link to Item
  - Young, SR, Liu, WH, and Berchuck, A. "Dual-color FISH studies of HER2/neu and centromere 17 in archived paraffin-embedded ovarian cancer samples." CYTOGENETICS AND CELL GENETICS 82, no. 1-2 (1998): 136-137. Link to Item
  - Layfield, LJ, Saria, EA, Berchuck, A, Dodge, RK, Thompson, JK, Conlon, DH, and Kerns, BJ. "Prognostic value of MIB-1 in advanced ovarian carcinoma as determined using automated immunohistochemistry and quantitative image analysis." J Surg Oncol 66, no. 4 (December 1997): 230-236. Link to Item
  - Schildkraut, JM, Bastos, E, Halabi, S, and Berchuck, A. "Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer - Response." JOURNAL OF THE NATIONAL CANCER INSTITUTE 89, no. 22 (November 19, 1997): 1727-1727. Full Text Link to Item
  - Berchuck, A, and Schildkraut, J. "Oral contraceptive pills. Prevention of ovarian cancer and other benefits." N C Med J 58, no. 6 (November 1997): 404-407. (Review) Link to Item
  - Choi, C, Cho, S, Horikawa, I, Berchuck, A, Wang, N, Cedrone, E, Jhung, SW, Lee, JB, Kerr, J, Chenevix-Trench, G, Kim, S, Barrett, JC, and Koi, M. "Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas." Genes, Chromosomes & Cancer 20, no. 3 (November 1997): 234-242. Full Text
  - Risinger, JI, Hayes, AK, Berchuck, A, and Barrett, JC. "PTEN/MMAC1 mutations in endometrial cancers." Cancer Res 57, no. 21 (November 1, 1997): 4736-4738. Link to Item
  - Berchuck, A, and Carney, M. "Human ovarian cancer of the surface epithelium." Biochem Pharmacol 54, no. 5 (September 1, 1997): 541-544. (Review) Link to Item
  - Packenham, JP, du Manoir, S, Schrock, E, Risinger, JI, Dixon, D, Denz, DN, Evans, JA, Berchuck, A, Barrett, JC, Devereux, TR, and Ried, T. "Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization." Mol Carcinog 19, no. 4 (August 1997): 273-279. Link to Item
  - Schildkraut, JM, Bastos, E, and Berchuck, A. "Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer." J Natl Cancer Inst 89, no. 13 (July 2, 1997): 932-938. Link to Item
  - Lancaster, JM, Berchuck, A, Futreal, PA, and Wiseman, RW. "Dideoxy fingerprinting assay for BRCA1 mutation analysis." Molecular Carcinogenesis 19, no. 3 (July 1997): 176-179. Full Text
  - Clifford, SL, Kaminetsky, CP, Cirisano, FD, Dodge, R, Soper, JT, Clarke-Pearson, DL, and Berchuck, A. "Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer." Am J Obstet Gynecol 176, no. 6 (June 1997): S229-S232. Link to Item
  - Mooney, EE, Robboy, SJ, Hammond, CB, Berchuck, A, and Bentley, RC. "Signet-ring cell carcinoma of the endometrium: a primary tumor masquerading as a metastasis." Int J Gynecol Pathol 16, no. 2 (April 1997): 169-172. Link to Item
  - Berchuck, A, and Cirisano, F. "Genetics of ovarian cancer." Endocrinologist 7, no. 2 (January 1, 1997): 103-106. (Review) Full Text
  - Berchuck, A. "Endometrial carcinoma and its precursors." Curr Ther Endocrinol Metab 6 (1997): 599-602. (Review) Link to Item
  - Berchuck, A, Cirisano, F, Lancaster, JM, Schildkraut, JM, Wiseman, RW, Futreal, A, and Marks, JR. "Role of BRCA1 mutation screening in the management of familial ovarian cancer." American Journal of Obstetrics and Gynecology 175, no. 3 PART I (December 1, 1996): 738-746.
  - Rubin, SC, Benjamin, I, Behbakht, K, Takahashi, H, Morgan, MA, LiVolsi, VA, Berchuck, A, Muto, MG, Garber, JE, Weber, BL, Lynch, HT, and Boyd, J. "Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1." N Engl J Med 335, no. 19 (November 7, 1996): 1413-1416. Full Text Link to Item
  - Kohler, MF, Carney, P, Dodge, R, Soper, JT, Clarke-Pearson, DL, Marks, JR, and Berchuck, A. "p53 overexpression in advanced-stage endometrial adenocarcinoma." Am J Obstet Gynecol 175, no. 5 (November 1996): 1246-1252. Link to Item
  - Lancaster, JM, Brownlee, HA, Bell, DA, Futreal, PA, Marks, JR, Berchuck, A, Wiseman, RW, and Taylor, JA. "Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer." Molecular Carcinogenesis 17, no. 3 (November 1996): 160-162. Full Text
  - van den Brule, FA, Buicu, C, Berchuck, A, Bast, RC, Deprez, M, Liu, FT, Cooper, DN, Pieters, C, Sobel, ME, and Castronovo, V. "Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma." Human Pathology 27, no. 11 (November 1996): 1185-1191. Full Text
  - Vaughn, JP, Cirisano, FD, Huper, G, Berchuck, A, Futreal, PA, Marks, JR, and Iglehart, JD. "Cell cycle control of BRCA2." Cancer Research 56, no. 20 (October 1996): 4590-4594.
  - Berchuck, A, Cirisano, F, Lancaster, JM, Schildkraut, JM, Wiseman, RW, Futreal, A, and Marks, JR. "Role of BRCA1 mutation screening in the management of familial ovarian cancer." Am J Obstet Gynecol 175, no. 3 Pt 1 (September 1996): 738-746. (Review) Link to Item
  - Berchuck, A, Cirisano, F, Lancaster, JM, Schildkraut, JM, Wiseman, RW, Futreal, A, and Marks, JR. "Role of BRCA1 mutation screening in the management of familial ovarian cancer." AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 175, no. 3 (September 1996): 738-746. Link to Item
  - Elbendary, AA, Cirisano, FD, Evans, AC, Davis, PL, Iglehart, JD, Marks, JR, and Berchuck, A. "Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells." Clin Cancer Res 2, no. 9 (September 1996): 1571-1575. Link to Item
  - Risinger, JI, Umar, A, Boyd, J, Berchuck, A, Kunkel, TA, and Barrett, JC. "Mutation of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair." Nat Genet 14, no. 1 (September 1996): 102-105. Full Text Link to Item
  - Terry, LA, Boyd, J, Alcorta, D, Lyon, T, Solomon, G, Hannon, G, Berchuck, A, Beach, D, and Barrett, JC. "Mutational analysis of the p21/WAF1/CIP1/SDI1 coding region in human tumor cell lines." Molecular Carcinogenesis 16, no. 4 (August 1996): 221-228. Full Text
  - Lancaster, JM, Wooster, R, Mangion, J, Phelan, CM, Cochran, C, Gumbs, C, Seal, S, Barfoot, R, Collins, N, Bignell, G, Patel, S, Hamoudi, R, Larsson, C, Wiseman, RW, Berchuck, A, Iglehart, JD, Marks, JR, Ashworth, A, Stratton, MR, and Futreal, PA. "BRCA2 mutations in primary breast and ovarian cancers." Nature Genetics 13, no. 2 (June 1996): 238-240. Full Text
  - Vaughn, JP, Davis, PL, Jarboe, MD, Huper, G, Evans, AC, Wiseman, RW, Berchuck, A, Iglehart, JD, Futreal, PA, and Marks, JR. "BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells." Cell Growth Differ 7, no. 6 (June 1996): 711-715. Link to Item
  - Lancaster, JM, Cochran, CJ, Brownlee, HA, Evans, AC, Berchuck, A, Futreal, PA, and Wiseman, RW. "Detection of BRCA1 mutations in women with early-onset ovarian cancer by use of the protein truncation test." J Natl Cancer Inst 88, no. 8 (April 17, 1996): 552-554. Link to Item
  - Olt, G, Soper, J, Ramakrishnan, S, Xu, F, Berchuck, A, Clarke-Pearson, D, Dodge, R, and Bast, RC. "Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancer." American Journal of Obstetrics and Gynecology 174, no. 4 (April 1996): 1316-1319. Full Text
  - Boente, MP, Hamilton, TC, Godwin, AK, Buetow, K, Kohler, MF, Hogan, WM, Berchuck, A, and Young, RC. "Early ovarian cancer: a review of its genetic and biologic factors, detection, and treatment." Curr Probl Cancer 20, no. 2 (March 1996): 83-137. (Review) Link to Item
  - Lancaster, JM, Wiseman, RW, and Berchuck, A. "An inevitable dilemma: prenatal testing for mutations in the BRCA1 breast-ovarian cancer susceptibility gene." Obstetrics and Gynecology 87, no. 2 (February 1996): 306-309. Full Text
  - Berchuck, A, Kohler, MF, and Bast, RC. "Molecular genetic features of ovarian cancer." Prog Clin Biol Res 394 (1996): 269-284. (Review) Link to Item
  - Boente, MP, Godwin, AK, Kohler, MF, Berchuck, A, Hamilton, TC, Buetow, K, Michael Hogan, W, and Young, RC. "Early ovarian cancer: A review of ITS genetic and biologic factors, detection, and treatment." Current Problems in Cancer 20, no. 2 (January 1, 1996): 86-137. Full Text
  - Fayed, S, Wu, S, Lidor, Y, Super, M, Berchuck, A, Bast, J, and Wiener, JR. "Detection and partial purification of a 30 kDa ovarian carcinoma-associated protein." Cancer Molecular Biology 3, no. 5 (January 1, 1996): 915-926.
  - Hussein, AM, Petros, WP, Ross, M, Vredenburgh, JJ, Affrontil, ML, Jones, RB, Shpall, EJ, Rubin, P, Elkordy, M, Gilbert, C, Gupton, C, Egorin, MJ, Soper, J, Berchuck, A, Clarke-Person, D, Berry, DA, and Peters, WP. "A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies." Cancer Chemother Pharmacol 37, no. 6 (1996): 561-568. Link to Item
  - Risinger, JI, Umar, A, Boyer, JC, Evans, AC, Berchuck, A, Kunkel, TA, and Barrett, JC. "Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity." Cancer Res 55, no. 23 (December 1, 1995): 5664-5669. Link to Item
  - Soper, JT, Clarke-Pearson, DL, Berchuck, A, Rodriguez, G, and Hammond, CB. "5-Day methotrexate for women with metastatic gestational trophoblastic disease." Acog Current Journal Review 8, no. 1 (December 1, 1995): 45-null.
  - Berchuck, A, and Bast, RC. "p53-based gene therapy of ovarian cancer: magic bullet?." Gynecol Oncol 59, no. 2 (November 1995): 169-170. Link to Item
  - Berchuck, A, and Boyd, J. "Molecular basis of endometrial cancer." Cancer 76, no. 10 Suppl (November 1995): 2034-2040. (Review) Full Text
  - Evans, AC, Soper, JT, Clarke-Pearson, DL, Berchuck, A, Rodriguez, GC, and Hammond, CB. "Gestational trophoblastic disease metastatic to the central nervous system." Gynecol Oncol 59, no. 2 (November 1995): 226-230. Link to Item
  - Hurteau, JA, Woolas, RP, Jacobs, IJ, Oram, DC, Kurman, CC, Rubin, LA, Nelson, DL, Berchuck, A, Bast, RC, and Mills, GB. "Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer." Cancer 76, no. 9 (November 1995): 1615-1620. Full Text
  - Berchuck, A, Anspach, C, Evans, AC, Soper, JT, Rodriguez, GC, Dodge, R, Robboy, S, and Clarke-Pearson, DL. "Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma." Gynecol Oncol 59, no. 1 (October 1995): 20-24. Full Text Link to Item
  - FUTRCAL, PA, GUMBS, C, BERCHUCK, A, and WISEMAN, RW. "FREQUENT ALLELIC DELETION OF CHROMOSOME 1P IN PRIMARY OVARIAN-CANCER - MAPPING OF 2 TUMOR SUPRESSOR GENE REGIONS AND PRELIMINARY-ANALYSIS OF CANDIDATE GENES." AMERICAN JOURNAL OF HUMAN GENETICS 57, no. 4 (October 1995): 11-11. Link to Item
  - LIU, JR, CONAWAY, M, RODRIGUEZ, GC, SOPER, JT, CLARKEPEARSON, DL, and BERCHUCK, A. "RELATIONSHIP BETWEEN RACE AND INTERVAL TO TREATMENT IN ENDOMETRIAL CANCER." OBSTETRICS AND GYNECOLOGY 86, no. 4 (October 1995): 486-490. Full Text Link to Item
  - Liu, JR, Conaway, M, Rodriguez, GC, Soper, JT, Clarke-Pearson, DL, and Berchuck, A. "Relationship between race and interval to treatment in endometrial cancer." Obstet Gynecol 86, no. 4 Pt 1 (October 1995): 486-490. Link to Item
  - Woolas, RP, Conaway, MR, Xu, F, Jacobs, IJ, Yu, Y, Daly, L, Davies, AP, O'Briant, K, Berchuck, A, and Soper, JT. "Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic masses." Gynecologic Oncology 59, no. 1 (October 1995): 111-116. Full Text
  - Kohler, MF, Berkholz, A, Risinger, JI, Elbendary, A, Boyd, J, and Berchuck, A. "Mutational analysis of the estrogen-receptor gene in endometrial carcinoma." Obstet Gynecol 86, no. 1 (July 1995): 33-37. Full Text Link to Item
  - Havrilesky, LJ, Elbendary, A, Hurteau, JA, Whitaker, RS, Rodriguez, GC, and Berchuck, A. "Chemotherapy-induced apoptosis in epithelial ovarian cancers." Obstet Gynecol 85, no. 6 (June 1995): 1007-1010. Link to Item
  - Lessey, BA, Albelda, S, Buck, CA, Castelbaum, AJ, Yeh, I, Kohler, M, and Berchuck, A. "Distribution of integrin cell adhesion molecules in endometrial cancer." The American Journal of Pathology 146, no. 3 (March 1995): 717-726.
  - Schildkraut, JM, Collins, NK, Dent, GA, Tucker, JA, Barrett, JC, Berchuck, A, and Boyd, J. "Loss of heterozygosity on chromosome 17q11-21 in cancers of women who have both breast and ovarian cancer." Am J Obstet Gynecol 172, no. 3 (March 1995): 908-913. Link to Item
  - Soper, JT, Evans, AC, Rodriguez, G, Berchuck, A, Clarke-Pearson, DL, and Hammond, CB. "Etoposide-platin combination therapy for chemorefractory gestational trophoblastic disease." Gynecol Oncol 56, no. 3 (March 1995): 421-424. Full Text Link to Item
  - Havrilesky, LJ, Hurteau, JA, Whitaker, RS, Elbendary, A, Wu, S, Rodriguez, GC, Bast, RC, and Berchuck, A. "Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta." Cancer Res 55, no. 4 (February 15, 1995): 944-948. Link to Item
  - Soper, JT, Rodriguez, G, Berchuck, A, and Clarke-Pearson, DL. "Long and short gracilis myocutaneous flaps for vulvovaginal reconstruction after radical pelvic surgery: comparison of flap-specific complications." Gynecol Oncol 56, no. 2 (February 1995): 271-275. Full Text Link to Item
  - Bast, RC, Boyer, CM, Xu, FJ, Wiener, J, Dabel, R, Woolas, R, Jacobs, I, and Berchuck, A. "Molecular approaches to prevention and detection of epithelial ovarian cancer." Journal of Cellular Biochemistry. Supplement 23 (January 1995): 219-222. (Review)
  - Berchuck, A, and Boyd, J. "Molecular basis of endometrial cancer." Cancer 76, no. 10 S (January 1, 1995): 2034-2040. Full Text
  - Berchuck, A. "Biomarkers in the endometrium." J Cell Biochem Suppl 23 (1995): 174-178. (Review) Link to Item
  - Berchuck, A. "Biomarkers in the ovary." Journal of Cellular Biochemistry. Supplement 23 (January 1995): 223-226. (Review)
  - Liu, JR, Conaway, M, Rodriguez, GC, Soper, JT, Clarke-Pearson, DL, and Berchuck, A. "Relationship between race and interval to treatment in endometrial cancer." Obstetrics and Gynecology 86, no. 4 PART 1 (January 1, 1995): 486-490. Full Text
  - Lococo, S, Covens, A, Carney, M, Franssen, E, Dogde, R, Rosen, B, Osborne, R, Kerr, I, Buckman, R, Soper, J, Rodriguez, G, Depetrillo, A, Clarke-Pearson, D, and Berchuck, A. "Does aggressive therapy improve survival in suboptimal stage IIIc/IV ovarian cancer? A Canadian-American comparative study." Gynecologic Oncology 59, no. 2 (1995): 194-199. Full Text
  - Elbendary, A, Berchuck, A, Davis, P, Havrilesky, L, Bast, RC, Iglehart, JD, and Marks, JR. "Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells." Cell Growth Differ 5, no. 12 (December 1994): 1301-1307. Link to Item
  - Soper, JT, Evans, AC, Conaway, MR, Clarke-Pearson, DL, Berchuck, A, and Hammond, CB. "Evaluation of prognostic factors and staging in gestational trophoblastic tumor." Obstet Gynecol 84, no. 6 (December 1994): 969-973. Link to Item
  - Rodriguez, GC, Hughes, CL, Soper, JT, Berchuck, A, Clarke-Pearson, DL, and Hammond, CB. "Serum progesterone for the exclusion of early pregnancy in women at risk for recurrent gestational trophoblastic neoplasia." Obstet Gynecol 84, no. 5 (November 1994): 794-797. Link to Item
  - Futreal, PA, Liu, Q, Shattuck-Eidens, D, Cochran, C, Harshman, K, Tavtigian, S, Bennett, LM, Haugen-Strano, A, Swensen, J, and Miki, Y. "BRCA1 mutations in primary breast and ovarian carcinomas." Science (New York, N.Y.) 266, no. 5182 (October 1994): 120-122. Full Text
  - Fujino, T, Risinger, JI, Collins, NK, Liu, FS, Nishii, H, Takahashi, H, Westphal, EM, Barrett, JC, Sasaki, H, and Kohler, MF. "Allelotype of endometrial carcinoma." Cancer Research 54, no. 16 (August 1994): 4294-4298.
  - Berchuck, A, Elbendary, A, Havrilesky, L, Rodriguez, GC, and Bast, RC. "Pathogenesis of ovarian cancers." J Soc Gynecol Investig 1, no. 3 (July 1994): 181-190. Link to Item
  - Hurteau, J, Rodriguez, GC, Whitaker, RS, Shah, S, Mills, G, Bast, RC, and Berchuck, A. "Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites." Cancer 74, no. 1 (July 1994): 93-99. Full Text
  - Soper, JT, Clarke-Pearson, DL, Berchuck, A, Rodriguez, G, and Hammond, CB. "5-day methotrexate for women with metastatic gestational trophoblastic disease." Gynecol Oncol 54, no. 1 (July 1994): 76-79. Full Text Link to Item
  - Lukes, AS, Kohler, MF, Pieper, CF, Kerns, BJ, Bentley, R, Rodriguez, GC, Soper, JT, Clarke-Pearson, DL, Bast, RC, and Berchuck, A. "Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer." Cancer 73, no. 9 (May 1994): 2380-2385. Full Text
  - Risinger, JI, Berchuck, A, Kohler, MF, and Boyd, J. "Mutations of the E-cadherin gene in human gynecologic cancers." Nat Genet 7, no. 1 (May 1994): 98-102. Full Text Link to Item
  - Wiener, JR, Hurteau, JA, Kerns, BJ, Whitaker, RS, Conaway, MR, Berchuck, A, and Bast, RC. "Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas." American Journal of Obstetrics and Gynecology 170, no. 4 (April 1994): 1177-1183. Full Text
  - Wu, S, Meeker, WA, Wiener, JR, Berchuck, A, Bast, RC, and Boyer, CM. "Transfection of ovarian cancer cells with tumor necrosis factor-alpha (TNF-alpha) antisense mRNA abolishes the proliferative response to interleukin-1 (IL-1) but not TNF-alpha." Gynecol Oncol 53, no. 1 (April 1994): 59-63. Link to Item
  - Xu, FJ, Yu, YH, Daly, L, Anselmino, L, Hass, GM, Berchuck, A, Rodriguez, GC, Soper, JT, Clarke-Pearson, DL, and Hollis, D. "OVX1 as a marker for early stage endometrial carcinoma." Cancer 73, no. 7 (April 1994): 1855-1858. Full Text
  - Myers, ER, Clarke-Pearson, DL, Olt, GJ, Soper, JT, and Berchuck, A. "Preoperative coagulation testing on a gynecologic oncology service." Obstet Gynecol 83, no. 3 (March 1994): 438-444. Link to Item
  - Rodriguez, GC, Clarke-Pearson, DL, Soper, JT, Berchuck, A, Synan, I, and Dodge, RK. "The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer." Obstetrics and Gynecology 83, no. 3 (March 1994): 445-448.
  - Wiener, JR, Kerns, BJ, Harvey, EL, Conaway, MR, Iglehart, JD, Berchuck, A, and Bast, RC. "Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression." Journal of the National Cancer Institute 86, no. 5 (March 1994): 372-378. Full Text
  - Berchuck, A, Kohler, MF, Hopkins, MP, Humphrey, PA, Robboy, SJ, Rodriguez, GC, Soper, JT, Clarke-Pearson, DL, and Bast, RC. "Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors." Gynecol Oncol 52, no. 2 (February 1994): 232-236. Full Text Link to Item
  - Kerns, BJ, Jordan, PA, Faerman, LL, Berchuck, A, Bast, RC, and Layfield, LJ. "Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis." Am J Clin Pathol 101, no. 2 (February 1994): 192-197. Link to Item
  - BERCHUCK, A, KOHLER, MF, MARKS, JR, WISEMAN, R, BOYD, J, and BAST, RC. "THE P53 TUMOR-SUPPRESSOR GENE FREQUENTLY IS ALTERED IN GYNECOLOGIC CANCERS." AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 170, no. 1 (January 1994): 246-252. Link to Item
  - Bast, RC, Xu, F, Yu, Y, Crews, J, Argon, Y, Maier, L, Lidor, Y, Berchuck, A, and Boyer, CM. "Additive and synergistic interactions of monoclonal antibodies and immunotoxins reactive with breast and ovarian cancer." Immunology Series 61 (January 1994): 23-30. (Review)
  - Berchuck, A, Kohler, MF, Marks, JR, Wiseman, R, Boyd, J, and Bast, RC. "The p53 tumor suppressor gene frequently is altered in gynecologic cancers." Am J Obstet Gynecol 170, no. 1 Pt 1 (January 1994): 246-252. (Review) Link to Item
  - Berchuck, A, Kohler, MF, Marks, JR, Wiseman, R, Boyd, J, and Bast, RC. "The p53 tumor suppressor gene frequently is altered in gynecologic cancers." American Journal of Obstetrics and Gynecology 170, no. 1 (January 1, 1994): 246-252. Full Text
  - Liu, FS, Kohler, MF, Marks, JR, Bast, RC, Boyd, J, and Berchuck, A. "Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas." Obstet Gynecol 83, no. 1 (January 1994): 118-124. Link to Item
  - Secord, AA, Sayer, R, Snyder, SA, Broadwater, G, Rodriguez, GC, Berchuck, A, and Blackwell, K. "Second-look laparotomy in ovarian cancer." Gynecologic Oncology 55, no. 3 (January 1, 1994): S122-S127. Full Text
  - Soper, JT, Evans, AC, Clarke-Pearson, DL, Berchuck, A, Rodriguez, G, and Hammond, CB. "Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease." Obstet Gynecol 83, no. 1 (January 1994): 113-117. Link to Item
  - van den Brûle, FA, Berchuck, A, Bast, RC, Liu, FT, Gillet, C, Sobel, ME, and Castronovo, V. "Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas." Eur J Cancer 30A, no. 8 (1994): 1096-1099. Link to Item
  - van den Brûle, FA, Berchuck, A, Bast, RC, Liu, FT, Gillet, C, Sobel, ME, and Castronovo, V. "Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas." European Journal of Cancer 30, no. 8 (January 1, 1994): 1096-1099. Full Text
  - Berchuck, A, and Dodge, RK. "Interval to treatment in endometrial cancer." Am J Obstet Gynecol 169, no. 6 (December 1993): 1655-1656. (Letter) Link to Item
  - Leopold, KA, Oleson, JR, Clarke-Pearson, D, Soper, J, Berchuck, A, Samulski, TV, Page, RL, Blivin, J, Tomberlin, JK, and Dewhirst, MW. "Intraperitoneal cisplatin and regional hyperthermia for ovarian carcinoma." Int J Radiat Oncol Biol Phys 27, no. 5 (December 1, 1993): 1245-1251. Link to Item
  - Soisson, AP, Olt, G, Soper, JT, Berchuck, A, Rodriguez, G, and Clarke-Pearson, DL. "Prevention of superficial wound separation with subcutaneous retention sutures." Gynecol Oncol 51, no. 3 (December 1993): 330-334. Full Text Link to Item
  - Risinger, JI, Berchuck, A, Kohler, MF, Watson, P, Lynch, HT, and Boyd, J. "Genetic instability of microsatellites in endometrial carcinoma." Cancer Res 53, no. 21 (November 1, 1993): 5100-5103. Link to Item
  - Woolas, RP, Xu, FJ, Jacobs, IJ, Yu, YH, Daly, L, Berchuck, A, Soper, JT, Clarke-Pearson, DL, Oram, DH, and Bast, RC. "Elevation of multiple serum markers in patients with stage I ovarian cancer." Journal of the National Cancer Institute 85, no. 21 (November 1993): 1748-1751. Full Text
  - Kohler, MF, Marks, JR, Wiseman, RW, Jacobs, IJ, Davidoff, AM, Clarke-Pearson, DL, Soper, JT, Bast, RC, and Berchuck, A. "Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer." J Natl Cancer Inst 85, no. 18 (September 15, 1993): 1513-1519. Link to Item
  - BOYD, J, KOHLER, MF, BERCHUCK, A, WATSON, P, LYNCH, HT, and RISINGER, JI. "MICROSATELLITE INSTABILITY IN SPORADIC ENDOMETRIAL CARCINOMAS AND THOSE ASSOCIATED WITH HNPCC." AMERICAN JOURNAL OF HUMAN GENETICS 53, no. 3 (September 1993): 22-22. Link to Item
  - Boente, MP, Hurteau, J, Rodriguez, GC, Bast, RC, and Berchuck, A. "The biology of ovarian cancer." Curr Opin Oncol 5, no. 5 (September 1993): 900-907. (Review) Link to Item
  - Kohler, MF, Nishii, H, Humphrey, PA, Saski, H, Marks, J, Bast, RC, Clarke-Pearson, DL, Boyd, J, and Berchuck, A. "Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias." Am J Obstet Gynecol 169, no. 3 (September 1993): 690-694. Link to Item
  - Lidor, YJ, Xu, FJ, Martínez-Maza, O, Olt, GJ, Marks, JR, Berchuck, A, Ramakrishnan, S, Berek, JS, and Bast, RC. "Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cells." Exp Cell Res 207, no. 2 (August 1993): 332-339. Full Text Link to Item
  - Xu, FJ, Yu, YH, Daly, L, DeSombre, K, Anselmino, L, Hass, GM, Berchuck, A, Soper, JT, Clarke-Pearson, DL, and Boyer, C. "OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 11, no. 8 (August 1993): 1506-1510. Full Text
  - Jordan, PA, Kerns, BJ, Pence, JC, Kohler, MF, Bast, RC, Kinney, RB, and Berchuck, A. "Determination of proliferation index in advanced ovarian cancer using quantitative image analysis." Am J Clin Pathol 99, no. 6 (June 1993): 736-740. Link to Item
  - McKenzie, SJ, DeSombre, KA, Bast, BS, Hollis, DR, Whitaker, RS, Berchuck, A, Boyer, CM, and Bast, RC. "Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer." Cancer 71, no. 12 (June 1993): 3942-3946. Full Text
  - KOHLER, MF, KERNS, BJM, HUMPHREY, PA, MARKS, JR, BAST, RC, and BERCHUCK, A. "MUTATION AND OVEREXPRESSION OF P53 IN EARLY-STAGE EPITHELIAL OVARIAN-CANCER." Obstetrics and Gynecology 81, no. 5 (May 1, 1993): 643-650. (Academic Article) Link to Item
  - Kohler, MF, Kerns, BJ, Humphrey, PA, Marks, JR, Bast, RC, and Berchuck, A. "Mutation and overexpression of p53 in early-stage epithelial ovarian cancer." Obstet Gynecol 81, no. 5 ( Pt 1) (May 1993): 643-650. Link to Item
  - Sasaki, H, Nishii, H, Takahashi, H, Tada, A, Furusato, M, Terashima, Y, Siegal, GP, Parker, SL, Kohler, MF, and Berchuck, A. "Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma." Cancer Res 53, no. 8 (April 15, 1993): 1906-1910. Link to Item
  - Wu, S, Boyer, CM, Whitaker, RS, Berchuck, A, Wiener, JR, Weinberg, JB, and Bast, RC. "Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression." Cancer Res 53, no. 8 (April 15, 1993): 1939-1944. Link to Item
  - Clarke-Pearson, DL, Synan, IS, Dodge, R, Soper, JT, Berchuck, A, and Coleman, RE. "A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery." American Journal of Obstetrics and Gynecology 168, no. 4 (April 1993): 1146-1153. Full Text
  - Jacobs, IJ, Smith, SA, Wiseman, RW, Futreal, PA, Harrington, T, Osborne, RJ, Leech, V, Molyneux, A, Berchuck, A, and Ponder, BA. "A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus." Cancer Res 53, no. 6 (March 15, 1993): 1218-1221. Link to Item
  - Bast, RC, Boyer, CM, Jacobs, I, Xu, FJ, Wu, S, Wiener, J, Kohler, M, and Berchuck, A. "Cell growth regulation in epithelial ovarian cancer." Cancer 71, no. 4 Suppl (February 15, 1993): 1597-1601. (Review) Link to Item
  - Xu, F, Lupu, R, Rodriguez, GC, Whitaker, RS, Boente, MP, Berchuck, A, Yu, Y, DeSombre, KA, Boyer, CM, and Bast, RC. "Antibody-induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185." Int J Cancer 53, no. 3 (February 1, 1993): 401-408. Link to Item
  - Berchuck, A, Kohler, MF, Boente, MP, Rodriguez, GC, Whitaker, RS, and Bast, RC. "Growth regulation and transformation of ovarian epithelium." Cancer 71, no. 2 Suppl (January 15, 1993): 545-551. (Review) Link to Item
  - Bast, RC, Boyer, CM, Jacobs, I, Xu, FJ, Wu, S, Wiener, J, Kohler, M, and Berchuck, A. "Cell growth regulation in epithelial ovarian cancer." Cancer 71, no. 4 S (January 1, 1993): 1597-1601. Full Text
  - Berchuck, A, Kohler, MF, Boente, MP, Rodriguez, GC, Whitaker, RS, and Bast, RC. "Growth regulation and transformation of ovarian epithelium." Cancer 71, no. 2 S (January 1, 1993): 545-551. Full Text
  - Kohler, MF, Kerns, BJM, Humphrey, PA, Marks, JR, Bast, RC, and Berchuck, A. "Mutation and overexpression of p53 in early-stage epithelial ovarian cancer." Obstetrics and Gynecology 81, no. 5 I (January 1, 1993): 643-650.
  - RODRIGUEZ, GC, BOENTE, MP, BERCHUCK, A, WHITAKER, RS, OBRIANT, KC, XU, FJ, and BAST, RC. "THE EFFECT OF ANTIBODIES AND IMMUNOTOXINS REACTIVE WITH HER-2/NEU ON GROWTH OF OVARIAN AND BREAST-CANCER CELL-LINES." AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 168, no. 1 (January 1993): 228-232. Full Text Link to Item
  - Rodriguez, GC, Boente, MP, Berchuck, A, Whitaker, RS, O’Briant, KC, Xu, F, and Bast, RC. "The effect of antibodies and immunotoxins reactive with HER-2/neu on growth of ovarian and breast cancer cell lines." American Journal of Obstetrics and Gynecology 168, no. 1 (January 1, 1993): 228-232. Full Text
  - Rodríguez, GC, Boente, MP, Berchuck, A, Whitaker, RS, O'Briant, KC, Xu, F, and Bast, RC. "The effect of antibodies and immunotoxins reactive with HER-2/neu on growth of ovarian and breast cancer cell lines." American Journal of Obstetrics and Gynecology 168, no. 1 Pt 1 (January 1993): 228-232. Full Text
  - WOOLAS, R, XU, FJ, DALY, L, SOPER, JT, BERCHUCK, A, RODRIGUEZ, G, CLARKEPEARSON, DL, BOYER, CM, and BAST, RC. "SCREENING STRATEGIES FOR OVARIAN-CANCER." DIAGNOSTIC ONCOLOGY 3, no. 6 (1993): 287-293. Link to Item
  - Jacobs, IJ, Kohler, MF, Wiseman, RW, Marks, JR, Whitaker, R, Kerns, BA, Humphrey, P, Berchuck, A, Ponder, BA, and Bast, RC. "Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation." J Natl Cancer Inst 84, no. 23 (December 2, 1992): 1793-1798. Link to Item
  - Boente, MP, Berchuck, A, Rodriguez, GC, Davidoff, A, Whitaker, R, Xu, FJ, Marks, J, Clarke-Pearson, DL, and Bast, RC. "The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cells." American Journal of Obstetrics and Gynecology 167, no. 6 (December 1992): 1877-1882. Full Text
  - Soisson, AP, Soper, JT, Berchuck, A, Dodge, R, and Clarke-Pearson, D. "Radical hysterectomy in obese women." Obstet Gynecol 80, no. 6 (December 1992): 940-943. Link to Item
  - Soper, JT, Johnson, P, Johnson, V, Berchuck, A, and Clarke-Pearson, DL. "Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma." Obstet Gynecol 80, no. 6 (December 1992): 949-953. Link to Item
  - Olt, G, Berchuck, A, Soisson, AP, Boyer, CM, and Bast, RC. "Fibronectin is an immunosuppressive substance associated with epithelial ovarian cancer." Cancer 70, no. 8 (October 1992): 2137-2142. Full Text
  - Rodriguez, GC, Soper, JT, Berchuck, A, Oleson, J, Dodge, R, Montana, G, and Clarke-Pearson, DL. "Improved palliation of cerebral metastases in epithelial ovarian cancer using a combined modality approach including radiation therapy, chemotherapy, and surgery." J Clin Oncol 10, no. 10 (October 1992): 1553-1560. Full Text Link to Item
  - Wiener, JR, Berchuck, A, and Bast, RC. "Biology and therapy with biologic agents in gynecologic cancer." Curr Opin Oncol 4, no. 5 (October 1992): 946-954. (Review) Link to Item
  - Berchuck, A, Kohler, MF, and Bast, RC. "Oncogenes in ovarian cancer." Hematology/Oncology Clinics of North America 6, no. 4 (August 1992): 813-827. (Review) Full Text
  - Ignar-Trowbridge, D, Risinger, JI, Dent, GA, Kohler, M, Berchuck, A, McLachlan, JA, and Boyd, J. "Mutations of the Ki-ras oncogene in endometrial carcinoma." Am J Obstet Gynecol 167, no. 1 (July 1992): 227-232. Link to Item
  - Kerns, BJ, Jordan, PA, Moore, MB, Humphrey, PA, Berchuck, A, Kohler, MF, Bast, RC, Iglehart, JD, and Marks, JR. "p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry." The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society 40, no. 7 (July 1992): 1047-1051. Full Text
  - O'Briant, K, Chrysson, N, Hunter, V, Tyson, F, Tanner, M, Daly, L, George, SL, Berchuck, A, Soper, J, and Fowler, W. "Ha-ras polymorphisms in epithelial ovarian cancer." Gynecol Oncol 45, no. 3 (June 1992): 299-302. Link to Item
  - Soper, JT, Berchuck, A, Dodge, R, and Clarke-Pearson, DL. "Adjuvant therapy with intraperitoneal chromic phosphate (32P) in women with early ovarian carcinoma after comprehensive surgical staging." Obstet Gynecol 79, no. 6 (June 1992): 993-997. Link to Item
  - Bast, RC, Jacobs, I, and Berchuck, A. "Malignant transformation of ovarian epithelium." J Natl Cancer Inst 84, no. 8 (April 15, 1992): 556-558. Link to Item
  - Kohler, MF, Berchuck, A, Davidoff, AM, Humphrey, PA, Dodge, RK, Iglehart, JD, Soper, JT, Clarke-Pearson, DL, Bast, RC, and Marks, JR. "Overexpression and mutation of p53 in endometrial carcinoma." Cancer Res 52, no. 6 (March 15, 1992): 1622-1627. Link to Item
  - Berchuck, A, Boente, MP, and Bast, RC. "The use of tumor markers in the management of patients with gynecologic carcinomas." Clin Obstet Gynecol 35, no. 1 (March 1992): 45-54. (Review) Link to Item
  - Berchuck, A, Rodriguez, G, Olt, G, Whitaker, R, Boente, MP, Arrick, BA, Clarke-Pearson, DL, and Bast, RC. "Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-beta." American Journal of Obstetrics and Gynecology 166, no. 2 (February 1992): 676-684. Full Text
  - Berchuck, A, Boente, MP, Kerns, BJ, Kinney, RB, Soper, JT, Clarke-Pearson, DL, Bast, RC, and Bacus, SS. "Ploidy analysis of epithelial ovarian cancers using image cytometry." Gynecol Oncol 44, no. 1 (January 1992): 61-65. Link to Item
  - XU, FJ, RAMAKRISHNAN, S, DALY, L, SOPER, JT, BERCHUCK, A, CLARKEPEARSON, D, and BAST, RC. "INCREASED SERUM LEVELS OF MACROPHAGE COLONY-STIMULATING FACTOR IN OVARIAN-CANCER." American Journal of Obstetrics and Gynecology 165, no. 5 (November 1, 1991): 1356-1362. (Academic Article) Link to Item
  - Xu, FJ, Ramakrishnan, S, Daly, L, Soper, JT, Berchuck, A, Clarke-Pearson, D, and Bast, RC. "Increased serum levels of macrophage colony-stimulating factor in ovarian cancer." Am J Obstet Gynecol 165, no. 5 Pt 1 (November 1991): 1356-1362. Link to Item
  - Soper, JT, Berchuck, A, and Clarke-Pearson, DL. "Adjuvant intraperitoneal chromic phosphate therapy for women with apparent early ovarian carcinoma who have not undergone comprehensive surgical staging." Cancer 68, no. 4 (August 1991): 725-729. Full Text
  - Marks, JR, Davidoff, AM, Kerns, BJ, Humphrey, PA, Pence, JC, Dodge, RK, Clarke-Pearson, DL, Iglehart, JD, Bast, RC, and Berchuck, A. "Overexpression and mutation of p53 in epithelial ovarian cancer." Cancer Res 51, no. 11 (June 1, 1991): 2979-2984. Link to Item
  - Soper, JT, Couchman, G, Berchuck, A, and Clarke-Pearson, D. "The role of partial sigmoid colectomy for debulking epithelial ovarian carcinoma." Gynecol Oncol 41, no. 3 (June 1991): 239-244. Link to Item
  - Cliby, W, Soisson, AP, Berchuck, A, and Clarke-Pearson, DL. "Stage I small cell carcinoma of the vulva treated with vulvectomy, lymphadenectomy, and adjuvant chemotherapy." Cancer 67, no. 9 (May 1991): 2415-2417. (Review) Full Text
  - Rodriguez, GC, Berchuck, A, Whitaker, RS, Schlossman, D, Clarke-Pearson, DL, and Bast, RC. "Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factor." American Journal of Obstetrics and Gynecology 164, no. 3 (March 1991): 745-750. Full Text
  - Berchuck, A, Rodriguez, GC, Kamel, A, Dodge, RK, Soper, JT, Clarke-Pearson, DL, and Bast, RC. "Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer." American Journal of Obstetrics and Gynecology 164, no. 2 (February 1991): 669-674. Full Text
  - BERCHUCK, A, RODRIGUEZ, G, KINNEY, RB, SOPER, JT, DODGE, RK, CLARKEPEARSON, DL, and BAST, RC. "OVEREXPRESSION OF HER-2 NEU IN ENDOMETRIAL CANCER IS ASSOCIATED WITH ADVANCED STAGE DISEASE." AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 164, no. 1 (January 1991): 15-21. Full Text Link to Item
  - Berchuck, A, Rodriguez, G, Kinney, RB, Soper, JT, Dodge, RK, Clarke-Pearson, DL, and Bast, RC. "Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease." Am J Obstet Gynecol 164, no. 1 Pt 1 (January 1991): 15-21. Link to Item
  - Berchuck, A, Rodriguez, G, Kinney, RB, Soper, JT, Dodge, RK, Clarke-Pearson, DL, and Bast, RC. "Overexpression of HER-2 neu in endometrial cancer is associated with advanced stage disease." American Journal of Obstetrics and Gynecology 164, no. 1 PART 1 (January 1, 1991): 15-21. Full Text
  - Soper, JT, Berchuck, A, and Clarke-Pearson, DL. "The clinical significance of blood transfusion at the time of radical hysterectomy." Obstet Gynecol 77, no. 1 (January 1991): 165-166. (Letter) Link to Item
  - Xu, FJ, Bast, RC, and Clarke-Pearson, D. "Increased serum levels of macrophage colony-stimulating factor in ovarian cancer." American Journal of Obstetrics and Gynecology 165, no. 4 (January 1, 1991): 1356-1362. Full Text
  - HUNTER, VJ, DALY, L, HELMS, M, SOPER, JT, BERCHUCK, A, CLARKEPEARSON, DL, and BAST, RC. "THE PROGNOSTIC-SIGNIFICANCE OF CA-125 HALF-LIFE IN PATIENTS WITH OVARIAN-CANCER WHO HAVE RECEIVED PRIMARY CHEMOTHERAPY AFTER SURGICAL CYTOREDUCTION." AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 163, no. 4 (October 1990): 1164-1167. Full Text Link to Item
  - Hunter, VJ, Daly, L, Helms, M, Soper, JT, Berchuck, A, Clarke-Pearson, DL, and Bast, RC. "The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreduction." Am J Obstet Gynecol 163, no. 4 Pt 1 (October 1990): 1164-1167. Link to Item
  - Kohler, MF, Berchuck, A, Baker, ME, Szpak, CA, Soper, JT, and Clarke-Pearson, DL. "Computed tomography-guided fine-needle aspiration of retroperitoneal lymph nodes in gynecologic oncology." Obstet Gynecol 76, no. 4 (October 1990): 612-616. Link to Item
  - SOPER, JT, BERCHUCK, A, OLT, GJ, SOISSON, AP, CLARKEPEARSON, DL, and BAST, RC. "PREOPERATIVE EVALUATION OF SERUM CA-125, TAG-72, AND CA-15-3 IN PATIENTS WITH ENDOMETRIAL CARCINOMA." AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 163, no. 4 (October 1990): 1204-1209. Full Text Link to Item
  - Soper, JT, Berchuck, A, Olt, GJ, Soisson, AP, Clarke-Pearson, DL, and Bast, RC. "Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma." Am J Obstet Gynecol 163, no. 4 Pt 1 (October 1990): 1204-1209. Link to Item
  - BERCHUCK, A, RODRIGUEZ, G, KAMEL, A, SOPER, JT, CLARKEPEARSON, DL, and BAST, RC. "EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND HER-2 NEU IN NORMAL AND NEOPLASTIC CERVIX, VULVA, AND VAGINA." OBSTETRICS AND GYNECOLOGY 76, no. 3 (September 1990): 381-387. Link to Item
  - Berchuck, A, Rodriguez, G, Kamel, A, Soper, JT, Clarke-Pearson, DL, and Bast, RC. "Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina." Obstetrics and Gynecology 76, no. 3 Pt 1 (September 1990): 381-387.
  - Olt, G, Berchuck, A, and Bast, RC. "The role of tumor markers in gynecologic oncology." Obstet Gynecol Surv 45, no. 9 (September 1990): 570-577. (Review) Link to Item
  - Shpall, EJ, Clarke-Pearson, D, Soper, JT, Berchuck, A, Jones, RB, Bast, RC, Ross, M, Lidor, Y, Vanacek, K, and Tyler, T. "High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer." Gynecol Oncol 38, no. 3 (September 1990): 386-391. Link to Item
  - Berchuck, A, Kamel, A, Whitaker, R, Kerns, B, Olt, G, Kinney, R, Soper, JT, Dodge, R, Clarke-Pearson, DL, and Marks, P. "Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer." Cancer Research 50, no. 13 (July 1990): 4087-4091.
  - Soisson, AP, Geszler, G, Soper, JT, Berchuck, A, and Clarke-Pearson, DL. "A comparison of symptomatology, physical examination, and vaginal cytology in the detection of recurrent cervical carcinoma after radical hysterectomy." Obstet Gynecol 76, no. 1 (July 1990): 106-109. Link to Item
  - Soisson, AP, Soper, JT, Clarke-Pearson, DL, Berchuck, A, Montana, G, and Creasman, WT. "Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer." Gynecologic Oncology 37, no. 3 (June 1990): 390-395. Full Text
  - Berchuck, A, Olt, GJ, Soisson, AP, Kamel, A, Soper, JT, Boyer, CM, Clarke-Pearson, DL, Leslie, DS, and Bast, RC. "Heterogeneity of antigen expression in advanced epithelial ovarian cancer." Am J Obstet Gynecol 162, no. 4 (April 1990): 883-888. Link to Item
  - Berchuck, A, Olt, GJ, Everitt, L, Soisson, AP, Bast, RC, and Boyer, CM. "The role of peptide growth factors in epithelial ovarian cancer." Obstet Gynecol 75, no. 2 (February 1990): 255-262. Link to Item
  - Berchuck, A, Rodriguez, G, Kamel, A, Soper, JT, Clarke-Pearson, DL, and Bast, RC. "Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina." Obstetrics and Gynecology 76, no. 3 (January 1, 1990): 381-387.
  - Berchuck, A, Rubin, SC, Hoskins, WJ, Saigo, PE, Pierce, VK, and Lewis, JL. "Treatment of endometrial stromal tumors." Gynecol Oncol 36, no. 1 (January 1990): 60-65. Link to Item
  - Hunter, VJ, Daly, L, Helms, M, Soper, JT, Berchuck, A, Clarke-Pearson, DL, and Bast, RC. "The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreduction." American Journal of Obstetrics and Gynecology 163, no. 4 PART 1 (January 1, 1990): 1164-1167. Full Text
  - Olt, GJ, Berchuck, A, and Bast, RC. "Gynecologic tumor markers." Semin Surg Oncol 6, no. 6 (1990): 305-313. (Review) Link to Item
  - Soper, JT, Berchuck, A, Olt, GJ, Soisson, AP, Clarke-Pearson, DL, and Bast, RC. "Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma." American Journal of Obstetrics and Gynecology 163, no. 4 PART 1 (January 1, 1990): 1204-1209. Full Text
  - Berchuck, A, Soisson, AP, Olt, GJ, Soper, JT, Clarke-Pearson, DL, Bast, RC, and McCarty, KS. "Epidermal growth factor receptor expression in normal and malignant endometrium." American Journal of Obstetrics and Gynecology 161, no. 5 (November 1989): 1247-1252. Full Text
  - Soisson, AP, Berchuck, A, Lessey, BA, Soper, JT, Clarke-Pearson, DL, McCarty, KS, and Bast, RC. "Immunohistochemical expression of TAG-72 in normal and malignant endometrium: correlation of antigen expression with estrogen receptor and progesterone receptor levels." American Journal of Obstetrics and Gynecology 161, no. 5 (November 1989): 1258-1263. Full Text
  - Soper, JT, Larson, D, Hunter, VJ, Berchuck, A, and Clarke-Pearson, DL. "Short gracilis myocutaneous flaps for vulvovaginal reconstruction after radical pelvic surgery." Obstet Gynecol 74, no. 5 (November 1989): 823-827. Link to Item
  - Berchuck, A, MacDonald, PC, Milewich, L, and Casey, ML. "Transforming growth factor-beta inhibits prostaglandin production in amnion and A431 cells." Prostaglandins 38, no. 4 (October 1989): 453-464. Link to Item
  - Berchuck, A, Soisson, AP, Soper, JT, Clarke-Pearson, DL, Bast, RC, and McCarty, KS. "Reactivity of epidermal growth factor receptor monoclonal antibodies with human uterine tissues." Archives of Pathology & Laboratory Medicine 113, no. 10 (October 1989): 1155-1158.
  - Soper, JT, Berchuck, A, Creasman, WT, and Clarke-Pearson, DL. "Pelvic exenteration: factors associated with major surgical morbidity." Gynecol Oncol 35, no. 1 (October 1989): 93-98. Link to Item
  - Massad, LS, Santoriello, K, and Berchuck, A. "Pneumoperitoneum due to peritoneovaginal fistula following hysterectomy." Int J Gynaecol Obstet 29, no. 3 (July 1989): 257-261. (Review) Link to Item
  - Berchuck, A, Soisson, AP, Clarke-Pearson, DL, Soper, JT, Boyer, CM, Kinney, RB, McCarty, KS, and Bast, RC. "Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential." Cancer Res 49, no. 8 (April 15, 1989): 2091-2095. Link to Item
  - Yazigi, R, Berchuck, A, Casey, ML, and MacDonald, PC. "Effect of epidermal growth factor on ornithine decarboxylase activity in A431 cells." Anticancer Research 9, no. 1 (January 1989): 209-213.
  - Berchuck, A, Rubin, SC, Hoskins, WJ, Saigo, PE, Pierce, VK, and Lewis, JL. "Treatment of uterine leiomyosarcoma." Obstet Gynecol 71, no. 6 Pt 1 (June 1988): 845-850. (Review) Link to Item
  - Berchuck, A, MacDonald, PC, Milewich, L, and Casey, ML. "Epidermal growth factor, vanadate, and 12-O-tetradecanoylphorbol-13-acetate inhibit growth and stimulate prostaglandin E2 production in A431 cells." Mol Cell Endocrinol 57, no. 1-2 (May 1988): 87-92. Link to Item
  - Berchuck, A, Rubin, SC, Hoskins, WJ, Saigo, PE, Pierce, VK, and Jr, JLL. "Treatment of uterine leiomyosarcoma." Obstetrics and Gynecology 71, no. 6 I (1988): 845-850.
  - Berchuck, A, and Mullin, TJ. "Cervical adenoid cystic carcinoma associated with ascites." Gynecol Oncol 22, no. 2 (October 1985): 201-211. Link to Item
  - Berchuck, A, and Sokol, RJ. "Cervicovaginal fistula formation: a new complication of Shirodkar cerclage." American Journal of Perinatology 1, no. 3 (April 1984): 263-265. Full Text
  - Berchuck, A, and Sokol, RJ. "Previous cesarean section, placenta increta, and uterine rupture in second-trimester abortion." American Journal of Obstetrics and Gynecology 145, no. 6 (March 1983): 766-767. Full Text
- Book Sections
  - Guillem, JG, Berchuck, A, Norton, JA, Subhedar, P, Seastedt, KP, and Untch, BR. "Role of surgery in cancer prevention." In DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 402-419. November 16, 2018.
  - Guillem, JG, Berchuck, A, Moley, JF, Norton, JA, Gabram-Mendola, SGA, and Hui, VW. "Role of surgery in cancer prevention." In DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology: Tenth Edition. January 7, 2015.
  - Gaillard, S, Maxwell, GL, Sood, AK, and Berchuck, A. "Biology and genetics." In Berek and Hacker's Gynecologic Oncology: Sixth Edition, 2-38. November 11, 2014.
  - Berchuck, A, Levine, DA, Farley, JH, and Birrer, MJ. "Molecular pathogenesis of gynecologic cancers." In Principles and Practice of Gynecologic Oncology: Sixth Edition, 30-59. May 8, 2013.
  - Lu, KH, Berchuck, A, and Kauff, ND. "Hereditary gynecologic cancers." In Principles and Practice of Gynecologic Oncology: Sixth Edition, 60-69. May 8, 2013.
  - Larry Maxwell, G, Risinger, JI, Carl Barrett, J, and Berchuck, A. "The molecular genetics of endometrial cancer." In Uterine Cancer, 69-89. January 1, 2005.
- Other Articles
  - Meeks, HD, Song, H, Michailidou, K, Bolla, MK, Dennis, J, Wang, Q, Barrowdale, D, Frost, D, EMBRACE, , McGuffog, L, Ellis, S, Feng, B, Buys, SS, Hopper, JL, Southey, MC, Tesoriero, A, kConFab Investigators, , James, PA, Bruinsma, F, Campbell, IG, Australia Ovarian Cancer Study Group, , Broeks, A, Schmidt, MK, Hogervorst, FBL, HEBON, , Beckman, MW, Fasching, PA, Fletcher, O, Johnson, N, Sawyer, EJ, Riboli, E, Banerjee, S, Menon, U, Tomlinson, I, Burwinkel, B, Hamann, U, Marme, F, Rudolph, A, Janavicius, R, Tihomirova, L, Tung, N, Garber, J, Cramer, D, Terry, KL, Poole, EM, Tworoger, SS, Dorfling, CM, van Rensburg, EJ, Godwin, AK, Guénel, P, Truong, T, GEMO Study Collaborators, , Stoppa-Lyonnet, D, Damiola, F, Mazoyer, S, Sinilnikova, OM, Isaacs, C, Maugard, C, Bojesen, SE, Flyger, H, Gerdes, A-M, Hansen, TVO, Jensen, A, Kjaer, SK, Hogdall, C, Hogdall, E, Pedersen, IS, Thomassen, M, Benitez, J, González-Neira, A, Osorio, A, Hoya, MDL, Segura, PP, Diez, O, Lazaro, C, Brunet, J, Anton-Culver, H, Eunjung, L, John, EM, Neuhausen, SL, Ding, YC, Castillo, D, Weitzel, JN, Ganz, PA, Nussbaum, RL, Chan, SB, Karlan, BY, Lester, J, Wu, A, Gayther, S, Ramus, SJ, Sieh, W, Whittermore, AS, Monteiro, ANA, Phelan, CM, Terry, MB, Piedmonte, M, Offit, K, Robson, M, Levine, D, Moysich, KB, Cannioto, R, Olson, SH, Daly, MB, Nathanson, KL, Domchek, SM, Lu, KH, Liang, D, Hildebrant, MAT, Ness, R, Modugno, F, Pearce, L, Goodman, MT, Thompson, PJ, Brenner, H, Butterbach, K, Meindl, A, Hahnen, E, Wappenschmidt, B, Brauch, H, Brüning, T, Blomqvist, C, Khan, S, Nevanlinna, H, Pelttari, LM, Aittomäki, K, Butzow, R, Bogdanova, NV, Dörk, T, Lindblom, A, Margolin, S, Rantala, J, Kosma, V-M, Mannermaa, A, Lambrechts, D, Neven, P, Claes, KBM, Maerken, TV, Chang-Claude, J, Flesch-Janys, D, Heitz, F, Varon-Mateeva, R, Peterlongo, P, Radice, P, Viel, A, Barile, M, Peissel, B, Manoukian, S, Montagna, M, Oliani, C, Peixoto, A, Teixeira, MR, Collavoli, A, Hallberg, E, Olson, JE, Goode, EL, Hart, SN, Shimelis, H, Cunningham, JM, Giles, GG, Milne, RL, Healey, S, Tucker, K, Haiman, CA, Henderson, BE, Goldberg, MS, Tischkowitz, M, Simard, J, Soucy, P, Eccles, DM, Le, N, Borresen-Dale, A-L, Kristensen, V, Salvesen, HB, Bjorge, L, Bandera, EV, Risch, H, Zheng, W, Beeghly-Fadiel, A, Cai, H, Pylkäs, K, Tollenaar, RAEM, Ouweland, AMWVD, Andrulis, IL, Knight, JA, OCGN, , Narod, S, Devilee, P, Winqvist, R, Figueroa, J, Greene, MH, Mai, PL, Loud, JT, García-Closas, M, Schoemaker, MJ, Czene, K, Darabi, H, McNeish, I, Siddiquil, N, Glasspool, R, Kwong, A, Park, SK, Teo, SH, Yoon, S-Y, Matsuo, K, Hosono, S, Woo, YL, Gao, Y-T, Foretova, L, Singer, CF, Rappaport-Feurhauser, C, Friedman, E, Laitman, Y, Rennert, G, Imyanitov, EN, Hulick, PJ, Olopade, OI, Senter, L, Olah, E, Doherty, JA, Schildkraut, J, Koppert, LB, Kiemeney, LA, Massuger, LFAG, Cook, LS, Pejovic, T, Li, J, Borg, A, Öfverholm, A, Rossing, MA, Wentzensen, N, Henriksson, K, Cox, A, Cross, SS, Pasini, BJ, Shah, M, Kabisch, M, Torres, D, Jakubowska, A, Lubinski, J, Gronwald, J, Agnarsson, BA, Kupryjanczyk, J, Moes-Sosnowska, J, Fostira, F, Konstantopoulou, I, Slager, S, Jones, M, PRostate cancer AssoCiation group To Investigate Cancer Associated aLterations in the genome, , Antoniou, AC, Berchuck, A, Swerdlow, A, Chenevix-Trench, G, Dunning, AM, Pharoah, PDP, Hall, P, Easton, DF, Couch, FJ, Spurdle, AB, and Goldgar, DE. "BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers." Journal of the National Cancer Institute 108, no. 2 (February 2016). Full Text
  - "Retraction. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 30, no. 6 (February 2012): 678-null. Full Text
  - Potti, A, Dressman, HK, Bild, A, Riedel, RF, Chan, G, Sayer, R, Cragun, J, Cottrill, H, Kelley, MJ, Petersen, R, Harpole, D, Marks, J, Berchuck, A, Ginsburg, GS, Febbo, P, Lancaster, J, and Nevins, JR. "Retraction: Genomic signatures to guide the use of chemotherapeutics." Nature Medicine 17, no. 1 (January 2011): 135-null. Full Text
  - Potti, A, Dressman, HK, Bild, A, Riedel, RF, Chan, G, Sayer, R, Cragun, J, Cottrill, H, Kelley, MJ, Petersen, R, Harpole, D, Marks, J, Berchuck, A, Ginsburg, GS, Febbo, P, Lancaster, J, and Nevins, JR. "Erratum: Genomic signatures to guide the use of chemotherapeutics (Nature Medicine (2006) 12 (1294-1300))." Nature Medicine 17, no. 1 (January 1, 2011): 135-null. Full Text
  - Potti, A, Dressman, HK, Bild, A, Riedel, RF, Chan, G, Sayer, R, Cragun, J, Cottrill, H, Kelley, MJ, Petersen, R, Harpole, D, Marks, J, Berchuck, A, Ginsburg, GS, Febbo, P, Lancaster, J, and Nevins, JR. "Corrigendum: Genomic signatures to guide the use of chemotherapeutics (Nature Medicine (2006) 12, (1294-1300))." Nature Medicine 14, no. 8 (August 1, 2008): 889-null. Full Text
  - Potti, A, Dressman, HK, Bild, A, Riedel, RF, Chan, G, Sayer, R, Cragun, J, Cottrill, H, Kelley, MJ, Petersen, R, Harpole, D, Marks, J, Berchuck, A, Ginsburg, GS, Febbo, P, Lancaster, J, and Nevins, JR. "Erratum: Genomic signatures to guide the use of chemotherapeutics (Nature (2006) 12, (1294-1300))." Nature Medicine 13, no. 11 (November 1, 2007): 1388-null. Full Text
  - Dressman, HK, Berchuck, A, Chan, G, Zhai, J, Bild, A, Sayer, R, Cragun, J, Clarke, J, Whitaker, RS, Li, L, Gray, J, Marks, J, Ginsburg, GS, Potti, A, West, M, Nevins, JR, and Lancaster, JM. "An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer." J Clin Oncol 25, no. 5 (February 10, 2007): 517-525. Full Text Link to Item
  - Potti, A, Dressman, HK, Bild, A, Riedel, RF, Chan, G, Sayer, R, Cragun, J, Cottrill, H, Kelley, MJ, Petersen, R, Harpole, D, Marks, J, Berchuck, A, Ginsburg, GS, Febbo, P, Lancaster, J, and Nevins, JR. "Genomic signatures to guide the use of chemotherapeutics." Nature Medicine 12, no. 11 (November 2006): 1294-1300. Full Text
  - Andrew, B, Iversen, ES, Lancaster, JM, Dressman, HK, West, M, Nevins, JR, Marks, JR, and Miller, BE. "Prediction of optimal versus suboptimal cytoreduction of advanced-stage serious ovarian cancer with the use of microarrays." Women'S Oncology Review 4, no. 3 (September 1, 2004): 203-204. Full Text
  - Berchuck, A, Maxwell, GL, and Marks, JR. "Relationship between alterations in the p53 gene and chemosensitivity of ovarian cancers." Cme Journal of Gynecologic Oncology 4, no. 1 (December 1, 1999): 78-81. (Review)
- Conference Papers
  - Gaillard, S, Dumbauld, C, Bilewski, A, Ehrisman, JA, Secord, AA, Havrilesky, LJ, Berchuck, A, Weinhold, K, Chan, C, and Yi, J. "Evaluating the repertoire of immune checkpoint markers expressed on peripheral and ascites CD8(+) T cells in ovarian cancer." May 20, 2017. Full Text Link to Item
  - Moss, H, Myers, E, Berchuck, A, and Havrilesky, LJ. "Cost-effectiveness of ovarian cancer screening: An analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) from a U.S. health system perspective." : American Society of Clinical Oncology (ASCO), May 20, 2017. Full Text
  - Doherty, JA, Greene, CS, Rudd, JE, Tafe, LJ, Alberg, AJ, Bandera, EV, Barnholtz-Sloan, J, Bondy, M, Cote, ML, Funkhouser, E, Moorman, PG, Peters, ES, Schwartz, AG, Terry, P, Bentley, R, Berchuck, A, Marks, JR, and Schildkraut, JM. "Abstract 3407: Gene expression subtypes of high grade serous ovarian cancer in African American women." July 15, 2016. Full Text
  - Lee, AW, Bomkamp, A, Bandera, EV, Jensen, A, Ramus, SJ, Goodman, MT, Rossing, MA, Modugno, F, Moysich, KB, Chang-Claude, J, Rudolph, A, Gentry-Maharaj, A, Terry, KL, Gayther, SA, Cramer, DW, Doherty, JA, Schildkraut, JM, Kjaer, SK, Ness, RB, Menon, U, Berchuck, A, Mukherjee, B, Roman, L, Pharoah, PD, Chenevix-Trench, G, Wu, AH, Pike, MC, and Pearce, CL. "Abstract 797: A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer." July 15, 2016. Full Text
  - Ehrisman, JA, Abbott, S, Harmon, Z, Secord, AA, Berchuck, A, Lee, PS, Valea, FA, Broadwater, G, Li, X, Havrilesky, LJ, and Hall, A. "Prospective Evaluation of Lymph Node Processing at Staging Surgery for High-Grade Endometrial Cancer." February 2016. Link to Item
  - Huang, Z, Visco, Z, Sfakianos, G, Whitaker, R, Berchuck, A, and Murphy, S. "Abstract POSTER-BIOL-1319: Temporal shifts in the epigenetic regulation of tight junctions from primary to recurrent ovarian cancer." : American Association for Cancer Research (AACR), August 15, 2015. Full Text
  - Mo, L, Kennedy, M, Berchuck, A, Cianciolo, G, Bachelder, RE, and Pizzo, SV. "Abstract POSTER-THER-1420: Ascites drives ovarian cancer stem-like cell growth: therapeutic opportunities." : American Association for Cancer Research (AACR), August 15, 2015. Full Text
  - Huang, Z, Visco, Z, Sfakianos, G, Whitaker, R, Berchuck, A, and Murphy, SK. "Abstract 2236: Emergence of epigenetic regulation of tight junction genes in recurrent serous epithelial ovarian cancer." : American Association for Cancer Research (AACR), August 1, 2015. Full Text
  - Permuth-Wey, J, Reid, BM, Chen, YA, Lin, H-Y, Monteiro, A, Chen, Z, Berchuck, A, Chenevix-Trench, G, Doherty, J, Gayther, S, Goode, E, Iversen, E, Pearce, L, Pharoah, PDP, Phelan, C, Ramus, S, Rossing, MA, Schildkraut, J, and Sellers, T. "Abstract 4635: Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility." : American Association for Cancer Research (AACR), August 1, 2015. Full Text
  - Reid, BM, Permuth-Wey, J, Chen, YA, Lin, H-Y, Monteiro, A, Chen, Z, Berchuck, A, Chenevix-Trench, G, Doherty, J, Gayther, S, Goode, EL, Iversen, E, Pearce, L, Pharoah, P, Phelan, C, Ramus, S, Rossing, MA, Schildkraut, J, and Sellers, T. "Abstract 4634: Variants within super-enhancer regulatory elements associate with epithelial ovarian cancer risk." : American Association for Cancer Research (AACR), August 1, 2015. Full Text
  - Sellers, TA, Reid, BM, Chen, YA, Lin, H-Y, Richards, E, Teer, J, Monteiro, A, Chen, Z, Berchuck, A, Chenevix-Trench, G, Doherty, J, Goode, E, Iverson, E, Pearce, L, Pharoah, P, Phelan, C, Ramus, S, Rossing, MA, Schildkraut, J, Cheng, J, Gayther, S, and Permuth-Wey, J. "Abstract 4633: Evidence that long non-coding RNA variants associate with epithelial ovarian cancer risk." : American Association for Cancer Research (AACR), August 1, 2015. Full Text
  - Winham, SJ, Fridley, BL, Larson, MC, Fogarty, Z, Berchuck, A, Chen, YA, Lin, H-Y, Chenevix-Trench, G, Permuth-Wey, J, Sellers, TA, Pirie, A, and Goode, EL. "Abstract 4636: Investigation of exome variants associated with overall survival in ovarian cancer." : American Association for Cancer Research (AACR), August 1, 2015. Full Text
  - Teoh, D, Lowery, WJ, Jiang, X, Ehrisman, J, Halvorson, P, Broadwater, G, Bentley, R, Secord, AA, Sobolewski, C, Berchuck, A, Havrilesky, LJ, Valea, FA, and Lee, PS. "Vaginal cuff thermal injury by mode of colpotomy at total laparoscopic hysterectomy: a randomized clinical trial." February 2015. Full Text
  - Kelemen, LE, Tyrer, J, Phelan, CM, Ramus, SJ, Berchuck, A, Gayther, SA, Goode, EL, Pearce, CL, Schildkraut, JM, Chenevix-Trench, G, Monteiro, AN, Goodman, MT, Sellers, TA, and Pharoah, PP. "Abstract 3283: GWAS identifies risk variants for mucinous ovarian carcinoma." October 1, 2014. Full Text
  - Permuth-Wey, J, Chen, YA, Chen, Z, Berchuck, A, Chenevix-Trench, G, Doherty, J, Gayther, S, Goode, EL, Iversen, E, Monteiro, AN, Pearce, L, Pharoah, PD, Phelan, CM, Pirie, A, Ramus, S, Rossing, MA, and Schildkraut, JM. "Abstract 946: Exome genotyping array identifies rare and low-frequency variants that may be associated with ovarian cancer risk." October 1, 2014. Full Text
  - Stevens, EV, Whitaker, R, Guinet, A, Chang, C-Y, Grenier, C, Marks, J, McDonnell, DP, Murphy, SK, Berchuck, A, and Gaillard, S. "Abstract 4570: Role of ERRalpha in ovarian cancer." October 1, 2014. Full Text
  - Witkowski, L, Carrot-Zhang, J, Albrecht, S, Hamel, N, Tomiak, E, Grynspan, D, Saloustros, E, Gilpin, C, Silva-Smith, R, Plourde, F, Rivera, B, Castellsagué, E, Wu, M, Fahiminiya, S, Nadaf, J, Saskin, A, Arseneault, M, Karabakhtsian, RG, Reilly, EA, Ueland, FR, Margiolaki, A, Pavlakis, K, Castellino, SM, Lamovec, J, Roth, LM, Ulbright, TM, Bender, T, Longy, M, Berchuck, A, Tischkowitz, M, Siebert, R, Nagel, I, Georgoulias, V, Stewart, CJR, McCluggage, G, Arseneau, J, Clarke, BA, Riazalhosseini, Y, Hasselblatt, M, Majewski, J, and Foulkes, WD. "Abstract LB-89: Germ-line and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type." : American Association for Cancer Research (AACR), October 1, 2014. Full Text
  - Havrilesky, LJ, Secord, AA, Ehrisman, JA, Berchuck, A, Valea, FA, Lee, PS, Gaillard, S, Cella, D, Weinfurt, K, Abernethy, AP, and Reed, SD. "Relative influence of factors determining a woman’s preference for treatment options in ovarian cancer." : American Society of Clinical Oncology (ASCO), May 20, 2014. Full Text
  - Havrilesky, LJ, Secord, AA, Ehrisman, J, Berchuck, A, Valea, FA, Lee, PS, Cella, D, Weinfurt, K, Abernethy, AP, and Reed, SD. "Relative Influence of Factors Determining a Woman’s Preference for Treatment Options in Ovarian Cancer: A Discrete Choice Experiment." : Elsevier BV, May 2014. Full Text
  - Amankwah, EK, Tyrer, J, Lin, H-Y, Tsai, Y-Y, Chen, Z, Han, G, Qu, X, Goode, E, Cunninghan, J, Iverson, E, Ramus, S, Berchuck, A, Schildkraut, J, Monteiro, A, Gayther, S, Narod, S, Pharoah, P, Sellers, TA, and Phelan, C. "Abstract 1352: Epithelial-mesenchymal transition (EMT) gene variants influence epithelial ovarian cancer risk in women of European, African and Asian ancestry." : American Association for Cancer Research (AACR), April 15, 2013. Full Text
  - Jim, H, Tyrer, J, Lin, H-Y, Han, G, Qu, X, Goode, EL, Chen, Z, Tsai, Y-Y, Cunningham, JM, Iversen, E, Ramus, S, Berchuck, A, Schildkraut, J, Monteiro, A, Gayther, S, Narod, SA, Sellers, TA, Pharoah, P, and Phelan, CM. "Abstract 4850: Variation in circadian rhythm genes influence epithelial ovarian cancer risk and invasiveness." : American Association for Cancer Research (AACR), April 15, 2013. Full Text
  - Park, J, Huang, Z, Berchuck, A, and Murphy, S. "Abstract 4767: Preclinical mouse model of recurrent epithelial ovarian cancer." : American Association for Cancer Research (AACR), April 15, 2013. Full Text
  - Siamakpour- Reihani, S, Jiang, C, Turner, T, Owzar, K, Berchuck, A, Dewhirst, M, and Alvarez Secord, A. "Abstract 330A: Differential expression of angiogenic genes in invasive high grade serous ovarian carcinomas." : American Association for Cancer Research (AACR), April 15, 2013. Full Text
  - Barry, W, Chen, W, Sfakianos, G, Isner, P, Datto, M, Kuderer, N, Lyman, G, Abernethy, A, Ginsburg, G, and Berchuck, A. "A genomic-based signature of response to chemotherapy in ovarian cancer fails to predict clinical outcome in two independent cohorts." October 2011. Full Text Link to Item
  - Chino, JP, Havrilesky, L, Berchuck, A, and Jones, E. "Secondary Malignancy after Radiation for Endometrial Cancer: Comparing No Radiation, External Beam, and Brachytherapy." 2010. Full Text Link to Item
  - Baba, T, Convery, PA, Matsumura, N, Whitaker, RS, Perry, T, Huang, Z, Mori, S, Kondoh, E, Bentley, RC, Fujii, S, Marks, JR, Berchuck, A, and Murphy, SK. "Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer." March 2008. Link to Item
  - Lee, PS, Teaberry, V, Bland, AE, Huang, Z, Secord, AA, Berchuck, A, and Murphy, SK. "MAL, a gene associated with survival in epithelial ovarian cancer, is epigenetically regulated." March 2008. Link to Item
  - Rubatt, JM, Darcy, KM, Hutson, A, Bean, SM, Havrilesky, LJ, Lee, PS, Grace, LA, Berchuck, A, and Secord, AA. "Prognostic relevance of microvessel density in previously untreated, advanced-stage epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study." March 2008. Link to Item
  - Baba, T, Convey, P, Matsumura, N, Whitaker, RS, Perry, T, Huang, Z, Mori, S, Kondoh, E, Bentley, RC, Fujii, S, Berchuck, A, Murphy, SK, and Marks, JR. "Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer." 2008. Link to Item
  - Berchuck, A, Lancaster, JM, Iversen, ES, Luo, J, Levine, DA, Boyd, J, Secord, AA, Marks, JR, Nevins, JR, and Dressman, H. "Most early-stage serous ovarian cancers have gene expression profiles predictive of long-term survival." March 2007. Link to Item
  - Ramiah, VS, Potti, A, Peterson, R, Harpole, D, Berchuck, A, and Ortel, TL. "Gene expression patterns identify patients with non-small cell lung cancer (NSCLC) and ovarian cancer who are at increased risk for venous thromboembolism (VTE)." November 16, 2006. Link to Item
  - Secord, AA, Havrilesky, LJ, Higgins, RV, Nycum, LR, Kohler, MF, Puls, LE, Holloway, R, Soper, JT, Valea, FA, and Berchuck, A. "A comparison of combination docetaxel/carboplatin versus sequential docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer." June 20, 2006. Link to Item
  - WriQht, JD, Alvarezsecord, A, Numnum, TM, Rocconi, RP, Powell, MA, Berchuck, A, Alvarez, RD, Trinkaus, K, Rader, JS, and Mutch, DG. "A multi-institutional evaluation of the safety and efficacy of bevacizumab for recurrent, platinum-resistant ovarian cancer." June 20, 2006. Link to Item
  - Bild, AH, Yao, G, Chang, JT, Wang, QL, Potti, A, Harpole, D, Lancaster, J, Berchuck, A, Olson, JA, Marks, J, Dressman, HK, West, M, and Nevins, JR. "Oncogenic pathway signatures in human cancers as a guide to targeted therapies." November 2005. Link to Item
  - Cragaun, JM, Elahi, A, Boulware, D, Beam, C, Sayer, R, Maxwell, GL, Sutphen, R, Berchuck, A, and Lancaster, JM. "Characterization of the insulin-like growth factor pathway in endometrial cancers." June 1, 2005. Link to Item
  - Lancaster, JM, Bild, A, Pittman, J, Sayer, R, Whitaker, RS, Marks, J, Mike, W, Dressman, H, Nevins, J, and Berchuck, A. "Gene expression profiles that predict response to platinum and identify patterns of pathway deregulation in advanced ovarian cancer." June 1, 2005. Link to Item
  - Martino, MA, Elahi, A, Sutphen, R, Klippel, C, Boren, T, Dressman, HK, Berchuck, A, and Lancaster, JM. "Expression analysis of genes involved in ovarian cancer metastasis." June 1, 2005. Link to Item
  - Schildkraut, JM, Berchuck, A, Murphy, S, Marks, J, Moorman, P, Calingaert, B, and Halabi, S. "Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer." November 2004. Link to Item
  - Berchuck, A, Secord, AA, Havrilesky, LJ, Wenham, R, Soper, JT, and Clarke-Pearson, DL. "Phase I/II trial of combination topotecan and vinorelbine in patients with refractory gynecologic cancer." July 15, 2004. Link to Item
  - Jones, EL, Prosnitz, LR, Samulski, TV, Soper, J, Berchuck, A, Clarke-Pearson, D, Dewhirst, MN, and Vujaskovic, Z. "Intraperitoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma." July 15, 2004. Link to Item
  - Secord, AA, Jones, E, Hahn, CA, Havrilesky, LJ, Soper, JT, Berchuck, A, Clarke-Pearson, DL, and Prosnitz, LR. "Phase I/II trial of intravenous liposomal doxorubicin and whole abdomen hyperthermia in patients with refractory ovarian cancer." July 15, 2004. Link to Item
  - Berchuck, A, Iversen, E, Lancaster, JM, Henriott, A, Dressman, H, West, M, Nevins, JR, and Marks, JR. "Prediction of long-term versus short-term survival in advanced stage serous ovarian cancer using expression microarrays." February 2004. Link to Item
  - Berchuck, A, Henriott, A, Wenham, RM, Calingaert, B, Ali, S, Rodriguez, GC, Marks, JR, and Schildkraut, JM. "Progesterone receptor promoter+331/G/A polymorphism is associated with deceased risk of epithelial ovarian cancer." November 2003. Link to Item
  - Berchuck, A, Brewer, M, Rodriguez, G, and Campbell, I. "Discussion: Ovarian Cancer Prevention." : Elsevier BV, January 2003. Full Text
  - Gray, JW, Suzuki, S, Kuo, WL, Polikoff, D, Deavers, M, Smith-McCune, K, Berchuck, A, Pinkel, D, Albertson, D, and Mills, GB. "Specific keynote: Genome copy number abnormalities in ovarian cancer." January 2003. Full Text Link to Item
  - Rodriguez, GC, Barnes, J, Anderson, K, Petitte, J, Windham, J, Lancaster, J, Wenham, R, Berchuck, A, Kopelovich, L, and Carver, D. "Evaluation of ovarian cancer preventive agents in the chicken." October 2002. Link to Item
  - Schildkraut, JM, Wenham, R, Lancaster, J, Calingaert, B, McLean, K, Halabi, S, Marks, J, and Berchuck, A. "A case-control study of candidate ovarian cancer susceptibility polymorphisms." October 2002. Link to Item
  - Berchuck, A, Schildkraut, JM, Marks, JR, and Futreal, PA. "Managing hereditary ovarian cancer risk." : Wiley, December 1, 1999. Full Text
  - Berchuck, A, Schildkraut, JM, Marks, JR, and Futreal, PA. "Managing hereditary ovarian cancer risk." : Wiley, October 15, 1999. Full Text
  - Berchuck, A, and Cirisano, F. "Pathogenesis of ovarian cancer: Role of ovulation and molecular changes." 1996. Link to Item
  - Berchuck, A, and Boyd, J. "Molecular basis of endometrial cancer." : Wiley, November 15, 1995. Full Text
  - Bast, RC, Boyer, CM, Jacobs, I, Xu, FJ, Wu, S, Wiener, J, Kohler, M, and Berchuck, A. "Cell growth regulation in epithelial ovarian cancer." : Wiley, February 15, 1993. Full Text
  - BERCHUCK, A, KOHLER, MF, BOENTE, MP, RODRIGUEZ, GC, WHITAKER, RS, and BAST, RC. "GROWTH-REGULATION AND TRANSFORMATION OF OVARIAN EPITHELIUM." January 15, 1993. Link to Item
  - BAST, RC, BOYER, CM, BERCHUCK, A, XU, FJ, WU, S, LIDOR, Y, MAIER, LA, CREWS, JR, ROSSE, M, VREDENBURGH, JJ, SHPALL, EJ, and PETERS, WP. "NEW STRATEGIES FOR THE MANAGEMENT OF OVARIAN AND BREAST-CANCER BASED ON BIOLOGY AND PHARMACOLOGY." 1992. Link to Item
Teaching & Mentoring
Recent Courses
- OBGYN 405C: Gynecologic Cancer Sub-Internship 2019
- OBGYN 420C: Gynecologic Cancer 2018

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

In the News

Subject Headings

Selected Grants

Selected Publications

Books

Academic Articles

Book Sections

Other Articles

Conference Papers

Recent Courses